def14a
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o |
|
Preliminary Proxy Statement |
|
o |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
þ |
|
Definitive Proxy Statement |
|
o |
|
Definitive Additional Materials |
|
o |
|
Soliciting Material Pursuant to §240.14a-12 |
EXPRESS-1 EXPEDITED SOLUTIONS, INC.
(Name of Registrant as Specified In Its Charter)
N/A
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ |
|
No fee required. |
|
o |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
(1) |
|
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
|
(2) |
|
Aggregate number of securities to which transaction applies: |
|
|
|
|
|
|
|
(3) |
|
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined): |
|
|
|
|
|
|
|
(4) |
|
Proposed maximum aggregate value of transaction: |
|
|
|
|
|
|
|
(5) |
|
Total fee paid: |
|
|
|
|
|
o |
|
Fee paid previously with preliminary materials. |
|
o |
|
Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing
by registration statement number, or the Form or Schedule and the
date of its filing. |
|
(1) |
|
Amount Previously Paid: |
|
|
|
|
|
|
|
(2) |
|
Form, Schedule or Registration Statement No.: |
|
|
|
|
|
|
|
(3) |
|
Filing Party: |
|
|
|
|
|
|
|
(4) |
|
Date Filed: |
|
|
|
|
|
EXPRESS-1
EXPEDITED SOLUTIONS, INC.
3399 South Lakeshore Drive, Suite 225
Saint Joseph, Michigan 49085
August 3, 2011
Dear Fellow Stockholders:
On behalf of the Board of Directors of Express-1 Expedited
Solutions, Inc., a Delaware Corporation (the
Company, we,
us or our), we invite you
to join us at a special meeting of stockholders of the Company,
which will be held in the Express-1, Inc. Training Center
located at 441 Post Road, Buchanan, MI 49107, at 9:00 a.m.,
Eastern Daylight Time, on September 1, 2011.
On June 13, 2011, the Company entered into an Investment
Agreement (the Investment Agreement) with
Jacobs Private Equity, LLC (JPE) and the
other investors party thereto (including by joinders thereto)
(collectively with JPE, the Investors),
providing for an aggregate investment by the Investors of up to
$150,000,000 in cash in the Company, including amounts payable
upon exercise of the warrants described herein. Up to an
aggregate of $135,000,000 of such investment will be made by
JPE. The Investment Agreement has been approved by the
Companys Board of Directors, acting upon the unanimous
recommendation of a special committee composed of independent
directors. Following the closing of the transactions
contemplated by the Investment Agreement, JPE will be the
controlling stockholder of the Company, and Bradley Jacobs, the
Managing Member of JPE, will become Chairman of the Board of
Directors of the Company. Mr. Jacobs will also become the
Companys Chief Executive Officer following the closing.
The Company expects to use the proceeds primarily to make
strategic acquisitions and any balance will be used for general
corporate purposes.
As controlling stockholder, JPE intends to cause the Company to
leverage its prominent positions in expedited transportation
solutions, freight brokerage and freight forwarding to make the
Company a platform for growth through strategic acquisitions and
organic expansion, with a view to building a multi-billion
dollar market leader.
Subject to the terms and conditions of the Investment Agreement,
upon the closing, the Company will issue to the Investors, for
$75,000,000 in cash, (i) shares of Series A
Convertible Perpetual Preferred Stock of the Company (the
Preferred Stock), which will initially be
convertible into an aggregate of 42,857,143 shares of
Company common stock (subject to adjustment in connection with
the contemplated reverse stock split described below) and will
vote together with the Company common stock on an
as-converted basis on all matters on which the
Company common stock may vote, except as otherwise required by
law, and (ii) warrants to purchase 42,857,143 shares
of Company common stock at an initial exercise price of $1.75
per share (subject to adjustment in connection with the
contemplated reverse stock split described below) (the
Warrants, and together with the Preferred
Stock, the Securities). We refer to this
investment as the Equity Investment, and to
the Equity Investment collectively with the other transactions
contemplated by the Investment Agreement as the
Proposed Transaction.
In connection with the closing of the Equity Investment, the
common stock of the Company will undergo a 4:1 reverse stock
split.
Upon the closing of the Equity Investment, the Board of
Directors will be reconstituted such that: (i) there will
be eight Board members, (ii) one of such directors will be
James Martell, our current Chairman, (iii) seven of such
directors will be designated by JPE (including Bradley Jacobs),
(iv) each standing committee of the Board will be
reconstituted in a manner reasonably acceptable to JPE and
(v) Bradley Jacobs will become the Chairman of the Board.
After giving effect to the reconstitution of the Board, a
majority of the members of the Board will continue to be
independent.
You will be asked, at the special meeting of the Companys
stockholders, to vote to approve, as a condition to the Equity
Investment, each of the following:
|
|
|
|
1.
|
The issuance of the Securities, which will constitute an
issuance of securities convertible into or exercisable for a
number of shares of Company common stock in excess of 20% of our
presently outstanding common stock, and thus requires the
approval of stockholders in accordance with NYSE Amex Rule 713;
|
|
|
2.
|
An amendment to the certificate of incorporation of the Company
(as amended, the Company Certificate) to
increase the number of authorized shares of Company common stock
to 150,000,000 shares;
|
|
|
3.
|
An amendment to the Company Certificate to give effect to a
4-for-1
reverse stock split of the Company common stock;
|
|
|
4.
|
An amendment to the Company Certificate providing that any
vacancy on our Board of Directors shall be filled by the
remaining directors or director (consistent with our existing
by-laws); and
|
|
|
5.
|
The 2011 Omnibus Incentive Compensation Plan, to be implemented
following the closing.
|
The failure of the Companys stockholders to approve any of
the foregoing Proposals 1 through 5 will prevent the
Company from consummating the Proposed Transaction.
In addition, you will be asked, at the special meeting of the
Companys stockholders, to vote to approve an amendment to
the Company Certificate to change the name of the Company to XPO
Logistics, Inc. The implementation of this Proposal 6 is
conditioned on approval of each of Proposals 1 through 5.
The Board of Directors believes that the Proposed Transaction
and Proposal 6 are in the best interests of the Company and
its stockholders and, therefore, recommends that the
Companys stockholders vote FOR
Proposals 1 through 6 at the special meeting.
The proxy statement attached to this letter provides you with
information about the Proposed Transaction and the special
meeting of the Companys stockholders. We encourage you to
read the entire proxy statement carefully. You may also obtain
more information about the Company from documents we have filed
with the Securities and Exchange Commission. See Where
You Can Find Additional Information in the
accompanying proxy statement.
Regardless of the number of shares of Company common stock
you own, your vote is important. Because certain of the
Proposals require the approval of a majority of the outstanding
shares of Company common stock, the failure to vote on any such
Proposal will have the same effect as a vote against such
Proposal. Whether or not you plan to attend the special meeting,
please take the time to submit a proxy by following the
instructions on your proxy card as soon as possible. If your
shares of Company common stock are held in an account at a
broker, dealer, commercial bank, trust company or other nominee,
you should instruct such broker or other nominee how to vote in
accordance with the voting instruction form furnished by such
broker or other nominee.
Voting by proxy will not prevent you from voting your shares in
person if you subsequently choose to attend the special meeting.
Thank you for your cooperation and continued support.
Sincerely,
Michael R. Welch
Director and Chief Executive Officer
THE
ACCOMPANYING PROXY STATEMENT IS DATED AUGUST 3, 2011
AND IS FIRST BEING MAILED TO STOCKHOLDERS ON OR ABOUT
AUGUST 4, 2011.
EXPRESS-1
EXPEDITED SOLUTIONS, INC.
3399 South Lakeshore Drive, Suite 225
Saint Joseph, Michigan 49085
NOTICE OF SPECIAL MEETING OF
STOCKHOLDERS
TO BE HELD ON SEPTEMBER 1, 2011
NOTICE IS HEREBY GIVEN that a special meeting of stockholders of
Express-1 Expedited Solutions, Inc., a Delaware corporation (the
Company, we,
us or our), will be
held in the Express-1, Inc. Training Center, located at 441 Post
Road, Buchanan, MI 49107, at 9:00 a.m., Eastern Daylight
Time, on September 1, 2011, for the following purposes:
|
|
|
|
1.
|
To approve the issuance to Jacobs Private Equity, LLC
(JPE) and the other investors party to the
Investment Agreement, dated as of June 13, 2011 (the
Investment Agreement), for $75,000,000 in
cash, of (i) 75,000 shares of Series A
Convertible Perpetual Preferred Stock of the Company (the
Preferred Stock), which are initially
convertible into an aggregate of 42,857,143 shares of
Company common stock at a conversion price of $1.75 per share
(subject to adjustment in connection with the Reverse Stock
Split (as defined below)), and (ii) warrants to purchase
42,857,143 shares of Company common stock at an exercise
price of $1.75 per share (subject to adjustment in connection
with the Reverse Stock Split) (the Warrants,
and together with the Preferred Stock, the
Securities);
|
|
|
2.
|
To approve an amendment to the certificate of incorporation of
the Company (as amended, the Company
Certificate) to increase the number of authorized
shares of Company common stock to 150,000,000 shares;
|
|
|
3.
|
To approve an amendment to the Company Certificate to give
effect to a
4-for-1
reverse stock split of the Company common stock (the
Reverse Stock Split);
|
|
|
4.
|
To approve an amendment to the Company Certificate providing
that any vacancy on our Board of Directors shall be filled by
the remaining directors or director;
|
|
|
5.
|
To adopt the 2011 Omnibus Incentive Compensation Plan (the
Plan);
|
|
|
|
|
6.
|
To approve an amendment to the Company Certificate to change the
name of the Company to XPO Logistics, Inc.;
|
|
|
|
|
7.
|
To approve the adjournment of the special meeting, if necessary
or appropriate, to solicit additional proxies if there are
insufficient votes at the time of the special meeting to adopt
Proposals 1 through 5; and
|
|
|
|
|
8.
|
To transact such other business as may properly come before the
special meeting or any adjournment or postponement thereof.
|
Only stockholders of record as of the close of business on
August 1, 2011, are entitled to notice of and to vote at
the special meeting and at any adjournment or postponement of
the special meeting. All stockholders of record are cordially
invited to attend the special meeting in person.
The issuance of the Securities (Proposal 1) and the
adoption of the Plan (Proposal 5) require the
affirmative vote of a majority of the shares of Company common
stock voting thereon at a meeting at which a quorum is present.
The amendment to increase the number of authorized shares of
Company common stock (Proposal 2), the amendment to give
effect to the Reverse Stock Split (Proposal 3), the
amendment to provide that vacancies on the Board of Directors
shall be filled by the remaining directors or director
(Proposal 4) and
the amendment to effect the Company name change
(Proposal 6) require the affirmative vote of a
majority of the shares of Company common stock outstanding at
the close of business on the record date. The approval of the
adjournment of the special meeting
(Proposal 7) requires the affirmative vote of a
majority of the shares of Company common stock present and
entitled to vote at the special meeting, whether or not a quorum
is present.
The failure of the Companys stockholders to approve any
of Proposals 1 through 5 will prevent the Company from
consummating the transactions contemplated by the Investment
Agreement and effecting the Company name change
(Proposal 6).
Even if you plan to attend the special meeting in person, we
request that you submit a proxy by following the instructions on
your proxy card as soon as possible and thus ensure that your
shares will be represented at the special meeting if you are
unable to attend. Because Proposals 2, 3, 4 and 6 require
the affirmative vote of a majority of the shares of Company
common stock outstanding at the close of business on the record
date, the failure to vote on any such Proposal will have the
same effect as a vote against such Proposal. If you sign, date
and return your proxy card without indicating how you wish to
vote, your vote will be counted as a vote FOR
Proposals 1 through 6 (and, if necessary and appropriate,
Proposal 7). If your shares of Company common stock are
held in an account at a broker, dealer, commercial bank, trust
company or other nominee, you should instruct such broker or
other nominee how to vote in accordance with the voting
instruction form furnished by such broker or other nominee.
Whether you attend the special meeting or not, you may revoke a
proxy at any time before your proxy is voted at the special
meeting. You may do so by properly delivering a later-dated
proxy either by mail, the internet or telephone or by attending
the special meeting in person and voting. You also may revoke
your proxy by delivering a notice of revocation to the Company
(Attention: Chief Executive Officer, 3399 South Lakeshore Drive,
Suite 225, Saint Joseph, Michigan 49085) prior to the
vote at the special meeting. If you hold your shares through a
broker, dealer, commercial bank, trust company or other nominee,
you should follow the instructions of such broker or other
nominee regarding revocation of proxies.
By order of the Board of Directors,
Michael R. Welch
Director and Chief Executive Officer
Saint Joseph, Michigan
August 3, 2011
Important Notice Regarding the Availability of Proxy
Materials for the Stockholders Meeting To Be Held on
September 1, 2011
This proxy statement for the special meeting to be held on
September 1, 2011, is available free of charge at
www.envisionreports.com/XPO2.
ii
SUMMARY
VOTING INSTRUCTIONS
Ensure that your shares of Company common stock can be voted
at the special meeting by submitting your proxy or contacting
your broker, dealer, commercial bank, trust company or other
nominee.
If your shares of Company common stock are registered in
the name of a broker, dealer, commercial bank, trust company or
other nominee: check the voting instruction card
forwarded by your broker or other nominee to see which voting
options are available or contact such broker or other nominee in
order to obtain directions as to how to ensure that your shares
of Company common stock are voted at the special meeting.
If your shares of Company common stock are registered in
your name: submit your proxy as soon as possible by
telephone, via the internet or by signing, dating and returning
the enclosed proxy card in the enclosed postage-paid envelope,
so that your shares of Company common stock can be voted at the
special meeting.
Instructions regarding telephone and internet voting are
included on the proxy card.
Because Proposals 2, 3, 4 and 6 require the affirmative
vote of a majority of the shares of Company common stock
outstanding at the close of business on the record date, the
failure to vote on any such Proposal will have the same effect
as a vote against such Proposal. The failure of the
Companys stockholders to approve any of Proposals 1
through 5 will prevent the Company from consummating the
transactions contemplated by the Investment Agreement and
effecting the Company name change (Proposal 6). If you
sign, date and return your proxy card without indicating how you
wish to vote, your vote will be counted as a vote
FOR Proposals 1 through 6 (and, if necessary
and appropriate, Proposal 7).
For additional questions about the Proposed Transaction,
assistance in submitting proxies or voting shares of Company
common stock, or to request additional copies of the proxy
statement or the enclosed proxy card, please contact the Company
at
(269) 429-9761.
iii
|
|
|
|
|
Investment Agreement, dated as of June 13,
2011, by and among Jacobs Private Equity, LLC, each of the other
investors party thereto and Express-1 Expedited Solutions,
Inc.
|
|
|
Fairness Opinion of Ladenburg
Thalmann & Co. Inc.
|
|
|
Voting Agreement, dated as of June 13, 2011,
between Jacobs Private Equity, LLC and Michael R. Welch
|
|
|
Voting Agreement, dated as of June 13, 2011,
between Jacobs Private Equity, LLC and Daniel Para
|
v
QUESTIONS
AND ANSWERS ABOUT THE SPECIAL MEETING AND THE
PROPOSALS
The following questions and answers address briefly some
questions you may have regarding the special meeting and the
Proposals. These questions and answers may not address all
questions that may be important to you as a stockholder of the
Company. Please refer to the more detailed information contained
elsewhere in this proxy statement, the annexes to this proxy
statement and the documents referred to or incorporated by
reference in this proxy statement.
|
|
|
Q: |
|
Why did I receive these proxy materials? |
|
A: |
|
We are providing these proxy materials in connection with the
solicitation by our Board of Directors of proxies to be voted at
the special meeting in connection with the transactions
contemplated by the Investment Agreement (such transactions,
collectively, the Proposed Transaction), as
further described in this proxy statement. |
|
Q: |
|
What items of business will be voted on at the special
meeting? |
|
|
|
A: |
|
The business expected to be voted on at the special meeting is a
series of Proposals related to the Proposed Transaction,
described in detail in this proxy statement. |
|
|
|
Q: |
|
What is the Proposed Transaction? |
|
A: |
|
The Investment Agreement with JPE and the other investors party
thereto (including by joinders thereto) (collectively with JPE,
the Investors) provides for an aggregate
investment by the Investors of up to $150,000,000 in cash in the
Company (including amounts payable upon exercise of the
Warrants). Pursuant to the Investment Agreement, at the closing,
the Investors will invest an aggregate of $75,000,000 in cash
into the Company in return for the Companys issuance of: |
|
|
|
|
|
75,000 shares of Preferred Stock, which
shares will initially be convertible into 42,857,143 shares
of Company common stock at an initial conversion price of $1.75
per share of Company common stock (before giving effect to the
contemplated Reverse Stock Split, and subject to customary
anti-dilution adjustments); the Preferred Stock carries an
annual cash dividend of 4% and will generally vote together with
the Company common stock on an as-converted basis on
all matters; and
|
|
|
|
|
|
Warrants to purchase 42,857,143 shares of
Company common stock at an initial exercise price of $1.75 per
share (before giving effect to the Reverse Stock Split, and
subject to customary anti-dilution adjustments); the Warrants
will be exercisable for 10 years.
|
|
|
|
|
|
We refer to the foregoing transactions as the Equity
Investment. |
|
|
|
In addition, in connection with the Equity Investment, among
other things: |
|
|
|
The number of authorized shares of Company
common stock will be increased to 150,000,000;
|
|
|
|
|
|
The Company common stock will undergo the
Reverse Stock Split;
|
|
|
|
|
|
The Company Certificate will be amended to
provide that any vacancy on our Board of Directors shall be
filled by the remaining directors or director (consistent with
our by-laws as currently in effect);
|
|
|
|
The Company will implement a new Omnibus
Incentive Compensation Plan; and
|
|
|
|
The Board of Directors will be reconstituted
such that: (i) there will be eight directors, (ii) one
of such directors will be James Martell, our current Chairman
(or a replacement acceptable to JPE), (iii) seven of such
directors will be designated by JPE (including Bradley Jacobs,
the Managing Member of JPE), (iv) each standing committee
of the Board will be reconstituted in a manner reasonably
acceptable to JPE and (v) Bradley Jacobs will become the
Chairman of the Board; and JPE will have certain ongoing Board
nomination rights tied to its equity interest in the Company.
|
1
|
|
|
|
|
Following the closing Mr. Jacobs will become the
Companys Chief Executive Officer. |
|
|
|
Q: |
|
What was the market price of our common stock upon the
signing of the Investment Agreement and upon the mailing of this
proxy statement? |
|
|
|
A: |
|
On June 13, 2011, which was the last trading day before we
entered into the Investment Agreement, the closing price of the
Company common stock was $2.19 per share. On August 3,
2011, which was the last trading day before this proxy statement
was mailed, the closing price of the Company common stock was
$3.36 per share. |
|
|
|
Q: |
|
What will I receive in the Proposed Transaction? |
|
A: |
|
You will not receive any consideration in the Proposed
Transaction. Your shares of Company common stock will remain
outstanding following the closing of the Proposed Transaction,
and you will continue to participate as a stockholder by virtue
of such shares. |
|
Q: |
|
What percentage of the Companys voting stock will the
Investors own upon completion of the Proposed Transaction? |
|
|
|
A: |
|
As of the record date, there were 33,011,561 shares of
Company common stock outstanding, plus outstanding options to
purchase an additional 3,267,750 shares of Company common
stock. Based upon the number of shares of Company common stock
outstanding on the record date, and excluding any shares
issuable upon the exercise of currently outstanding options, the
Investors would have held in the aggregate approximately 56.5%
of the total voting power of the Companys capital stock
before giving effect to the exercise of any Warrants, and
approximately 72.2% of the total voting power of the
Companys capital stock after giving effect to the exercise
of all of the Warrants. Because the Preferred Stock votes on an
as converted basis, the conversion of the Preferred
Stock into Company common stock will not reduce the general
voting power of the Investors allocable to the Preferred Stock
upon its issuance. The Reverse Stock Split will not affect the
relative percentage of the voting power held by any stockholder
or any of the Investors (except as a result of any cash paid in
lieu of fractional shares in connection with the Reverse Stock
Split). |
|
|
|
Q: |
|
Where and when is the special meeting? |
|
|
|
A: |
|
The special meeting will be held in the Express-1, Inc. Training
Center located at 441 Post Road, Buchanan, MI 49107, at
9:00 a.m., Eastern Daylight Time, on September 1,
2011. To obtain directions to be able to attend the special
meeting and vote in person please contact Becky Scamehorn,
Accounting Manager, at (269) 695-4953. |
|
|
|
Q: |
|
What vote is required to approve the Proposals? |
|
|
|
A: |
|
The issuance of the Securities (Proposal 1) and the
adoption of the Plan (Proposal 5) require the
affirmative vote of a majority of the shares of Company common
stock voting thereon at a meeting at which a quorum is present.
The amendment to increase the number of authorized shares of
Company common stock (Proposal 2), the amendment to give
effect to the Reverse Stock Split (Proposal 3), the
amendment to provide that vacancies on the Board of Directors
shall be filled by the remaining directors or director
(Proposal 4) and the amendment to effect the Company
name change (Proposal 6) require the affirmative vote of a
majority of the shares of Company common stock outstanding at
the close of business on the record date. The approval of the
adjournment of the special meeting
(Proposal 7) requires the affirmative vote of a
majority of the shares of Company common stock present and
entitled to vote at the special meeting, whether or not a quorum
is present. If the Companys stockholders fail to approve
any of Proposals 1 through 5, the Proposed Transaction will
not occur. |
|
|
|
Q: |
|
What are my voting choices? |
|
A: |
|
You may vote FOR or AGAINST or you may
ABSTAIN from voting on any Proposal to be voted on
at the special meeting. Your shares will be voted as you
specifically instruct. If you sign your proxy or voting
instruction card without giving specific instructions, your
shares will be voted in |
2
|
|
|
|
|
accordance with the recommendations of our Board of Directors
and in the discretion of the proxy holders on any other matters
that properly come before the meeting. Because Proposals 2,
3, 4 and 6 require the affirmative vote of a majority of the
shares of Company common stock outstanding at the close of
business on the record date, an abstention on any such Proposal
will have the same effect as a vote against such Proposal. The
failure of the Companys stockholders to approve any of
Proposals 1 through 5 will prevent the Company from
consummating the Proposed Transaction and effecting the Company
name change. |
|
|
|
Q: |
|
How does the Companys Board of Directors recommend that
I vote? |
|
|
|
A: |
|
Our Board of Directors, after careful consideration and acting
on the unanimous recommendation of a special committee composed
entirely of independent directors, recommends that our
stockholders vote FOR the approval of each of
Proposals 1 through 6 and FOR
Proposal 7 to approve the adjournment of the special
meeting, if necessary or appropriate, to solicit additional
proxies if there are insufficient votes at the time of the
special meeting to approve each of Proposals 1 through 5. |
|
|
|
|
|
James Martell, our current Chairman, is an Investor in the
Equity Investment and is expected to continue as a member of the
Board of Directors following the closing of the Equity
Investment, and consequently he recused himself from the
Boards approval of the Proposed Transaction and
recommendation of the Proposals. |
|
|
|
|
|
You should read The Proposed
TransactionBackground of the Proposed
Transaction and The Proposed
TransactionReasons for the Proposed Transaction
for a discussion of the factors that our special committee and
Board of Directors considered in deciding to recommend the
approval of the Proposals. In addition, in considering the
recommendation of the special committee and the Board of
Directors in connection with the Proposed Transaction, you
should be aware that some of the Companys directors and
executive officers may have interests that are different from,
or in addition to, the interests of our stockholders generally.
See The Proposed TransactionInterests of the
Companys Directors and Executive Officers in the Proposed
Transaction, beginning on page 35. |
|
|
|
Q: |
|
Who can attend and vote at the special meeting? |
|
|
|
A: |
|
All stockholders of record as of the close of business on
August 1, 2011, the record date for the special meeting,
are entitled to receive notice of and to attend and vote at the
special meeting, or any postponement or adjournment thereof. If
you wish to attend the special meeting and your shares of
Company common stock are held in an account at a broker, dealer,
commercial bank, trust company or other nominee (i.e., in
street name), you will need to bring a copy of your
voting instruction card or statement reflecting your share
ownership as of the record date. Street name holders
who wish to vote at the special meeting will need to obtain a
proxy from the broker, dealer, commercial bank, trust company or
other nominee that holds their shares of Company common stock.
Seating will be limited at the special meeting. Admission to the
special meeting will be on a first-come, first-served basis. |
|
|
|
Q: |
|
How will our directors and executive officers vote on the
Proposals? |
|
|
|
A: |
|
Our directors and current executive officers have informed us
that, as of the date of this proxy statement, they intend to
vote all of their shares of Company common stock in favor of the
approval of each of the Proposals. In particular, each of
Michael Welch, Chief Executive Officer and a director of the
Company, and Daniel Para, an officer and director of the
Company, entered into voting agreements with JPE, pursuant to
which they have agreed, in their capacities as stockholders of
the Company and subject to the terms of such agreements, to,
among other things, vote their shares of Company common stock in
favor of the Proposals, and have granted JPE a proxy in respect
of their shares of Company common stock in connection therewith.
As of August 1, 2011, the record date for the special
meeting, and excluding any shares issuable upon the exercise of
currently outstanding options, our directors and current
executive officers owned, in the aggregate,
4,289,917 shares of Company common stock, or collectively
approximately 13.0% of the outstanding shares of Company common
stock. |
3
|
|
|
Q: |
|
What do I need to do now? |
|
A: |
|
We urge you to read this proxy statement carefully, including
its annexes, and to consider how the Proposed Transaction
affects you. Then just mail your completed, dated and signed
proxy card in the enclosed return envelope as soon as possible
so that your shares can be voted at the special meeting of our
stockholders. Holders of record may also vote by telephone or
the internet by following the instructions on the proxy card. |
|
Q: |
|
What happens if I do not respond or if I respond and fail to
indicate my voting preference or if I abstain from voting? |
|
|
|
A: |
|
If you fail to sign, date and return your proxy card or fail to
vote by telephone or internet as provided on your proxy card,
your shares of Company common stock will not be counted towards
establishing a quorum for the special meeting, which requires
holders representing a majority of the outstanding shares of
Company common stock to be present in person or by proxy. If you
respond and do not indicate your voting preference, we will
count your proxy as a vote in favor of the approval of each of
the Proposals. Because Proposals 2, 3, 4 and 6 require the
affirmative vote of a majority of the shares of Company common
stock outstanding at the close of business on the record date,
the failure to vote on any such Proposal will have the same
effect as a vote against such Proposal. The failure of the
Companys stockholders to approve any of Proposals 1
through 5 will prevent the Company from consummating the
Proposed Transaction and effecting the Company name change. |
|
|
|
Q: |
|
If my shares are held in street name by my
broker, dealer, commercial bank, trust company or other nominee,
will such broker or other nominee vote my shares for me? |
|
|
|
A: |
|
You should instruct your broker or other nominee on how to vote
your shares using the instructions provided by such broker or
other nominee. Absent specific voting instructions, brokers or
other nominees who hold shares of Company common stock in
street name for customers are prevented by NYSE Amex
rules from exercising voting discretion in respect of
non-routine or contested matters. The Company expects that NYSE
Amex will evaluate the Proposals to be voted on at the special
meeting to determine whether each Proposal is a routine or
non-routine matter. Shares not voted by a broker or other
nominee because such broker or other nominee does not have
instructions or cannot exercise discretionary voting power with
respect to one or more Proposals are referred to as broker
non-votes. Such broker non-votes may not be counted for
the purpose of determining the presence of a quorum at the
special meeting in the absence of a routine Proposal. In
addition, because Proposals 2, 3, 4 and 6 require the
affirmative vote of a majority of the shares of Company common
stock outstanding at the close of business on the record date, a
broker non-vote with respect to any of Proposals 2, 3, 4 or
6 will have the same effect as a vote against such Proposal.
Therefore, it is important that you instruct your broker or
other nominee on how to vote your shares of Company common stock
held in street name in accordance with the voting
instructions provided by such broker or other nominee, because
the failure of the Companys stockholders to approve any of
Proposals 1 through 5 will prevent the Company from
consummating the Proposed Transaction. |
|
|
|
Q: |
|
How do I vote my shares held in the Companys Employee
Stock Ownership Plan? |
|
|
|
A: |
|
The trustee of the plan will vote your plan shares as you direct
on your proxy card. If you do not vote your plan shares or if
you sign and return a proxy card but fail to indicate how you
wish to vote, the trustee will vote your plan shares in
accordance with the direction of the plans named
fiduciary, unless it is contrary to applicable law to do so. You
must complete, sign and return your proxy card, or vote by phone
or through the internet, no later than 1:00 a.m., Eastern
Daylight Time, on September 1, 2011, for the shares
represented by the proxy to be voted in the manner directed
therein. |
|
|
|
Q: |
|
Can I change my vote after I have mailed my proxy card? |
|
A: |
|
Yes. Whether you attend the special meeting or not, you may
revoke a proxy at any time before your proxy is voted at the
special meeting. You may do so by properly delivering a
later-dated proxy either by mail, the internet or telephone or
by attending the special meeting in person and voting. You also |
4
|
|
|
|
|
may revoke your proxy by delivering a notice of revocation to
the Company (Attention: Chief Executive Officer, 3399 South
Lakeshore Drive, Suite 225, Saint Joseph, Michigan
49085) prior to the vote at the special meeting. If you
hold your shares through a broker, dealer, commercial bank,
trust company or other nominee, you should follow the
instructions of such broker or other nominee regarding
revocation of proxies. |
|
Q: |
|
Am I entitled to appraisal rights? |
|
A: |
|
No. You will have no right under Delaware law to seek
appraisal of your shares of Company common stock in connection
with the Proposed Transaction. |
|
Q: |
|
What is householding and how does it affect
me? |
|
A: |
|
We have adopted a procedure approved by the Securities and
Exchange Commission (SEC) called
householding. Under this procedure, stockholders of
record who have the same address and last name will receive only
one copy of our Notice of Special Meeting and proxy statement,
unless one or more of these stockholders notifies us that they
wish to continue receiving individual copies. This procedure
will reduce our printing costs and postage fees. Stockholders
who participate in householding will continue to receive
separate proxy cards. |
|
|
|
If you are eligible for householding, but you and other
stockholders of record with whom you share an address currently
receive multiple copies of our Notice of Special Meeting and
proxy statement, or if you hold stock in more than one account,
and in either case you wish to receive only a single copy of
each of these documents for your household, you may contact our
transfer agent, Computershare at: |
|
|
|
Computershare |
|
|
7530 Lucerne Drive, Suite 305 |
|
|
Cleveland, OH 44130 |
|
|
(440) 239-7361 |
|
|
|
In addition, this proxy statement, the accompanying Notice of
Special Meeting and the proxy card are available on the internet
at www.envisionreports.com/XPO2. |
|
|
|
If you participate in householding and wish to receive a
separate copy of this Notice of Special Meeting and proxy
statement, or if you do not wish to participate in householding
and prefer to receive separate copies of these documents in the
future, please contact Computershare as indicated above. |
|
|
|
If your shares of Company common stock are held in an account at
a broker, dealer, commercial bank, trust company or other
nominee, you should also call such broker or other nominee for
additional information. |
|
Q: |
|
Can I obtain an electronic copy of proxy material? |
|
|
|
A: |
|
Yes, this proxy statement, the accompanying Notice of Special
Meeting and the proxy card are available on the internet at
www.envisionreports.com/XPO2. |
|
|
|
Q: |
|
Who can help answer my other questions? |
|
A: |
|
If you have more questions about the Proposed Transaction or the
Proposals, you should contact the Company at
(269) 429-9761.
If you have questions regarding voting, you should contact the
proxy solicitation agent, Innisfree M&A Incorporated
(Innisfree), toll-free at (888) 750-5834. If
your shares of Company common stock are held in an account at a
broker, dealer, commercial bank, trust company or other nominee,
you should also call such broker or other nominee for additional
information. |
5
SUMMARY
The following summary highlights selected information from this
proxy statement and may not contain all of the information that
may be important to you. Accordingly, we encourage you to read
carefully this entire proxy statement, its annexes and the
documents referred to or incorporated by reference in this proxy
statement. Each item in this summary includes a page reference
directing you to a more complete description of that item.
The
Parties to the Proposed Transaction (Page 12)
Express-1 Expedited Solutions, Inc.
3399 South Lakeshore Drive, Suite 225
Saint Joseph, Michigan 49085
(269) 429-9761
The Company is a non-asset-based, third-party logistics services
provider that uses a network of relationships with ground, sea
and air carriers to find the best transportation solutions for
its customers. The Company offers its services through three
distinct business units: Express-1, Inc. (expedited
transportation solutions), the fifth largest U.S. expedited
freight service provider, according to The Journal of Commerce;
Concert Group Logistics, Inc. (domestic and international
freight forwarding); and Bounce Logistics, Inc. (premium
truckload brokerage). The Company serves more than 4,000 retail,
commercial, manufacturing and industrial customers through six
U.S. operations centers and 22 agent locations. In 2010,
the Company completed more than 144,000 transactions for
customers and generated revenues of approximately
$158 million. More information about the Company may be
found in the documents we file with the SEC. See Where
You Can Find Additional Information on page 96.
Jacobs Private Equity, LLC
350 Round Hill Road
Greenwich, CT 06831
(203) 413-4000
JPE is an investment vehicle of Bradley Jacobs.
Since 1979, Bradley Jacobs has founded and led four highly
successful companies, including two multi-billion dollar,
publicly-traded corporations: United Rentals (NYSE: URI), the
worlds largest equipment rental company, and United Waste
Systems, which was sold in 1997 for $2.5 billion. As
Chairman of United Rentals from 1997 through 2007,
Mr. Jacobs grew the company to $3.9 billion in
revenues, with more than 700 branch locations,
13,000 employees, and a ranking as the 536th largest
public corporation in America by Fortune magazine.
In 1989, Mr. Jacobs founded United Waste and built it into
the fifth largest solid waste management business in North
America. In 1987, he founded Hamilton Resources (UK) Ltd., a
worldwide oil trading company that served major oil companies
and oil-producing countries and generated annual revenues of
approximately $1 billion. In 1979, he co-founded Amerex Oil
Associates, Inc., creating one of the worlds largest oil
brokerage firms, with an annual gross contract volume of
approximately $4.7 billion.
Business
Strategy
As controlling stockholder, JPE intends to cause the Company to
leverage its prominent positions in expedited transportation
solutions, freight brokerage and freight forwarding to make the
Company a platform for growth through strategic acquisitions and
organic expansion, with a view to building a multi-billion
dollar market leader.
The
Special Meeting
Time, Place and Date (Page 13)
The special meeting will be held in the Express-1, Inc. Training
Center located at 441 Post Road, Buchanan, MI 49107, at 9:00
a.m., Eastern Daylight Time, on September 1, 2011.
6
Purpose (Page 13)
You will be asked to consider and vote upon the following
Proposals in connection with the Proposed Transaction, the
approval of each of which is a condition to the closing of the
Proposed Transaction:
|
|
|
|
|
The issuance of the Securities, which will constitute an
issuance of securities convertible into or exercisable for a
number of shares of Company common stock in excess of 20% of our
presently outstanding common stock, and thus requires the
approval of stockholders in accordance with NYSE Amex Rule 713
(Proposal 1);
|
|
|
|
An amendment to the Company Certificate to increase the number
of authorized shares of Company common stock to
150,000,000 shares (Proposal 2);
|
|
|
|
|
|
An amendment to the Company Certificate to give effect to the
Reverse Stock Split (Proposal 3);
|
|
|
|
|
|
An amendment to the Company Certificate providing that any
vacancy on our Board of Directors shall be filled by the
remaining directors or director (consistent with our existing
by-laws) (Proposal 4); and
|
|
|
|
To adopt the Plan (Proposal 5).
|
In addition, you will be asked to consider and vote upon an
amendment to the Company Certificate to change the name of the
Company to XPO Logistics, Inc. (Proposal 6).
In conjunction with the special meeting, you will also be asked
to approve the adjournment of the special meeting, if necessary
or appropriate, to solicit additional proxies if there are
insufficient votes at the time of the special meeting to adopt
Proposals 1 through 5. You will also be asked to transact
such other business as may properly come before the special
meeting or any adjournment or postponement thereof.
Record Date and Voting (Page 13)
You are entitled to vote at the special meeting if you owned
shares of Company common stock as of the close of business on
August 1, 2011, the record date for the special meeting.
You will have one vote for each share of Company common stock
that you owned on the record date. There are
33,011,561 shares of Company common stock entitled to be
voted.
Vote Required (Page 13)
The issuance of the Securities (Proposal 1) and the
adoption of the Plan (Proposal 5) require the
affirmative vote of a majority of the shares of Company common
stock voting thereon at a meeting at which a quorum is present.
The amendment to increase the number of authorized shares of
Company common stock (Proposal 2), the amendment to give
effect to the Reverse Stock Split (Proposal 3), the
amendment to provide that vacancies on the Board of Directors
shall be filled by the remaining directors or director
(Proposal 4) and the amendment to effect the Company
name change (Proposal 6) require the affirmative vote of a
majority of shares of Company common stock outstanding at the
close of business on the record date. The approval of the
adjournment of the special meeting
(Proposal 7) requires the affirmative vote of a
majority of the shares of Company common stock present and
entitled to vote at the special meeting, whether or not a quorum
is present. Failure to approve any of Proposals 1 through 5
will cause the Proposed Transaction not to occur.
Voting and Proxies (Page 13)
Any Company stockholder entitled to vote may vote by returning
the enclosed proxy card or by telephone or internet in
accordance with the instructions on the enclosed proxy card, or
by appearing at the special meeting. If your shares are held in
street name by your broker, dealer, commercial bank,
trust company or other nominee, you should instruct such broker
or other nominee on how to vote your shares using the
instructions provided by such broker or other nominee.
7
Share Ownership of Directors and Executive Officers
(Page 14)
As of August 1, 2011, the record date for the special
meeting, and excluding any shares issuable upon the exercise of
currently outstanding options, our directors and current
executive officers beneficially owned, in the aggregate,
4,289,917 shares of Company common stock, or collectively
approximately 13.0% of the outstanding shares of Company common
stock.
Revocability of Proxy (Page 14)
Whether you attend the special meeting or not, you may revoke a
proxy at any time before your proxy is voted at the special
meeting. You may do so by properly delivering a later-dated
proxy either by mail, telephone or the internet or by attending
the special meeting in person and voting. You also may revoke
your proxy by delivering a notice of revocation to the Company
(Attention: Chief Executive Officer, 3399 South Lakeshore Drive,
Suite 225, Saint Joseph, Michigan 49085) prior to the
vote at the special meeting.
Simply attending the special meeting will not constitute
revocation of a proxy. If you have instructed your broker,
dealer, commercial bank, trust company or other nominee to vote
your shares, the above-described options for revoking your proxy
do not apply and instead you must follow the directions provided
by such broker or other nominee regarding revocation of proxies.
Recommendation
of the Companys Board of Directors
(Page 27)
After careful consideration, our Board of Directors, acting upon
the unanimous recommendation of a special committee composed of
independent directors, recommends that the Companys
stockholders vote FOR the approval of each of
Proposals 1 through 6 (and, if necessary and appropriate,
Proposal 7).
Financial
Advisors Opinion (Page 28)
Ladenburg Thalmann & Co. Inc.
(Ladenburg) has delivered to the special
committee of the Companys Board of Directors its opinion,
dated June 12, 2011, to the effect that, as of
June 12, 2011, based upon and subject to the assumptions
made, matters considered, procedures followed and limitations on
Ladenburgs review as set forth in the opinion, the
Proposed Transaction is fair, from a financial point of view, to
our stockholders. The full text of the written opinion, setting
forth the assumptions made, matters considered, procedures
followed and limitations in connection with the opinion, is
attached as Annex B to this proxy statement. We recommend
that you read the opinion in its entirety.
Ownership
Upon Closing (Page 35)
As of the record date, there were 33,011,561 shares of
Company common stock outstanding, plus outstanding options to
purchase an additional 3,267,750 shares of Company common
stock. Based upon the number of shares of Company common stock
outstanding on the record date, and excluding any shares
issuable upon the exercise of currently outstanding options, the
Investors would have held in the aggregate approximately 56.5%
of the total voting power of the capital stock of the Company
before giving effect to the exercise of any Warrants, and
approximately 72.2% of the total voting power of the capital
stock of the Company after giving effect to the exercise of all
of the Warrants. Because the Preferred Stock votes on an
as converted basis, the conversion of the Preferred
Stock into Company common stock will not reduce the general
voting power of the Investors allocable to the Preferred Stock
upon its issuance. The Reverse Stock Split will not affect the
relative percentage of the voting power held by any stockholder
or Investor (except as a result of any cash paid in lieu of
fractional shares in connection with the Reverse Stock Split).
Interests
of the Companys Directors and Executive Officers in the
Proposed Transaction (Page 35)
Our directors and executive officers may have interests in the
Proposed Transaction that are different from, or in addition to,
yours, including the vesting of stock options and the
entitlement to certain other benefits pursuant to their
employment agreements. James Martell, our current Chairman, is
an Investor in the Equity Investment and is expected to continue
as a member of the Board of Directors following the closing of
the Equity Investment, and consequently he recused himself from
the Board of Directors approval of the
8
Proposed Transaction and recommendation of the Proposals. Our
Board of Directors was aware of these interests and considered
them, among other matters, in making its determinations.
When the
Proposed Transaction Will be Completed (Page 43)
We anticipate completing the Proposed Transaction in the third
quarter of 2011, subject to receipt of stockholder approvals and
satisfaction of the other closing conditions.
No
Solicitation of Transactions (Page 48)
The Investment Agreement contains restrictions on our ability to
solicit or engage in discussions or negotiations with third
parties regarding specified transactions involving the Company.
Notwithstanding these restrictions, under certain circumstances,
our Board of Directors may respond to a bona fide written
unsolicited proposal for an alternative acquisition. In certain
circumstances, we may also change our recommendation to the
Companys stockholders, terminate the Investment Agreement
and enter into an agreement with respect to a superior
acquisition proposal.
Composition
of Board of Directors (Page 50)
Upon the closing, the Board of Directors of the Company will be
reconstituted such that: (i) there will be eight Board
members, (ii) one of such directors will be James Martell,
our current Chairman (or a replacement acceptable to JPE),
(iii) seven of such directors will be designated by JPE
(including Bradley Jacobs), (iv) each standing committee of
the Board will be reconstituted in a manner reasonably
acceptable to JPE and (v) Bradley Jacobs will become the
Chairman of the Board. After giving effect to the reconstitution
of the Board, a majority of the members of the Board will
continue to be independent. Additionally, following the closing,
JPE will be entitled to nominate for election to the Board in
connection with each meeting of stockholders at which directors
are to be elected (i) a majority of the directors on the
Board, for so long as JPE controls at least 33% of the total
voting power of the capital stock of the Company on a
fully-diluted basis or (ii) 25% of the directors on the
Board, for so long as JPE controls at least 20% (but less than
33%) of the total voting power of the capital stock of the
Company on a fully-diluted basis.
Conditions
to Closing (Page 51)
The respective obligations of the Investors and the Company to
complete the Proposed Transaction are subject to the
satisfaction or waiver of certain conditions, including the
condition that Proposals 1 through 5 have been approved by
the stockholders.
The Company and JPE have determined that no filing under the
Hart-Scott-Rodino
Antitrust Improvements Act of 1976 (the HSR
Act), or any similar antitrust approval, is required
in connection with the Equity Investment.
The obligations of the Investors to complete the Proposed
Transaction are also subject to the satisfaction or waiver of
certain conditions, including that (i) the representations
and warranties of the Company in the Investment Agreement that
are qualified by materiality or material adverse effect must be
true and correct and all representations and warranties which
are not so qualified must be true and correct in all material
respects, (ii) the performance by the Company in all
material respects of all of its obligations in the Investment
Agreement, (iii) no material adverse effect has occurred
and (iv) all consents and approvals required to effect the
Equity Investment have been obtained, among others.
The obligations of the Company to complete the Proposed
Transaction are also subject to the satisfaction or waiver of
certain conditions, including that (i) the representations
and warranties of each Investor in the Investment Agreement that
are qualified by materiality must be true and correct and all
representations and warranties which are not so qualified must
be true and correct in all material respects and (ii) the
performance by the Investors in all material respects of all of
their obligations under the Investment Agreement.
9
Termination
of the Investment Agreement (Page 52)
The Company and JPE may agree in writing to terminate the
Investment Agreement at any time prior to completing the Equity
Investment, even after the stockholders of the Company have
voted on the Proposals. The Investment Agreement may also be
terminated at any time prior to completing the Equity Investment
in certain other circumstances, including by either JPE or the
Company if the closing has not occurred on or before
December 13, 2011, so long as the failure to complete the
Equity Investment is not the result of the failure of the
terminating party to comply with the terms of the Investment
Agreement. The Investment Agreement may also be terminated at
any time prior to stockholder approval of Proposals 1
through 5 (i) by JPE if the Board of Directors changes its
recommendation to the stockholders regarding the Proposals and
(ii) by the Company in order to enter into a definitive
agreement to consummate a superior acquisition
proposal.
Termination
Fee and Expenses (Page 53)
Upon termination of the Investment Agreement in connection with
a superior proposal and certain other circumstances
described in the Investment Agreement, the Company may be
obligated to pay JPE a termination fee equal either to
$2,249,000 or $2,774,000, determined as provided in the
Investment Agreement. In addition, in the event the closing
occurs or the Investment Agreement is terminated in certain
specified circumstances, the Company will be obligated to
reimburse up to $1,000,000 of expenses of JPE. JPE is obligated
under the Investment Agreement to reimburse the Company for fees
paid by the Company to KPMG LLP in certain circumstances.
Preferred
Stock Certificate of Designation (Page 55)
Pursuant to the Investment Agreement, the Company has agreed to
file the Certificate of Designation of Series A Convertible
Perpetual Preferred Stock of Express-1 Expedited Solutions, Inc.
(the Certificate of Designation) with respect
to the Preferred Stock, which sets forth the rights,
designations and preferences of the Preferred Stock.
The
Warrants (Page 57)
Pursuant to the Investment Agreement, the Company has agreed to
issue warrant certificates with respect to the Warrants (each, a
Warrant Certificate), which will govern the
terms of the Warrants.
Registration
Rights Agreement (Page 58)
Pursuant to the Investment Agreement, the Company has agreed to
enter into a Registration Rights Agreement concurrently with the
closing. The Registration Rights Agreement provides the
Investors with certain rights to cause the Company to register
the shares of Preferred Stock, the Warrants and shares of
Company common stock issued or issuable upon conversion of the
Preferred Stock or upon exercise of the Warrants.
Market
Price of Our Stock (Page 60)
The Company common stock is traded on the NYSE Amex under the
trading symbol XPO. On June 13, 2010, which was
the last trading day before we entered into the Investment
Agreement, the closing price of the Company common stock was
$2.19 per share. On August 3, 2011, which was the last
trading day before this proxy statement was mailed, the closing
price of the Company common stock was $3.36 per share.
10
CAUTIONARY
STATEMENT CONCERNING FORWARD-LOOKING INFORMATION
This proxy statement and the documents incorporated by reference
herein contain forward-looking statements. Statements that are
not historical facts, including statements about beliefs or
expectations, are forward-looking statements. These statements
are based on plans, estimates and projections at the time the
statements are made, and readers should not place undue reliance
on them. In some cases, readers can identify forward-looking
statements by the use of forward-looking terms such as
may, will, should,
expect, intend, plan,
anticipate, believe,
estimate, predict, potential
or continue or the negative of these terms or other
comparable terms. Forward-looking statements involve inherent
risks and uncertainties and readers are cautioned that a number
of important factors could cause actual results to differ
materially from those contained in any such forward-looking
statements. Factors that could cause actual results to differ
materially from those described in this proxy statement and the
documents incorporated by reference herein include, among
others: uncertainties as to the timing of the Equity Investment;
the possibility that competing transaction proposals will be
made; the possibility that various closing conditions for the
Equity Investment may not be satisfied or waived; the
possibility that the Warrants, if issued, will not be exercised;
general economic and business conditions; the possibility that
the Company may be unable to identify suitable acquisition
candidates or otherwise execute its business plan after closing;
and other factors. Readers are cautioned not to place undue
reliance on the forward-looking statements included in this
proxy statement and the documents incorporated by reference
herein, which speak only as of the date hereof or of the
applicable incorporated document. Neither the Company nor any
other person undertakes any obligation to update any of these
statements in light of new information or future events. Some
important factors (but not necessarily all factors) that could
negatively affect our revenues, growth strategies, future
profitability and operating results, or that otherwise could
cause actual results to differ materially from those expressed
in or implied by any forward-looking statement, include the
following:
|
|
|
|
|
the risk that the Proposed Transaction is not completed;
|
|
|
|
the possibility that alternative takeover proposals will or will
not be made;
|
|
|
|
the amount of fees and expenses related to the Proposed
Transaction;
|
|
|
|
the effect of the announcement of the Proposed Transaction on
our business relationships;
|
|
|
|
the diversion of managements attention from ongoing
business concerns;
|
|
|
|
the inability of the Company to identify suitable acquisition
candidates, integrate acquisitions or access the capital markets
or otherwise fail to execute its business plan after closing;
|
|
|
|
changes in business and economic conditions and other adverse
conditions in our markets;
|
|
|
|
increased competition could lead to negative pressure on our
pricing and the need for increased marketing;
|
|
|
|
our inability to maintain, establish or renew relationships with
customers, whether due to competition or other factors;
|
|
|
|
the Investment Agreements contractual restrictions on the
conduct of the business prior to the completion of the Proposed
Transaction;
|
|
|
|
our operating results and business generally, including our
ability to retain key employees; and
|
|
|
|
other risks set forth in the Companys filings with the
SEC, which filings are available without charge at www.sec.gov.
|
11
THE
PARTIES TO THE PROPOSED TRANSACTION
Express-1
Expedited Solutions, Inc.
The Company is a non-asset-based, third-party logistics services
provider that uses a network of relationships with ground, sea
and air carriers to find the best transportation solutions for
its customers. The Company offers its services through three
distinct business units: Express-1, Inc. (expedited
transportation solutions), the fifth largest U.S. expedited
freight service provider, according to The Journal of
Commerce; Concert Group Logistics, Inc. (domestic and
international freight forwarding); and Bounce Logistics, Inc.
(premium truckload brokerage). The Company serves more than
4,000 retail, commercial, manufacturing and industrial customers
through six U.S. operations centers and 22 agent locations.
In 2010, the Company completed more than 144,000 transactions
for customers and generated revenues of approximately
$158 million. Our principal executive office is located at
3399 South Lakeshore Drive, Suite 225, Saint Joseph,
Michigan 49085. Our telephone number is
(269) 429-9761.
More information about the Company may be found in the documents
we file with the SEC. See Where You Can Find Additional
Information on page 96.
Jacobs
Private Equity, LLC
JPE was formed by Bradley Jacobs to make a substantial equity
investment in a company with the potential for exceptional value
creation. Since 1979, Bradley Jacobs has founded and led four
highly successful companies, including two multi-billion dollar,
publicly-traded corporations: United Rentals (NYSE: URI), the
worlds largest equipment rental company, and United Waste
Systems, which was sold in 1997 for $2.5 billion. As
Chairman of United Rentals from 1997 through 2007, Jacobs grew
the company to $3.9 billion in revenues, with more than 700
branch locations, 13,000 employees and a ranking as the
536th largest public corporation in America by Fortune
magazine.
In 1989, Jacobs founded United Waste and built it into the fifth
largest solid waste management business in North America. In
1987, he founded Hamilton Resources (UK) Ltd., a worldwide oil
trading company that served major oil companies and
oil-producing countries and generated annual revenues of
approximately $1 billion. In 1979, he co-founded Amerex Oil
Associates, Inc., creating one of the worlds largest oil
brokerage firms, with an annual gross contract volume of
approximately $4.7 billion. The mailing address of the
principal executive offices of JPE is Jacobs Private Equity,
LLC, 350 Round Hill Road, Greenwich, CT 06831. The telephone
number is
(203) 413-4000.
12
THE
SPECIAL MEETING
Time,
Place and Purpose of the Special Meeting
This proxy statement is being furnished to our stockholders as
part of the solicitation of proxies by our Board of Directors
for use at the special meeting that will be held in the
Express-1, Inc. Training Center located at 441 Post Road,
Buchanan, MI 49107, at 9:00 a.m., Eastern Daylight Time, on
September 1, 2011.
The purpose of the special meeting is for our stockholders to
consider and vote to approve the Proposals in connection with
the Proposed Transaction. Our stockholders must approve each of
Proposals 1 through 5 for the Proposed Transaction to
occur. If our stockholders fail to approve any of
Proposals 1 through 5, the Proposed Transaction will not
occur and the Company name change will not be effectuated.
This proxy statement and the enclosed form of proxy are first
being mailed to our stockholders on or about August 4, 2011.
Record
Date and Voting
The holders of record of shares of Company common stock as of
the close of business on August 1, 2011, the record date
for the special meeting, are entitled to receive notice of, and
to vote at, the special meeting. On the record date, there were
33,011,561 outstanding shares of Company common stock.
Holders representing a majority of the outstanding shares of
Company common stock on August 1, 2011, represented in
person or by proxy, will constitute a quorum for purposes of the
special meeting. A quorum is necessary to hold the special
meeting. For purposes of determining the presence of a quorum,
abstentions will be included in determining the number of shares
present and voting at the special meeting; however, broker
non-votes will not be included in the number of shares present
and voting at the special meeting. Any shares of common stock
held in treasury by the Company or by any of its subsidiaries
are not considered to be outstanding for purposes of determining
a quorum. Once a share is represented at the special meeting, it
will be counted for the purpose of determining a quorum at the
special meeting and any adjournment or postponement of the
special meeting. However, if a new record date is set for the
adjourned special meeting, then a new quorum will have to be
established.
Required
Vote
Each outstanding share of Company common stock on August 1,
2011 entitles the holder to one vote at the special meeting. The
issuance of the Securities (Proposal 1) and the
adoption of the Plan (Proposal 5) require the
affirmative vote of a majority of the shares of Company common
stock voting thereon at a meeting at which a quorum is present.
The amendment to increase the number of authorized shares of
Company common stock (Proposal 2), the amendment to give
effect to the Reverse Stock Split (Proposal 3), the
amendment to provide that vacancies on the Board of Directors
shall be filled by the remaining directors or director
(Proposal 4) and the amendment to effect the Company
name change (Proposal 6) require the affirmative vote
of a majority of the shares of Company common stock outstanding
at the close of business on the record date. The approval of the
adjournment of the special meeting
(Proposal 7) requires the affirmative vote of a
majority of the shares of Company common stock present and
entitled to vote at the special meeting, whether or not a quorum
is present. Proposals 1 through 5 are conditioned on each
other, and Proposal 6 is conditioned on Proposals 1 through
5. If the stockholders fail to approve any of Proposals 1
through 5, the Proposed Transaction will not occur and the
Company name change will not be effectuated. In order for your
shares of Company common stock to be included in the vote, you
must vote your shares by completing, signing, dating and
returning the enclosed proxy card or by voting by telephone or
the internet in accordance with the instructions set forth on
the proxy card, or by voting in person at the special meeting.
If your shares are held in street name by your
broker, dealer, commercial bank, trust company or other nominee,
you should instruct your broker or other nominee on how to vote
your shares using the instructions provided by such broker or
other nominee. If you have not received such voting instructions
or require further information regarding such voting
instructions, contact your broker or other nominee and they can
give you directions on how to vote your shares. Absent specific
voting instructions, brokers or other
13
nominees who hold shares of Company common stock in
street name for customers are prevented by NYSE Amex
rules from exercising voting discretion in respect of
non-routine or contested matters. The Company expects that NYSE
Amex will evaluate the Proposals to be voted on at the special
meeting to determine whether each Proposal is a routine or
non-routine matter. Shares not voted by a broker or other
nominee because such broker or other nominee does not have
instructions or cannot exercise discretionary voting power with
respect to one or more Proposals are referred to as broker
non-votes. Such broker non-votes may not be counted for
the purpose of determining the presence of a quorum at the
special meeting in the absence of a routine Proposal. In
addition, because Proposals 2, 3, 4 and 6 require the
affirmative vote of a majority of the shares of Company common
stock outstanding at the close of business on the record date, a
broker non-vote with respect to any of Proposals 2, 3, 4 or
6 will have the same effect as a vote against such Proposal.
Therefore, it is important that you instruct your broker or
other nominee on how to vote your shares of Company common stock
held in street name in accordance with the voting
instructions provided by such broker or other nominee, because
the failure of the Companys stockholders to approve any of
Proposals 1 through 5 will prevent the Company from
consummating the Proposed Transaction.
Our directors and current executive officers have informed us
that, as of the date of this proxy statement, they intend to
vote all of their shares of Company common stock in favor of the
approval of each of the Proposals with respect to the Proposed
Transaction. In particular, each of Michael Welch, Chief
Executive Officer and a director of the Company, and Daniel
Para, an officer and director of the Company, have entered into
voting agreements with JPE, pursuant to which they have agreed,
in their capacities as stockholders of the Company and subject
to the terms of such agreements, to, among other things, vote
their shares of Company common stock in favor of the Proposals,
and have granted JPE a proxy in respect of their shares of
Company common stock in connection therewith. As of
August 1, 2011, the record date for the special meeting,
and excluding any shares issuable upon the exercise of currently
outstanding options, our directors and current executive
officers beneficially owned, in the aggregate,
4,289,917 shares of Company common stock, or collectively
approximately 13.0% of the outstanding shares of Company common
stock.
Proxies;
Revocation
If you vote your shares of Company common stock by properly
completing, signing, dating and returning the enclosed proxy
card or by voting by telephone or the internet in accordance
with the instructions set forth on the proxy card, your shares
will be voted at the special meeting as you have indicated. If
you vote by returning the enclosed proxy card and no
instructions are indicated on your signed and dated proxy card,
your shares of Company common stock will be voted
FOR Proposals 1 through 6 (and, if necessary
and appropriate, Proposal 7) at the special meeting.
Whether you attend the special meeting or not, you may revoke
your proxy at any time before the vote is taken at the special
meeting. You may do so by properly delivering a later-dated
proxy either by mail, the internet or telephone or attending the
special meeting in person and voting. You also may revoke your
proxy by delivering a notice of revocation to the Company
(Attention: Chief Executive Officer, 3399 South Lakeshore Drive,
Suite 225, Saint Joseph, Michigan 49085) prior to the
vote at the special meeting.
If you have instructed your broker, dealer, commercial bank,
trust company or other nominee to vote your shares, the
above-described options for revoking your proxy do not apply and
instead you must follow the directions provided by such broker
or other nominee to change these instructions.
The Company does not expect that any matter other than the
Proposals will be brought before the special meeting. If,
however, such a matter is properly presented at the special
meeting or any adjournment or postponement of the special
meeting, the persons appointed as proxies will have
discretionary authority to vote the shares represented by duly
executed proxies in accordance with their discretion and
judgment only with respect to routine and uncontested matters.
No such discretionary authority to vote such shares will exist
with respect to non-routine or contested matters pursuant to
NYSE Amex rules and applicable law.
The Company will pay the cost of this proxy solicitation, other
than the fees and expenses of Innisfree, which will be paid by
JPE. In addition to soliciting proxies by mail, directors,
officers and employees of the Company may solicit proxies
personally and by telephone, facsimile or other electronic means
of
14
communication. These persons will not receive additional or
special compensation for such solicitation services. The Company
will, upon request, reimburse brokers, dealers, commercial
banks, trust companies or other nominees for their expenses in
sending proxy materials to their customers who are beneficial
owners and obtaining their voting instructions. JPE has retained
Innisfree to assist in the solicitation of proxies for the
special meeting and will pay Innisfree a fee not to exceed
$25,000, plus reimbursement of
out-of-pocket
expenses.
Independent
Registered Public Accountants
Representatives of KPMG LLP, the principal independent
registered public accountant for the Company for the fiscal year
ending December 31, 2011, are not expected to be present at
the special meeting. Representatives of Pender
Newkirk & Company LLP, the principal independent
registered public accountant for the Company for the fiscal year
ending December 31, 2010, are not expected to be present at
the special meeting.
Adjournments
and Postponements
Although it is not expected, the special meeting may be
adjourned or postponed for the purpose of soliciting additional
proxies. Any adjournment or postponement may be made without
notice, other than by an announcement made at the special
meeting, by approval of the holders of a majority of the
outstanding shares of Company common stock present in person or
represented by proxy at the special meeting, whether or not a
quorum exists. Any signed proxies received by the Company will
be voted in favor of an adjournment or postponement in these
circumstances. Any adjournment or postponement of the special
meeting for the purpose of soliciting additional proxies will
allow Company stockholders who have already sent in their
proxies to revoke them at any time prior to their use.
15
THE
PROPOSED TRANSACTION
Description
of the Proposed Transaction
On June 13, 2011, the Company entered into the Investment
Agreement with JPE and the other Investors party thereto,
providing for an aggregate investment by the Investors of up to
$150,000,000 in cash in the Company, including amounts payable
upon exercise of the Warrants. Up to an aggregate of
$135,000,000 of such investment will be made by JPE. The
Investment Agreement has been approved by the Companys
Board of Directors, acting upon the unanimous recommendation of
a special committee composed of independent directors. Following
the closing of the Proposed Transaction, JPE will be the
controlling stockholder of the Company, and Bradley Jacobs, the
Managing Member of JPE, will become Chairman of the Board of
Directors of the Company. Mr. Jacobs will also become the
Companys Chief Executive Officer following the closing.
Under the terms of the Investment Agreement, the Investors will
invest $75,000,000 in cash into the Company in exchange for
75,000 shares of Preferred Stock and 42,857,143 Warrants
exercisable into one share each of Company common stock. The
Preferred Stock will have an initial liquidation preference of
$1,000 per share, for an aggregate initial liquidation
preference of $75,000,000. The Preferred Stock will be
convertible at any time, in whole or in part and from time to
time, at the option of the holder thereof into a number of
shares of Company common stock equal to the then-applicable
liquidation preference divided by the conversion price, which
will initially be $1.75 per share of Company common stock
(before giving effect to the contemplated Reverse Stock Split,
and subject to customary anti-dilution adjustments), for an
effective initial aggregate conversion rate of
42,857,143 shares of Company common stock. The Preferred
Stock will pay quarterly cash dividends equal to the greater of
(i) the as-converted dividends on the
underlying Company common stock for the relevant quarter and
(ii) 4% per annum of the then-applicable liquidation
preference. Accrued and unpaid dividends for any completed
quarter will accrete to liquidation preference for all purposes.
The Preferred Stock is not redeemable or subject to any required
offer to purchase, and will vote together with the
Companys common stock on an as-converted basis
on all matters, except as otherwise required by law, and
separately as a class with respect to certain matters
implicating the rights of holders of shares of Preferred Stock.
The terms of the Preferred Stock are more fully set forth in
Exhibit A to the Investment Agreement, which is filed
herewith as Annex A and incorporated by reference herein.
Each Warrant will initially be exercisable at any time and from
time to time from the closing date until the tenth anniversary
of the closing date, at the option of the holder thereof, into
one share of Company common stock at an initial exercise price
of $1.75 in cash per share of Company common stock (before
giving effect to the contemplated Reverse Stock Split, and
subject to customary anti-dilution adjustments). The initial
aggregate number of shares of Company common stock subject to
Warrants will be 42,857,143 shares. The terms of the
Warrants are more fully set forth in Exhibit B to the
Investment Agreement, which is filed herewith as Annex A
and incorporated by reference herein.
Upon the closing of the Equity Investment, the Board of
Directors will be reconstituted such that: (i) there will
be eight Board members, (ii) one of such directors will be
James Martell, our current Chairman, (iii) seven of such
directors will be designated by JPE (including Bradley Jacobs),
(iv) each standing committee of the Board will be
reconstituted in a manner reasonably acceptable to JPE and
(v) Bradley Jacobs will become the Chairman of the Board.
After giving effect to the reconstitution of the Board of
Directors, a majority of the members of the Board will continue
to be independent.
In addition to the Equity Investment, the Proposed Transaction
contemplates: (i) an amendment to the Company Certificate
to increase the number of authorized shares of Company common
stock to 150,000,000 shares; (ii) an amendment to the
Company Certificate to give effect to the Reverse Stock Split;
(iii) an amendment to the Company Certificate providing
that any vacancy on our Board of Directors shall be filled by
the remaining directors or director (consistent with our
existing by-laws as currently in effect); and
(iv) implementation of the Plan.
16
Business
Strategy
As controlling stockholder, JPE intends to leverage the
Companys prominent positions in expedited transportation
solutions, freight brokerage and freight forwarding to make the
Company a platform for growth, with a view to building a
multi-billion dollar market leader. JPE intends to grow the
Company organically and through multiple strategic acquisitions.
Bradley Jacobs, the Managing Member of JPE, has extensive
experience growing companies in fragmented industries. Since
1979, he has founded and led four highly successful companies,
including two multi-billion dollar, publicly-traded
corporations: United Rentals, the worlds largest equipment
rental company, and United Waste Systems, which was sold for
$2.5 billion. Mr. Jacobs co-founded United Rentals in
1997 to capitalize on the early-stage consolidation
opportunities in the construction equipment rental industry in
North America. As chairman of United Rentals from 1997 through
2007, Mr. Jacobs grew the company to $3.9 billion in
revenues. Mr. Jacobs oversaw the completion of over 400
acquisitions at United Rentals and United Waste Systems. In
addition, he has been instrumental in raising more than
$6 billion in the debt and equity markets since 1992.
The combined annual revenues of international freight forwarding
and domestic freight brokerage companies are approximately
$200,000,000,000. Of the over 10,000 licensed freight brokers in
the industry, only a few dozen have revenues in excess of
$200,000,000 per year. Given this size and fragmentation, JPE
views the Companys industry segments as a prime
opportunity for consolidation and growth in market share. In
addition, JPE intends to grow the Company organically by
utilizing the increased access to capital markets, and reduced
working capital constraints, that it expects to result from the
Proposed Transaction.
JPE intends to cause the Company to pursue dynamic growth in the
freight brokerage business though strategic acquisitions. JPE
also intends to cause the Company to pursue robust internal
growth through new hires.
In the freight forwarding business, JPE intends to generate
additional growth at the Company by increasing the number of
domestic agents (currently 22) by approximately 10 agents
over the next several years. In addition, JPE intends to cause
the Company to expand its presence in international freight
forwarding by growing its existing owned operations in Florida
by hiring additional personnel, and by acquiring additional
international freight forwarding businesses both domestically
and abroad and expanding those acquired companies organically by
hiring additional personnel.
JPE intends to cause the Company to grow the expedited
transportation solutions business in the near-term organically
through accelerated recruiting of owner-operators and the hiring
of additional sales and support personnel. In addition, JPE
intends to cause the Company to pursue complimentary
acquisitions on a selective basis.
The foregoing description of the post-closing business strategy
of the Company includes forward-looking statements that are
subject to numerous risks and uncertainties. See
Cautionary Statement Concerning Forward-Looking
Information on page 11 of this proxy statement.
Background
of the Proposed Transaction
Our Board of Directors and senior management periodically review
the Companys long-term strategic plan with the goal of
maximizing stockholder value. As part of this ongoing process,
the Board and senior management also have periodically reviewed
strategic alternatives that may be available to the Company.
On April 19, 2010, at a regularly scheduled meeting of the
Board of Directors, Michael Welch, the Companys Chief
Executive Officer, presented managements then current
estimates for first quarter results and managements then
current outlook for the second quarter and full year performance
to the Board. A discussion ensued regarding the Companys
financial and operational performance relative to the valuation
placed on the Company by the public equity markets. The Board of
Directors agreed that the market valuation of the Company, which
had changed little over the last several years, failed to
accurately reflect the Companys financial and operational
results. The Board of Directors concluded that industry research
analysts were not
17
focusing on the Company and that the Company was not well
positioned to attract the interest of institutional investors,
principally because of its size. The Board resolved to have
preliminary discussions with investment bankers to determine if
other strategic alternatives were available to the Company that
would provide more value to the Companys stockholders.
Over the ensuing 30 days, members of the Board of Directors
discussed the Companys financial and operational
performance with a number of investment banks. Based on those
discussions, James Martell, the Chairman of the Board, contacted
Calvin Pete Whitehead, Jennifer H. Dorris and John
F. Affleck-Graves, each of whom is independent under the rules
of the NYSE Amex, and requested that they, as a special
committee of the Board of Directors, take additional steps to
analyze the Companys business and outlook, industry
positioning and potential strategic planning and alternatives,
and to formally interview investment banks to serve as financial
advisors to the special committee. On May 27, 2010,
Mr. Whitehead, Mrs. Dorris and Mr. Affleck-Graves
held an initial meeting via teleconference to discuss the
foregoing.
On June 8, 2010, the special committee and
Roetzel & Andress, L.P.A., the Companys outside
legal counsel (R&A), interviewed
BB&T Capital Markets, a division of Scott &
Stringfellow, LLC (BB&T), and on
June 9, 2010, interviewed Eve Partners, LLC
(Eve). Each investment bank was seeking to
act as financial advisor to the special committee. The
investment banks discussed the Companys current financial
and operational performance, the Companys valuation and
stock price challenges despite the Companys long-term
track record of revenue and profit growth, and their knowledge
of the Companys business sector. The investment banks
presented a variety of strategic alternatives to the special
committee, including a potential sale of the Company or an
equity capital raise transaction, to help address these issues.
The investment banks also discussed possible outcomes and
responded to the special committees questions.
On June 9, 2010, at a regularly scheduled meeting of the
Board of Directors attended by R&A, Mr. Whitehead
presented to the Board of Directors a summary of the meetings
between the special committee and the investment banks. The
Board of Directors discussed its knowledge of BB&T and Eve,
the involvement of BB&T and Eve in the transportation
industry, transactions in which BB&T or Eve had provided
consulting services and the ability of BB&T and Eve to
assist the Company with an in-depth analysis of all possible
strategic alternatives. Thereafter the Board of Directors
formally set forth the mandate of the special committee and
adopted a Charter of the Special Committee. The Board of
Directors delegated to the special committee full power and
authority in connection with its evaluation of strategic
alternatives, including full power and authority to
(i) formulate, establish, oversee and direct a process for
the identification, evaluation and negotiation of a potential
sale of the Company, (ii) evaluate and negotiate the terms
of any proposed definitive or other agreements in respect of a
potential sale of the Company, (iii) make recommendations
to the Board in respect of any potential transaction, including,
but not limited to, any recommendation to not proceed with or to
recommend that the Companys stockholders reject a
potential sale of the Company and (iv) make recommendations
to the Board of Directors that the Board of Directors take other
actions or consider other matters that the special committee
deems necessary or appropriate with respect to any potential
sale of the Company or potential strategic transactions.
Later on June 9, 2010, after considering the presentations
made by each investment bank, including their respective
qualifications, reputation and experience, the special committee
elected to engage BB&T and Eve to serve jointly as
financial advisors to the special committee.
Over the following three weeks, the special committee, R&A,
BB&T and Eve communicated several times to discuss the
fiduciary duties of the special committee and the Board of
Directors, the potential risks and benefits involved in the
execution of the Companys business plan as an independent
company, strategic alternatives available to the Company, and
the process of identifying parties interested in engaging in a
strategic transaction with the Company. Ultimately it was
determined that the special committee, through BB&T and
Eve, would conduct a controlled process with the goal of
effecting a go-private sale of the Company.
On June 30, 2010, a kick-off meeting was held among
Mr. Whitehead, BB&T, Eve and the Companys
executive management team. The parties discussed due diligence,
process, strategy, timing and the universe of
18
financial and strategic buyers that might be interested in
engaging in a transaction with the Company. Later that day the
Companys stock price closed at $1.26 per share of Company
common stock.
Over the ensuing six weeks, BB&T and Eve conducted
extensive due diligence on the Company, assisted the Company in
the preparation of financial projections, established an
electronic data site populated with Company due diligence
materials and prepared and finalized a Confidential Information
Memorandum and a buyers list.
On August 23, 2010, BB&T and Eve began contacting 51
prospective acquirors. Throughout the remainder of August and
early September the special committee negotiated and entered
into nondisclosure agreements with 39 interested parties. The
agreements contained customary restrictions on the disclosure
and use of confidential information, standstill provisions
restricting the prospective acquirors ability to purchase
our securities or engage in other takeover activities without
our consent, and certain nonsolicitation provisions. Upon
execution of the nondisclosure agreement the prospective
acquirors were given the Companys Confidential Information
Memorandum and information on the process going forward.
By September 24, 2010, BB&T and Eve had received six
initial indications of interest (each, an
IOI) for the Company, with prices ranging
from $1.59 to $2.50 per share of Company common stock. Each IOI
was subject to certain stated assumptions and to further due
diligence.
From October 5, 2010 through October 12, 2010, Company
management, BB&T and Eve conducted management presentations
with the five prospective acquirors that had submitted IOIs with
the highest per share consideration. The prospective acquirors
were granted access to the Companys electronic data room.
On October 12, 2010, the Companys stock price closed
at $2.35 per share of Company common stock.
On October 20, 2010, at a regularly scheduled meeting of
the Board of Directors attended by R&A, BB&T and Eve,
Mr. Whitehead updated the Board of Directors on the status
of the strategic process being conducted by BB&T and Eve. A
discussion ensued regarding the process timeline, feedback
received regarding the management presentations and the recent
increase in the Companys stock price. R&A discussed
the Boards and special committees fiduciary duties
at length. The Board members evaluated the IOIs received
relative to the option of the Company to continue as an
independent publicly-traded company, and the Board members asked
questions of BB&T and Eve. The Board and the special
committee determined that it was appropriate to continue the
strategic process. Mr. Affleck-Graves was removed from the
special committee at his request, due to his stated concern that
his indirect business associations with one of more of the
potential acquirors might be perceived as adversely affecting
his independence in the strategic process.
On October 28, 2010, BB&T and Eve received two letters
of intent (each, an LOI), and on
October 29, 2010, BB&T and Eve received a third LOI,
setting forth offers to acquire the Company for prices ranging
from $2.26 per share to $2.70 per share. The following day the
Companys stock price closed at $2.45 per share.
On November 8, 2010, at a special meeting of the Board of
Directors attended by BB&T and Eve in person and by
R&A telephonically, BB&T and Eve presented a summary
of the three LOIs received, including an analysis of total
consideration to stockholders, transaction multiples and
premiums, key valuation and financing terms, key process terms,
key legal terms and sources and uses of the transaction
consideration.
During the following week the potential acquirors conducted
extensive due diligence on the Company, and BB&T and Eve
held several discussions with each acquiror in an effort to
convince each acquiror to increase the price per share set forth
in their respective LOI. Ultimately the potential acquirors with
the lowest per share purchase prices dropped out of the bidding,
leaving one final potential acquiror.
On November 16, 2010, the Companys stock price closed
at $2.59 per share. The remaining potential acquiror notified
BB&T and Eve that it intended to stand still until early
2011.
On December 9, 2010, BB&T and Eve introduced JPE and
its principal Bradley Jacobs to the special committee. Based on
Mr. Jacobs track record of successfully growing
businesses, the special committee expressed interest in
exploring Mr. Jacobs business strategy of rapidly
building a multi-billion dollar logistics company using the
Company as a platform.
19
On December 15, 2010, JPE executed a confidentiality
agreement with the Company and received access to the
Companys electronic data room.
On January 20, 2011, Michael Welch met with Mr. Jacobs
and discussed generally the Company and Mr. Jacobs
business strategy.
On February 23, 2011, the remaining potential acquiror
notified BB&T and Eve that it continued to evaluate a
strategic transaction with the Company, but that the potential
acquiror was not prepared to move forward at that time.
On February 28, 2011, BB&T advised the special
committee that JPE was going to stand still until further notice.
On March 1, 2011, at a meeting of the Board of Directors,
the special committee discussed the current status of the
strategic process and that both remaining potential acquirors
were currently on hold, and it was decided to suspend the
strategic process. BB&T and Eve were advised of the special
committees decision.
On April 15, 2011, a conference call was held to discuss
JPEs renewed interest in the Company. Participating on the
call were Mr. Martell, Michael Welch, John Welch, the
Companys Chief Financial Officer, Mr. Whitehead and
R&A. The parties discussed JPE, Mr. Jacobs and the
Companys financial and operational performance.
Mr. Whitehead agreed to convene the special committee to
re-open the strategic process that had been put on hold on
March 1, 2011, and to conduct additional diligence on JPE
and Mr. Jacobs.
On April 18, 2011, JPE submitted a nonbinding term sheet
outlining a private investment in the Company of up to
$150,000,000. The proposal involved the purchase of $75,000,000
in liquidation preference of convertible preferred stock,
convertible at the holders option into
45,454,545 shares of Company common stock at $1.65 per
share, subject to adjustment. The preferred stock carried a
dividend, payable in cash, at the greater of 1.00% of
liquidation preference per quarter and the
as-converted dividends on the underlying shares of
Company common stock for the relevant quarter. The preferred
stock would vote on an as-converted basis with the Company
common stock. Additionally, the investors would receive warrants
to purchase 45,454,545 shares of Company common stock at an
exercise price of $1.65 per share with a term of 10 years.
The securities would be purchased in two stages. In stage one,
on the date of the execution of an investment agreement, the
Company would issue to JPE, and JPE would purchase for cash,
(i) shares of convertible preferred stock convertible into
a number of shares of Company common stock equal to 9.95% of the
number of shares of Company common stock outstanding immediately
prior to such issuance, and (ii) warrants to purchase a
number of shares of Company common stock equal to 9.95% of the
number of shares of Company common stock outstanding immediately
prior to such issuance. The stage one purchase was to be made
for a portion of the $75,000,000 that corresponded to the
portion of the total convertible preferred stock issued in stage
one. In stage two, subject to and as soon as practicable
following the approval by the stockholders of the Company of the
remaining equity issuances contemplated by the investment
agreement, the Company would issue to JPE, and JPE would
purchase for cash, (i) the balance of the shares of
convertible preferred stock remaining to be issued after stage
one and (ii) the balance of the warrants remaining to be
issued after stage one. The stage two purchase was to be made
for the balance of the $75,000,000 remaining following the
investment in stage one. At the closing of stage two, the Board
of Directors would be reconstituted in its entirety with
individuals acceptable to JPE, and the Board would appoint
Mr. Jacobs as the Chairman of the Board of the Company. JPE
would have Board representation rights in its capacity as a
holder of shares of convertible preferred stock.
On April 20, 2011, a conference call was held to discuss
the JPE proposal. Participating on the call were
Mr. Whitehead, Mrs. Dorris, Mr. Martell, Michael
Welch, BB&T and R&A. BB&T presented the terms of
the JPE proposal to the participants, discussed the market for
PIPE transactions in detail, and provided a background of
Mr. Jacobs and his prior business dealings at United
Rentals, Inc. and United Waste Systems, Inc. The special
committee expressed concern over the two stage aspect of the
proposal under which JPE would receive an estimated 17% interest
in the Company (making JPE the Companys largest
stockholder), and the Company would have material contractual
obligations to JPE, in each case without having received
20
stockholder approval. Questions were also raised regarding
JPEs intended use of proceeds. Ms. Dorris requested
that BB&T provide an analysis of change of control PIPE
transactions not involving financial institutions or negative
EBITDA companies. The special committee directed BB&T to
discuss its concerns with JPE.
On April 28, 2011, Eve advised the special committee that,
upon advice of counsel, it had elected to waive its rights under
the Eve engagement letter with respect to the potential
transaction with JPE, to avoid any potential conflict of
interest that could potentially arise as a result of Eves
ongoing involvement with JPE in connection with other M&A
transactions. From that point forward Eve ceased participating
in the Companys strategic process.
On May 2, 2011, a meeting between the Company and JPE was
held to provide JPE with an opportunity to present its business
plan to the Company. Present were all members of the Board of
Directors (Mr. Affleck-Graves participated telephonically),
John Welch, representatives of BB&T, Mr. Jacobs, a
representative of JPEs outside legal advisor Cravath,
Swaine & Moore LLP (Cravath),
representatives of JPEs outside financial advisors
Deutsche Bank Securities Inc. and UBS Investment Bank, and
R&A (telephonically). During the meeting Mr. Jacobs
discussed his personal and business background, the details of
his proposed investment in the Company and his intended use of
proceeds. At the conclusion of the presentation the parties
agreed that if the transaction were to go forward it would be in
the form of a single stage investment that would close only upon
receipt of stockholder approval. The Board of Directors and its
advisors continued to discuss the JPE proposal after
Mr. Jacobs and his advisors left the meeting. The parties
discussed the fiduciary duties of the Board of Directors. It was
agreed that the JPE proposal had potential merit, but that the
potential dilution to the Companys stockholders was a
significant concern and that the effective price per Company
common share needed to be increased.
On May 4, 2011, Mr. Affleck-Graves accepted a
re-appointment as a member of the special committee. BB&T
provided the special committee with a written analysis
summarizing the premiums/discounts of other PIPE transactions
and follow-on offerings in which the offering size was greater
than the pre-money market capitalization of the issuing company.
The special committee asked BB&T for its view on the
ability of the Company to raise funds through a PIPE offering,
registered direct offering or other follow-on offering.
On May 6, 2011, the special committee and R&A met via
conference call. R&A presented a detailed description of
the Board of Directors fiduciary duties in change of
control transactions. The parties discussed the terms of the JPE
proposal, Mr. Jacobs commitment to the Companys
industry and the obligations of the special committee and the
Board to the Companys stockholders. The special committee
agreed that additional information was needed before it could
determine whether to continue discussions with JPE.
Specifically, the special committee requested that BB&T
prepare an analysis of the following strategic alternatives
available to the Company: (i) continue as a stand-alone
entity, growing organically; (ii) continue as a stand-alone
entity, with both organic growth and growth through
acquisitions; (iii) sell the Company in a go-private
transaction to either a financial or a strategic buyer; and
(iv) accept the JPE proposal.
On May 9, 2011, BB&T provided the special committee
and R&A with a written analysis of the four strategic
alternatives requested by the special committee. The analysis
described in detail each strategic alternative and the projected
Company stock price through 2015. The JPE proposal resulted in
the highest projected stock price in each year of the analysis.
Members of the special committee and R&A discussed the
report over the following several days. The special committee
agreed to proceed with the JPE proposal to the extent JPE would
agree to increase the effective price from $1.65 per share to
$1.75 per share.
On May 13, 2011, JPE submitted a revised term sheet
providing for a single stage transaction in which the
transaction would not close until stockholder approval was
received (and other customary closing conditions were
satisfied). The price was increased to $1.75 per share. In
consideration for the concessions, JPE required that the Company
agree to a no-shop provision. The special committee, after
consultation with R&A regarding the Companys ability
to receive third-party proposals during a no-shop period, agreed
to pursue a transaction on the general terms set forth in the
revised term sheet. BB&T communicated this to JPE and a
timeline for in-depth due diligence was agreed upon.
21
On May 20, 2011 and May 21, 2011, Mr. Whitehead
and R&A conducted telephone interviews with two financial
advisory firms regarding the preparation and issuance of a
fairness opinion.
During the week of May 23, 2011, JPEs accounting
advisors, KPMG LLP (KPMG), conducted
extensive due diligence on the Company, primarily at the offices
of the Companys independent registered public accounting
firm Pender Newkirk & Company LLP.
On May 23, 2011, Cravath presented R&A with the
initial draft of the investment agreement, which R&A
forwarded to the special committee and to BB&T.
On May 24, 2011, after considering the presentations made
by each financial advisory firm, including their respective
qualifications, reputation and experience, the special committee
engaged Ladenburg to render an opinion to the special committee
as to whether, on the date of such opinion, the consideration to
be received by the Company in connection with the JPE
transaction is fair, from a financial point of view, to the
Companys stockholders.
On May 25, 2011, R&A presented the special committee
with a memo summarizing the material terms of the investment
agreement and R&As proposed revisions thereto. The
following day a conference call was held between the special
committee and R&A to discuss R&As proposed
revisions to the investment agreement. The primary areas of
concern were the Companys inability to terminate the
agreement upon receipt of a superior proposal, the ability to
treat as a superior proposal offers to acquire a majority of the
Company but less than all or substantially all of the Company,
the Companys obligation to reimburse JPE for all of
JPEs transaction-related costs and expenses, the amount of
the termination fee, the length of the tail period during which,
in certain circumstances, the Company would be obligated to pay
the termination fee, the requirement that the Company engage
KPMG to conduct a re-audit of the Companys financial
statements for the years ended December 31, 2008, 2009 and
2010, and to conduct a full internal control over financial
reporting audit, the inclusion of a cashless exercise feature in
the warrants, and the right of JPE to nominate persons to fill
80% of the seats on the Board of Directors as long as JPE holds
at least 50% of the equity securities purchased by JPE in the
transaction. After R&As presentation the parties
discussed the Board of Directors fiduciary duties to the
Companys stockholders and the impact certain of the
proposed terms would have on the special committees
ability to maximize stockholder value. The special committee
directed R&A to negotiate the proposed revisions to the
investment agreement directly with Cravath.
On May 27, 2011, R&A and Cravath discussed the
proposed revisions to the investment agreement. As a result of
those discussions, JPE agreed to allow the Company to terminate
the investment agreement upon receipt of a superior proposal to
acquire all or substantially all of the Company, but only in the
event the Company concurrently entered into an agreement with
the third party to effectuate the superior proposal, to decrease
the termination fee from 3.5% of the Companys equity value
to 3.0%, and to eliminate the cashless exercise feature from the
warrants. Left as open issues were the amount of JPE expenses to
be reimbursed by the Company, JPEs ability to nominate
directors and the Companys obligation to engage KPMG for a
re-audit of the Companys financial statements and an audit
of the Companys internal control over financial reporting.
JPE rejected the Companys request to be able to treat as a
superior proposal a takeover proposal for the acquisition of
less than all or substantially all of the Company.
On May 28, 2011 and May 29, 2011, the special
committee and R&A discussed the outstanding issues under
the investment agreement and related transaction documents. The
parties agreed the following revisions should be requested: that
the Company would have no obligation to reimburse JPEs
expenses in the event of a stockholder no vote or if
the Company were to terminate the investment agreement as a
result of a JPE breach, that the Company would agree to engage
KPMG for the re-audits for 2009 and 2010, but not for an audit
of internal control over financial reporting, the elimination of
JPEs ability to nominate persons to serve on the Board,
that Daniel Para, the Chief Executive Officer of Concert Group
Logistics, Inc., and Michael Welch should be able to terminate
their voting agreements with JPE in the event of a superior
proposal (whether or not the investment agreement was
terminated), and that the Company should be able to treat as a
superior proposal a takeover proposal to acquire a majority of
the Company but less than all or substantially all of the
Company. The Company also requested a reduction in the term of
the warrants from 10 years to one year.
22
On May 30, 2011, R&A and Cravath discussed the
proposed revisions to the investment agreement. During the
discussions Cravath advised of JPEs estimate that the JPE
expenses subject to Company reimbursement would be approximately
$1.5 million and JPEs agreement to eliminate the
reimbursement requirement should JPE breach the investment
agreement. JPE maintained that JPEs expenses should be
reimbursed in the event of a stockholder no vote.
The negotiation of JPEs nomination rights continued. JPE
again rejected R&As request that the Company be able
to treat as a superior proposal certain takeover proposals
involving offers for a majority of the Company but less than all
or substantially all of the Company.
On May 31, 2011, Mr. Whitehead and R&A discussed
the status of negotiations and agreed to present JPE with a set
of terms that would resolve all of the outstanding issues. The
Company was willing to withdraw its request that the term of the
warrants be reduced to one year, was willing to accept the
payment of JPEs expenses up to a cap of $1.5 million
and was willing to provide JPE the right to nominate a majority
of the Board as long as JPE holds at least 33% of the
Companys voting rights and 25% of the Board as long as JPE
holds at least 20% of the Companys voting rights. The
Company maintained its position that a superior proposal should
include proposals to acquire a majority of the Company.
On May 31, 2011, R&A and Cravath discussed the
Companys proposal during a series of conference calls. The
following day Cravath distributed revised transaction documents
evidencing the foregoing.
In the evening of June 1, 2011, the special committee met
with R&A to discuss the status of negotiations with JPE and
Ladenburgs fairness opinion. Immediately thereafter the
Board of Directors held a meeting attended by all Board members,
R&A, BB&T and John Welch. Mr. Martell recused
himself from the meeting after being advised that JPE was
interested in having Mr. Martell remain on the Board
post-closing, and that if Mr. Martell desired, JPE would
extend to Mr. Martell an opportunity to invest in the JPE
transaction along with JPE and the other investors.
Mr. Whitehead began the meeting with a general status
update of the special committees negotiations with JPE and
Cravath. Next, R&A presented a detailed description of all
material terms of the JPE transaction documents as then drafted.
In so doing R&A identified all outstanding issues, and
provided a background of the negotiations that had transpired
over the prior week. The Board deliberated over the terms of the
transaction, and R&A discussed with the Board the
Boards fiduciary duties. The Board expressed its desire
that the Companys obligation to pay JPEs expenses,
and to pay a termination fee, be limited to the greatest extent
possible. Further, the Board supported the special
committees position that it should be able to terminate
the investment agreement if it receives a superior proposal to
acquire a majority (but less than all or substantially all) of
the Company. After the Board meeting was adjourned, a series of
conference calls were conducted between R&A and Cravath
during which R&A conveyed the special committees
position on the outstanding issues.
On June 3, 2011, the special committee held a conference
call with R&A to discuss the status of negotiations with
JPE. It was agreed that R&A and Cravath had reached an
impasse, and that R&A would cease working on the JPE
transaction unless and until the remaining issues were resolved.
Mr. Whitehead directed BB&T to advise JPE of the
foregoing, and to attempt to continue negotiations directly with
Mr. Jacobs on the Companys behalf. Mr. Whitehead
advised BB&T that the special committee might be able to
accept the inability to terminate the investment agreement upon
receipt of a majority (but less than all or substantially all)
superior proposal, as long as in connection therewith the voting
agreements with Mr. Para and Michael Welch could be
terminated. Mr. Whitehead also suggested that if JPE was
willing to increase the pricing of the transaction the special
committee would likely withdraw its remaining demands.
Over the next several days extensive negotiations took place
between the special committee and its advisors and JPE and its
advisors in an unsuccessful attempt to resolve the outstanding
issues.
On June 7, 2011, the Board held a telephonic meeting in
which R&A participated (Mr. Martell was not present).
R&A provided an update on the outstanding issues. The Board
suggested that Mike Welch attempt to resolve the outstanding
issues directly with Mr. Jacobs. Following the meeting
Mr. Welch and Mr. Jacobs had a telephone conference
but were unable to resolve the outstanding issues.
23
On June 8, 2011, the special committee, through R&A,
advised Cravath that if JPE was willing to limit the
Companys obligations to pay expenses and termination fees
the proposed transaction could likely move forward.
On June 9, 2011, Cravath advised that JPE was willing to
reduce the cap on the termination fee (which was equal to 3% of
the post-announcement equity value) to 4.5% of pre-announcement
equity value from 5% of pre-announcement equity value, and that
the termination fee payable in any event other than the
termination by the Company upon receipt of a superior proposal
for all or substantially all of the Company, or by JPE due to a
change in recommendation by the Company in connection with a
superior proposal, would be limited to 3% of pre-announcement
equity value.
Later on June 9, 2011, following the Companys annual
meeting of stockholders, Mr. Whitehead and Mrs. Dorris
discussed the current status of negotiations with JPE. Still
later that day the Board of Directors met via conference call
(Mr. Martell was not present), during which R&A
presented an outline of the Companys obligations to pay
JPEs expenses and termination fees under the current draft
of the investment agreement. A discussion ensued about the
transaction generally and the concessions that had been obtained
from JPE to date. At the conclusion of the meeting, the special
committee contacted BB&T and directed BB&T to contact
JPE and advise that if JPE would be willing to reduce the cap on
reimbursable expenses from $1.5 million to $1 million,
the special committee would be in a position to support the
transaction and recommend it to the Board for approval.
On June 10, 2011, JPE advised that the reduction of the cap
on reimbursable expenses from $1.5 million to
$1 million was acceptable.
On June 12, 2011, the special committee held a telephonic
meeting with R&A to discuss the final terms of the
investment agreement and related documents. Immediately
thereafter the Board of Directors held a telephonic meeting also
attended by John Welch, R&A, BB&T and Ladenburg
(Mr. Martell did not attend). R&A presented a summary
of the terms of the investment agreement and related documents,
and discussed the fiduciary duties of the members of the special
committee and the Board. Next, Ladenburg reviewed with the Board
Ladenburgs financial analyses of the consideration and
delivered to the Board an oral opinion, which opinion was
confirmed by delivery of a written opinion, dated June 12,
2011, to the effect that, as of that date and based on and
subject to various assumptions, matters considered and
limitations described in its opinion, the transaction with JPE
is fair, from a financial point of view, to the Companys
stockholders. Next, BB&T outlined the strategic
alternatives available to the Company, and presented the Board
with BB&Ts opinion that the Proposed Transaction with
JPE represents a superior potential outcome for the
Companys stockholders relative to the other possible
alternatives. The special committee, having deliberated
regarding the terms of the Proposed Transaction, the Ladenburg
presentation and opinion and the BB&T presentation,
unanimously determined that the investment agreement and the
transactions contemplated thereby are advisable and in the best
interests of the Company and the Companys stockholders,
and recommended that the Board approve the investment agreement
and the transactions contemplated thereby, and that the Board
recommend that the Companys stockholders vote to approve
the Equity Investment as set forth in the investment agreement,
certain amendments to the Companys certificate of
incorporation as set forth in the investment agreement and the
omnibus incentive compensation plan as set forth in the
investment agreement. Following the special committees
recommendation to the Board, the Board, by unanimous vote of
those directors in attendance, determined that the investment
agreement and the transactions contemplated thereby are
advisable and in the best interests of the Company and the
Companys stockholders, and recommended that the
Companys stockholders vote to approve the Equity
Investment as set forth in the investment agreement, certain
amendments to the Companys certificate of incorporation as
set forth in the investment agreement and the omnibus incentive
compensation plan as set forth in the investment agreement.
On June 13, 2011, the Company and JPE executed the
investment agreement and other transaction documents, and
Mr. Para and Michael Welch executed voting agreements.
On June 14, 2011, prior to the opening of the market, the
Company and JPE issued a joint press release announcing the
execution of the investment agreement, and filed a
Form 8-K
with the SEC describing the terms of the Transaction.
24
Reasons
for the Proposed Transaction
In reaching its determination, the special committee consulted
with and received the advice of its financial and legal
advisors, discussed certain issues with the Companys
senior management team, and considered a number of factors that
it believed supported its decision to recommend that the Company
enter into the Investment Agreement and consummate the Equity
Investment, and recommend that the stockholders vote in favor of
the Proposals, including, but not limited to, the following
material factors:
|
|
|
|
|
the per share price contemplated by the Proposed Transaction was
a reasonable discount to the Companys market price in
light of JPEs business strategy, JPEs ability to
effectuate its business strategy, the stated use of proceeds and
the higher multiples received by mid-cap and large-cap public
companies in the Companys industry;
|
|
|
|
the financial analyses presented to the special committee by
BB&T and shared with the Board of Directors, as well as the
opinion of BB&T that the Proposed Transaction represents a
superior potential outcome for the Companys stockholders
relative to the other possible alternatives;
|
|
|
|
the financial analyses presented to the special committee by
Ladenburg and shared with the Board of Directors, as well as the
opinion of Ladenburg, dated June 12, 2011, to the special
committee, which expressly allows reliance on the opinion by
those members of the Board of Directors who are not members of
the special committee, to the effect that, as of that date, and
based upon and subject to the various assumptions made,
procedures followed, matters considered and qualifications and
limitations set forth therein, the Proposed Transaction is fair,
from a financial point of view, to the Companys
stockholders; the full text of the written opinion of Ladenburg
is attached as Annex B to this proxy statement;
|
|
|
|
the possible alternatives to the Proposed Transaction, including
an alternative sales process or continuing as a standalone
company with or without additional bolt-on acquisitions, which
alternatives the special committee evaluated with the assistance
of Ladenburg and BB&T and determined were less favorable to
the Companys stockholders than the Proposed Transaction
given the potential risks, rewards and uncertainties associated
with those alternatives;
|
|
|
|
the extensive efforts made by the Company and its advisors over
a period of many months to solicit interest on the part of
potential acquirors of the Company, with the result that
BB&T spoke to approximately 50 potentially interested
parties;
|
|
|
|
the expectation that the market price of the Companys
shares would increase significantly following announcement of
the Proposed Transaction and allow existing stockholders to sell
their shares at a premium to the then-current market price;
|
|
|
|
the fact that the Companys stockholders would have the
ability to share in any upside that might result from any future
improved performance on the part of the Company;
|
|
|
|
the reputation of JPE and Mr. Jacobs;
|
|
|
|
the Companys business, operations, financial condition,
strategy and prospects, as well as the risks involved in
achieving those prospects, the nature of the third-party
logistics industry, and general industry, economic and market
conditions, both on an historical and on a prospective basis;
|
|
|
|
the likelihood that the Proposed Transaction would be completed
based on, among other things (not in any relative order of
importance):
|
|
|
|
|
|
the absence of a financing condition in the Investment Agreement;
|
|
|
|
the likelihood and anticipated timing of completing the Proposed
Transaction in light of the scope of the conditions to
completion, including the absence of significant required
regulatory approvals; and
|
|
|
|
the ability of JPE and Mr. Jacobs to complete the Proposed
Transaction, raise funds in follow-on offerings and complete
accretive acquisitions on a large-scale basis;
|
25
|
|
|
|
|
the other terms of the Investment Agreement and related
agreements, including:
|
|
|
|
|
|
the Companys ability, at any time from and after the
execution of the Investment Agreement but prior to the time the
Companys stockholders adopt the Proposals, to consider and
respond to an unsolicited written acquisition proposal, to
furnish confidential information to the person making such a
proposal and to engage in discussions or negotiations with the
person making such a proposal, if the special committee, prior
to taking any such actions, determines in good faith that such
acquisition proposal either constitutes a superior proposal or
could reasonably be expected to lead to a superior proposal;
|
|
|
|
the Board of Directors ability (acting upon the
recommendation of the special committee), under certain
circumstances, to withhold, withdraw, qualify or modify its
recommendation that its stockholders vote to adopt the Proposals;
|
|
|
|
the Companys ability, under certain circumstances, to
terminate the Investment Agreement in order to enter into an
agreement providing for a superior acquisition proposal,
provided that the Company complies with its obligations relating
to the entering into of any such agreement and concurrently with
the termination of the Investment Agreement pays to JPE a
termination fee determined in accordance with the Investment
Agreement, in connection with an agreement for a superior
acquisition proposal, plus up to $1 million of JPEs
expenses; and
|
|
|
|
the termination fee and expenses payable to JPE under certain
circumstances, including as described above, in connection with
a termination of the Investment Agreement, which the special
committee concluded were reasonable in the context of
termination fees and expenses payable in comparable transactions
and in light of the overall terms of the Investment Agreement,
including the total consideration.
|
The special committee also believed that sufficient procedural
safeguards were and are present to ensure the fairness of the
Proposed Transaction and to permit the special committee to
represent effectively the interests of the Companys
stockholders. These procedural safeguards include:
|
|
|
|
|
the fact that the special committee is comprised of three
independent directors who are not affiliated with JPE or the
other Investors and are not employees of the Company or any of
its subsidiaries;
|
|
|
|
|
|
the fact that, other than their receipt of Board of Directors
and special committee fees (which are not contingent upon the
consummation of the Proposed Transaction or the special
committees or the Boards recommendation of the
Proposed Transaction) and their interests described under
The Proposed TransactionInterests of the
Companys Directors and Executive Officers in the Proposed
Transaction on page 35, members of the special
committee do not have interests in the Proposed Transaction
different from, or in addition to, those of the Companys
unaffiliated stockholders;
|
|
|
|
|
|
the fact that the determination to engage in discussions related
to the Proposed Transaction and the consideration and
negotiation of the price and other terms of the Proposed
Transaction was conducted entirely under the oversight of the
members of the special committee without the involvement of any
director who is affiliated with the Investors or is a member of
the Companys management and without any limitation on the
authority of the special committee to act with respect to any
alternative transaction or any related matters;
|
|
|
|
the recognition by the special committee that it had the
authority not to recommend the approval of the Proposed
Transaction or any other transaction;
|
|
|
|
the special committees extensive negotiations with JPE,
which, among other things, resulted in an increase in the
effective price from $1.65 to $1.75 per share and resulted in
significantly better contractual terms than initially proposed
by JPE, including the ability of the Company to terminate the
Investment Agreement upon the receipt of superior proposal for
all or substantially all of the Company and entry into an
agreement with respect to same; the capping of JPEs
reimbursable expenses at $1 million; and the elimination of
the cashless exercise provision from the Warrants;
|
26
|
|
|
|
|
the fact that the special committee was advised by BB&T, as
financial advisor, and R&A, as legal advisor, and the fact
that the special committee requested and received from Ladenburg
an opinion (based upon and subject to the various assumptions
made, procedures followed, matters considered and qualifications
and limitations set forth therein), as of June 12, 2011,
with respect to the fairness of the Proposed Transaction to the
Companys stockholders from a financial point of
view; and
|
|
|
|
the fact that the terms and conditions of the Investment
Agreement and related agreements were designed to allow the
Company to change its recommendation to the Companys
stockholders or terminate the Investment Agreement entirely,
upon receipt of a superior proposal, depending on the nature of
the superior proposal.
|
In the course of its deliberations, the special committee also
considered a variety of risks and other countervailing factors
related to entering into the Proposed Transaction, including
(not in any relative order of importance):
|
|
|
|
|
the risk that the Proposed Transaction might not be completed in
a timely manner or at all;
|
|
|
|
the restrictions on the conduct of the Companys business
prior to the completion of the Equity Investment, which may
delay or prevent the Company from undertaking business
opportunities that may arise or any other action it would
otherwise take with respect to the operations of the Company
pending completion of the Equity Investment;
|
|
|
|
the risks and costs to the Company if the Proposed Transaction
does not close, including the diversion of management and
employee attention, potential employee attrition and the
potential disruptive effect on business and customer
relationships;
|
|
|
|
the possibility that the up to $1 million in JPEs
expenses plus the applicable termination fee payable by the
Company upon the termination of the Investment Agreement could
discourage other potential acquirors from making a competing bid
to acquire the Company; and
|
|
|
|
if the Proposed Transaction is not completed, the Company will
be required to pay its own expenses associated with the
Investment Agreement, the Equity Investment and the other
transactions contemplated by the Investment Agreement as well
as, under certain circumstances, pay JPE a termination fee
and/or
reimburse JPEs expenses (up to a $1 million cap), in
connection with the termination of the Investment Agreement.
|
The foregoing discussion of the factors considered by the
special committee is not intended to be exhaustive, but rather
includes the principal factors considered by the special
committee. The special committee collectively reached the
conclusion to approve the Proposed Transaction, the Investment
Agreement and the other transactions contemplated by the
Investment Agreement in light of the various factors described
above and other factors that the members of the special
committee believed were appropriate. In view of the wide variety
of factors considered by the special committee in connection
with its evaluation of the Proposed Transaction and the
complexity of these matters, the special committee did not
consider it practical, and did not attempt, to quantify, rank or
otherwise assign relative weights to the specific factors it
considered in reaching its decision and did not undertake to
make any specific determination as to whether any particular
factor, or any aspect of any particular factor, was favorable or
unfavorable to the ultimate determination of the special
committee. Rather, the special committee made its recommendation
based on the totality of information presented to it and the
investigation conducted by it. In considering the factors
discussed above, individual members of the special committee may
have given different weights to different factors.
Recommendation
of the Companys Board of Directors
After careful consideration, the Companys Board of
Directors (excluding Mr. Martell, who recused himself),
acting upon the unanimous recommendation of the special
committee of the Board of Directors:
|
|
|
|
|
has determined that the Proposed Transaction and the related
Proposals are advisable and in the best interests of the Company
and its stockholders;
|
27
|
|
|
|
|
recommends that the Companys stockholders vote
FOR the approval of the issuance of the Securities
(Proposal 1), the amendment to increase the number of
authorized shares of Company common stock (Proposal 2), the
amendment to give effect to the Reverse Stock Split
(Proposal 3), the amendment to provide that vacancies on
the Board of Directors shall be filled by the remaining
directors or director (Proposal 4), the adoption of the
Plan (Proposal 5) and the amendment to effect the Company
name change (Proposal 6); and
|
|
|
|
|
|
if necessary and appropriate, recommends the approval of the
adjournment of the special meeting to solicit additional proxies
if there are insufficient votes at the time of the special
meeting to adopt Proposals 1 through 5 (Proposal 7).
|
Financial
Advisors Opinion
Ladenburg made a presentation to our Board of Directors on
June 12, 2011 and subsequently delivered its written
opinion to the special committee of our Board of Directors. The
opinion stated that, as of June 12, 2011, based upon and
subject to the assumptions made, matters considered, procedures
followed and limitations on Ladenburgs review as set forth
in the opinion, the Proposed Transaction is fair, from a
financial point of view, to our stockholders. The financial
terms and other terms of the Proposed Transaction were
determined pursuant to negotiations between us, JPE and each of
our respective advisors and not pursuant to any recommendation
from Ladenburg.
The full text of Ladenburgs written opinion dated as of
June 12, 2011, which sets forth the assumptions made,
matters considered, procedures followed, and limitations on the
review undertaken by Ladenburg in rendering its opinion, is
attached as Annex B to this proxy statement and is
incorporated herein by reference. Ladenburgs opinion is
not intended to be, and does not constitute, a recommendation to
you as to how you should vote or act with respect to the
Proposed Transaction or any other matter relating thereto. The
summary of the Ladenburg opinion set forth in this proxy
statement is qualified in its entirety by reference to the full
text of the opinion. We urge you to read the opinion carefully
and in its entirety.
Ladenburgs opinion is for the use and benefit of our Board
of Directors in connection with its consideration of the
Proposed Transaction. Ladenburgs opinion may not be used
by any other person or for any other purpose without
Ladenburgs prior written consent. Ladenburgs opinion
should not be construed as creating any fiduciary duty on its
part to any party.
Ladenburg was not requested to opine as to, and its opinion does
not address, the relative merits of the Proposed Transaction as
compared to any alternative business strategy that might exist
for us, whether we should complete the Proposed Transaction, and
other alternatives to the Proposed Transaction that might exist
for us. Ladenburg has not been retained to render an opinion as
to whether the Proposed Transaction is the best reasonably
available to us. Ladenburg does not express any opinion as to
the underlying valuation or future performance of the Company or
the price at which our securities might trade at any time in the
future.
Ladenburgs analysis and opinion are necessarily based upon
market, economic and other conditions, as they existed on, and
could be evaluated as of, June 12, 2011. Accordingly,
although subsequent developments may affect its opinion,
Ladenburg assumed no obligation to update, review or reaffirm
its opinion to us or any other person.
In arriving at its opinion, Ladenburg took into account an
assessment of general economic, market and financial conditions,
as well as its experience in connection with similar
transactions and securities valuations generally. In so doing,
among other things, Ladenburg:
|
|
|
|
|
Reviewed a draft of the Investment Agreement dated as of
June 10, 2011;
|
|
|
|
Reviewed a draft of the Certificate of Designation of the
Preferred Stock as of June 10, 2011;
|
|
|
|
Reviewed a draft of the Warrant Certificate as of June 10,
2011;
|
28
|
|
|
|
|
Reviewed publicly available financial information and other data
with respect to the Company that it deemed relevant, including
its Annual Report on
Form 10-K
for the year ended December 31, 2010 and its Quarterly
Report on
Form 10-Q
for the quarter ended March 31, 2011;
|
|
|
|
Reviewed non-public information and other data with respect to
the Company, including financial projections for the five-year
period ending December 31, 2015 (the Standalone
Projections), and other internal financial information
and management reports;
|
|
|
|
Reviewed financial projections prepared by the Company and
BB&T, assuming one bolt-on acquisition per year starting in
2012 (Standalone with Acquisitions
Projections);
|
|
|
|
Reviewed financial projections assuming the Proposed Transaction
takes place (JPE Projections);
|
|
|
|
Reviewed and analyzed the Proposed Transactions pro forma
impact on the Companys outstanding securities and
stockholder ownership;
|
|
|
|
Considered the historical financial results and present
financial condition of the Company;
|
|
|
|
Reviewed certain publicly available information concerning the
trading of, and the trading market for, the Companys
common stock;
|
|
|
|
Reviewed and analyzed the Companys projected unlevered
free cash flows derived from the Standalone Projections and
prepared a discounted cash flow analysis;
|
|
|
|
Reviewed and analyzed certain financial characteristics of
publicly-traded companies that were deemed to have
characteristics comparable to the Company;
|
|
|
|
Reviewed and analyzed certain financial characteristics of
target companies in transactions where such target company was
deemed to have characteristics comparable to that of the Company;
|
|
|
|
Reviewed and compared the terms of the Proposed Transaction to
the terms of certain private investments in public equity
(PIPE) and follow-on offering transactions;
|
|
|
|
Reviewed and discussed with the Companys management, other
Company representatives, JPE and BB&T certain financial and
operating information furnished by them, including the
Standalone Projections, Standalone with Acquisitions Projections
and JPE Projections (collectively, the
Projections); and
|
|
|
|
Performed such other analyses and examinations as were deemed
appropriate.
|
In arriving at its opinion, with our consent, Ladenburg relied
upon and assumed, without assuming any responsibility for
independent verification, the accuracy and completeness of all
of the financial and other information that was supplied or
otherwise made available to Ladenburg and Ladenburg further
relied upon the assurances of our management that we were not
aware of any facts or circumstances that would make any such
information inaccurate or misleading. With respect to the
financial information and the Projections reviewed, Ladenburg
assumed that such information was reasonably prepared on a basis
reflecting the best currently available estimates and judgments,
and that such information provided a reasonable basis upon which
it could make its analysis and form an opinion. The Projections
were solely used in connection with the rendering of
Ladenburgs fairness opinion. Stockholders should not place
reliance upon such Projections, as they are not necessarily an
indication of what our revenues and profit margins will be in
the future. The Projections were prepared by our management, JPE
and BB&T and are not to be interpreted as projections of
future performance (or guidance) by the Company.
Ladenburg assumed that the Proposed Transaction will be
consummated in a manner that complies in all respects with
applicable foreign, federal, state and local laws, rules and
regulations. Ladenburg assumed, with our consent, that the final
executed forms of the Investment Agreement, Certificate of
Designation and Warrant Certificate do not differ in any
material respect from the drafts Ladenburg reviewed and that the
Proposed Transaction will be consummated on the terms set forth
in the Investment Agreement, without further amendments thereto,
and without waiver by the Company of conditions to any of its
obligations thereunder or in the alternative that any such
amendments or waivers thereto will not be detrimental to the
Company or its stockholders in any material respect.
29
In connection with rendering its opinion, Ladenburg performed
certain financial, comparative and other analyses as summarized
below. Each of the analyses conducted by Ladenburg was carried
out to provide a different perspective on the Proposed
Transaction, and to enhance the total mix of information
available. Ladenburg did not form a conclusion as to whether any
individual analysis, considered in isolation, supported or
failed to support its opinion. Further, the summary of
Ladenburgs analyses described below is not a complete
description of the analyses underlying Ladenburgs opinion.
The preparation of a fairness opinion is a complex process
involving various determinations as to the most appropriate and
relevant methods of financial analysis and the application of
those methods to the particular circumstances and, therefore, a
fairness opinion is not readily susceptible to partial analysis
or summary description. In arriving at its opinion, Ladenburg
made qualitative judgments as to the relevance of each analysis
and factors that it considered. Also, Ladenburg may have given
various analyses more or less weight than other analyses, and
may have deemed various assumptions more or less probable than
other assumptions, so that the range of valuations resulting
from any particular analysis described below should not be taken
to be Ladenburgs view of the value of our assets. The
estimates contained in Ladenburgs analyses and the ranges
of valuations resulting from any particular analysis are not
necessarily indicative of actual values or actual future
results, which may be significantly more or less favorable than
suggested by such analyses. Also, analyses relating to the value
of businesses or assets neither purport to be appraisals nor do
they necessarily reflect the prices at which businesses or
assets may actually be sold. Accordingly, Ladenburgs
analyses and estimates are inherently subject to substantial
uncertainty. Ladenburg believes that its analyses must be
considered as a whole and that selecting portions of its
analyses or the factors it considered, without considering all
analyses and factors collectively, could create a misleading or
incomplete view of the process underlying the analyses performed
by Ladenburg in connection with the preparation of its opinion.
The summaries of the financial reviews and analyses include
information presented in tabular format. To fully understand
Ladenburgs financial reviews and analyses, you must read
the tables together with the accompanying text of each summary.
The tables alone do not constitute a complete description of the
financial analyses, including the methodologies and assumptions
underlying the analyses, and if viewed in isolation could create
a misleading or incomplete view of the financial analyses
Ladenburg performed.
The analyses performed were prepared solely as part of
Ladenburgs analysis of the fairness of the Proposed
Transaction to our stockholders from a financial point of view,
and were provided to the special committee of our Board of
Directors in connection with the delivery of Ladenburgs
opinion. Ladenburgs opinion was just one of the several
factors the special committee and our Board of Directors took
into account in making its determination to approve the Proposed
Transaction, including those described elsewhere in this proxy
statement.
Analysis
of Terms
Ladenburg analyzed 41 convertible preferred and common stock
PIPEs and 34 follow-on offerings of U.S. traded companies
since January 2008, where the shares issued in all transactions
exceeded the shares outstanding at the time of the transaction
and the transaction values were between $20 million and
$1 billion. The analysis focused on the following terms:
|
|
|
|
|
Security discount/premium
|
|
|
|
Coupon
|
|
|
|
Warrant coverage
|
|
|
|
Warrant discount/premium
|
Ladenburg noted that the security discount and the coupon of the
Equity Investment are not outliers as compared to the universe
of reviewed transactions and they do not appear unreasonable
when compared to the terms of other transactions. However,
Ladenburg noted that the warrant coverage and warrant discount
are significantly higher than the mean and median of comparable
transactions, particularly those of profitable companies.
30
Valuation
Overview
Ladenburg reviewed three strategic alternatives deemed to be
currently available for the Company and generated an indicated
per share equity valuation range for each alternative.
The Standalone alternative assumed the Company
continues on its current growth trajectory with no future
acquisitions or capital raises. Ladenburg generated an indicated
valuation range for this alternative based on comparable company
analysis, comparable transaction analysis and discounted cash
flow analyses, each as more fully discussed below. Ladenburg
weighted the three approaches 60%, 20%, 20%, and arrived at an
indicated equity value per share range of approximately $2.20 to
approximately $2.60.
The Standalone with Acquisitions alternative assumed
the Company completes one bolt-on acquisition every year
(starting in 2012) and was based on the Standalone with
Acquisitions Projections prepared by the Company and BB&T.
Under this alternative, the Company would achieve accelerated
growth and increased scale and thus command a higher EBITDA
multiple at the end of the projection period (2015) than
under the Standalone alternative. Ladenburg generated an
indicated valuation range for this alternative based on
discounting the projected 2015 share price of $8.81 by
utilizing discount rates ranging from 19.5% to 20.5%, and
arrived at an indicated equity value per share range of
approximately $3.80 to approximately $3.90. For purposes of
Ladenburgs analyses, EBITDA means earnings
before interest, taxes, depreciation and amortization, as
adjusted for add-backs for non-cash stock compensation expenses
and one-time charges.
The JPE PIPE alternative assumed the Proposed
Transaction takes place and the Company would raise additional
capital subsequent to the Proposed Transaction to support
acquisitions. This alternative was based on the JPE Projections
prepared by JPE and BB&T and assumed that the Company, as a
result of its significantly increased size, would command a
higher EBITDA multiple at the end of the projection period
(2015) than under the Standalone with Acquisitions
alternative. Ladenburg generated an indicated valuation range
for this alternative based on discounting the projected
2015 share price of $10.63 by utilizing discount rates
ranging from 20.5% to 25.5%, and arrived at an indicated equity
value per share range of approximately $3.80 to approximately
$4.50.
Ladenburg noted that the indicated equity value per share range
in the JPE PIPE alternative was higher than the indicated value
ranges in the other two alternatives.
Standalone
Comparable Company Analysis
A selected comparable company analysis reviews the trading
multiples of publicly traded companies that are similar to the
Company with respect to business and revenue model, operating
sector, size and target customer base.
31
Ladenburg identified the following 13 companies that it
deemed comparable to the Company with respect to their industry
sector and operating model:
Large-Cap
Comparables:
|
|
|
|
|
CH Robinson Worldwide Inc.
|
|
|
|
Expeditors International of Washington Inc.
|
Mid-Cap
Comparables:
|
|
|
|
|
Landstar System Inc.
|
|
|
|
Uti Worldwide Inc.
|
|
|
|
Hub Group Inc.
|
|
|
|
Forward Air Corp.
|
|
|
|
Roadrunner Transportation Systems, Inc.
|
|
|
|
Echo Global Logistics, Inc.
|
|
|
|
Quality Distribution Inc.
|
|
|
|
Universal Truckload Services Inc.
|
|
|
|
Pacer International Inc.
|
Small-Cap
Comparables:
|
|
|
|
|
AutoInfo Inc.
|
|
|
|
US1 Industries Inc.
|
Multiples utilizing enterprise value were used in the analyses.
For comparison purposes, all operating profits including EBITDA
were normalized to exclude unusual and extraordinary expenses
and income. For purposes of Ladenburgs analyses,
enterprise value means equity value plus all
interest-bearing debt less cash.
Ladenburg generated the following multiples worth noting with
respect to the comparable companies:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Enterprise Value Multiple
of
|
|
Mean
|
|
|
Median
|
|
|
High
|
|
|
Low
|
|
|
LTM EBITDA All Comparables
|
|
|
11.1
|
x
|
|
|
11.7
|
x
|
|
|
17.8
|
x
|
|
|
5.1
|
x
|
LTM EBITDA Small-Cap Comparables
|
|
|
5.8
|
x
|
|
|
5.8
|
x
|
|
|
6.6
|
x
|
|
|
5.1
|
x
|
The Company, from a size perspective, is most comparable to the
Small-Cap Comparables. Ladenburg noted that the Small-Cap
Comparables are less profitable than the Company, with EBITDA
margins ranging from approximately 2.1% to 2.9%, compared with
the Companys approximately 6.2%. Further, the Small-Cap
Comparables experienced lower growth than the Company, with
one-year EBITDA growth average of 55.8%, compared with the
Companys approximately 68.4%. In addition, AutoInfos
leverage is significantly higher than that of the Company.
Ladenburg selected an appropriate multiple range for the Company
by examining the range indicated by the comparable companies and
taking into account certain company-specific factors. Ladenburg
selected multiples above the mean of the Small-Cap Comparable
companies to reflect the Companys higher growth and lower
leverage. Based on the above factors, Ladenburg applied EBITDA
multiples of 6.5x to 7.5x to the Companys LTM EBITDA, and
calculated a range of indicated enterprise values for the
Company. Ladenburg then deducted net debt of approximately
$2.0 million to derive a per share range of equity values
of approximately $1.90 to approximately $2.30, based on
approximately 34.0 million outstanding shares and
in-the-money
options/warrants utilizing the treasury stock method.
32
None of the comparable companies have characteristics identical
to the Company. An analysis of publicly-traded comparable
companies is not mathematical; rather it involves complex
considerations and judgments concerning differences in financial
and operating characteristics of the comparable companies and
other factors that could affect the public trading of the
comparable companies.
Standalone
Comparable Transaction Analysis
A comparable transaction analysis involves a review of merger,
acquisition and asset purchase transactions involving target
companies that are in related industries to the Company. The
comparable transaction analysis generally provides the widest
range of values due to the varying importance of an acquisition
to a buyer (i.e., a strategic buyer willing to pay more than a
financial buyer) in addition to the potential differences in the
transaction process (i.e., competitiveness among potential
buyers).
Ladenburg located 25 transactions announced since January 2008
involving target companies providing freight transport and
logistics services and for which financial information was
available.
|
|
|
Target
|
|
Acquiror
|
|
DBA Distribution Services, Inc.
|
|
Radiant Logistics, Inc. (OTCPK:RLGT)
|
Wim Bosman Holding B.V.
|
|
Mainfreight Limited (NZSE:MFT)
|
Dynamex Inc.
|
|
TransForce Inc. (TSX:TFI)
|
Morgan Southern, Inc.
|
|
Roadrunner Transportation Systems (NYSE:RRTS)
|
Total Logistic Control LLC
|
|
Ryder Integrated Logistics Inc.
|
ATC Technology Corporation
|
|
Laxey Partners Ltd.
|
Mar-Ter Spedizioni S.p.A.
|
|
Mid Industry Capital SpA (BIT:MIC)
|
Summit Logistics International
|
|
Toll Holdings Ltd.
|
Air Tiger Express Companies, Inc.
|
|
Kawasaki Kisen Kaisha Ltd. (TSE:9107)
|
Livingston International Income Fund
|
|
Sterling Partners; CPP Investment Board
|
RayTrans Distribution Services, Inc.
|
|
Echo Global Logistics, Inc. (NasdaqGS:ECHO)
|
Adcom Express, Inc.
|
|
Radiant Logistics, Inc. (OTCPK:RLGT)
|
LGT Logistics Holding AB
|
|
Axcel Industriinvestor A/S
|
J Martens AS
|
|
Kuehn & Nagel International AG (SWX:KNIN)
|
ATS Andlauer Transportation Services Limited Partnership
|
|
Andlauer Management Group Inc.
|
ELI-Logistik GmbH
|
|
Wincanton plc (LSE:WIN)
|
Alloin Transports
|
|
Kuehne & Nagel International AG (SWX:KNIN)
|
ABX LOGISTICS Worldwide S.A./N.V.
|
|
DSV A/S (CPSE:DSV)
|
CrossGlobe Group
|
|
Pine Creek Partners
|
Service Express, Inc.
|
|
Forward Air Solutions, Inc.
|
Transera International Logistics Ltd.
|
|
CH Robinson Worldwide Inc. (NasdaqGS:CHRW)
|
Compagnie Européenne de Prestations Logistiques SAS
|
|
Arcapita Bank B.S.C.(c); European Capital Ltd.
|
Groupe Malherbe
|
|
Natixis Investissement Partners
|
Pinch Holdings, Inc.
|
|
Forward Air Corp.
|
Concert Group Logistics, Inc.
|
|
Express-1 Expedited Solutions, Inc. (AMEX:XPO)
|
Based on the information disclosed with respect to the targets
in each of the comparable transactions, Ladenburg calculated and
compared the enterprise values as a multiple of LTM revenue and
LTM EBITDA.
Ladenburg noted the following with respect to the multiples
generated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Multiple of Enterprise Value
to
|
|
Mean
|
|
|
Median
|
|
|
High
|
|
|
Low
|
|
|
LTM revenue
|
|
|
0.69
|
x
|
|
|
0.49
|
x
|
|
|
3.33
|
x
|
|
|
0.18
|
x
|
LTM EBITDA
|
|
|
7.7
|
x
|
|
|
6.9
|
x
|
|
|
13.9
|
x
|
|
|
4.5
|
x
|
Ladenburg selected an appropriate multiple range for the Company
by examining the range indicated by the comparable companies and
taking into account certain company-specific factors. Based on
the above
33
factors, Ladenburg applied EBITDA multiples of 7.0x to 8.0x to
the Companys LTM EBITDA, and calculated a range of
indicated enterprise values for the Company. Ladenburg then
deducted net debt of approximately $2.0 million to derive a
per share range of equity values of approximately $2.10 to
approximately $2.40, based on approximately 34.0 million
outstanding shares and
in-the-money
options/warrants utilizing the treasury stock method.
None of the target companies in the comparable transactions have
characteristics identical to the Company. Accordingly, an
analysis of comparable business combinations is not
mathematical; rather it involves complex considerations and
judgments concerning differences in financial and operating
characteristics of the target companies in the comparable
transactions and other factors that could affect the respective
acquisition values.
Standalone
Discounted Cash Flow Analysis
A discounted cash flow analysis estimates value based upon a
companys projected future free cash flow discounted at a
rate reflecting risks inherent in its business and capital
structure. Unlevered free cash flow represents the amount of
cash generated and available for principal, interest and
dividend payments after providing for ongoing business
operations.
While the discounted cash flow analysis is the most scientific
of the methodologies used, it is dependent on projections and is
further dependent on numerous industry-specific and
macroeconomic factors.
Ladenburg utilized the Standalone Projections, which forecast a
compound annual growth rate, or CAGR, of approximately 32.6%
EBITDA growth from fiscal year, or FY, 2010 through FY2013,
representing an EBITDA margin improvement from approximately
6.5% to approximately 8.4% and a revenue CAGR of approximately
21.8%.
To arrive at a present value, Ladenburg utilized discount rates
ranging from 15.0% to 17.0%. This was based on an estimated
weighted average cost of capital of 16.0% (based on an estimated
weighted average cost of debt of 2.5% and 17.5% estimated cost
of equity). The cost of equity calculation was derived utilizing
the unlevered beta of the comparable companies, the appropriate
equity risk and size premiums and a company specific risk
factor, reflecting the risks associated with the Standalone
Projections, including, but not limited to, achieving the
projected revenue and EBITDA growth.
Ladenburg presented a range of terminal values at the end of the
forecast period by applying a range of terminal exit multiples
based on EBITDA as well as long term perpetual growth.
Utilizing terminal EBITDA multiples of between 5.5x and 6.5x and
long term perpetual growth rates of between 4.5% and 5.5%,
Ladenburg calculated a range of indicated enterprise values and
then deducted net debt of approximately $2.0 million to
derive a per share range of equity values of approximately $3.00
to approximately $3.80, based on approximately 34.0 million
outstanding shares and
in-the-money
options/warrants utilizing the treasury stock method.
Conclusion
Based on the information and analyses set forth above, Ladenburg
delivered its written opinion to the special committee of our
Board of Directors, which stated that, as of June 12, 2011,
based upon and subject to the assumptions made, matters
considered, procedures followed and limitations on its review as
set forth in the opinion, the Proposed Transaction is fair, from
a financial point of view, to the Companys stockholders.
As part of its investment banking business, Ladenburg regularly
is engaged in the evaluation of businesses and their securities
in connection with mergers, acquisitions, corporate
restructurings, negotiated underwritings, private placements and
for other purposes. We determined to use the services of
Ladenburg because it is a recognized investment banking firm
that has substantial experience in similar matters. Ladenburg
has received a fee of $140,000, of which $90,000 was paid upon
execution of the engagement letter and $40,000 was paid when
Ladenburg notified the Company that Ladenburg was prepared to
deliver the opinion. Ladenburg is also entitled to reimbursement
for its reasonable expenses, including attorneys fees.
34
Also, we have agreed to indemnify Ladenburg and related persons
and entities for certain liabilities that may relate to, or
arise out of, its engagement. Further, Ladenburg has not
previously provided, nor are there any pending agreements to
provide, any other services to us.
In the ordinary course of business, Ladenburg, certain of
Ladenburgs affiliates, as well as investment funds in
which Ladenburg or its affiliates may have financial interests,
may acquire, hold or sell long or short positions, or trade or
otherwise effect transactions in debt, equity and other
securities and financial instruments (including bank loans and
other obligations) of, or investments in, the Company or any
other party that may be involved in the Proposed Transaction and
their respective affiliates.
Ownership
Upon Closing
Set forth below is a table depicting the ownership of Company
common stock upon the closing of the Proposed Transaction, based
on the following assumptions (and without giving effect to the
Reverse Stock Split):
|
|
|
|
|
the number of outstanding shares of Company common stock is
based upon the number outstanding as of the record date of
August 1, 2011;
|
|
|
|
|
|
the Preferred Stock is immediately converted at the closing;
|
|
|
|
the Warrants are immediately exercised at the closing; and
|
|
|
|
no options for the purchase of Company common stock will be
exercised.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of Shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
of
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock Owned
|
|
|
|
|
|
|
Shares of
|
|
|
Preferred
|
|
|
Common Stock Owned
|
|
|
Number of
|
|
|
Common Stock Owned
|
|
|
Assuming Conversion of all
|
|
|
|
|
|
|
Common
|
|
|
Stock
|
|
|
Assuming Conversion
|
|
|
Warrants
|
|
|
Assuming Exercise of
|
|
|
Preferred Stock and Exercise
|
|
|
|
|
Name
|
|
Stock Owned
|
|
|
Owned
|
|
|
of all Preferred Stock
|
|
|
Owned
|
|
|
all Warrants
|
|
|
of all Warrants
|
|
|
|
|
|
|
|
|
|
|
|
|
# of Shares
|
|
|
% of
|
|
|
|
|
|
# of Shares
|
|
|
% of
|
|
|
# of Shares of
|
|
|
% of
|
|
|
|
|
|
|
|
|
|
|
|
|
of Common
|
|
|
Common
|
|
|
|
|
|
of Common
|
|
|
Common
|
|
|
Common
|
|
|
Common
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
|
Stock
|
|
|
|
|
|
Stock
|
|
|
Stock
|
|
|
Stock
|
|
|
Stock
|
|
|
|
|
Investors
|
|
|
38,160
|
|
|
|
75,000
|
|
|
|
42,895,303
|
|
|
|
56.5
|
|
|
|
42,857,143
|
|
|
|
42,895,303
|
|
|
|
56.5
|
|
|
|
85,752,446
|
|
|
|
72.2
|
|
|
|
|
|
Other Stockholders
|
|
|
32,973,401
|
|
|
|
0
|
|
|
|
32,973,401
|
|
|
|
43.5
|
|
|
|
0
|
|
|
|
32,973,401
|
|
|
|
43.5
|
|
|
|
32,973,401
|
|
|
|
27.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
33,011,561
|
|
|
|
75,000
|
|
|
|
75,868,704
|
|
|
|
|
|
|
|
42,857,143
|
|
|
|
75,868,704
|
|
|
|
|
|
|
|
118,725,847
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Use of
Proceeds
The Company expects to use the proceeds of the Equity Investment
primarily to make strategic acquisitions and any balance will be
used for general corporate purposes.
Interests
of the Companys Directors and Executive Officers in the
Proposed Transaction
In considering the recommendation of the Board of Directors that
you vote to approve the Proposals, you should be aware that
aside from their interests as Company stockholders, the
Companys directors and executive officers have interests
in the Proposed Transaction that may be different from, or in
addition to, those of other Company stockholders generally. The
members of the special committee and the Board of Directors were
aware of and considered these interests, among other matters, in
evaluating and negotiating the Proposed Transaction, and in
recommending to the Companys stockholders that the
Proposals be approved. See the section entitled The
Proposed TransactionBackground of the Proposed
Transaction beginning on page 17. The
Companys stockholders should take these interests into
account in deciding whether to vote FOR the approval
and adoption of the Proposals.
As described in more detail below, the interests of the
Companys directors and executive officers in the Proposed
Transaction that are different from, or in addition to, those of
other Company stockholders may include:
|
|
|
|
|
the accelerated vesting of option awards held by our directors
and executive officers under certain circumstances, in each case
following consummation of the Equity Investment;
|
35
|
|
|
|
|
in the case of executive officers, the receipt of certain
severance payments and benefits upon termination of employment
under certain circumstances following consummation of the Equity
Investment; and
|
|
|
|
|
|
in the case of Messrs. Michael Welch, John Welch and Para,
the grant of new option awards.
|
In addition, James Martell, who is currently the Chairman of the
Board of Directors, will continue as a director following the
closing and will participate with JPE as an Investor in the
Proposed Transaction. Mr. Martell recused himself from the
activities of the Board of Directors relating to the Proposed
Transaction after being advised that JPE was interested in
having Mr. Martell remain on the Board post-closing and
that, if Mr. Martell desired, JPE would extend to
Mr. Martell an opportunity to invest in the Proposed
Transaction along with JPE.
These interests are described in more detail below, and certain
of them are quantified in the tables that follow the narrative
below.
Company
Stock Options
The Investment Agreement does not provide for special treatment
of outstanding options to purchase shares of our common stock,
and outstanding options do not automatically vest under the
terms of our stock option plan as a result of the Proposed
Transaction. As discussed in more detail under
Employment Agreements with Executive
Officers on page 36 and
Arrangements with our Directors on
page 38, pursuant to their amended employment agreements,
unvested options granted prior to June 13, 2011 and held by
our executive officers and Daniel Para, a director of the
Company and Chief Executive Officer of Concert Group Logistics,
Inc., a wholly owned subsidiary of the Company, will vest and
become immediately exercisable upon consummation of the Equity
Investment. In consideration for accelerating the vesting of
unvested options and the grant of new options, each executive
officer and Mr. Para agreed to significantly expand the scope of
his restrictive covenants with respect to duration, definition
of competitive activities and geographic restrictions and agreed
that a certain number of the shares of Company common stock
issued upon exercise of such options will be subject to a
lock-up. Except for the options held by Mr. Martell, each
unvested option held by our non-employee directors will vest and
become immediately exercisable upon consummation of the Equity
Investment, at which time such directors services on the
Board of Directors will cease.
Employment
Agreements with Executive Officers
We have previously entered into employment agreements with each
of Messrs. Michael Welch, as Chief Executive Officer, and
John Welch, as Chief Financial Officer. In connection with the
Proposed Transaction, we have entered into amendments to these
employment agreements, dated July 18, 2011. The amended
employment agreements are effective immediately upon execution
but will be null and void and of no further force or effect if
the Equity Investment is not consummated. Pursuant to the
amended employment agreements, the term of each of
Messrs. Michael Welchs and John Welchs
employment agreement was extended until the third anniversary of
the consummation of the Equity Investment.
Pursuant to the amended employment agreements, unvested options
granted prior to June 13, 2011 and held by our executive
officers as of the closing will vest and become immediately
exercisable upon consummation of the Equity Investment. In
addition, a certain number of shares of Company common stock
that are issued to Messrs. Michael Welch and John Welch
upon exercise of any options that were granted to them prior to
June 13, 2011 will be subject to a lock-up until the third
anniversary and first anniversary, respectively, of the
consummation of the Equity Investment. In the case of
Mr. Michael Welch, the lock-up is with respect to
60,000 shares of Company common stock, and in the case of
Mr. John Welch, the lock-up is with respect to
5,000 shares of Company common stock.
Under the amended agreements with each of Messrs. Michael
Welch and John Welch, if the executive officers employment
is terminated without cause (as defined in the employment
agreements), or if the executive officer resigns for good reason
(as defined in the employment agreements) within one year
36
following a change in control (as defined in the employment
agreements), such as the Proposed Transaction, then the
executive officer will receive:
|
|
|
|
|
a lump-sum payment equal to the sum of (a) one years
base salary and (b) the greater of (1) the executive
officers performance-based bonus payments for the year
preceding the date of termination or (2) the executive
officers average annual performance-based bonus during the
two years immediately preceding the termination; and
|
|
|
|
|
|
one year of continued benefits for the executive officer and his
dependents under all health, dental, disability, accident and
life insurance plans or arrangements in which the executive
officer or his dependents were participating immediately prior
to the date of the executive officers termination.
|
Under their respective amended employment agreements with the
Company, Messrs. Michael Welch and John Welch are subject
to certain restrictive covenants regarding competition,
solicitation, interference, confidentiality and disparagement.
Prior to amending their employment agreements,
Messrs. Michael Welch and John Welch were subject to
competition and solicitation covenants during their employment
and for the one-year period following termination of their
employment, and a confidentiality covenant that applied during
employment and at all times thereafter. In consideration for
extending the term of his employment agreement, accelerating the
vesting of unvested options and the grant of stock options
(described below) and, in the case of Mr. John Welch, increasing
his annual base salary from $160,000 to $180,000, each named
executive officer agreed to significantly expand the scope of
his restrictive covenants with respect to duration, definition
of competitive activities and geographic restrictions. The
non-competition, customer non-solicitation and
non-interference
covenants apply during their employment and for the three-year
period following the termination of their employment, the
employee non-solicitation covenant applies during their
employment and for the five-year period following the
termination of their employment and the confidentiality and
non-disparagement covenants apply during their employment and at
all times thereafter.
Pursuant to the amended employment agreements, each of
Messrs. Michael Welch and John Welch received a grant of
options to purchase shares of Company common stock on
July 22, 2011, with an exercise price per share of $4.23,
the closing price per share of Company common stock on such
date. Messrs. Michael Welch and John Welch received 200,000
and 175,000 options to purchase shares of Company common stock,
respectively. The options will vest, subject to the executive
officers continued employment with the Company, in three
equal annual installments on each anniversary of the
consummation of the Equity Investment. For the avoidance of
doubt, none of the options that were granted to Messrs. Michael
Welch and John Welch on July 22, 2011 will accelerate
vesting upon consummation of the Proposed Transaction, and the
Proposed Transaction will not constitute a change in control of
the Company for purposes of such options. Under the amended
employment agreements, Messrs. Michael Welch and John Welch
are each subject to an option clawback provision. In the event
of a breach of the restrictive covenants contained in their
amended employment agreements with the Company, the termination
of the executive officers employment by the Company for
cause or any financial restatements or material loss to the
Company to which the executive officer has materially
contributed due to the executives fraud or willful
misconduct, any unexercised options (whether vested or unvested)
that were granted on or after June 13, 2011 and that the
executive holds at the time of such breach, termination or
misconduct, as applicable, will be immediately forfeited.
The following definitions apply to the amended employment
agreements with each of Messrs. Michael Welch and John
Welch.
Cause, for purposes of the amended employment
agreements, generally means (i) the executive
officers material violation of any of the provisions of
their employment agreement, or the rules, policies,
and/or
procedures of the Company, or commission of any material act of
fraud, misappropriation, breach of fiduciary duty or theft
against or from the Company, (ii) the executive
officers violation of any law, rule or regulation of a
governmental authority or regulatory body with jurisdiction over
the Company or the executive officer relative to the conduct of
the executive officer in connection with the Companys
business or its securities or (iii) the conviction of the
executive officer of a felony under the laws of the United
States of America or any state therein. In the event the
executive officer engages in conduct described in
clauses (i) or (ii) of the definition of cause, the
executive officer will have an opportunity to cure such conduct
within
37
30 days after the Company provides written notice to the
executive officer. If the executive officer fails to cure such
conduct within the
30-day
period or, if the executive officer commits the same violation
within 12 months of receiving notice from the Company, then
the Company may terminate the executive officers
employment for cause.
Good reason, for purposes of the amended
employment agreements, will exist if, without the executive
officers express written consent (i) the Company
assigns to the executive officer duties of a non-executive
nature or for which the executive officer is not reasonably
equipped by his skills and experience, (ii) the Company
reduces the salary of the executive officer, or materially
reduces the amount of paid vacations to which he is entitled, or
his fringe benefits and perquisites, (iii) the Company
requires the executive officer to relocate his principal
business office or his principal place of residence greater than
50 miles outside of St. Joseph, Michigan, or assigns to the
executive officer duties that would reasonably require such
relocation, (iv) the Company requires the executive
officer, or assigns duties to the executive officer that would
reasonably require him, to spend more than 60 normal working
days away from the St. Joseph, Michigan area during any
consecutive
12-month
period, (v) the Company fails to provide office facilities,
secretarial services and other administrative services to the
executive officer, which are substantially equivalent to the
facilities and services provided to executive officer on the
date the executive officer entered into the employment agreement
or (vi) the Company terminates incentive plans and benefit
plans or arrangements, or reduces or limits the executive
officers participation therein relative to the level of
participation of other executives of similar rank, to such an
extent as to materially reduce the aggregate value of the
executive officers incentive compensation and benefits
below their aggregate value as of the date the executive officer
entered into the employment agreement. In the case of
Mr. John Welch, pursuant to his amended employment
agreement, good reason will also exist if the
Company replaces him as Chief Financial Officer. Notwithstanding
the existence of an event constituting good reason, a
termination shall not be considered to be for good reason unless
the executive officer notifies the Company of the existence of
the condition constituting good reason within 45 days
following the initial existence thereof, the Company fails to
remedy the condition within 30 days following receipt of
such notice, and the executive officer terminates employment
within the earlier of 90 days following the initial
existence of such condition and 15 days following notice
from the Company that it will not remedy such condition.
Arrangements
with our Directors
Amended
Employment Agreement with Mr. Para
We have previously entered into an employment agreement with
Mr. Para, a director of the Company, in his capacity as
Chief Executive Officer of Concert Group Logistics, Inc. In
connection with the Proposed Transaction, we have entered into
an amendment to Mr. Paras employment agreement, dated
July 18, 2011, which extends the term of his employment
agreement to the third anniversary of the consummation of the
Equity Investment. The amended employment agreement is effective
immediately upon execution but will be null and void and of no
further force or effect if the Equity Investment is not
consummated.
Pursuant to his amended employment agreement, unvested options
granted prior to June 13, 2011 and held by Mr. Para as
of the closing will vest and become immediately exercisable upon
consummation of the Equity Investment. In addition,
60,000 shares of Company common stock that are issued to
Mr. Para upon exercise of any options that were granted to
him prior to June 13, 2011 will be subject to a lock-up
until the third anniversary of the consummation of the Equity
Investment.
Under the amended employment agreement with Mr. Para, if
his employment is terminated without cause (as defined in his
employment agreement), or if Mr. Para resigns for good
reason (as defined in his employment agreement) within one year
following a change in control (as defined in his employment
agreement), such as the Proposed Transaction, then Mr. Para
will receive:
|
|
|
|
|
a lump-sum payment equal to the sum of
(a) 18-months
base salary and (b) the greater of
(1) Mr. Paras performance-based bonus payments
for the year preceding the date of termination or
(2) Mr. Paras average annual performance-based
bonus during the two years immediately preceding the date of
termination; and
|
38
|
|
|
|
|
18-months
continued benefits for Mr. Para and his dependents under
all health, dental, disability, accident and life insurance
plans or arrangements in which Mr. Para or his dependents
were participating immediately prior to the date of
Mr. Paras termination.
|
Under his amended employment agreement, if Mr. Paras
employment is terminated without cause at any time other than
within one year following a change in control, such as the
Proposed Transaction, then Mr. Para will receive any bonus
that the Company has determined in writing has been earned as of
the date of termination plus base salary for the
18-month
period following termination (which, pursuant to his amended
employment agreement, was increased from the one-year period
following termination), payable in accordance with the
Companys normal payroll practices.
Under his amended employment agreement, Mr. Para is subject
to the same restrictive covenants and option clawback provisions
to which Messrs. Michael Welch and John Welch are subject.
Prior to amending his employment agreement, Mr. Para was
subject to competition and solicitation covenants during his
employment and for the one-year period following termination of
his employment, and a confidentiality covenant that applied
during employment and at all times thereafter. In consideration
for extending the term of his employment agreement, increasing
his annual base salary from $180,000 to $240,000, increasing his
severance payments, accelerating the vesting of his unvested
options and the grant of stock options (described below),
Mr. Para agreed to significantly expand the scope of his
restrictive covenants with respect to duration, definition of
competitive activities and geographic restrictions.
In addition, pursuant to his amended employment agreement,
Mr. Para received a grant of 200,000 options to purchase
shares of Company common stock on July 22, 2011, with an
exercise price per share of $4.23, the closing price per share
of Company common stock on such date. The options will vest on
terms substantially similar to the options that were granted to
Messrs. Michael Welch and John Welch on July 22, 2011.
For the avoidance of doubt, none of the options that were
granted to Mr. Para on July 22, 2011 will accelerate vesting
upon consummation of the Proposed Transaction, and the Proposed
Transaction will not constitute a change in control of the
Company for purposes of such options.
In addition, the definitions contained in Mr. Paras
amended employment agreement are identical to the definitions
contained in the amended employment agreement with
Mr. Michael Welch, except that (a) clause (i) of
the definition of good reason applies only if the Company
assigns to Mr. Para a position or duties that the Company
does not consider to be at the managerial level and
(b) clauses (iii) and (iv) of the definition of
good reason apply with respect to the greater Chicago
metropolitan area instead of St. Joseph, Michigan. As with the
employment agreements with Messrs. Michael Welch and John
Welch, the Proposed Transaction will be a change of control
under Mr. Paras employment agreement.
Arrangements
with Other Directors
Under the terms of the option award agreement for options
granted to directors pursuant to the Companys Amended and
Restated 2001 Stock Option Plan, if, within one year following a
change in control of the Company (which includes the Proposed
Transaction), the directors service as a member of the
Board of Directors ceases for any reason, then any unvested
options held by such director will immediately vest and become
exercisable upon the cessation of service. Pursuant to the
Investment Agreement, with the exception of Mr. James
Martell, the service of the Companys current directors
will terminate upon the consummation of the Proposed Transaction
and their outstanding options will vest and become exercisable
at such time.
Mr. Martell, who is currently Chairman of the Board of
Directors, and who will continue as a director following the
consummation of the Proposed Transaction, will be an Investor in
the Proposed Transaction. The details of Mr. Martells
investment are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Number of Shares
|
|
|
|
|
|
|
Shares of
|
|
|
of Common Stock
|
|
|
Aggregate
|
|
|
|
Preferred
|
|
|
Subject to
|
|
|
Purchase
|
|
Director
|
|
Stock(1)
|
|
|
Warrants(2)
|
|
|
Price
|
|
|
|
|
James J. Martell
|
|
|
725
|
|
|
|
414,286
|
|
|
$
|
725,000
|
|
39
|
|
|
(1) |
|
Shares of Preferred Stock have an initial conversion price of
$1.75 per share of Company common stock, without giving effect
to the Reverse Stock Split. Giving effect to the Reverse Stock
Split, shares of Preferred Stock have an initial conversion
price of $7.00 per share of Company common stock. |
|
|
|
(2) |
|
Share numbers in this column do not give effect to the Reverse
Stock Split. The initial exercise price of the Warrants is $1.75
per share of Company common stock, without giving effect to the
Reverse Stock Split. Giving effect to the Reverse Stock Split,
the initial exercise price of the Warrants is $7.00 per share of
Company common stock. |
Quantification
of Payments and Benefits
The following table shows the amounts of payments and benefits
that each director and executive officer of the Company would
receive in connection with the Proposed Transaction, assuming
the consummation of the Proposed Transaction occurred on
August 1, 2011, the latest practicable date prior to the
mailing of this proxy statement, and, as applicable, the service
of the director ceased and the employment of the executive
officer was terminated by the Company without cause or by the
executive officer for good reason, in each case, on such date.
Executive
Officers and Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Perquisites and
|
|
|
|
Name
|
|
|
Cash
($)(1)
|
|
|
Equity ($)
|
|
|
Benefits
($)(2)
|
|
|
Total ($)
|
Executive Officers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Michael R. Welch
|
|
|
|
391,900
|
|
|
|
|
88,827(3
|
)
|
|
|
|
5,909
|
|
|
|
|
486,636
|
|
President and Chief
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John D. Welch Chief
|
|
|
|
256,000
|
|
|
|
|
34,886(3
|
)
|
|
|
|
5,717
|
|
|
|
|
296,603
|
|
Financial Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Director
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Daniel Para Director,
|
|
|
|
407,300
|
|
|
|
|
102,857(3
|
)
|
|
|
|
7,926
|
|
|
|
|
518,083
|
|
President and Chief
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive Officers of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Concert Group Logistics,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-employee Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
James J. Martell
|
|
|
|
|
|
|
|
|
24,255(4
|
)
|
|
|
|
|
|
|
|
|
24,255
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jay N. Taylor
|
|
|
|
|
|
|
|
|
25,022(4
|
)
|
|
|
|
|
|
|
|
|
25,022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Calvin (Pete) R. Whitehead
|
|
|
|
|
|
|
|
|
24,017(4
|
)
|
|
|
|
|
|
|
|
|
24,017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jennifer H. Dorris
|
|
|
|
|
|
|
|
|
34,994(4
|
)
|
|
|
|
|
|
|
|
|
34,994
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John F. AffleckGraves
|
|
|
|
|
|
|
|
|
22,890(4
|
)
|
|
|
|
|
|
|
|
|
22,890
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
As described above, the cash payments to the named executive
officers and Mr. Para consist of (a) a lump-sum
payment equal to the sum of the employees one years
base salary, in the case of Messrs. Michael Welch and John
Welch, or 18-months base salary, in the case of Mr. Para,
and (b) the greater of (1) his
performance-based
bonus payments for the year preceding the date of termination or
(2) his average annual bonus during the two years
immediately preceding the termination payment, in each case,
payable upon a qualifying termination of employment following
the consummation of the Equity Investment. The salary and bonus
components of the cash severance, respectively, for each
employee are as follows: (i) Mr. Michael
Welch $240,000 and $151,900; (ii) Mr. John
Welch $180,000 and $76,000; and
(ii) Mr. Para $240,000 and $47,300. The
cash payments are double-trigger in that they |
40
|
|
|
|
|
are payable upon a qualifying termination of the executive
officers employment within one year following consummation
of the Proposed Transaction. These cash payments are based on
each employees base salary as of August 1, 2011 and
bonus payments made with respect to 2010 and 2009. As a result,
if the employees base salary or bonus payment increases
prior to the date the employees employment is terminated,
actual payment to the employee may be greater than set forth in
this table. |
|
|
|
(2) |
|
The amounts in this column represent the aggregate incremental
cost to the Company with respect to continued health and welfare
benefits to be provided to the employee and his dependents for a
period of one year, in the case of Messrs. Michael Welch
and John Welch, or 18 months, in the case of Mr. Para,
following a qualifying termination of employment within one year
following consummation of the Proposed Transaction. The Company
has assumed, for purposes of the calculation, that the costs to
the Company for the relevant period will be the same as the
costs to the Company for 2010. |
|
|
|
(3) |
|
As described above, the equity amounts for Messrs. Michael
Welch, John Welch and Para consist of accelerated vesting of
unvested option awards, which is single-trigger in
that, pursuant to their amended employment agreements, unvested
options granted prior to June 13, 2011 and held by our
executive officers and Mr. Para as of consummation of the Equity
Investment will vest and become immediately exercisable upon
consummation of the Equity Investment. The value of the option
awards is based on the average per share closing price of
Company common stock over the five business days following
public announcement of the Proposed Transaction, or $2.772. As a
result, if the per share price of Company common stock increases
prior to the date the holder exercises the option award, the
actual equity amount may be greater than set forth in this table. |
|
|
|
(4) |
|
As described above, the equity amounts for our non-employee
directors consist of accelerated vesting of unvested option
awards, which is double-trigger in that it will
occur immediately upon cessation of services on the board for
any reason, in each case, within one year following consummation
of the Proposed Transaction. Pursuant to the Investment
Agreement, with the exception of Mr. James Martell, the
service of each of the Companys current directors will
terminate upon the consummation of the Proposed Transaction and
their outstanding options will vest and become exercisable at
such time. The value of the option awards is based on the
average per share closing price of Company common stock over the
five business days following public announcement of the Proposed
Transaction, or $2.772. As a result, if the per share price of
Company common stock increases prior to the date the holder
exercises the option award, the actual equity amounts may be
greater than set forth in this table. |
Payment
in Respect of Vested Options
|
|
|
|
|
|
|
|
|
|
|
|
|
Resulting Consideration
|
|
|
Number of Shares Underlying
|
|
from Vested Option
|
Name
|
|
Vested Option
Awards(#)(1)
|
|
Awards($)(2)
|
|
Executive Officers
|
|
|
|
|
|
|
|
|
Michael Welch
|
|
|
425,000
|
|
|
|
784,033
|
|
John Welch
|
|
|
45,111
|
|
|
|
64,742
|
|
Directors
|
|
|
|
|
|
|
|
|
Daniel
Para(1)
|
|
|
57,639
|
|
|
|
93,393
|
|
James J. Martell
|
|
|
284,722
|
|
|
|
493,125
|
|
Jay N. Taylor
|
|
|
181,944
|
|
|
|
335,878
|
|
Calvin (Pete) R. Whitehead
|
|
|
184,722
|
|
|
|
339,633
|
|
Jennifer H. Dorris
|
|
|
178,472
|
|
|
|
329,656
|
|
John F. AffleckGraves
|
|
|
160,417
|
|
|
|
243,460
|
|
|
|
|
(1) |
|
Share numbers in this column do not give effect to the Reverse
Stock Split. |
|
|
|
(2) |
|
The value of the option awards is based on the average per share
closing price of the Company common stock over the five business
days following public announcement of the Proposed Transaction,
or $2.772. |
41
|
|
|
|
|
As a result, if the per share price of Company common stock
increases prior to the date the holder exercises the option
award, actual equity amounts may be greater than set forth in
this table. |
Regulatory
Approvals
Under the Investment Agreement, the Company and the Investors
have agreed to use their reasonable best efforts to obtain all
required governmental approvals in connection with the
completion of the Proposed Transaction.
The Company and JPE have determined that no filing under the HSR
Act is required in connection with the Equity Investment.
We are unaware of any material federal, state or foreign
regulatory requirements or approvals required for completion of
the Equity Investment.
Special
Considerations
The presence of a significant stockholder may affect the ability
of a third party to acquire the Company. As of the record date,
there were 33,011,561 shares of Company common stock
outstanding, plus outstanding options to purchase an additional
3,267,750 shares of Company common stock. Based upon the
number of shares of Company common stock outstanding on the
record date, and excluding any shares issuable upon the exercise
of currently outstanding options, JPE would have held in the
aggregate approximately 50.8% of the total voting power of the
Companys capital stock before giving effect to the
exercise of any Warrants, and approximately 65.0% of the total
voting power of the Companys capital stock after giving
effect to the exercise of all of the Warrants. Because the
Preferred Stock votes on an as converted basis, the
conversion of the Preferred Stock into Company common stock will
not reduce the general voting power of the Investors allocable
to the Preferred Stock upon its issuance. The Reverse Stock
Split will not affect the relative percentage of the voting
power held by JPE or any other stockholder (except as a result
of any cash paid in lieu of fractional shares in connection with
the Reverse Stock Split).
In addition, it is expected that the Company will use the
proceeds of the Equity Investment principally to make
acquisitions, and JPE intends following the closing to raise
additional capital to consummate acquisitions. The additional
capital may include debt financing, which would increase the
Companys leverage risk and debt service expense, or
additional equity financing, which would further dilute the
ownership of the Companys existing stockholders.
U.S.
Federal Income Tax Matters
For U.S. Federal income tax purposes, no income, gain or
loss will be recognized by the Companys stockholders in
connection with the Proposed Transaction.
Absence
of Appraisal Rights
The Company is incorporated in the State of Delaware and,
accordingly, subject to the Delaware General Corporation Law, or
the DGCL. The Companys stockholders are
not entitled to appraisal rights under the DGCL with respect to
the Proposed Transaction.
42
THE
INVESTMENT AGREEMENT
On June 13, 2011, the Company entered into the Investment
Agreement with the Investors. The summary of the material terms
of the Investment Agreement below and elsewhere in this proxy
statement is qualified in its entirety by reference to the
Investment Agreement, a copy of which is attached to this proxy
statement as Annex A and which we incorporate by reference
into this document. This summary may not contain all of the
information about the Investment Agreement that is important to
you. We encourage you to read carefully the Investment Agreement
in its entirety.
Consideration
to be Paid in the Equity Investment
Subject to the terms and conditions of the Investment Agreement,
upon the closing, the Company will issue to the Investors, for
$75,000,000 in cash, (i) an aggregate of 75,000 shares
of Preferred Stock and (ii) Warrants to purchase
42,857,143 shares of common stock of the Company (subject
to adjustment in connection with the contemplated Reverse Stock
Split).
Investor
Representative
In the Investment Agreement, JPE is empowered to act on behalf
of the other Investors in connection with the transactions
contemplated thereunder. This appointment entitles JPE to, among
other things:
|
|
|
|
|
exercise discretion in agreeing to amendments to the Investment
Agreement;
|
|
|
|
exercise discretion in executing and delivering waivers in
connection with the transactions contemplated by the Investment
Agreement;
|
|
|
|
exercise discretion in making necessary agreements in connection
with the Investment Agreement; and
|
|
|
|
communicate to, and receive communications from, the Company on
behalf of the Investors.
|
Closing
of the Equity Investment
Unless the Company and JPE agree otherwise, the Equity
Investment will close on a date to be specified by the Company
and JPE not later than two days after the satisfaction or waiver
of all the conditions in the Investment Agreement. The parties
expect to close the Equity Investment in the third quarter of
2011.
In the event that any Investor (other than JPE) breaches its
obligation to pay to the Company at the closing its portion of
the purchase price for the Securities in accordance with the
Investment Agreement, JPE is obligated to purchase such
Securities from the Company. In that event, JPE has the right,
in its sole discretion, to delay the closing for a period of up
to five business days.
Representations
and Warranties of the Company and the Investors
The representations and warranties of the Company contained in
the Investment Agreement have been made solely for the benefit
of the Investors. In addition, such representations and
warranties (a) have been made only for purposes of the
Investment Agreement, (b) have been qualified by
confidential disclosures made to the Investors in connection
with the Investment Agreement, (c) are subject to
materiality qualifications contained in the Investment Agreement
which may differ from what may be viewed as material by
investors generally, (d) were made only as of the date of
the Investment Agreement or such other date as is specified in
the Investment Agreement and (e) have been included in the
Investment Agreement for the purpose of allocating risk between
the contracting parties rather than establishing matters as
facts. Accordingly, the summary of the representations and
warranties set forth below and the Investment Agreement annexed
hereto are included in this filing only to provide stockholders
with information regarding the terms of the Investment Agreement
and not to provide investors with any other factual information
regarding the Company or its business. The Companys
stockholders should not rely on the representations and
warranties or any descriptions thereof as characterizations of
the actual state of facts or condition of the Company or any of
its subsidiaries or affiliates. Moreover, information concerning
the subject matter of the representations and
43
warranties may change after the date of the Investment
Agreement, which subsequent information may or may not be fully
reflected in the Companys public disclosures.
Our representations and warranties relate to, among other things:
|
|
|
|
|
our and our subsidiaries proper organization, good
standing and corporate power to operate our businesses;
|
|
|
|
our certificate of incorporation and by-laws and those of our
subsidiaries;
|
|
|
|
the absence of encumbrances on our capital stock;
|
|
|
|
the due issuance of the Preferred Stock;
|
|
|
|
our capitalization, including in particular the number of shares
of preferred stock, common stock and stock options outstanding
and the status of our indebtedness;
|
|
|
|
our corporate power and authority to enter into the Investment
Agreement and to consummate the transactions contemplated
thereby;
|
|
|
|
the absence of any violation of or conflict with our
organizational documents, applicable law or certain agreements
as a result of entering into the Investment Agreement and
consummating the transactions contemplated thereby;
|
|
|
|
required consents and approvals of governmental entities as a
result of the transactions contemplated by the Investment
Agreement;
|
|
|
|
our SEC filings since January 1, 2009 and the financial
statements contained therein;
|
|
|
|
our implementation of certain internal controls over financial
reporting and a system of disclosure controls as required by the
Exchange Act and the Sarbanes-Oxley Act;
|
|
|
|
the accuracy and completeness of information supplied by us in
this proxy statement;
|
|
|
|
the absence of certain changes and events, including any
material adverse effect, since January 1, 2011;
|
|
|
|
the absence of litigation or outstanding court orders against us;
|
|
|
|
material and certain other specified contracts;
|
|
|
|
our possession of all licenses and permits necessary to operate
our properties and carry on our business;
|
|
|
|
employment and labor matters affecting us, including matters
relating to our employee benefit plans;
|
|
|
|
tax matters;
|
|
|
|
environmental matters;
|
|
|
|
real property owned and leased by us and title to assets;
|
|
|
|
our intellectual property;
|
|
|
|
our compliance with the Foreign Corrupt Practices Act of 1977,
as amended;
|
|
|
|
the absence of any application of Section 203 of the DGCL
or other state takeover laws;
|
|
|
|
the required vote of our stockholders in connection with the
approval of the transactions contemplated by the Investment
Agreement;
|
|
|
|
the absence of undisclosed brokers fees;
|
|
|
|
receipt by us of a fairness opinion from Ladenburg
Thalmann & Co. Inc.;
|
44
|
|
|
|
|
our insurance arrangements; and
|
|
|
|
our compliance with applicable securities laws in conjunction
with the offer and sale of the Securities (including applicable
exemptions from registration under the Securities Act of 1933,
as amended, and the rules promulgated by the SEC thereunder).
|
For purposes of the Investment Agreement, material
adverse effect means any state of facts, change,
development, event, effect, condition, occurrence, action or
omission that, alone or together with any other state of facts,
change, development, event, effect, condition, occurrence,
action or omission, (i) materially adversely affects the
business, assets, properties, financial condition or results of
operations of the Company and its subsidiaries, taken as a
whole, or (ii) prevents, materially impedes or materially
delays the consummation by the Company of the Equity Investment
or the other transactions contemplated by the Investment
Agreement.
However, none of the following will be deemed either alone or in
combination to constitute, and none of the following will be
taken into account in determining whether there has been or
would be, a material adverse effect on the Company:
|
|
|
|
|
general legal, market, economic or political conditions
affecting the industry in which the Company operates, provided
that such conditions do not disproportionately affect the
Company and its subsidiaries, taken as a whole, in relation to
other companies in the industry in which the Company operates;
|
|
|
|
changes affecting general worldwide economic or capital market
conditions (including changes in interest or exchange rates),
provided that such changes do not disproportionately affect the
Company and its subsidiaries, taken as a whole, in relation to
other companies in the industry in which the Company operates;
|
|
|
|
the pendency or announcement of the Investment Agreement or the
anticipated consummation of the Equity Investment, including any
reaction of any customer, employee, supplier, service provider,
partner or other constituency to the identity of the Investors
or any of the transactions contemplated by the Investment
Agreement;
|
|
|
|
any decrease in the market price or trading volume of the
Company common stock (except that the underlying cause or causes
of any such decrease may be deemed to constitute, in and of
itself or themselves, a material adverse effect and
may be taken into consideration when determining whether there
has occurred a material adverse effect);
|
|
|
|
the Companys failure to meet any internal or published
projections, forecasts or other predictions or published
industry analyst expectations of financial performance (except
that the underlying cause or causes of any such failure may be
deemed to constitute, in and of itself or themselves, a
material adverse effect and may be taken into
consideration when determining whether there has occurred a
material adverse effect);
|
|
|
|
any change in GAAP which occurs or becomes effective after the
date of the Investment Agreement;
|
|
|
|
actions or omissions of the Company or any of its subsidiaries
taken with the prior written consent of JPE; and
|
|
|
|
any natural disaster, any act or threat of terrorism or war
anywhere in the world, any armed hostilities or terrorist
activities anywhere in the world, any threat or escalation of
armed hostilities or terrorist activities anywhere in the world
to the extent they do not disproportionately affect the Company
and its subsidiaries, taken as a whole, in relation to other
companies in the industry in which the Company operates.
|
45
In the Investment Agreement, the Investors make various
customary representations and warranties. Their representations
and warranties relate to, among other things:
|
|
|
|
|
their proper organization and good standing;
|
|
|
|
their corporate or other power and authority to enter into the
Investment Agreement and to consummate the transactions
contemplated by the Investment Agreement;
|
|
|
|
the accuracy and completeness of information supplied by them in
this proxy statement;
|
|
|
|
the sufficiency of their available funds at closing to
consummate the Equity Investment;
|
|
|
|
matters relating to the absence of any application of
Section 203 of the DGCL;
|
|
|
|
their status as accredited investors;
|
|
|
|
the appropriate advice obtained and the due diligence
investigation made with respect to the Investment Agreement and
the transactions contemplated thereby; and
|
|
|
|
their understanding of the limitations on transfers and other
restrictions on the Securities they will receive pursuant to the
Equity Investment.
|
Conduct
of Our Business Pending the Closing
Under the Investment Agreement, we have agreed that, subject to
certain exceptions set forth in the Investment Agreement,
between June 13, 2011 and the closing we and our
subsidiaries will:
|
|
|
|
|
conduct our business in the ordinary course in all material
respects; and
|
|
|
|
use commercially reasonable efforts to keep available the
services of our and our subsidiaries current officers and
employees, and preserve our assets, technology and current
relationships with customers, suppliers and other persons with
whom we have material business dealings.
|
We have also agreed that during the same period, subject to
certain exceptions set forth in the Investment Agreement,
neither we nor our subsidiaries will:
|
|
|
|
|
declare or pay any dividends or make other distributions with
respect to our or our subsidiaries capital stock;
|
|
|
|
split, combine, reclassify, redeem, purchase or otherwise
acquire any of our or our subsidiaries capital stock;
|
|
|
|
modify any term of our or our subsidiaries indebtedness;
|
|
|
|
issue, deliver, sell, pledge or otherwise encumber any of our or
our subsidiaries equity interests, or securities
convertible into, exchangeable for or exercisable for, or any
options, warrants, calls or other rights to acquire, any of our
or our subsidiaries equity interests;
|
|
|
|
adopt or implement any stockholder rights plan or similar
arrangement;
|
|
|
|
amend or propose to amend our or our subsidiaries
organizational documents;
|
|
|
|
acquire any business or business entity or any division thereof,
or any other assets other than immaterial assets acquired in the
ordinary course of business;
|
|
|
|
sell, lease, license, sell and lease back, mortgage or encumber
or otherwise dispose of any of our or our subsidiaries
material properties or assets, except in the ordinary course of
business;
|
|
|
|
repurchase, prepay or incur any indebtedness, or make loans,
advances or capital contributions to or investments in any other
person;
|
|
|
|
incur or commit to incur any capital expenditures that are
individually in excess of $200,000 or in the aggregate are in
excess of $500,000;
|
46
|
|
|
|
|
settle or satisfy any claims, actions or proceedings, other than
in the ordinary course of business, for amounts not in excess of
$200,000 or waive any material benefits of, or modify in any
adverse respect, or fail to enforce, any confidentiality,
standstill or similar contract;
|
|
|
|
enter into any lease or sublease of real property or modify in
any material respect or exercise any right to renew any lease or
sublease of real property, or acquire any interest in real
property;
|
|
|
|
modify or amend in any material respect or terminate any
material contracts or waive any right to enforce rights or
claims thereunder;
|
|
|
|
increase, adopt, terminate or amend compensation, retention,
severance or benefit plan arrangements, or grant any award
thereunder;
|
|
|
|
form any subsidiary;
|
|
|
|
enter into any contract which will conflict with the Proposed
Transaction or otherwise result in any violation or breach under
such contract upon consummation of the Proposed Transaction or
give rise to any loss or the creation of any material
encumbrance as a result of the Proposed Transaction;
|
|
|
|
take any action or fail to take any action which would be
expected to result in any representation or warranty becoming
untrue;
|
|
|
|
adopt or enter into any collective bargaining agreement or other
labor union contract;
|
|
|
|
write down the book value of any material assets or make changes
to financial or tax accounting practices except as required by
GAAP or applicable law;
|
|
|
|
engage in any trade loading practices or other promotional sales
or discount activity with the effect of accelerating to prior
fiscal quarters sales to the trade that would otherwise be
expected to occur in subsequent fiscal quarters;
|
|
|
|
engage in any practice which would have the effect of postponing
to subsequent fiscal quarters payments by the Company or any of
its subsidiaries that would otherwise be expected to be made in
prior fiscal quarters;
|
|
|
|
engage in any promotional sales otherwise outside the ordinary
course of business or inconsistent with past practice;
|
|
|
|
enter into, extend or renew any contract pursuant to which the
Company or any of its subsidiaries agrees not to compete with
any person in any area or to engage in any activity or business
that is material to the Company and its subsidiaries, or
containing any provisions contemplating a change in
control or similar event with respect to the Company or
one or more of its subsidiaries, including provisions requiring
consent or approval of any person in the event of a change in
control or otherwise having the effect of providing that the
consummation of the transactions contemplated by the Investment
Agreement will materially conflict with such contract or give
rise under such contract to any right of termination or other
adverse right; or
|
|
|
|
authorize or commit, resolve or agree to take any of the
foregoing actions.
|
Stockholders
Meeting
We have agreed to, as promptly as reasonably practicable after
the date of the Investment Agreement, establish a record date
for, duly call, give notice of, convene and hold a meeting of
our stockholders, and have agreed to cause such meeting to occur
by the 45th calendar day following the mailing of this
proxy statement, for the purpose of obtaining stockholder
approval of the Proposals, regardless of whether our Board of
Directors has determined at any time that the Investment
Agreement is no longer advisable or recommends that the
stockholders of the Company vote against the Proposals (subject
to our right to terminate the Investment Agreement in certain
circumstances), subject to certain exceptions specified in the
Investment Agreement. As of the date of this proxy statement, we
have established a record date of August 1, 2011 and duly
called such a meeting to be convened and held on
September 1, 2011.
47
In addition, we have agreed, subject to the exceptions set forth
in the following section, that our Board of Directors will
recommend to our stockholders that they vote in favor of the
Proposals and include such recommendation in this proxy
statement, and to use our reasonable best efforts to solicit
stockholder approval of the Proposals.
No
Solicitation of Transactions
We have agreed that neither we nor any of our subsidiaries,
directors, officers, employees, investment bankers or other
representatives will, directly or indirectly:
|
|
|
|
|
solicit, initiate, knowingly encourage or take any action to
knowingly facilitate any takeover proposal or inquiry or the
making of any proposal that could reasonably be expected to lead
to a takeover proposal; or
|
|
|
|
enter into, continue or otherwise participate in any discussions
or negotiations regarding, or furnish any information to any
person or otherwise cooperate with any person with respect to,
any takeover proposal.
|
However, prior to the receipt of stockholder approval of
Proposals 1 through 5, if we receive an unsolicited bona
fide written takeover proposal from a third party that our Board
of Directors (acting upon the affirmative recommendation of the
special committee), after consultation with our financial
advisor and outside legal counsel, determines in good faith
constitutes or could reasonably be expected to lead to a
superior proposal, we may, and we may permit our subsidiaries
and representatives to, furnish information with respect to the
Company and our subsidiaries to the person making such takeover
proposal pursuant to a nondisclosure agreement which contains
terms that are no less restrictive than those contained in the
nondisclosure agreement with JPE (provided that all such
information has been or is provided to JPE), and participate in
discussions or negotiations with the person making such takeover
proposal.
For purposes of the Investment Agreement, takeover
proposal means any inquiry, proposal or offer from any
person or group relating to, or that could reasonably be
expected to lead to, any merger, consolidation, business
combination, recapitalization, merger, consolidation,
liquidation or dissolution involving the Company, or the direct
or indirect acquisition (including by way of any tender offer,
exchange offer, liquidation, joint venture or other similar
transaction), of:
|
|
|
|
|
assets or businesses representing 15% or more of the total
revenue, net income, EBITDA or assets of the Company and its
subsidiaries, taken as a whole; or
|
|
|
|
15% or more of the outstanding shares of Company common stock or
of any class of capital stock of, or other equity or voting
interests in, one or more subsidiaries of the Company which, in
the aggregate, directly or indirectly hold assets or businesses
representing 15% or more of the total revenue, net income,
EBITDA or assets of the Company and its subsidiaries, taken as a
whole.
|
For purposes of the Investment Agreement, superior
proposal means any binding bona fide written offer
which did not result from a breach of the above restrictions,
and which:
|
|
|
|
|
if consummated, would result in the offering person (or, in the
case of a direct merger between such person and the Company, the
stockholders of such person) acquiring, directly or indirectly,
50% or more of the voting power of the capital stock of the
Company or 50% or more of the assets of the Company and its
subsidiaries, taken as a whole; and
|
|
|
|
in the good faith judgment of the Board of Directors (acting
upon the affirmative recommendation of the special committee)
(after consultation with its financial advisor and outside legal
counsel), (i) is more favorable to the holders of Company
common stock than the Equity Investment from a financial point
of view (taking into account all of the terms and conditions of
such proposal and the Investment Agreement (including any
changes to the terms of the Investment Agreement proposed by the
Investors in response to such superior proposal or otherwise))
and (ii) is reasonably capable of being completed, taking
into account all financial, legal, regulatory and other aspects
of such proposal.
|
48
We have agreed that neither the Board of Directors nor any
committee thereof will (or will agree or resolve to):
|
|
|
|
|
withdraw or modify in a manner adverse to the Investors, or
propose publicly to withdraw or modify in a manner adverse to
the Investors, the approval, recommendation or declaration of
advisability by the Board of Directors or any such committee of
the transactions contemplated by the Investment
Agreement; or
|
|
|
|
approve, recommend or declare advisable, or propose publicly to
approve, recommend or declare advisable, any takeover proposal.
|
We refer to any action described in the foregoing bullets as an
adverse recommendation change.
In addition, we have agreed that neither the Board of Directors
nor any committee thereof will (or will agree or resolve to)
cause or permit the Company to enter into any letter of intent,
memorandum of understanding, acquisition agreement, merger
agreement or other agreement (each of which we refer to as an
acquisition agreement) constituting or
related to, or which is intended to or is reasonably likely to
lead to, any takeover proposal (other than a permitted
nondisclosure agreement).
Notwithstanding the foregoing two paragraphs, at any time prior
to stockholder approval of Proposals 1 through 5, the Board of
Directors may:
|
|
|
|
|
in response to a superior proposal or an
intervening event, effect an adverse recommendation
change; or
|
|
|
|
in response to a superior acquisition proposal,
cause the Company to enter into a definitive agreement to
consummate such superior acquisition proposal and concurrently
terminate the Investment Agreement;
|
in each case, if the Board of Directors determines in good
faith, after consultation with its outside legal counsel and its
financial advisor, that the failure to do so would be
inconsistent with its fiduciary duties to the stockholders of
the Company under applicable law. However, the Board of
Directors and the committees thereof may not, and will cause the
Company not to, take any of the actions described in the
foregoing two bullets unless:
|
|
|
|
|
the Board of Directors has first provided prior written notice
to JPE that it is prepared to take such action, which notice
must, in the case of a superior proposal, attach the most
current version of any written agreement relating to the
superior proposal, and, in the case of an intervening event,
attach information describing the intervening event; and
|
|
|
|
JPE does not make, within three business days after the receipt
of such notice, a proposal that would, in the good faith
judgment of the Board of Directors (acting upon the affirmative
recommendation of the special committee) (after consultation
with its financial advisor and outside legal counsel), cause the
offer previously constituting a superior proposal to no longer
constitute a superior proposal, or obviate the need for an
adverse recommendation change as a result of an intervening
event (and any amendment or modification of such superior
proposal requires a new notice and a new three business day
period).
|
During the three business day period described above, the
Company is obligated to negotiate in good faith with JPE
regarding any revisions to the terms of the Investment Agreement
proposed by JPE.
For purposes of the Investment Agreement, the term
superior acquisition proposal means a
superior proposal that, if consummated, would result in the
offering person (or, in the case of a direct merger between such
person and the Company, the stockholders of such person)
acquiring, directly or indirectly, all or substantially all of
the voting power of the capital stock of the Company or all or
substantially all of the assets of the Company and its
subsidiaries, taken as a whole.
For purposes of the Investment Agreement, the term
intervening event means an event or other
information (other than any related to a takeover proposal),
unknown to the Board of Directors as of the date
49
of the Investment Agreement, which becomes known prior to
stockholder approval of Proposals 1 through 5 and which causes
the Board of Directors to determine in good faith, after
consultation with its outside legal counsel and its financial
advisor, that its failure to effect an adverse recommendation
change would be inconsistent with its fiduciary duties to the
stockholders of the Company under applicable law.
In addition, we have agreed to, as promptly as possible and in
any event within 24 hours after the receipt thereof, advise
JPE of any takeover proposal and the terms and conditions of,
and other facts regarding, such takeover proposal, and to keep
JPE informed on a reasonably current basis of the status and
other developments with respect to such takeover proposal and
promptly provide JPE with copies of all documentation relating
to such takeover proposal.
Re-Audit
Engagement
We have agreed to engage (and have as of the date of this proxy
statement engaged) an independent registered public accounting
firm of national reputation designated by JPE for the purpose of
re-auditing the historical consolidated financial statements of
the Company for fiscal years 2009 and 2010. In the event that
the closing does not occur (other than as a result of the
termination of the Investment Agreement by the Company in
connection with a superior acquisition proposal, or
by JPE as a result of a breach by the Company or an
adverse recommendation change) and the engagement of
the new auditor is terminated in connection with the termination
of the Investment Agreement, JPE is obligated to reimburse the
Company for the fees and expenses of the accounting firm.
Agreement
to Take Further Action and to Use Reasonable Best
Efforts
Subject to the terms and conditions of the Investment Agreement,
each party has agreed to use its reasonable best efforts to take
all actions necessary, proper or advisable to consummate and to
make effective the transactions contemplated by the Investment
Agreement. Among other things, each party has committed to use
such efforts to cooperate with each other to obtain all
necessary consents, approvals and authorizations from
governmental authorities and third parties.
The Company and JPE have determined that no filing under the HSR
Act, or any similar antitrust approval, is required in
connection with the Equity Investment.
Composition
of Board of Directors
Upon the closing of the Equity Investment, the Board will be
reconstituted such that: (1) there will be eight Board
members, (2) one of such directors will be James Martell
(or a replacement acceptable to JPE), (3) seven of such
directors will be designated by JPE (including Bradley Jacobs),
(4) each standing committee of the Board will be
reconstituted in a manner reasonably acceptable to JPE and
(5) Bradley Jacobs will become the Chairman of the Board.
In connection with each meeting of stockholders of the Company
at which directors are to be elected to serve on the Board of
Directors, the Company has agreed to take all necessary steps to
nominate the candidates appointed by JPE and to use its
reasonable best efforts to cause the Board of Directors to
unanimously recommend that the stockholders of the Company vote
in favor of each such person for election to the Board of
Directors. If, for any reason, a candidate appointed by JPE is
determined to be unqualified to serve on the Board of Directors
because such appointment would constitute a breach of the
fiduciary duties of the Board of Directors or applicable law or
stock exchange requirements, JPE will have the right to
designate an alternative person. Each person so appointed will
hold office as a director of the Company for such term as is
provided in the Companys constituent documents or until
his or her death, resignation or removal from the Board of
Directors or until his or her successor has been duly elected
and qualified. If any such appointee ceases to serve as a
director of the Company for any reason during his or her term,
the Company will use its reasonable best efforts to cause the
Board of Directors to fill the vacancy with a replacement
designated by JPE.
50
Subject to applicable law and stock exchange requirements, JPE
will have the right to designate:
|
|
|
|
|
no less than a majority of the members of the Board of Directors
for so long as JPE owns Preferred Stock, Company common stock or
other voting securities, or Warrants exercisable for such
securities, representing, in the aggregate, no less than 33% of
the total voting power of the capital stock of the Company,
calculated on a fully-diluted basis; and
|
|
|
|
no less than 25% of the members of the Board of Directors for so
long as JPE owns Preferred Stock, Company common stock or other
voting securities, or Warrants exercisable for such securities,
representing, in the aggregate, less than 33% but greater than
or equal to 20% of the total voting power of the capital stock
of the Company, calculated on a fully-diluted basis.
|
None of the foregoing will prevent the Board of Directors from
acting in accordance with its fiduciary duties or applicable law
or stock exchange requirements or from acting in good faith in
accordance with the Companys constituent documents, while
giving due consideration to the intent of the Investment
Agreement.
The board representation rights of JPE under the Investment
Agreement are in addition to, and not in limitation of,
JPEs voting rights as a holder of capital stock of the
Company.
Mr. James Martell, who is currently Chairman of the Board
of the Company, and who will continue as a director on the
reconstituted Board of Directors as described above and will be
an Investor in the Equity Investment, recused himself from Board
of Directors approval of the Investment Agreement and related
recommendations.
Conditions
to Closing
The respective obligations of the Investors and the Company to
complete the Equity Investment are subject to the satisfaction
or waiver of the following conditions:
|
|
|
|
|
Proposals 1 through 5 shall have been approved by the
stockholders;
|
|
|
|
|
|
any waiting period applicable to the transactions contemplated
by the Investment Agreement under the HSR Act shall have been
terminated or shall have expired, and any other approval under
any other applicable antitrust or similar law shall have been
obtained or terminated or shall have expired (the Company has
determined that no antitrust approval is necessary in connection
with the Equity Investment); and
|
|
|
|
no temporary restraining order, preliminary or permanent
injunction or other judgment issued by any court of competent
jurisdiction or other legal restraint or prohibition that has
the effect of preventing, prohibiting or making illegal the
consummation of the Equity Investment shall be in effect.
|
The obligations of the Investors to complete the Equity
Investment are further subject to the satisfaction or waiver of
the following conditions:
|
|
|
|
|
the representations and warranties made by the Company in the
Investment Agreement that are qualified by materiality or
material adverse effect must be true and correct and the
representations and warranties which are not so qualified must
be true and correct in all material respects, in each case as of
the date of the Investment Agreement and on the date of the
closing with the same effect as though made on the closing date
(except that those representations and warranties that speak as
of a specified date will be determined as of such date);
|
|
|
|
the Company has performed in all material respects all
obligations required to be performed by it under the Investment
Agreement at or prior to the closing;
|
|
|
|
there being no litigation brought or threatened by any
governmental entity challenging or seeking to restrain the
consummation of the transactions contemplated by the Investment
Agreement or seeking to obtain damages in relation thereto, or
seeking to limit the Investors ability to acquire
|
51
|
|
|
|
|
and exercise full ownership rights of any Warrants, shares of
Preferred Stock or Company common stock, or any legal restraint
in effect that could reasonably be expected to result in any
such effects;
|
|
|
|
|
|
all material governmental consents and approvals required to
effect the Equity Investment have been obtained;
|
|
|
|
since the date of the Investment Agreement, no material adverse
effect or any state of facts, change, development, event,
effect, condition, occurrence, action or omission that is
reasonably likely to have a material adverse effect has occurred;
|
|
|
|
the Certificate of Designation has been duly adopted by us and
duly filed with the Secretary of State of the State of Delaware;
|
|
|
|
we have executed and delivered the Registration Rights Agreement
in a form reasonably acceptable to JPE; and
|
|
|
|
there being no stop order or suspension of trading in effect
with respect to our common stock.
|
The obligation of the Company to complete the Equity Investment
is further subject to the satisfaction or waiver of the
following conditions:
|
|
|
|
|
the representations and warranties of each Investor in the
Investment Agreement that are qualified by materiality must be
true and correct and the representations and warranties which
are not so qualified must be true and correct in all material
respects, in each case as of the date of the Investment
Agreement and on the date of the closing with the same effect as
though made on the closing date (except that those
representations and warranties that speak as of a specified date
will be determined as of such date); and
|
|
|
|
each Investor has performed in all material respects all
obligations required to be performed by it under the Investment
Agreement at or prior to closing.
|
In the event of any breach by any Investor (other than JPE) that
would result in the failure of a closing condition, JPE will be
entitled, in its sole discretion, to purchase the shares of
Preferred Stock and Warrants otherwise allocable to the
breaching Investor on the terms set forth in the Investment
Agreement and, in such event, the breach by such Investor that
would otherwise result in the failure of a closing condition
will be deemed cured for purposes of the closing.
Termination
The Company and JPE may agree in writing to terminate the
Investment Agreement at any time prior to completing the Equity
Investment, even after the stockholders of the Company have
voted on the Proposals. The Investment Agreement may also be
terminated in certain other circumstances, including:
|
|
|
|
|
by either JPE or the Company if:
|
|
|
|
|
|
the closing has not occurred on or before December 13,
2011, provided that such right to terminate will not be
available to any party whose action or failure to act has been a
principal cause of or resulted in the failure of the Equity
Investment to occur on or before such date and such action or
failure to act constitutes a breach of the Investment Agreement;
|
|
|
|
certain legal restraints shall be in effect and shall have
become final and nonappealable; or
|
|
|
|
|
|
the stockholders meeting in respect of the Proposed Transaction
shall have been held and the stockholders shall not have
approved Proposals 1 through 5 at such meeting or at any
adjournment or postponement of such meeting;
|
|
|
|
|
|
by JPE prior to the receipt of approval by the stockholders of
Proposals 1 through 5 if an adverse recommendation change has
occurred;
|
52
|
|
|
|
|
there is a breach by the Company of its representations,
warranties, covenants or agreements in the Investment Agreement
such that the closing conditions would not be satisfied, and
that is incapable of being cured within 30 business days of such
breach, or if capable of being cured, the Company does not
commence to cure such breach within 10 business days after its
receipt of written notice of such breach; or
|
|
|
|
certain legal restraints shall be in effect and shall have
become final and nonappealable;
|
|
|
|
|
|
by the Company if there is a breach by any Investor of its
representations, warranties, covenants or agreements in the
Investment Agreement such that the closing conditions would not
be satisfied, and that is incapable of being cured by the
Investor or JPE within 30 business days of such breach, or if
capable of being cured, the Investor or JPE does not commence to
cure such breach within 10 business days after receipt of
written notice of such breach; or
|
|
|
|
|
|
by the Company prior to the receipt of approval by the
stockholders of Proposals 1 through 5 in order to enter into a
definitive agreement to consummate a superior acquisition
proposal.
|
Termination
Fees and Expenses
A termination fee equal to $2,774,000 (determined in accordance
with the Investment Agreement) is payable by the Company to JPE
if the Investment Agreement is terminated:
|
|
|
|
|
by JPE due to an adverse recommendation change made in
connection with a superior proposal; or
|
|
|
|
by the Company in order to enter into a definitive agreement to
consummate a superior acquisition proposal.
|
A termination fee of $2,249,000 is payable by the Company to JPE
if the Investment Agreement is terminated:
|
|
|
|
|
by JPE due to an adverse recommendation change made other than
in connection with a superior proposal; or
|
|
|
|
|
|
by either JPE or the Company due to the failure of the closing
to occur on or prior to December 13, 2011 or because the
stockholders meeting was held and Proposals 1 through 5 were not
approved at such meeting, or by JPE due to a breach of the
Investment Agreement by the Company, in each case in
circumstances in which:
|
|
|
|
|
|
prior to such termination, a takeover proposal was made to the
Company or its stockholders or any person publicly announced an
intention (whether or not conditional and whether or not
withdrawn) to make a takeover proposal or a takeover proposal
otherwise became publicly known; and
|
|
|
|
prior to the date that is nine months after such termination,
the Company or any of its subsidiaries enters into any
definitive contract to consummate any takeover proposal or any
takeover proposal is consummated (solely for purposes of this
bullet, the term takeover proposal has the meaning
set forth above, except that all references to 15% are deemed
references to 50%).
|
53
In addition, whether or not the closing occurs, the Company is
obligated to reimburse JPE for up to $1,000,000 of the expenses
incurred by JPE in connection with the transactions contemplated
by the Investment Agreement. However, such expenses are not
reimbursable by the Company if the Investment Agreement is
terminated:
|
|
|
|
|
by the mutual written consent of the Company and JPE;
|
|
|
|
|
|
by either JPE or the Company due to the failure of the closing
to occur on or prior to December 13, 2011 or because the
stockholders meeting was held and Proposals 1 through 5 were not
approved at such meeting (in each case, other than in
circumstances involving a takeover proposal in which the
termination fee described above is payable), or due to certain
legal restraints having come into effect and becoming final and
nonappealable; or
|
|
|
|
|
|
by the Company as a result of an Investor breach.
|
The reimbursement of JPEs expenses as provided above does
not relieve the Company of any obligation to pay any applicable
termination fee.
54
THE
PREFERRED STOCK CERTIFICATE OF DESIGNATION
The following is a summary of the material terms of the
Preferred Stock as contained in the Certificate of Designation
of Series A Convertible Perpetual Preferred Stock, which
will be filed with the Secretary of State of the State of
Delaware (the Certificate of Designation).
The Certificate of Designation is set forth in Exhibit A to
the Investment Agreement, which is filed herewith as
Annex A to this proxy statement and is incorporated by
reference herein. Stockholders are urged to carefully read the
Certificate of Designation in its entirety.
Authorized
Shares and Liquidation Preference
We will designate 75,000 authorized preferred shares as
Series A Convertible Perpetual Preferred Stock,
with a par value of $0.001 per share and an initial liquidation
preference of $1,000 per share, for an aggregate initial
liquidation preference of $75,000,000.
Ranking
The Preferred Stock will rank, with respect to dividend rights
and rights on liquidation,
winding-up
or dissolution, senior to Company common stock and each other
class or series of capital stock outstanding or established
after the date of issuance of the Preferred Stock the terms of
which do not expressly provide that it ranks on a parity with or
senior to the Preferred Stock as to dividend rights and rights
on liquidation,
winding-up
and dissolution. The Preferred Stock will rank on a parity with
or junior to each class or series of capital stock the terms of
which expressly provide for a pari passu or senior ranking
relative to the Preferred Stock, respectively.
Dividends
Dividends on the Preferred Stock will be payable quarterly,
when, as and if declared by the Board of Directors or a duly
authorized committee, out of the assets of the Company legally
available for the payment of dividends, on the
15th calendar day (or the following business day if the
15th is not a business day) of January, April, July and
October of each year at the rate per annum of 4% per share on
the then-applicable liquidation preference (subject to the
following paragraph). The amount of dividends payable for any
other period that is shorter or longer than a full quarterly
dividend period will be computed on the basis of a
360-day year
consisting of twelve
30-day
months.
In the event that dividends are paid on shares of Company common
stock in any dividend period with respect to the Preferred
Stock, then the dividend payable in respect of each share of
Preferred Stock for such period will be equal to the greater of
(1) the amount otherwise payable in respect of such share
of Preferred Stock in accordance with the foregoing paragraph
and (2) the product of (A) the aggregate dividends
payable per share of Company common stock in such dividend
period times (B) the number of shares of Company common
stock into which such share of Preferred Stock is then
convertible.
A dividend period with respect to a dividend payment date is the
period commencing on the preceding dividend payment date or, if
none, the date of original issuance, and ending on the day
immediately prior to the next dividend payment date.
The Company will make each dividend payment on the Preferred
Stock in cash.
Accretion
If the Company is unable to, or otherwise fails to, pay
dividends in full on the Preferred Stock on any dividend payment
date, the then-applicable liquidation preference will be
increased as of the first day of the immediately succeeding
dividend period by the amount of the unpaid dividends. The
amount of dividends payable for any dividend period following a
non-payment of dividends will be calculated on the basis of the
liquidation preference, including such accreted dividends,
determined as of the first day of the relevant dividend period.
The Company may pay all or a portion of any dividends so
accreted on any regular dividend payment date or any other date
fixed by the Board of Directors or a duly authorized committee.
55
Payment
Restrictions
No dividends may be declared or paid on any capital stock of the
Company ranking on a parity with or junior to the Preferred
Stock (including the Company common stock), and no such capital
stock may be redeemed or repurchased by or on behalf of the
Company, unless all accrued and unpaid dividends have been paid
on the Preferred Stock and any capital stock of the Company
ranking on a parity with the Preferred Stock. Notwithstanding
the foregoing, if full dividends have not been paid on the
Preferred Stock and any parity stock, dividends may be declared
and paid on the Preferred Stock and such parity stock so long as
the dividends are declared and paid pro rata.
Liquidation
In the event we voluntarily or involuntarily liquidate, dissolve
or wind up, the holders of the Preferred Stock will be entitled,
before any distribution to the holders of our common stock or
any other junior capital stock, and subject to the rights of our
creditors, to receive an amount equal to the greater of
(i) the aggregate accreted liquidation preference plus an
amount equal to any accrued and unpaid dividends (whether or not
declared) for the then-current dividend period and (ii) the
payment or distribution to which such holders would have been
entitled if the Preferred Stock were converted into Company
common stock immediately before such liquidation, dissolution or
winding-up.
Voting
Rights
The Preferred Stock will vote together with the Company common
stock on an as-converted basis on all matters,
except as otherwise required by law. In addition, the approval
of the holders of at least a majority of outstanding shares of
the Preferred Stock, voting separately as a single class, will
be required (1) for any amendment of the Company
Certificate if the amendment would alter the powers,
preferences, privileges or rights of the holders of Preferred
Stock so as to affect them adversely, (2) to issue,
authorize or increase the authorized amount of, or issue or
authorize any obligation or security convertible into or
evidencing a right to purchase, any capital stock of the Company
ranking on a parity with or senior to the Preferred Stock, or
(3) to reclassify any authorized capital stock of the
Company into any parity stock or senior stock, or any obligation
or security convertible into or evidencing a right to purchase
any parity stock or senior stock.
Conversion
The Preferred Stock will be convertible at any time, in whole or
in part and from time to time, at the option of the holder
thereof into a number of shares of Company common stock equal to
the then-applicable liquidation preference divided by the
then-applicable conversion price, which shall initially be $1.75
per share of Company common stock, for an effective initial
aggregate conversion rate of 42,857,143 shares of Company
common stock (before giving effect to the Reverse Stock Split).
After giving effect to the Reverse Stock Split, the Preferred
Stock will have a conversion price of $7.00 per share of Company
common stock.
The Preferred Stock will have the benefit of customary
anti-dilution adjustments.
Transfer
of Securities
The Preferred Stock and the shares of Company common stock
issuable upon conversion thereof will initially not be
registered under the Securities Act and may not be offered or
sold except in compliance with the registration requirements of
the Securities Act and any other applicable securities laws. The
above mentioned securities will have the benefit of certain
registration rights under the Securities Act pursuant to a
Registration Rights Agreement to be entered into by the Company
as described below.
Redemption
The Preferred Stock is not redeemable or subject to any required
offer to purchase.
56
THE
WARRANTS
The summary of the material terms of the Warrants below and
elsewhere in this proxy statement is qualified in its entirety
by reference to the Warrant Certificate, a copy of which is set
forth as Exhibit B to the Investment Agreement, which is
filed herewith as Annex A to this proxy statement and
incorporated by reference into this document. This summary may
not contain all of the information about the Warrants that is
important to you. We encourage you to read carefully the Warrant
Certificate in its entirety.
The Warrants will initially grant the holders the right to
purchase an aggregate of 42,857,143 shares of Company
common stock at an exercise price of $1.75 per share of Company
common stock, in each case subject to customary anti-dilution
adjustments and before giving effect to the Reverse Stock Split.
The Warrants will be exercisable at the option of the holder at
any time from the closing date until the tenth anniversary of
the closing date.
After giving effect to the Reverse Stock Split, the Warrants
will have an exercise price of $7.00 per share of Company common
stock, and the aggregate number of shares of Company common
stock subject to the Warrants will be 10,714,286 shares.
Transfer
of Securities
The Warrants and the shares of Company common stock issuable
upon exercise thereof will initially not be registered under the
Securities Act and may not be offered or sold except in
compliance with the registration requirements of the Securities
Act and any other applicable securities laws. The above
mentioned securities will have the benefit of certain
registration rights under the Securities Act pursuant to a
Registration Rights Agreement to be entered into by the Company
as described below.
Voting
Rights and Dividends
Holders of the Warrants (in their capacity as such) will not be
entitled to any rights of a stockholder of the Company,
including the right to vote or to consent with respect to any
matter, or to receive dividends, prior to exercising their
Warrants.
57
THE
REGISTRATION RIGHTS AGREEMENT
Pursuant to the Investment Agreement, the Company has agreed to
enter into a Registration Rights Agreement concurrently with the
closing. The summary of the material terms of the Registration
Rights Agreement below and elsewhere in this proxy statement is
qualified in its entirety by reference to the Summary of
Principal Registration Rights Provisions, a copy of which is set
forth in Exhibit C to the Investment Agreement, which is
filed herewith as Annex A to this proxy statement and
incorporated by reference into this document. This summary may
not contain all of the information about the Summary of
Principal Registration Rights Provisions that is important to
you. We encourage you to read carefully the Summary of Principal
Registration Rights Provisions in its entirety. In addition, the
complete terms of the Registration Rights Agreement are not yet
final.
The Registration Rights Agreement will provide the holders of
the Securities with certain rights to cause the Company to
register the sale of shares of Preferred Stock, Warrants and
shares of Company common stock issued or issuable upon
conversion of the Preferred Stock or upon exercise of the
Warrants, in each case other than any such securities that are
then freely transferable without registration pursuant to
Rule 144 under the Securities Act without limitation as to
volume, manner of sale or other restrictions under
Rule 144. We refer to the securities that are subject to
registration under the Registration Rights Agreement as provided
above as Registrable Securities.
Demand
Registrations
At any time on or after the closing of the Equity Investment,
holders of Registrable Securities representing no less than a
majority of the Company common stock constituting Registrable
Securities or issuable upon conversion of Preferred Stock or
exercise of Warrants constituting Registrable Securities may
request registration of the sale of such securities by giving
the Company written notice thereof. The Company must then use
reasonable best efforts to (1) file a registration
statement registering such Registrable Securities as promptly as
reasonably practicable and in any event within 30 days (if
on
Form S-3)
or 45 days (if on
Form S-1)
and (2) have such registration statement declared effective
as promptly as reasonably practicable thereafter (subject to
customary exceptions to be agreed). Such majority holders may
request a total of three demand registrations.
Piggyback
Registrations
If the Company registers its securities on a registration
statement that permits the inclusion of the Registrable
Securities, the Company must give JPE prompt written notice
thereof (subject to certain exceptions to be agreed). The
Company must then include on such registration statement all
Registrable Securities requested to be included therein (subject
to certain exceptions to be agreed).
Expenses
of Registration and Selling
Subject to certain exceptions, all expenses incurred in
connection with the registration or sale of the Registrable
Securities will be borne by the Company.
58
THE
VOTING AGREEMENTS
Concurrently with the execution of the Investment Agreement,
certain stockholders of the Company entered into Voting
Agreements with JPE. The summary of the material terms of the
Voting Agreements below and elsewhere in this proxy statement is
qualified in its entirety by reference to the two Voting
Agreements, copies of which are filed herewith as Annex C
and Annex D to this proxy statement and which we
incorporate by reference into this document. This summary may
not contain all of the information about the Voting Agreements
that is important to you. We encourage you to read carefully the
Voting Agreements in their entirety.
Pursuant to the Voting Agreements, each of Michael Welch, Chief
Executive Officer and a director of the Company, and Daniel
Para, an officer and director of the Company (the
Stockholders), have agreed in their
capacities as stockholders of the Company to vote their shares
of Company common stock in favor of the Equity Investment and
related approvals, and have granted JPE a proxy in respect of
their shares of Company common stock in connection therewith.
Voting
The Stockholders unconditionally agree to vote all of their
respective shares of Company common stock to approve the
Proposals. They further agree to vote their shares against and
not consent to the approval of any (1) takeover proposal,
(2) reorganization, recapitalization, liquidation or
winding-up
of the Company or (3) other extraordinary transaction
involving the Company or corporate action the consummation of
which would prevent, impede or delay the consummation of the
transactions contemplated by the Investment Agreement.
Irrevocable
Proxy
The Stockholders have granted an irrevocable proxy appointing
JPE as their attorney-in-fact and proxy, with full power of
substitution, for and in Stockholders names, to vote,
express consent or dissent, or otherwise to utilize such voting
power solely in the manner described above. The proxies so
granted will be automatically revoked upon termination of the
Voting Agreements in accordance with their terms.
Covenants
of Stockholders
Except as provided above, the Stockholders agree not to enter
into any voting trust or other arrangement with respect to the
voting of any shares of Company common stock. Nor will they
sell, assign or otherwise dispose of or encumber any shares of
Company common stock during the term of the agreements. They
similarly agree not to seek or solicit any such sale, assignment
or disposition of their shares of Company common stock, and must
provide prompt notice to JPE if they are approached by any
person for that purpose.
Subsequent
Acquisitions of Shares
In the event that either Stockholder acquires ownership of, or
the power to vote or direct the voting of, any shares of Company
common stock following the date of his respective Voting
Agreement, such shares will, without further action of the
parties, be subject to the provisions of such Voting Agreement.
Termination
The Voting Agreements automatically terminate upon the earliest
of (1) the termination of the Investment Agreement,
(2) the consummation of the Equity Investment and
(3) the date of any amendment, modification, change or
waiver of the Investment Agreement that results in a change to
the terms of the Securities that is material and adverse to the
Company and that is not consented to in writing by the
Stockholder in his sole discretion prior to such amendment,
modification, change or waiver of the Investment Agreement.
59
MARKET
PRICE OF THE COMPANY COMMON STOCK
The Company common stock is traded on the NYSE Amex under the
symbol XPO. The following table sets forth the high
and low daily closing sales prices per share of Company common
stock on the NYSE Amex for the periods indicated.
Market
Information
|
|
|
|
|
|
|
|
|
|
|
Company Common Stock
|
|
|
|
High
|
|
|
Low
|
|
|
Fiscal Year 2009:
|
|
|
|
|
|
|
|
|
1st Quarter
|
|
|
$1.15
|
|
|
|
$0.67
|
|
2nd Quarter
|
|
|
$0.95
|
|
|
|
$0.77
|
|
3rd Quarter
|
|
|
$0.96
|
|
|
|
$0.81
|
|
4th Quarter
|
|
|
$1.29
|
|
|
|
$0.91
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year 2010:
|
|
|
|
|
|
|
|
|
1st Quarter
|
|
|
$1.65
|
|
|
|
$1.22
|
|
2nd Quarter
|
|
|
$1.56
|
|
|
|
$1.26
|
|
3rd
Quarter
|
|
|
$1.88
|
|
|
|
$1.24
|
|
4th Quarter
|
|
|
$2.82
|
|
|
|
$1.99
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year 2011:
|
|
|
|
|
|
|
|
|
1st Quarter
|
|
|
$3.03
|
|
|
|
$2.12
|
|
2nd Quarter
|
|
|
$3.32
|
|
|
|
$2.07
|
|
3rd Quarter (through August 3, 2011)
|
|
|
$4.25
|
|
|
|
$3.09
|
|
On June 13, 2011, which was the last trading day before we
entered into the Investment Agreement, the closing price of the
Company common stock was $2.19 per share. On August 3,
2011, which was the last trading day before this proxy statement
was mailed, the closing price of the Company common stock was
$3.36 per share.
60
PROPOSAL 1
ISSUANCE OF PREFERRED STOCK AND WARRANTS
General
The Board of Directors has unanimously approved (excluding James
Martell, who recused himself from approval), subject to
stockholder approval, the issuance to JPE and the other
Investors of 75,000 shares of Preferred Stock and of
42,857,143 Warrants exercisable into one share each of Company
common stock.
The Preferred Stock will have an initial liquidation preference
of $1,000 per share, for an aggregate initial liquidation
preference of $75,000,000. The Preferred Stock will be
convertible at any time, in whole or in part and from time to
time, at the option of the holder thereof, into a number of
shares of Company common stock equal to the then-applicable
liquidation preference divided by the conversion price, which
shall initially be $1.75 per share of Company common stock
(before giving effect to the contemplated Reverse Stock Split,
and subject to customary anti-dilution adjustments), for an
effective initial aggregate conversion rate of
42,857,143 shares of Company common stock. The Preferred
Stock will pay quarterly cash dividends equal to the greater of
(1) the as-converted dividends on the
underlying Company common stock for the relevant quarter and
(2) 4% of the then-applicable liquidation preference per
annum. Accrued and unpaid dividends for any quarter will accrete
to liquidation preference for all purposes. The Preferred Stock
is not redeemable or subject to any required offer to purchase,
and will vote together with the Companys common stock on
an as-converted basis on all matters, except as
otherwise required by law, and separately as a class with
respect to certain matters implicating the rights of holders of
shares of the Preferred Stock. The terms of the Preferred Stock
are more fully set forth in Exhibit A to the Investment
Agreement, which is filed herewith as Annex A and
incorporated by reference herein.
Each Warrant will initially be exercisable at any time and from
time to time from the closing date until the tenth anniversary
of the closing date, at the option of the holder thereof, into
one share of Company common stock at an initial exercise price
of $1.75 in cash per share of Company common stock (before
giving effect to the contemplated Reverse Stock Split, and
subject to customary anti-dilution adjustments). The initial
aggregate number of shares of Company common stock subject to
Warrants will be 42,857,143 shares (before giving effect to
the contemplated Reverse Stock Split). The terms of the Warrants
are more fully set forth in Exhibit B to the Investment
Agreement, which is filed herewith as Annex A and
incorporated by reference herein.
Section 713 of the NYSE Amex Company Guide requires
stockholder approval prior to the issuance of common stock, or
securities convertible into or exercisable for common stock, in
any transaction or series of transactions involving the issuance
of common stock (or securities convertible into common stock)
equal to 20% or more of the presently outstanding common stock
for less than the greater of book or market value of the common
stock.
Purpose
of the Equity Issuance
The purpose of Proposal 1 is to permit the Equity
Investment, which will result in JPE becoming our controlling
stockholder and Bradley Jacobs becoming our Chairman of the
Board, and provide an opportunity for our existing stockholders
to participate in JPEs plans to grow the Company and
create value for our stockholders. The Equity Investment will
also provide initial capital to support JPEs plans to
cause the Company to pursue strategic acquisitions.
Under the Investment Agreement, receipt of stockholder approval
for the issuance of the Securities is a condition to closing the
Equity Investment. If such approval is not obtained, the
investment by the Investors will not be made, JPE will not
become majority stockholder of the Company and Bradley Jacobs
will not become Chairman of our Board of Directors and Chief
Executive Officer of the Company. You should read The
Proposed TransactionBackground of the Proposed
Transaction and The Proposed
TransactionReasons for the Proposed Transaction
on pages 17 and 25, respectively, for a discussion of the
factors that our special committee and Board of Directors
considered in deciding to recommend the approval of
Proposal 1.
61
Effect of
Proposal
If our stockholders approve this Proposal and the Equity
Investment is consummated, the Company could raise up to
$150,000,000 in additional capital and the Investors will
receive 75,000 shares of Preferred Stock and 42,857,143
Warrants (before giving effect to the contemplated Reverse Stock
Split). Based upon the number of outstanding shares of Company
common stock on the record date, and excluding any shares
issuable upon the exercise of currently outstanding options,
upon the closing, the Investors will own approximately 56.5% of
the total voting power of the capital stock of the Company
outstanding upon closing, and JPE would own approximately 50.8%
of the total voting power of the capital stock of the Company,
making JPE the largest stockholder of the Company. If the
Investors were to exercise their Warrants in full at the
closing, the Investors would own approximately 72.2% of the
total voting power of the capital stock of the Company and JPE
would own approximately 65.0% of the total voting power of the
capital stock of the Company. Additionally, the issuance of the
Preferred Stock and the Warrants (when the Warrants are
exercised) will have the effect of diluting the aggregate
interest owned by our existing stockholders from 100% of the
total voting power of the capital stock of the Company prior to
the transaction to approximately 27.8% of the total voting power
of the capital stock of the Company immediately following
consummation of the Equity Investment, assuming the Investors
exercise their Warrants in full immediately following the
consummation of the issuance. Also, our pro forma book value per
share as of December 31, 2010, after giving effect to the
issuance and payment of transaction costs, will increase from
approximately $1.05 per share to (x) approximately $1.53 per
share assuming the Investors exercise their Warrants in full
immediately following the consummation of the issuance and (y)
approximately $1.41 per share assuming the Investors do not
exercise any Warrants immediately following the consummation of
the issuance.
Relationship
to Other Proposals
Implementation of Proposal 1 is contingent upon obtaining
stockholder approval of Proposals 2 through 5.
Vote
Required
The affirmative vote of holders of a majority of the shares of
Company common stock voting thereon at a meeting at which a
quorum is present is required to approve Proposal 1
pursuant to NYSE Amex Company Guide Rule 713. The failure
of the Companys stockholders to approve any of
Proposals 1 through 5 will prevent the Company from
consummating the Proposed Transaction.
Recommendation
The Board of Directors (excluding Mr. Martell, who
recused himself), acting upon the affirmative recommendation of
the special committee, unanimously recommends that you vote
FOR Proposal 1.
62
PROPOSAL 2
AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO INCREASE THE
NUMBER OF AUTHORIZED SHARES OF COMPANY COMMON STOCK TO
150,000,000 SHARES
General
The Board of Directors has unanimously approved and declared
advisable (excluding Mr. Martell, who recused himself from
approval), subject to stockholder approval, an amendment to the
Company Certificate to increase the number of authorized shares
of our common stock, $0.001 par value, to
150,000,000 shares.
The following table summarizes the shares of Company common
stock outstanding, the shares held by the Company as treasury
shares and the shares reserved for issuance pursuant to the
Amended and Restated 2001 Stock Option Plan of the Company, as
well as the shares of Company common stock that must be reserved
for issuance upon conversion of the Preferred Stock and the
shares of Company common stock that must be reserved for
issuance upon exercise of the Warrants, in each case both before
and after the implementation of the Reverse Stock Split.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Before
|
|
|
|
|
|
|
|
|
|
Reverse Stock
|
|
|
After Reverse
|
|
|
|
|
|
|
Split (But
|
|
|
Stock Split
|
|
Company Common
|
|
|
|
|
After Increase
|
|
|
and Increase
|
|
Stock Shares:
|
|
August 1, 2011
|
|
|
in Authorized)
|
|
|
in Authorized
|
|
|
Outstanding
|
|
|
33,011,561
|
|
|
|
33,011,561
|
|
|
|
8,252,762
|
|
Treasury Shares
|
|
|
180,000
|
|
|
|
180,000
|
|
|
|
45,000
|
|
Reserved for 2001 Stock Option Plan
|
|
|
4,626,238
|
|
|
|
4,626,238
|
|
|
|
1,156,560
|
|
Underlying the Preferred Stock
|
|
|
|
|
|
|
42,857,143
|
|
|
|
10,714,286
|
|
Underlying the Warrants
|
|
|
|
|
|
|
42,857,143
|
|
|
|
10,714,286
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Potential outstanding
|
|
|
37,817,799
|
|
|
|
123,532,085
|
|
|
|
30,882,894
|
|
Available for future issuance
|
|
|
62,182,201
|
|
|
|
26,467,915
|
|
|
|
119,117,106
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total authorized
|
|
|
100,000,000
|
|
|
|
150,000,000
|
|
|
|
150,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares available for issuance as a percentage of potential
shares outstanding
|
|
|
164%
|
|
|
|
21%
|
|
|
|
386%
|
|
The increase in the number of authorized shares of Company
common stock would become effective upon the filing of the
certificate of amendment to the Company Certificate with the
Secretary of State of the State of Delaware.
Purpose
of Increasing Authorized Shares of Company Common
Stock
The purpose of increasing the authorized number of shares of
Company common stock is to provide for a sufficient number of
authorized shares to permit the full conversion of the Preferred
Stock and the full exercise of the Warrants, as well as to
provide the Company with sufficient common share capacity to
allow the flexibility for future equity financings to raise
funds to support the intended growth of the Companys
business, including through strategic acquisitions.
Effect of
Proposal
If this Proposal is approved, there will be a sufficient number
of shares of Company common stock to permit the full conversion
of the Preferred Stock and the full exercise of the Warrants and
to provide adequate financing flexibility to support JPEs
plan to grow the Companys business for the foreseeable
future. We do not currently have any material commitments which
would require the issuance of additional shares of Company
common stock, other than as described in this proxy statement
and the documents attached hereto.
63
The Board of Directors does not believe that an increase in the
number of authorized shares of Company common stock, without
more, will have a significant impact on the market price of our
common stock. The availability of significant authorized but
unissued shares of Company common stock will however (in
addition to enabling the consummation of the Equity Investment)
give the Company the flexibility to issue additional common
equity and cause additional dilution without further approval of
stockholders. The Board of Directors believes, however, that
this additional flexibility is warranted and in the best
interests of stockholders, as it would facilitate execution of
future financings and strategic acquisitions and thereby
facilitate the growth of the Companys business.
Relationship
to Other Proposals
Implementation of Proposal 2 is contingent upon obtaining
stockholder approval of Proposal 1 and Proposals 3
through 5.
Vote
Required
The affirmative vote of holders of a majority of the shares of
Company common stock outstanding at the close of business on the
record date is required to approve Proposal 2. Accordingly,
the failure to vote with respect to Proposal 2 will have
the same effect as a vote against Proposal 2. The failure
of the Companys stockholders to approve any of
Proposals 1 through 5 will prevent the Company from
consummating the Proposed Transaction.
Recommendation
The Board of Directors (excluding Mr. Martell, who
recused himself), acting upon the affirmative recommendation of
the special committee, unanimously recommends that you vote
FOR Proposal 2.
64
PROPOSAL 3
AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO EFFECT A 4:1
REVERSE STOCK SPLIT OF COMPANY COMMON STOCK
General
The Board of Directors has unanimously approved and declared
advisable (excluding Mr. Martell, who recused himself from
approval), subject to stockholder approval, an amendment to the
Company Certificate to effect the Reverse Stock Split.
In connection with the Reverse Stock Split, every four shares of
Company common stock will be combined into one share of Company
common stock. The amendment to the Company Certificate would not
proportionately reduce the number of shares of our authorized
preferred stock. In addition, Proposal 2 would be effected
after giving effect to the Reverse Stock Split, and thus our
authorized shares of Company common stock would not, after
giving effect to both Proposals 2 and 3, proportionately
reduce our authorized common stock (which will be 150,000,000
after giving effect to the implementation of both Proposals).
To avoid the existence of fractional shares of Company common
stock, stockholders of record who would otherwise hold
fractional shares of Company common stock as a result of the
Reverse Stock Split will be entitled to receive a cash payment
(without interest and subject to applicable withholding taxes)
in lieu of such fractional shares from our transfer agent. The
total amount of cash that will be paid to holders of fractional
shares following the Reverse Stock Split will be an amount equal
to the net proceeds attributable to the sale of such fractional
shares following the aggregation and sale by our transfer agent
of all fractional shares otherwise issuable. Holders of
fractional shares as a result of the Reverse Stock Split will be
paid such proceeds on a pro rata basis, according to the
fractional shares that they would otherwise own (without
interest and subject to applicable withholding taxes).
The Reverse Stock Split, if approved by the Companys
stockholders, would become effective upon the filing of the
certificate of amendment to the Company Certificate with the
Secretary of State of the State of Delaware.
Purpose
of the Reverse Stock Split
The Board of Directors is submitting this Proposal 3 to
stockholders for approval with the intent of increasing the
market price of shares of Company common stock after giving
effect to the Equity Investment to make the Company common stock
more attractive to a broader range of investors and thereby
increase the Companys flexibility for future equity
financings to support JPEs intended growth of the
Companys business, including through strategic
acquisitions, as well as to provide additional liquidity to the
Companys stockholders. We believe that the Reverse Stock
Split will make the Company common stock more attractive as the
current market price of the Company common stock may affect its
acceptability to certain institutional investors, professional
investors and other members of the investing public.
It should be noted, however, that although the Reverse Stock
Split is being proposed for the purpose of increasing the market
price of the Companys common stock, there can be no
assurance that such price increase can be achieved or
maintained. A number of factors will influence the future
trading price of the Company common stock, many of which are not
within the Companys control. As a result, there can be no
assurance that the Reverse Stock Split, if completed, will
result in the intended benefits described above, including that
the market price of the Company common stock will increase
following the Reverse Stock Split (either at all or in
proportion to the reduction in the number of shares of Company
common stock outstanding before the Reverse Stock Split), or
that the market price of the Company common stock will not
decrease in the future.
Effect of
Proposal
The Reverse Stock Split would affect all of the holders of
Company common stock and would not affect any stockholders
percentage ownership interest or proportionate voting power,
except as described below under Fractional
Shares. The principal effect of the Reverse Stock
Split would be that every four
65
shares of Company common stock would be reclassified and
combined into one share of Company common stock.
The following table summarizes the shares of Company common
stock outstanding, the shares held by the Company as treasury
shares and the shares reserved for issuance pursuant to the
Amended and Restated 2001 Stock Option Plan of the Company, as
well as the shares of Company common stock that must be reserved
for issuance upon conversion of the Preferred Stock and the
shares of Company common stock that must be reserved for
issuance upon exercise of the Warrants, in each case both before
and after the implementation of the Reverse Stock Split.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Before
|
|
|
|
|
|
|
|
|
|
Reverse Stock
|
|
|
After Reverse
|
|
|
|
|
|
|
Split (But
|
|
|
Stock Split
|
|
Company Common
|
|
|
|
|
After Increase
|
|
|
and Increase
|
|
Stock Shares:
|
|
August 1, 2011
|
|
|
in Authorized)
|
|
|
in Authorized
|
|
|
Outstanding
|
|
|
33,011,561
|
|
|
|
33,011,561
|
|
|
|
8,252,762
|
|
Treasury Shares
|
|
|
180,000
|
|
|
|
180,000
|
|
|
|
45,000
|
|
Reserved for 2001 Stock Option Plan
|
|
|
4,626,238
|
|
|
|
4,626,238
|
|
|
|
1,156,560
|
|
Underlying the Preferred Stock
|
|
|
|
|
|
|
42,857,143
|
|
|
|
10,714,286
|
|
Underlying the Warrants
|
|
|
|
|
|
|
42,857,143
|
|
|
|
10,714,286
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Potential outstanding
|
|
|
37,817,799
|
|
|
|
123,532,085
|
|
|
|
30,882,894
|
|
Available for future issuance
|
|
|
62,182,201
|
|
|
|
26,467,915
|
|
|
|
119,117,106
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total authorized
|
|
|
100,000,000
|
|
|
|
150,000,000
|
|
|
|
150,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares available for issuance as a percentage of potential
shares outstanding
|
|
|
164%
|
|
|
|
21%
|
|
|
|
386%
|
|
The number of shares subject to our outstanding stock options
will automatically be reduced in the same ratio as the 4:1
Reverse Stock Split ratio. Accordingly, the per share exercise
price of those options will be increased in direct proportion to
the Reverse Stock Split ratio, so that the aggregate dollar
amount payable for the purchase of the shares of Company common
stock subject to the options will remain unchanged. In
connection with the Reverse Stock Split, the number of shares of
Company common stock issuable upon exercise or conversion of
outstanding stock options will be rounded to the nearest whole
share and no cash payment will be made in respect of such
rounding.
After giving effect to the Reverse Stock Split, the Preferred
Stock will have a conversion price of $7.00 per share of Company
common stock. Also after giving effect to the Reverse Stock
Split, the Warrants will have an exercise price of $7.00 per
share of Company common stock, and the aggregate number of
shares of Company common stock subject to the Warrants will be
10,714,286 shares.
The Reverse Stock Split may increase the number of our
stockholders who own odd lots of less than
100 shares of Company common stock. Brokerage commissions
and other costs of transactions in odd lots are generally higher
than the costs of transactions of more than 100 shares of
Company common stock.
The Reverse Stock Split would not affect the par value, nor any
of the terms, of the Company common stock. After the Reverse
Stock Split, all shares of Company common stock would have the
same voting rights and rights to dividends and other
distributions (if any). All shares of Company common stock other
than fractional shares would be reclassified and combined,
automatically and without further action on the
stockholders part, into the number of shares determined
according to the 4:1 Reverse Stock Split ratio.
After the Reverse Stock Split is consummated, Company common
stock will have new Committee on Uniform Securities
Identification Procedures (CUSIP) numbers,
which is a number used to identify securities, and stock
certificates with the older CUSIP numbers will need to be
exchanged for stock certificates with the new CUSIP numbers by
following the procedures described below.
66
Beneficial
Holders of Company Common Stock
Upon the implementation of the Reverse Stock Split, we intend to
treat shares of Company common stock held by stockholders
through a broker, dealer, commercial bank, trust company or
other nominee in the same manner as registered stockholders
whose shares are registered in their names. Brokers and other
nominees will be instructed to effect the Reverse Stock Split
for their beneficial holders holding Company common stock in
street name. However, these brokers and other nominees may have
different procedures than registered stockholders for processing
the Reverse Stock Split. Stockholders who hold shares of Company
common stock with a broker or other nominee and who have any
questions in this regard are encouraged to contact their broker
or other nominee.
Registered
Book-Entry Holders of Company Common Stock
Certain of our registered holders of Company common stock may
hold some or all of their shares electronically in book-entry
form with our transfer agent. These stockholders do not have
stock certificates evidencing their ownership of Company common
stock. They are, however, provided with a statement reflecting
the number of shares registered in their accounts. If a
stockholder holds registered shares in book-entry form with the
transfer agent, they will be sent a transmittal letter by our
agent and will need to return a properly completed and duly
executed transmittal letter in order to receive any cash payment
in lieu of fractional shares that may be payable to holders of
record following the Reverse Stock Split.
Holders
of Certificated Shares
Stockholders holding shares of Company common stock in
certificated form will be sent a transmittal letter by the
transfer agent after the Reverse Stock Split is consummated. The
letter of transmittal will contain instructions on how a
stockholder should surrender his, her or its certificate(s)
representing shares of Company common stock (the Old
Shares) to the transfer agent in exchange for a
book-entry with the Companys transfer agent representing
the appropriate number of shares of post-Reverse Stock Split
Company common stock (the New Shares). No New
Shares will be issued to a stockholder until such stockholder
has surrendered all Old Shares, together with a properly
completed and executed letter of transmittal, to the transfer
agent. No stockholder will be required to pay a transfer or
other fee to exchange Old Shares. Stockholders will then receive
confirmation from the transfer agent that a book entry has been
made for the New Shares, representing the number of shares of
Company common stock to which such stockholder is entitled as a
result of the Reverse Stock Split. Until surrendered, we will
deem outstanding Old Shares held by stockholders to be cancelled
and only to represent the number of shares of post-Reverse Stock
Split Company common stock to which these stockholders are
entitled. Any Old Shares submitted for exchange, whether because
of a sale, transfer or other disposition of stock, will
automatically be exchanged for New Shares. If Old Shares contain
a restrictive legend, the New Shares will be restricted. Upon
request to the transfer agent, stockholders may elect for the
transfer agent to deliver physical stock certificates
representing the New Shares in lieu of the book entry described
above.
STOCKHOLDERS SHOULD NOT DESTROY ANY STOCK CERTIFICATE(S) AND
SHOULD NOT SUBMIT ANY STOCK CERTIFICATE(S) UNTIL REQUESTED TO DO
SO.
Fractional
Shares
We do not intend to issue fractional shares of Company common
stock in connection with the Reverse Stock Split. Instead,
stockholders who otherwise would be entitled to receive
fractional shares because they hold a number of shares not
evenly divisible by the Reverse Stock Split ratio will receive a
cash payment in lieu of any fractional shares as a result of the
Reverse Stock Split. The total amount of cash that will be paid
to holders of fractional shares following the Reverse Stock
Split will be an amount equal to the net proceeds attributable
to the sale of such fractional shares following the aggregation
and sale by our transfer agent of all fractional shares
otherwise issuable. Specifically, the transfer agent will act on
account of the holders of those entitled to receive fractional
shares and will accumulate such fractional shares, sell the
shares and distribute the cash proceeds directly to the
stockholders entitled to receive the fractional shares (without
interest and subject to applicable withholding taxes).
67
Accounting
Matters
The proposed certificate of amendment will not affect the par
value of Company common stock and preferred stock per share,
which will each continue to have $0.001 par value per
share. As a result, the stated capital attributable to Company
common stock will be reduced proportionately based on the
Reverse Stock Split ratio (including a retroactive adjustment of
prior periods), and the additional paid-in capital account will
be credited with the amount by which the stated capital is
reduced. Reported per share net income or loss will be higher
because there will be fewer shares of Company common stock
outstanding.
Material
U.S. Federal Income Tax Consequences of the Reverse Stock
Split
The following summary describes the material U.S. Federal
income tax consequences of the Reverse Stock Split to holders of
Company common stock. This summary is based on the Internal
Revenue Code of 1986, as amended (the Code),
and current Treasury regulations, administrative rulings and
judicial decisions, all of which are subject to change, possibly
on a retroactive basis, and any such change could affect the
validity of this summary.
Each holder should consult its own tax advisor regarding the
U.S. Federal, state, local and foreign income tax
consequences of the Reverse Stock Split. This summary is
included for general information purposes only and does not
purport to address all aspects of U.S. Federal income tax
law that may be relevant to holders of Company common stock in
light of their particular circumstances. This summary also does
not address the tax consequences of the Reverse Stock Split to
holders subject to special tax rules, such as banks, insurance
companies, regulated investment companies, personal holding
companies, foreign entities, non-resident alien individuals,
broker-dealers and tax-exempt entities. This summary assumes
that the holders hold the Company common stock as capital
assets (as defined in Section 1221 of the Code).
As used herein, the term U.S. Holder
means a holder that is, for U.S. Federal income tax
purposes:
|
|
|
|
|
a citizen or resident of the United States;
|
|
|
|
a corporation (or other entity taxed as a corporation for
U.S. Federal income tax purposes) created or organized in
or under the laws of the United States or any political
subdivision thereof;
|
|
|
|
an estate the income of which is subject to U.S. Federal
income tax regardless of its source; or
|
|
|
|
a trust (A) if a U.S. court is able to exercise
primary supervision over the administration of the trust and one
or more U.S. person (as defined in the Code)
have the authority to control all substantial decisions of the
trust or (B) that has a valid election in effect to be
treated as a U.S. person.
|
If a partnership (or other entity classified as a partnership
for U.S. Federal income tax purposes) is the holder of
Company common stock, the U.S. Federal income tax treatment
of a partner in the partnership will generally depend on the
status of the partner and the activities of the partnership.
Partnerships that hold Company common stock, and partners in
such partnerships, should consult their own tax advisors
regarding the U.S. federal income tax consequences of the
Reverse Stock Split.
The Reverse Stock Split is intended to qualify as a
reorganization (within the meaning of
Section 368 of the Code) for U.S. Federal income tax
purposes. If it qualifies as such, except as provided in the
following paragraph, (i) no gain or loss should be
recognized by U.S. Holders, (ii) the aggregate tax
basis in the Company common stock received in the Reverse Stock
Split should equal the aggregate tax basis in Company common
stock surrendered therefor and (iii) the holding period of
the Company common stock received in the Reverse Stock Split
should include the holding period of the Company common stock
surrendered therefor.
If a U.S. Holder of Company common stock receives cash in
lieu of fractional shares, such holder generally will be treated
as if it received the fractional shares in the Reverse Stock
Split and then received the cash in redemption of the fractional
shares. The U.S. Holder generally should recognize capital
gain or loss equal to the difference between the amount of the
cash received in lieu of fractional shares and the portion of
such holders tax basis allocable to those fractional
shares.
68
Relationship
to Other Proposals
Implementation of Proposal 3 is contingent upon obtaining
stockholder approval of Proposals 1 through 2 and
Proposals 4 through 5.
Vote
Required
The affirmative vote of holders of a majority of the shares of
Company common stock outstanding at the close of business on the
record date is required to approve Proposal 3. Accordingly,
the failure to vote with respect to Proposal 3 will have
the same effect as a vote against Proposal 3. The failure
of the Companys stockholders to approve any of
Proposals 1 through 5 will prevent the Company from
consummating the Proposed Transaction.
Recommendation
The Board of Directors (excluding Mr. Martell, who
recused himself), acting upon the affirmative recommendation of
the special committee, unanimously recommends that you vote
FOR Proposal 3.
69
PROPOSAL 4
AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO PERMIT
VACANCIES ON THE BOARD OF DIRECTORS TO BE FILLED BY THE
REMAINING DIRECTORS
General
The Board of Directors has unanimously approved and declared
advisable (excluding Mr. Martell, who recused himself from
approval), subject to stockholder approval, an amendment to the
Company Certificate to provide that any vacancy on our Board of
Directors, whether resulting from an increase in the number of
directors or otherwise, shall be filled by the affirmative vote
of a majority of the directors then holding office, even if less
than a quorum, or a sole remaining director (consistent with
Section 5 of Article III of the Companys
existing by-laws). Furthermore, the amendment will provide that
any director elected to fill a vacancy not resulting from an
increase in the number of directors shall have the same
remaining term as that of his or her predecessor.
The ability of the remaining Board members to fill vacancies on
the Board of Directors would become effective upon the filing of
the certificate of amendment to the Company Certificate with the
Secretary of State of the State of Delaware.
Purpose
of Amendment
The purpose of this amendment to the Company Certificate is to
carry out the intent of the Investment Agreement regarding the
rights of JPE to fill vacancies on the Board of Directors.
Pursuant to the Investment Agreement, JPE is entitled to
nominate for election to the Board of Directors, in connection
with each meeting of stockholders at which directors are
elected, a number of directors tied to JPEs equity
interest in the Company. If any JPE appointee ceases to serve as
a director of the Company for any reason during his or her term,
the Company is required to use its reasonable best efforts to
cause the Board of Directors to fill the vacancy created thereby
with a replacement designated by JPE. In order to ensure that
such replacement rights are not superseded without the approval
of the Board of Directors, and to effectuate the intent of the
Investment Agreement, the current provision in the
Companys by-laws regarding the filling of vacancies by the
Board of Directors is proposed to be added to the Company
Certificate.
Although the Proposal is intended to effectuate the arrangements
set forth in the Investment Agreement, it may also discourage or
increase the cost of some takeover bids in the future,
especially where the stockholders wish to pack the
board, including some bids that a majority of the
independent stockholders believe would be in their best
interests to accept or where the reason for the desired change
is inadequate performance of the directors or management.
Effect of
Proposal
The amendment to the Company Certificate will provide that,
consistent with the Companys existing by-law provision,
any vacancy on our Board of Directors, whether resulting from an
increase in the number of directors or otherwise, shall be
filled by the affirmative vote of a majority of the directors
then holding office, even if less than a quorum, or a sole
remaining director. Furthermore, such newly appointed director
(unless the vacancy was a result of an increase in the size of
the Board of Directors) will serve for the full term of his or
her predecessor.
Relationship
to Other Proposals
Implementation of Proposal 4 is contingent upon obtaining
stockholder approval of Proposals 1 through 3 and
Proposal 5.
70
Vote
Required
The affirmative vote of holders of a majority of the shares of
Company common stock outstanding at the close of business on the
record date is required to approve Proposal 4. Accordingly,
the failure to vote with respect to Proposal 4 will have
the same effect as a vote against Proposal 4. The failure
of the Companys stockholders to approve any of
Proposals 1 through 5 will prevent the Company from
consummating the Proposed Transaction.
Recommendation
The Board of Directors (excluding Mr. Martell, who
recused himself), acting upon the affirmative recommendation of
the special committee, unanimously recommends that you vote
FOR Proposal 4.
71
PROPOSAL 5
ADOPTION OF THE 2011 OMNIBUS INCENTIVE COMPENSATION
PLAN
General
The Board of Directors has unanimously approved (excluding
Mr. Martell, who recused himself from approval), subject to
stockholder approval and the consummation of the Equity
Investment, the Plan. Our Board of Directors has approved the
Plan as a flexible omnibus incentive compensation plan that
would allow us to use different forms of compensation awards
following the consummation of the Equity Investment to attract,
retain and reward eligible participants under the Plan and
strengthen the mutuality of interests between management and our
stockholders. The purpose of the Plan would be to promote the
interests of the Company and our stockholders by
(1) attracting and retaining exceptional directors,
officers, employees and consultants (including prospective
directors, officers, employees and consultants) and
(2) enabling such individuals to participate in our
long-term growth and financial success. The Plan is intended to
replace the Express-1 Expedited Solutions, Inc., Amended and
Restated 2001 Stock Option Plan (the Stock Option
Plan), which would be automatically terminated,
replaced and superseded by the Plan on the date on which the
Plan is approved by our stockholders. Any stock options granted
under the Stock Option Plan would remain in effect pursuant to
their terms. If stockholder approval is not received or if the
Proposed Transaction is not consummated, the Stock Option Plan
will not be terminated, replaced and superseded and will remain
in place pursuant to its current terms.
Set forth below is a summary of the Plan, which is qualified in
its entirety by the specific language of the Plan set forth in
Exhibit D to the Investment Agreement, which is filed
herewith as Annex A to this proxy statement and
incorporated by reference herein.
Summary
of the Plan
Types
of Awards
The Plan would provide for the grant of options intended to
qualify as incentive stock options (ISOs)
under Section 422 of the Code, nonqualified stock options
(NSOs), stock appreciation rights
(SARs), restricted share awards, restricted
stock units (RSUs), performance compensation
awards, performance units, cash incentive awards, deferred share
units and other equity-based and equity-related awards, as well
as cash-based awards.
Plan
Administration
The Plan would be administered by the Compensation Committee of
our Board of Directors or such other committee our Board of
Directors designates to administer the Plan (the
Committee). Subject to the terms of the
Plan and applicable law, the Committee would have sole authority
to administer the Plan, including, but not limited to, the
authority to (1) designate plan participants,
(2) determine the type or types of awards to be granted to
a participant, (3) determine the number of shares of our
common stock to be covered by awards, (4) determine the
terms and conditions of awards, (5) determine the vesting
schedules of awards and, if certain performance criteria were
required to be attained in order for an award to vest or be
settled or paid, establish such performance criteria and certify
whether, and to what extent, such performance criteria have been
attained, (6) interpret, administer, reconcile any
inconsistency in, correct any default in
and/or
supply any omission in, the Plan, (7) establish, amend,
suspend or waive such rules and regulations and appoint such
agents as it should deem appropriate for the proper
administration of the Plan, (8) accelerate the vesting or
exercisability of, payment for or lapse of restrictions on,
awards, and (9) make any other determination and take any
other action that the Committee deemed necessary or desirable
for the administration of the Plan.
Shares Available
For Awards
Subject to adjustment for changes in capitalization and without
giving effect to the Reverse Stock Split, the aggregate number
of shares of the Companys common stock that would be
available to be delivered pursuant to awards granted under the
Plan (which will include any shares delivered pursuant to awards
granted
72
under the Stock Option Plan prior to the approval of the Plan
by our stockholders) would be equal to the sum of
(i) 2,000,000, (ii) any shares remaining available for
future grants of options under the Stock Option Plan as of the
date the Plan is approved by our stockholders (as of
August 1, 2011, 1,358,488 shares remained available
for future grants of options under the Stock Option Plan) plus
(iii) any shares with respect to options granted under the
Stock Option Plan that are forfeited following the date that the
Plan is approved by our stockholders (as of August 1, 2011,
options with respect to 3,267,750 shares were outstanding
under the Stock Option Plan), of which 2,000,000 shares
could be granted pursuant to incentive stock options, provided
that any shares with respect to options that are forfeited
pursuant to clause (iii), will only become available to be
delivered under the Plan pursuant to stock options and no other
type of award. Upon exercise of a stock-settled SAR, the maximum
aggregate number of shares available under the Plan would be
reduced by the actual number of shares delivered upon settlement
of such stock-settled SAR. Awards that are settled in cash would
not reduce the number of shares available for delivery under the
Plan. If, after the effective date of the Plan, any award
granted under the Plan or the Stock Option Plan were forfeited,
or otherwise expired, terminated or were canceled without the
delivery of all shares subject thereto, or were settled other
than by the delivery of shares (including cash settlement), then
the number of shares subject to such award that were not issued
would not be treated as issued for purposes of reducing the
maximum aggregate number of shares that may be delivered
pursuant the Plan. In addition, shares that were surrendered or
tendered to us in payment of the exercise price of an award or
any taxes required to be withheld in respect of an award would
become available again to be delivered pursuant to awards under
the Plan, provided that such surrendered or tendered shares
would not increase the number of shares that may be delivered
pursuant to ISOs under the Plan. Subject to adjustment for
changes in capitalization and without giving effect to the
Reverse Stock Split, the maximum number of shares of our common
stock that would be available to be granted pursuant to awards
to any participant in the Plan in any fiscal year would be
1,000,000. In the case of awards settled in cash based on the
fair market value of a share, the maximum aggregate amount of
cash that would be permitted to be paid pursuant to awards
granted to any participant in the Plan in any fiscal year would
be equal to the per-share fair market value as of the relevant
vesting, payment or settlement date multiplied by the maximum
number of shares which could be granted, as described above. The
maximum aggregate amount of cash and other property (valued at
fair market value) that would be permitted to be paid or
delivered pursuant to awards under the Plan (other than as
described in the two immediately preceding sentences) to any
participant in any fiscal year would be $3,000,000.
Changes
in Capitalization
In the event of any extraordinary dividend or other
extraordinary distribution, recapitalization, rights offering,
stock split, reverse stock split,
split-up or
spin-off affecting the shares of our common stock, the Committee
would make equitable adjustments and other substitutions to
awards under the Plan in the manner it determined to be
appropriate or desirable. In the event of any reorganization,
merger, consolidation, combination, repurchase or exchange of
our common stock or other similar corporate transactions, the
Committee in its discretion would be permitted to make such
adjustments and other substitutions to the Plan and awards under
the Plan as it deemed appropriate or desirable.
Upon consummation of the Reverse Stock Split, the Committee
would make equitable adjustments to the aggregate number of
shares of Company common stock that would be available to be
delivered pursuant to awards granted under the Plan, such that
the aggregate number would be equal to the sum of
(i) 500,000, (ii) any shares remaining available for
future grants of options under the Stock Option Plan as of the
date the Plan is approved by our stockholders (as of
August 1, 2011, 339,662 shares remained available for
future grants of options under the Stock Option Plan after
giving effect to the Reverse Stock Split) plus (iii) any
shares with respect to options granted under the Stock Option
Plan that are forfeited following the date that the Plan is
approved by our stockholders (as of August 1, 2011, options
with respect to 816,938 shares were outstanding under the
Stock Option Plan after giving effect to the Reverse Stock
Split), of which 500,000 shares could be granted pursuant
to incentive stock options after giving effect to the Reverse
Stock Split, provided that any shares with respect to options
that are forfeited pursuant to clause (iii), will only become
available to be delivered under the Plan pursuant to stock
options and no other type of award. After giving effect to the
73
Reverse Stock Split, the maximum number of shares of our common
stock that would be available to be granted pursuant to awards
to any participant in the Plan in any fiscal year would be
250,000.
Substitute
Awards
The Committee would be permitted to grant awards in assumption
of, or in substitution for, outstanding awards previously
granted by us or any of our affiliates or a company that we
acquired or with which we combined. Any shares issued by us
through the assumption of or substitution for outstanding awards
granted by a company that we acquired would not reduce the
aggregate number of shares of our common stock available for
awards under the Plan, except that awards issued in substitution
for ISOs would reduce the number of shares of our common stock
available for ISOs under the Plan.
Source
of Shares
Any shares of our common stock issued under the Plan would
consist, in whole or in part, of authorized and unissued shares
or of treasury shares.
Eligible
Participants
Any director, officer, employee or consultant (including any
prospective director, officer, employee or consultant) of us or
our affiliates would be eligible to participate in the Plan. The
Company currently expects that awards will be generally limited
to approximately 218 employees and non-employee directors
(of whom there are currently five eligible directors).
Stock
Options
The Committee would be permitted to grant both ISOs and NSOs
under the Plan. The exercise price for options would not be less
than the fair market value (as defined in the Plan) of the
Companys common stock on the grant date. The Committee
would not reprice any option granted under the Plan without the
approval of our stockholders. All options granted under the Plan
would be NSOs unless the applicable award agreement expressly
stated that the option was intended to be an ISO. Under the
proposed Plan, all ISOs and NSOs would be intended to qualify as
performance-based compensation under
Section 162(m) of the Code. Subject to the provisions of
the Plan and the applicable award agreement, the Committee would
determine, at or after the grant of an option, the vesting
criteria, term, methods of exercise and any other terms and
conditions of any option. Unless otherwise set forth in the
applicable award agreement, each option would expire upon the
earlier of (i) the tenth anniversary of the date the option
was granted and (ii) three months after the participant who
was holding the option ceased to be a director, officer,
employee or consultant for us or one of our affiliates. The
exercise price would be permitted to be paid with cash (or its
equivalent) or, in the sole discretion of the Committee, with
previously acquired shares of our common stock or through
delivery of irrevocable instructions to a broker to sell our
common stock otherwise deliverable upon the exercise of the
option (provided that there was a public market for our common
stock at such time), or, in the sole discretion of the
Committee, a combination of any of the foregoing, provided that
the combined value of all cash and cash equivalents and the fair
market value of any such shares so tendered to us as of the date
of such tender, together with any shares withheld by us in
respect of taxes relating to an option, was at least equal to
such aggregate exercise price.
Stock
Appreciation Rights
The Committee would be permitted to grant SARs under the Plan.
The exercise price for SARs would not be less than the fair
market value (as defined in the Plan) of our common stock on the
grant date. The Committee would not reprice any SAR granted
under the Plan without the approval of our stockholders. Upon
exercise of a SAR, the holder would receive cash, shares of our
common stock, other securities, other awards, other property or
a combination of any of the foregoing, as determined by the
Committee, equal in value to the excess, if any, of the fair
market value of a share of our common stock on the date of
exercise of the SAR over the exercise price of the SAR. Under
the Plan, all SARs would be intended to qualify as
74
performance-based
compensation under Section 162(m) of the Code.
Subject to the provisions of the Plan and the applicable award
agreement, the Committee would determine, at or after the grant
of a SAR, the vesting criteria, term, methods of exercise,
methods and form of settlement and any other terms and
conditions of any SAR. Unless otherwise set forth in the
applicable award agreement, each SAR would expire upon the
earlier of (i) the tenth anniversary of the date the SAR
was granted and (ii) three months after the participant who
was holding the SAR ceased to be a director, officer, employee
or consultant for us or one of our affiliates. Under certain
circumstances, the Committee would have the ability to
substitute, without the consent of the affected participant,
SARs for outstanding NSOs. No SAR granted under the Plan could
be exercised more than 10 years after the date of grant.
Restricted
Shares and Restricted Stock Units
Subject to the provisions of the Plan, the Committee would be
permitted to grant restricted shares and RSUs. Restricted shares
and RSUs would not be permitted to be sold, assigned,
transferred, pledged or otherwise encumbered except as provided
in the Plan or the applicable award agreement, except that the
Committee could determine that restricted shares and RSUs would
be permitted to be transferred by the participant for no
consideration. Restricted shares could be evidenced in such
manner as the Committee would determine.
An RSU would be granted with respect to one share of the
Companys common stock or have a value equal to the fair
market value of one such share. Upon the lapse of restrictions
applicable to an RSU, the RSU could be paid in cash, shares of
our common stock, other securities, other awards or other
property, as determined by the Committee, or in accordance with
the applicable award agreement. In connection with each grant of
restricted shares, except as provided in the applicable award
agreement, the holder would be entitled to the rights of a
stockholder (including the right to vote and receive dividends)
in respect of such restricted shares. The Committee would be
permitted to, on such terms and conditions as it might
determine, provide a participant who holds RSUs with dividend
equivalents, payable in cash, shares of our common stock, other
securities, other awards or other property. If a restricted
share or RSU were intended to qualify as performance-based
compensation under Section 162(m) of the Code, the
requirements described below in Performance Compensation
Awards would be required to be satisfied in order for such
restricted share or RSU to be granted or vest.
Performance
Units
Subject to the provisions of the Plan, the Committee would be
permitted to grant performance units to participants.
Performance units would be awards with an initial value
established by the Committee (or that was determined by
reference to a valuation formula specified by the Committee) at
the time of the grant. In its discretion, the Committee would
set performance goals that, depending on the extent to which
they were met during a specified performance period, would
determine the number
and/or value
of performance units that would be paid out to the participant.
The Committee, in its sole discretion, would be permitted to pay
earned performance units in the form of cash, shares of our
common stock or any combination thereof that would have an
aggregate fair market value equal to the value of the earned
performance units at the close of the applicable performance
period. The determination of the Committee with respect to the
form and timing of payout of performance units would be set
forth in the applicable award agreement. The Committee would be
permitted to, on such terms and conditions as it might
determine, provide a participant who holds performance units
with dividends or dividend equivalents, payable in cash, shares
of our common stock, other securities, other awards or other
property. If a performance unit were intended to qualify as
performance-based compensation under
Section 162(m) of the Code, the requirements below
described in Performance Compensation Awards would
be required to be satisfied.
Cash
Incentive Awards
Subject to the provisions of the Plan, the Committee would be
permitted to grant cash incentive awards to participants. In its
discretion, the Committee would determine the number of cash
incentive awards to be awarded, the duration of the period
which, and any condition under which, the cash incentive awards
would
75
vest or be forfeited, and any other terms and conditions
applicable to the cash incentive awards. Subject to the
provisions of the Plan, the holder of a cash incentive award
would receive payment based on the number and value of the cash
incentive award earned, which would be determined by the
Committee, in its discretion, based on the extent to which
performance goals or other conditions applicable to the cash
incentive award have been achieved. If a cash incentive award
were intended to qualify as performance-based
compensation under Section 162(m) of the Code, the
requirements described below in Performance Compensation
Awards would be required to be satisfied.
Other
Stock-Based Awards
Subject to the provisions of the Plan, the Committee would be
permitted to grant to participants other equity-based or
equity-related compensation awards, including vested stock. The
Committee would be permitted to determine the amounts and terms
and conditions of any such awards. If such an award were
intended to qualify as performance-based
compensation under Section 162(m) of the Code, the
requirements described below in Performance Compensation
Awards would be required to be satisfied.
Performance
Compensation Awards
The Committee would be permitted to designate any award granted
under the Plan (other than ISOs, NSOs and SARs) as a performance
compensation award in order to qualify such award as
performance-based compensation under
Section 162(m) of the Code. Awards designated as
performance compensation awards would be subject to the
following additional requirements:
|
|
|
|
|
Recipients of Performance Compensation
Awards. The Committee would, in its sole
discretion, designate within the first 90 days of a
performance period (or, if shorter, within the maximum period
allowed under Section 162(m) of the Code) the participants
who would be eligible to receive performance compensation awards
in respect of such performance period. The Committee would also
determine the length of performance periods, the types of awards
to be issued, the performance criteria that would be used to
establish the performance goals, the kinds and levels of
performance goals and any objective performance formula used to
determine whether a performance compensation award had been
earned for the performance period.
|
|
|
|
Performance Criteria Applicable to Performance Compensation
Awards. The performance criteria would be limited
to the following: (1) share price, (2) net income or
earnings before or after taxes (including earnings before
interest, taxes, depreciation and amortization),
(3) operating income, (4) earnings per share
(including specified types or categories thereof), (5) cash
flow (including specified types or categories thereof),
(6) cash flow return on capital, (7) revenues
(including specified types or categories thereof),
(8) return on shareholders equity, (9) return on
investment or capital, (10) return on assets,
(11) gross or net profitability/profit margins,
(12) objective measures of productivity or operating
efficiency, (13) costs (including specified types or
categories thereof), (14) budgeted expenses (operating and
capital), (15) market share (in the aggregate or by
segment), (16) level of amount of acquisitions,
(17) economic value-added, (18), enterprise value,
(19) book value, (20) working capital,
(21) safety and accident rates and (22) days sales
outstanding. These performance criteria would be permitted to be
applied on an absolute basis or be relative to one or more peer
companies or indices or any combination thereof or, if
applicable, be computed on an accrual or cash accounting basis.
The performance goals and periods could vary from participant to
participant and from time to time. To the extent required under
Section 162(m) of the Code, the Committee would, within the
first 90 days of the applicable performance period (or, if
shorter, within the maximum period allowed under
Section 162(m) of the Code), define in an objective manner
the method of calculating the performance criteria it selected
to use for the performance period.
|
|
|
|
Modification of Performance Goals. The
Committee would be permitted to adjust or modify the calculation
of performance goals for a performance period in the event of,
in anticipation of, or in recognition of, any unusual or
extraordinary corporate item, transaction, event or development
or
|
76
|
|
|
|
|
any other unusual or nonrecurring events affecting the Company,
any of its affiliates, subsidiaries, divisions or operating
units (to the extent applicable to such performance goal) or its
financial statements or the financial statements of any of its
affiliates, or changes in applicable rules, rulings, regulations
or other requirements of any governmental body or securities
exchange, accounting principles, law or business conditions, so
long as that adjustment or modification did not cause the
performance compensation award to fail to qualify as
performance-based compensation under
Section 162(m) of the Code.
|
|
|
|
|
|
Requirements to Receive Payment for 162(m)
Awards. Except as otherwise permitted by
Section 162(m) of the Code, in order to be eligible for
payment in respect of a performance compensation award for a
particular performance period, participants would be required to
be employed by us on the last day of the performance period, the
performance goals for such period would be required to be
satisfied and certified by the Committee and the performance
formula would be required to determine that all or some portion
of the performance compensation award had been earned for such
period.
|
|
|
|
Negative Discretion. The Committee would be
permitted to, in its sole discretion, reduce or eliminate the
amount of a performance compensation award earned in a
particular performance period, even if applicable performance
goals had been attained and without regard to any employment
agreement between us and a participant.
|
|
|
|
Limitations on Committee Discretion. Except as
otherwise permitted by Section 162(m) of the Code, in no
event could any discretionary authority granted to the Committee
under the Plan be used to grant or provide payment in respect of
performance compensation awards for which performance goals had
not been attained, increase a performance compensation award for
any participant at any time after the first 90 days of the
performance period (or, if shorter, within the maximum period
allowed under Section 162(m) of the Code) or increase a
performance compensation award above the maximum amount payable
under the underlying award.
|
|
|
|
Form of Payment. Performance compensation
awards (other than restricted shares, RSUs and other stock-based
awards) would be payable in cash or in restricted stock, RSUs or
fully vested shares of equivalent value and would be paid on the
terms determined by the Committee in its discretion. Any shares
of restricted stock or RSUs would be subject to the terms of the
Plan or any successor equity compensation plan and any
applicable award agreement. The number of shares of restricted
stock, RSUs or fully vested shares that is equivalent in value
to a particular dollar amount would be determined in accordance
with a methodology specified by the Committee within the first
90 days of a plan year (or, if shorter, the maximum period
allowed under Section 162(m) of the Code).
|
Amendment
and Termination of the Plan
Subject to any applicable law or government regulation, to any
requirement that must be satisfied if the Plan were intended to
be a stockholder-approved plan for purposes of
Section 162(m) of the Code and to the rules of the
applicable national stock exchange or quotation system on which
the shares may be listed or quoted, the Plan would be permitted
to be amended, modified or terminated by our Board of Directors
without the approval of our stockholders, except that
stockholder approval would be required for any amendment that
would (i) increase the maximum number of shares of our
common stock available for awards under the Plan or increase the
maximum number of shares of the Companys common stock that
could be delivered pursuant to ISOs granted under the Plan,
(ii) change the class of employees or other individuals
eligible to participate in the Plan, (iii) amend or
decrease the exercise price of any option or SAR,
(iv) cancel or exchange any option or SAR at a time when
its exercise price exceeds the fair market value of the
underlying shares or (v) allow repricing of any option or
SAR without stockholder approval. Under these provisions,
stockholder approval would not be required for all possible
amendments that might increase the cost of the Plan. No
modification, amendment or termination of the Plan that would
materially and adversely impair the rights of any participant
would be effective without the consent of the affected
participant, unless otherwise provided by the Committee in the
applicable award agreement.
77
The Committee would be permitted to waive any conditions or
rights under, amend any terms of, or alter, suspend,
discontinue, cancel or terminate any award previously granted,
prospectively or retroactively. However, unless otherwise
provided by the Committee in the applicable award agreement or
in the Plan, any such waiver, amendment, alteration, suspension,
discontinuance, cancellation or termination that would
materially and adversely impair the rights of any participant to
any award previously granted would not to that extent be
effective without the consent of the affected participant.
The Committee would be authorized to make adjustments in the
terms and conditions of awards in the event of any unusual or
nonrecurring corporate event (including the occurrence of a
change of control of the Company) affecting the Company, any of
its affiliates or its financial statements or the financial
statements of any of its affiliates, or of changes in applicable
rules, rulings, regulations or other requirements of any
governmental body or securities exchange, accounting principles
or law whenever the Committee, in its discretion, determined
that those adjustments were appropriate or desirable, including
providing for the substitution or assumption of awards,
accelerating the exercisability of, lapse of restrictions on, or
termination of, awards or providing for a period of time for
exercise prior to the occurrence of such event and, in its
discretion, the Committee would be permitted to provide for a
cash payment to the holder of an award in consideration for the
cancellation of such award.
Change
of Control
The Plan would provide that, unless otherwise provided in an
award agreement, in the event of a change of control of the
Company, unless provision was made in connection with the change
of control for assumption of, or substitution for, awards
previously granted:
|
|
|
|
|
any options and SARs outstanding as of the date the change of
control was determined to have occurred would become fully
exercisable and vested, as of immediately prior to the change of
control;
|
|
|
|
all performance units, cash incentive awards and other awards
designated as performance compensation awards would be paid out
as if the date of the change of control were the last day of the
applicable performance period and target performance
levels had been attained; and
|
|
|
|
all other outstanding awards would automatically be deemed
exercisable or vested and all restrictions and forfeiture
provisions related thereto would lapse as of immediately prior
to such change of control.
|
Unless otherwise provided pursuant to an award agreement, a
change of control would be defined to mean any of the following
events, generally:
|
|
|
|
|
during any period of 12 consecutive calendar months, a change in
the composition of a majority of the board of directors, as
constituted on the first day of such period, that was not
supported by a majority of the incumbent board of directors;
|
|
|
|
consummation of certain mergers or consolidations of the Company
with any other corporation following which the Companys
stockholders hold 50% or less of the combined voting power of
the surviving entity;
|
|
|
|
the stockholders approve a plan of complete liquidation or
dissolution of the Company; or
|
|
|
|
an acquisition by any individual, entity or group of beneficial
ownership of a percentage of the combined voting power of the
then outstanding voting securities entitled to vote generally in
the election of directors that was equal to or greater than 50%.
|
Although award agreements may provide for a different definition
of change of control than is provided for in the Plan, except in
the case of a transaction described in the third bullet above,
any definition of change of control set forth in any award
agreement would provide that a change of control would not occur
until consummation or effectiveness of a change in control of
the Company, rather than upon the announcement,
78
commencement, stockholder approval or other potential occurrence
of any event or transaction that, if completed, would result in
a change in control of the Company.
Term
of the Plan
No award would be permitted to be granted under the Plan after
the tenth anniversary of the date the Plan was approved by the
stockholders. The Plan would not become effective until the
consummation of the Proposed Transaction.
Certain
Federal Tax Aspects of the Plan
The following summary describes the U.S. Federal income tax
treatment associated with options awarded under the Plan. The
summary is based on the law as in effect on August 1, 2011.
The summary does not discuss state, local and foreign tax
consequences.
Incentive
Stock Options
Neither the grant nor the exercise of an ISO results in taxable
income to the optionee for regular U.S. federal income tax
purposes. However, an amount equal to (i) the per-share
fair market value on the exercise date minus the exercise price
at the time of grant multiplied by (ii) the number of
shares with respect to which the ISO is being exercised will
count as alternative minimum taxable income which,
depending on the particular facts, could result in liability for
the alternative minimum tax or AMT. If the optionee
does not dispose of the shares issued pursuant to the exercise
of an ISO until the later of the two-year anniversary of the
date of grant of the ISO and the one-year anniversary of the
date of the acquisition of those shares, then (a) upon a
later sale or taxable exchange of the shares, any recognized
gain or loss would be treated for tax purposes as a long-term
capital gain or loss and (b) the Company would not be
permitted to take a deduction with respect to that ISO for
federal income tax purposes.
If shares acquired upon the exercise of an ISO were disposed of
prior to the expiration of the two-year and one-year holding
periods described above (a disqualifying
disposition), generally the optionee would realize
ordinary income in the year of disposition in an amount equal to
the lesser of (i) any excess of the fair market value of
the shares at the time of exercise of the ISO over the amount
paid for the shares or (ii) the excess of the amount
realized on the disposition of the shares over the
participants aggregate tax basis in the shares (generally,
the exercise price). A deduction would be available to the
Company equal to the amount of ordinary income recognized by the
optionee. Any further gain realized by the optionee will be
taxed as short-term or long-term capital gain and would not
result in any deduction by the Company. A disqualifying
disposition occurring in the same calendar year as the year of
exercise would eliminate the alternative minimum tax effect of
the ISO exercise.
Special rules may apply where all or a portion of the exercise
price of an ISO is paid by tendering shares, or if the shares
acquired upon exercise of an ISO are subject to substantial
forfeiture restrictions. The foregoing summary of tax
consequences associated with the exercise of an ISO and the
disposition of shares acquired upon exercise of an ISO assumes
that the ISO is exercised during employment or within three
months following termination of employment. The exercise of an
ISO more than three months following termination of employment
will result in the tax consequences described below for NSOs,
except that special rules apply in the case of disability or
death. An individuals stock options otherwise qualifying
as ISOs will be treated for tax purposes as NSOs (and not as
ISOs) to the extent that, in the aggregate, they first become
exercisable in any calendar year for stock having a fair market
value (determined as of the date of grant) in excess of $100,000.
Nonqualified
Stock Options
An NSO (that is, a stock option that does not qualify as an ISO)
would result in no taxable income to the optionee or deduction
to the Company at the time it is granted. An optionee exercising
an NSO would, at that time, realize taxable compensation equal
to (i) the per-share fair market value on the exercise date
minus the exercise price at the time of grant multiplied by
(ii) the number of shares with respect to which the option
79
is being exercised. If the NSO was granted in connection with
employment, this taxable income would also constitute
wages subject to withholding and employment taxes. A
corresponding deduction would be available to the Company. The
foregoing summary assumes that the shares acquired upon exercise
of an NSO option are not subject to a substantial risk of
forfeiture.
Section 162(m)
Section 162(m) of the Code currently provides that if, in
any year, the compensation that is paid to our Chief Executive
Officer or to any of our three other most highly compensated
executive officers (currently excluding our Chief Financial
Officer) exceeds $1,000,000 per person, any amounts that exceed
the $1,000,000 threshold will not be deductible by us for
federal income tax purposes, unless the compensation qualifies
for an exception to Section 162(m) of the Code. Certain
performance-based awards under plans approved by stockholders
are not subject to the deduction limit. Stock options that would
be awarded under the Plan are intended to be eligible for this
performance-based exception.
Section 409A
Section 409A of the Code imposes restrictions on
nonqualified deferred compensation. Failure to satisfy these
rules results in accelerated taxation, an additional tax to the
holder of the amount equal to 20% of the deferred amount, and a
possible interest charge. Stock options granted with an exercise
price that is not less than the fair market value of the
underlying shares on the date of grant will not give rise to
deferred compensation for this purpose unless they
involve additional deferral features. Stock options that would
be awarded under the Plan are intended to be eligible for this
exception.
Securities
Authorized for Issuance Under Equity Compensation
Plans
The following table provides information about equity-based
awards outstanding and shares of the Companys common stock
available for future awards under all of our equity compensation
plans as of December 31, 2010.
EQUITY
COMPENSATION PLAN
INFORMATION(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
|
|
|
|
Remaining
|
|
|
|
|
|
|
|
|
|
Available for Future
|
|
|
|
|
|
|
|
|
|
Issuance
|
|
|
|
|
|
|
|
|
|
Under Equity
|
|
|
|
Number of Securities to be
|
|
|
Weighted-Average
|
|
|
Compensation
|
|
|
|
Issued Upon Exercise of
|
|
|
Exercise Price of
|
|
|
Plans (Excluding
|
|
|
|
Outstanding Options,
|
|
|
Outstanding Options,
|
|
|
Securities
|
|
|
|
Warrants and Rights
|
|
|
Warrants and Rights
|
|
|
Reflected in Column (a))
|
|
Plan Category
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
|
Equity compensation plans approved by security holders
|
|
|
3,005,250
|
|
|
$
|
1.18
|
|
|
|
2,122,446
|
|
Equity compensation plans not approved by security holders
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
Total
|
|
|
3,005,250
|
|
|
$
|
1.18
|
|
|
|
2,122,446
|
|
|
|
|
(1) |
|
Share numbers and exercise prices in this table do not give
effect to the Reverse Stock Split. |
80
The following New Plan Benefits table lists each person named in
the Summary Compensation Table, all current executive officers
as a group, all current directors (other than executive
officers) as a group and all current employees of the Company
(other than executive officers) as a group, indicating the
aggregate number of determinable awards to be granted under the
Plan to each of the foregoing.
NEW PLAN
BENEFITS
Express-1
Expedited Solutions, Inc., 2011 Omnibus Incentive Compensation
Plan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
Name and Principal
Position
|
|
|
Dollar Value
($)(1)
|
|
|
|
Units(2)
|
|
Michael R. Welch, Chief Executive Officer
|
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John D. Welch, Chief Financial Officer
|
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Current Executive Officers as a Group (two persons)
|
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Current Directors (other than Executive Officers) as a Group
(six persons)
|
|
|
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Current Employees (other than Executive Officers) as a Group
(211 persons)
|
|
|
$
|
|
|
|
|
|
150,000
|
(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Dollar value will be based upon the fair market value, as
defined in the Plan, of the Companys common stock on the
date of grant. |
|
|
|
(2) |
|
Share numbers in this column do not give effect to the Reverse
Stock Split. |
|
|
|
(3) |
|
Amount represents stock options to purchase 25,000 shares
that will be granted to each of two employees in January 2012
pursuant to their respective employment agreements, and stock
options to purchase 100,000 shares that will be granted to
one employee upon consummation of the Equity Investment pursuant
to his employment agreement. The stock options will have an
exercise price per share equal to the closing price of a share
of the Companys common stock as reported by the applicable
national stock exchange or quotation system on which the shares
may be listed or quoted on the business day immediately
preceding the date of grant, with respect to the 25,000 stock
options that will be granted to each of the two employees in
January 2012, and on the date of grant, with respect to the
100,000 options that will be granted to the one employee upon
consummation of the Equity Investment. |
Relationship
to Other Proposals
Implementation of Proposal 5 is contingent upon obtaining
stockholder approval of Proposals 1 through 4.
Required
Vote
The affirmative vote of holders of a majority of the shares of
Company common stock voting thereon at a meeting at which a
quorum is present is required to approve Proposal 5. The
failure of the Companys stockholders to approve any of
Proposals 1 through 5 will prevent the Company from
consummating the Proposed Transaction.
Recommendation
The Board of Directors (excluding Mr. Martell, who
recused himself), acting upon the affirmative recommendation of
the special committee, unanimously recommends that you vote
FOR Proposal 5.
81
PROPOSAL 6
AMENDMENT TO THE CERTIFICATE OF INCORPORATION
TO CHANGE THE NAME OF THE COMPANY TO XPO LOGISTICS,
INC.
General
The Board of Directors has unanimously approved and declared
advisable (excluding Mr. Martell, who recused himself from
approval), subject to stockholder approval, an amendment to the
Company Certificate changing the name of the Company from
Express-1 Expedited Solutions, Inc. to XPO Logistics, Inc.
The change of the name of the Company to XPO Logistics, Inc.
would become effective upon the filing of the certificate of
amendment to the Company Certificate with the Secretary of State
of the State of Delaware.
Purpose
of the Name Change
The purpose of the Company name change is to align our corporate
identity more closely with the focus of our operations and to
rebrand the Company commencing with JPEs acquisition of
control.
Relationship
to Other Proposals
Implementation of Proposal 6 is contingent upon obtaining
stockholder approval of Proposals 1 through 5. Approval of
Proposal 6 is not a condition to the closing of the
Proposed Transaction.
Vote
Required
The affirmative vote of holders of a majority of the shares of
Company common stock outstanding at the close of business on the
record date is required to approve Proposal 6. Accordingly,
the failure to vote with respect to Proposal 6 will have
the same effect as a vote against Proposal 6.
Recommendation
The Board of Directors (excluding Mr. Martell, who
recused himself), acting upon the affirmative recommendation of
the special committee, unanimously recommends that you vote
FOR Proposal 6.
82
PROPOSAL 7
PROPOSAL TO ADJOURN OR POSTPONE THE SPECIAL
MEETING
General
The special meeting may be adjourned to another time or place,
if necessary or appropriate, to solicit additional proxies if
there are insufficient votes at the time of the special meeting
to approve Proposals 1 through 5.
Purpose
If, at the special meeting, the number of shares of Company
common stock present in person or represented by proxy and
voting in favor of Proposals 1 through 5 is insufficient to
approve such Proposals, the Company intends to move to adjourn
the special meeting in order to enable our Board of Directors to
solicit additional proxies in favor of approval of Proposals 1
through 5. In such event, the Company will ask its stockholders
to vote only on the adjournment Proposal, and not on the other
Proposals. If the adjournment Proposal is approved, the Company
may elect to move to adjourn the special meeting in order to
enable the Board of Directors to solicit additional proxies in
favor of approval of Proposals 1 through 5.
Effect of
Proposal
In this Proposal, the Company is asking its stockholders to
authorize the holder of any proxy solicited by the Board of
Directors to vote in favor of adjourning or postponing the
special meeting to another time or place for the purpose of
soliciting additional proxies. If the stockholders approve this
Proposal 7, the Company could adjourn the special meeting
and use the additional time to solicit additional proxies,
including from stockholders who have previously voted.
Required
Vote
The affirmative vote of a majority of the shares of Company
common stock present and entitled to vote at the special
meeting, whether or not a quorum is present, is required to
approve Proposal 7.
Recommendation
The Board of Directors (excluding Mr. Martell, who
recused himself), acting on the affirmative recommendation of
the special committee, unanimously recommends a vote
FOR Proposal 7 to adjourn or postpone the
special meeting, if necessary or appropriate, to solicit
additional proxies.
83
COMPENSATION
OF DIRECTORS
The following table sets forth information concerning the
compensation of our directors for fiscal 2010.
2010
DIRECTOR
COMPENSATION(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or
|
|
|
Options
|
|
|
|
|
Name
|
|
Paid in Cash
|
|
|
Awards(2)
|
|
|
Total
|
|
|
Daniel Para
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
James J. Martell
|
|
$
|
30,000
|
|
|
$
|
11,950
|
|
|
$
|
41,950
|
|
Jay N. Taylor
|
|
$
|
5,500
|
|
|
$
|
15,910
|
|
|
$
|
21,410
|
|
Calvin (Pete) R. Whitehead
|
|
$
|
40,000
|
|
|
$
|
11,950
|
|
|
$
|
51,950
|
|
Jennifer H. Dorris
|
|
$
|
22,000
|
|
|
$
|
11,640
|
|
|
$
|
33,640
|
|
John F. AffleckGraves
|
|
$
|
6,000
|
|
|
$
|
11,950
|
|
|
$
|
17,950
|
|
|
|
|
(1) |
|
Compensation information for those members of the Board of
Directors who are also considered named executive officers of
the Company is disclosed in the section Executive
Compensation Summary Compensation Table. |
|
(2) |
|
Amounts shown are the aggregate grant date fair value of option
awards computed in accordance with Accounting Standards
Codification (ASC) Topic 718
Compensation-Stock Compensation. For a further
discussion of the assumptions used in the calculation of the
2010 grant date fair values for option awards pursuant to
ASC 718, please see Financial StatementsNotes
to Consolidated Financial StatementsFootnote No. 1
Stock Option Plan of the Companys Annual Report on
Form 10-K
for the year ended December 31, 2010. As of
December 31, 2010, the number of outstanding option awards
held by each of our directors (other than our named executive
officers) was as follows: Mr. Martell300,000 option
awards; Mr. Taylor200,000 option awards;
Mr. Whitehead200,000 option awards;
Ms. Dorris200,000 option awards;
Mr. Affleck-Graves175,000 option awards; and
Mr. Para125,000 option awards, 25,000 of which were
granted to Mr. Para in connection with his service on our
Board of Directors. |
Narrative
to Director Compensation
The Companys Board of Directors appoints the executive
officers to serve on the Board at the discretion of the Board.
For individual directors who are employees or those who are not
classified as independent, no additional cash compensation is
provided for service on the Board of Directors. The
Companys non-employee director compensation plan was last
modified this year to eliminate an annual grant of stock options
that was previously made to each non-employee director on his or
her anniversary of joining the Board. In the first quarter of
each year, the Board of Directors reviews the Companys
results and market comparisons for board compensation. Based
upon this review, a determination is made as to whether
modifications to the existing board compensation plan should be
considered. Under the current plan, new independent board
members are awarded a one-time grant of up to 100,000 options at
the then current market price at the time they join the Board of
Directors. All grants of options to board members vest monthly
over a three-year term and have a maturity date determined at
the time of grant, not to exceed 10 years. In addition to
stock option awards, each independent director also receives:
(i) $2,500 per fiscal quarter
(ii) $2,000 per day for each board meeting attended in
person;
(iii) $500 for participation in board or audit committee
conference calls; and
84
(iv) reasonable reimbursement of expenses associated with
attendance and participation at board meetings.
The following remuneration is also paid to the chairpersons of
the various committees. The chairperson of the Board of
Directors receives an annual fee of $25,000. The chairperson of
the Compensation Committee receives an annual fee of $10,000.
The chairperson of the Audit Committee receives an annual fee of
$15,000. The chairperson of the Nominating Committee receives an
annual fee of $5,000. Each of the chairperson fees is remitted
in four equal installments, throughout the year.
85
EXECUTIVE
COMPENSATION
The following Summary Compensation Table sets forth information
concerning the total compensation awarded to, earned by, or paid
to our Chief Executive Officer and Chief Financial Officer (the
named executive officers) for the years ended
December 31, 2010 and December 31, 2009. This Summary
Compensation Table is accompanied by an All Other
Compensation Table and an additional narrative discussion
as necessary to assist in the understanding of the information
presented in each of the tables.
SUMMARY
COMPENSATION TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonequity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Plan
|
|
|
Option
|
|
|
All Other
|
|
|
Total
|
|
|
|
|
|
|
Salary(1)
|
|
|
Bonus(2)
|
|
|
Compensation(3)
|
|
|
Awards(4)
|
|
|
Compensation(5)
|
|
|
Compensation
|
|
Name and Position
|
|
Year
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
Michael R. Welch
|
|
|
2010
|
|
|
|
205,000
|
|
|
|
30,000
|
|
|
|
151,900
|
|
|
|
27,900
|
|
|
|
4,000
|
|
|
|
418,800
|
|
Chief Executive Officer
|
|
|
2009
|
|
|
|
200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,800
|
|
|
|
205,800
|
|
John D.
Welch(6)
|
|
|
2010
|
|
|
|
130,000
|
|
|
|
20,000
|
|
|
|
76,000
|
|
|
|
27,500
|
|
|
|
1,000
|
|
|
|
254,500
|
|
Chief Financial Officer
|
|
|
2009
|
|
|
|
122,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,900
|
|
|
|
124,900
|
|
|
|
|
(1) |
|
Included in this column is the base salary paid to the named
executive officers during each year. |
(2) |
|
Included in this column is a discretionary cash bonus paid to
the named executive officers for 2010. For Mr. Michael
Welch, the $30,000 discretionary bonus was in lieu of $30,000
that was historically paid into a non-qualified deferred
compensation plan, which the Company decided to terminate. For
Mr. John Welch, the $20,000 discretionary bonus was made to
compensate him for the additional duties and responsibilities he
performed during 2010 when he became our Interim Chief Financial
Officer. |
(3) |
|
Included in this column is the performance-based annual cash
bonus awards earned in 2009 and 2010. The Companys annual
bonus plan is further detailed in the narrative following the
Summary Compensation Table. |
(4) |
|
Included in this column are the awards of stock options based
upon the Companys performance. In 2009, the named
executive officers did not receive any option awards. Amounts
shown are the aggregate grant date fair value of option awards
computed in accordance with ASC 718 and represent 60,000
and 50,000 option awards granted to Mr. Michael Welch and
Mr. John Welch, respectively. For a further discussion of
the assumptions used in the calculation of the 2010 grant date
fair values for option awards pursuant to ASC 718, please
see Financial StatementsNotes to Consolidated
Financial StatementsFootnote No. 1 Stock Option
Plan of the Companys Annual Report on
Form 10-K
for the year ended December 31, 2010. |
(5) |
|
Included in this column is other compensation items paid to the
named executive officers. Components of the other compensation
are further detailed in the subsequent table titled All
Other Compensation. |
(6) |
|
John Welch was appointed as the Chief Financial Officer of the
Company on January 1, 2011. Prior to the appointment, he
held the position of Interim Chief Financial Officer from
April 19, 2010 to December 31, 2010. He served as the
Corporate Controller prior to that appointment. |
86
All Other
Compensation Table
The following table describes each component of the All
Other Compensation column in the Summary Compensation
Table for our named executive officers in 2010 and 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Matching
|
|
|
|
|
|
|
|
|
|
|
|
|
Contributions
|
|
|
|
|
|
|
|
|
|
Perquisites and
|
|
|
to Retirement
|
|
|
|
|
|
|
|
|
|
Other Personal
|
|
|
and 401(k)
|
|
|
|
|
|
|
|
|
|
Benefits(1)
|
|
|
Plans(2)
|
|
|
Total
|
|
Name
|
|
Year
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
Michael R. Welch
|
|
|
2010
|
|
|
|
4,000
|
|
|
|
|
|
|
|
4,000
|
|
Chief Executive Officer
|
|
|
2009
|
|
|
|
4,000
|
|
|
|
1,800
|
|
|
|
5,800
|
|
John D. Welch
|
|
|
2010
|
|
|
|
1,000
|
|
|
|
|
|
|
|
1,000
|
|
Chief Financial Officer
|
|
|
2009
|
|
|
|
1,000
|
|
|
|
1,900
|
|
|
|
2,900
|
|
|
|
|
(1) |
|
Included in this column are primarily amounts for cell phone
reimbursements, automobile allowances and club dues. |
|
(2) |
|
Included in this column are matching contributions to the
Companys 401(k) plan. Only amounts contributed directly by
the employee are eligible for matching contributions and these
matches are identical to those available to other employees. |
Narrative
to Executive Compensation
Employment
Agreements with the Named Executive OfficersGeneral
Provisions
Although we have amended the employment agreements with our
named executive officers, unless otherwise noted, the following
description does not include the changes effected by the
amendments and describes such employment agreements as in effect
on December 31, 2010. For a description of the amended
employment agreements with our named executive officers, see
The Proposed TransactionInterests of the
Companys Directors and Executive Officers in the Proposed
TransactionEmployment Agreements with Executive
Officers on page 36.
The term of the employment agreement with Mr. Michael Welch
commenced on July 1, 2005 and was extended on July 1,
2008 to July 1, 2011. On June 10, 2011, the term of
Mr. Michael Welchs employment agreement was further
extended to July 1, 2012. During the term of the agreement,
Mr. Michael Welch will serve as the Chief Executive Officer
of the Company and, since January 1, 2011, is paid a base
salary at an annual rate of $240,000.
The term of the employment agreement with Mr. John Welch
commenced on January 1, 2011 and will continue for a period
of three years thereafter. Mr. John Welchs employment
agreement renews automatically for a two-year period unless
either party gives notice of non-renewal at least 60 days
prior to the end of the initial three-year term. During the term
of the agreement, Mr. John Welch will serve as the Chief
Financial Officer of the Company and will be paid a base salary
at an annual rate of $160,000, subject to annual review and
increase as determined by the Compensation Committee.
Messrs. Michael Welch and John Welch are also entitled to
receive annual cash bonuses during the term of their respective
employment agreements under the Companys executive bonus
plan, which is described in more detail under
Executive Annual Bonus Plan on
page 89.
The employment agreements of Messrs. Michael Welch and John
Welch provide that each executive officers employment may
be terminated by the Company upon death or disability, for cause
(as defined in the employment agreements) and by the Company
other than for cause. In addition, Mr. Michael Welch may
terminate his employment for good reason (as defined in the
employment agreements) either before or after a change of
control (as defined in the employment agreements) of the
Company, and Mr. John Welch may terminate his employment
for good reason within one year following a change of control of
the Company. See
87
Change-of-Control
Provisions on page 88 for a detailed discussion
of the payment and benefits payable to the named executive
officer in connection with a change of control of the Company.
If an executive officers employment is terminated due to
death or by the Company for cause, the executive officer is
entitled to payment of base salary through the date of death or
termination of employment. If an executive officers
employment is terminated due to disability, the executive
officer will be continue to receive the executive officers
base salary for 90 days from the date on which the
disability has been deemed to occur. If, prior to a change of
control of the Company, Mr. Michael Welchs employment
is terminated by the Company other than for cause or by
Mr. Welch for good reason, he will continue to receive his
base salary and any earned bonus for the one-year period
following such termination and all of Mr. Welchs
options will immediately vest and become exercisable. If, prior
to a change of control of the Company, Mr. John
Welchs employment is terminated by the Company other than
for cause, he will continue to receive his base salary for the
one-year period following such termination.
Under their respective employment agreements with the Company,
Messrs. Michael Welch and John Welch are subject to certain
restrictive covenants regarding competition, solicitation and
confidentiality. The non-competition and non-solicitation
covenants apply during their employment and for the one-year
period following the termination of their employment, and the
confidentiality covenant applies during the term of their
respective employment agreements and at all times thereafter.
Mr. Michael Welchs employment agreement also provides
for certain limited perquisites, including a $1,000 monthly
car allowance and up to $750 per month towards the cost of
country club dues.
Employment
Agreements with the Named Executive
OfficersChange-of-Control
Provisions
Further, if the employment of Messrs. Michael Welch or John
Welch is terminated by the Company without cause or by such
executive officer with good reason within one year following a
change of control of the Company, such executive officer is
entitled to (i) lump-sum severance equal to the sum of
(a) the executive officers annual base salary and
(b) an amount equal to the greater of (i) the
executive officers bonus payments for the year preceding
the date of termination, and (ii) the annual average of the
executive officers bonus payments during the two years
immediately preceding the date of termination. In addition, any
options held by the executive officer that are not yet
exercisable will immediately vest and become exercisable upon
termination.
Employment
Agreements with the Named Executive OfficersDefined
Terms
Cause, for purposes of the employment
agreements, generally means (i) the executive
officers material violation of any of the provisions of
their employment agreement, or the rules, policies,
and/or
procedures of the Company, or commission of any material act of
fraud, misappropriation, breach of fiduciary duty or theft
against or from the Company, (ii) the executive
officers violation of any law, rule or regulation of a
governmental authority or regulatory body with jurisdiction over
the Company or the executive officer relative to the conduct of
the executive officer in connection with the Companys
business or its securities or (iii) the conviction of the
executive officer of a felony under the laws of the United
States of America or any state therein. In the event the
executive officer engages in conduct described in
clauses (i) or (ii) of the definition of cause, the
executive officer will have an opportunity to cure such conduct
within 30 days after the Company provides written notice to
the executive officer. If the executive officer fails to cure
such conduct within the
30-day
period or, if the executive officer commits the same violation
within 12 months of receiving notice from the Company, then
the Company may terminate the executive officers
employment for cause.
Change of control, for purposes of the
employment agreements, generally means any of the following:
(i) the acquisition by any person or group of 50% or more
of the Companys voting securities; (ii) a merger or
consolidation of the Company with one or more corporations as a
result of which the holders of the Companys voting
securities immediately prior to such merger hold less than 80%
of the voting securities of the surviving or resulting
corporation; (iii) a transfer of all or substantially all
the property of the Company other than to an entity of which the
Company owns at least 80% of the voting securities; or
(iv) the election to the Board of Directors of the Company,
without the recommendation or approval of the incumbent Board of
88
Directors of the Company, of the lesser of (a) three
independent directors or (b) directors constituting a
majority of the number of directors of the Company then in
office.
Good reason, for purposes of the
employment agreements, will exist if, without the executive
officers express written consent (i) the Company
assigns to the executive officer duties of a non-executive
nature or for which the executive officer is not reasonably
equipped by his skills and experience, (ii) the Company
reduces the salary of the executive officer, or materially
reduces the amount of paid vacations to which he is entitled, or
his fringe benefits and perquisites, (iii) the Company
requires the executive officer to relocate his principal
business office or his principal place of residence greater than
50 miles outside of St. Joseph, Michigan, or assigns to the
executive officer duties that would reasonably require such
relocation, (iv) the Company requires the executive
officer, or assigns duties to the executive officer that would
reasonably require him, to spend more than 60 normal working
days away from the St. Joseph, Michigan, area during any
consecutive
12-month
period, (v) the Company fails to provide office facilities,
secretarial services and other administrative services to the
executive officer, which are substantially equivalent to the
facilities and services provided to executive officer on the
date the executive officer entered into the employment agreement
or (vi) the Company terminates incentive plans and benefit
plans or arrangements, or reduces or limits the executive
officers participation therein relative to the level of
participation of other executives of similar rank, to such an
extent as to materially reduce the aggregate value of the
executive officers incentive compensation and benefits
below their aggregate value as of the date the executive officer
entered into the employment agreement.
Option
Awards
During 2010, Messrs. Michael Welch and John Welch received
60,000 stock options and 50,000 stock options, respectively,
which were granted under the Companys Stock Option Plan.
The options vest monthly over a three-year period beginning on
the first of the month following the date of grant and have an
exercise price per share equal to the closing price of a share
of Company common stock on the date of grant.
Executive
Annual Bonus Plan
In addition to a base salary, each named executive officer was
eligible for a performance-based annual bonus for fiscal years
2010 and 2009. The annual bonus is designed to motivate
individual and team performance in attaining the current
years performance goals and business objectives. Annual
bonus payouts for the named executive officers are based on the
achievement of performance targets established by the
Compensation Committee. The targets are set in accordance with
and based on the Companys annual financial goals. The
Compensation Committee considers revenue and net income as
appropriate performance metrics because they reflect
Company-wide performance and align performance-based annual
bonuses with the interests of stockholders. For fiscal year
2010, each of Messrs. Michael Welch and John Welch was
eligible for a target bonus of 50% and 40% of base salary,
respectively, (or, $105,000 and $52,000, respectively) with the
opportunity to earn up to 200% of the target bonus if the
maximum performance level was reached for both equally-weighted
performance metrics. Based on achievement of performance goals
during 2010, Messrs. Michael Welch and John Welch earned
bonuses of $151,900 and $76,000, respectively, for fiscal year
2010. In fiscal year 2009, each of Messrs. Michael Welch
and John Welch were eligible for a target bonus of 50% and 30%
of base salary, respectively, (or, $100,000 and $36,600,
respectively) with the opportunity to earn up to 200% of the
target bonus if the maximum performance level was reached for
both equally-weighted performance metrics. Based on achievement
of performance goals during 2009, neither Mr. Michael Welch
nor Mr. John Welch earned a bonus for fiscal year 2009.
89
OUTSTANDING
EQUITY AWARDS AT FISCAL YEAR-END
The following table sets forth information concerning all stock
option grants held by our named executive officers as of
December 31, 2010. All outstanding equity awards are
options to purchase shares of our common stock.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option
Awards(1)
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities
|
|
|
Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underlying
|
|
|
Underlying
|
|
|
Option
|
|
|
|
|
|
|
|
|
|
|
|
|
Unexercised
|
|
|
Unexercised
|
|
|
Exercise
|
|
|
Option
|
|
|
|
Option Grant
|
|
|
Number
|
|
|
Options (#)
|
|
|
Options (#)
|
|
|
Price
|
|
|
Expiration
|
|
Name
|
|
Date
|
|
|
Granted
|
|
|
Exercisable
|
|
|
Unexercisable
|
|
|
($)
|
|
|
Date
|
|
|
Michael R. Welch
|
|
|
8/9/2004
|
|
|
|
500,000
|
|
|
|
500,000
|
|
|
|
|
|
|
|
1.45
|
|
|
|
8/9/2014
|
|
Chief Executive Officer
|
|
|
7/1/2005
|
|
|
|
100,000
|
|
|
|
100,000
|
|
|
|
|
|
|
|
0.57
|
|
|
|
7/1/2015
|
|
|
|
|
2/28/2006
|
|
|
|
50,000
|
|
|
|
50,000
|
|
|
|
|
|
|
|
0.79
|
|
|
|
2/28/2016
|
|
|
|
|
2/7/2007
|
|
|
|
60,000
|
|
|
|
60,000
|
|
|
|
|
|
|
|
1.48
|
|
|
|
2/7/2017
|
|
|
|
|
1/16/2008
|
|
|
|
60,000
|
|
|
|
58,333
|
|
|
|
1,667
|
|
|
|
0.98
|
|
|
|
1/16/2018
|
|
|
|
|
12/12/2008
|
|
|
|
150,000
|
|
|
|
100,000
|
|
|
|
50,000
|
|
|
|
0.92
|
|
|
|
12/13/2018
|
|
|
|
|
7/1/2010
|
|
|
|
60,000
|
|
|
|
8,333
|
|
|
|
51,667
|
|
|
|
1.26
|
|
|
|
7/1/2020
|
|
John D. Welch
|
|
|
2/7/2007
|
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
|
|
|
|
1.48
|
|
|
|
2/7/2017
|
|
Chief Financial Officer
|
|
|
1/16/2008
|
|
|
|
11,500
|
|
|
|
11,181
|
|
|
|
319
|
|
|
|
0.98
|
|
|
|
1/16/2018
|
|
|
|
|
3/2/2010
|
|
|
|
50,000
|
|
|
|
12,500
|
|
|
|
37,500
|
|
|
|
1.45
|
|
|
|
3/2/2020
|
|
|
|
|
(1) |
|
All stock option awards vest monthly over a three-year period
following the date of the grant, except for the stock options
granted to Mr. Michael Welch in 2004, which vested monthly
over a five-year period following the date of grant. |
Retirement
Benefits
Each of the named executive officers is entitled to participate
in the Companys tax-qualified defined contribution 401(k)
plan on the same basis as all other eligible employees. The
Company matches the contributions of participants, subject to
certain criteria, and the matches available to the named
executive officers are identical to those available to other
employees. Under the terms of the 401(k) plan, as prescribed by
the Internal Revenue Code of 1986, as amended, the contribution
of any participating employee is limited to the lesser of 100%
of annual salary before taxes or a maximum dollar amount
($16,500 for 2010), subject to a $5,500 increase for
participants who are age 50 or older. The amount of the
Companys matching payments for each of the named executive
officers is included in the All Other Compensation
column of the Summary Compensation Table.
90
SECURITY
OWNERSHIP BY CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth information known to us, as of
August 1, 2011, relating to the beneficial ownership of
shares of Company common stock by:
(i) Each person who is known by us to be the beneficial
owner of more than 5% of the Companys outstanding common
stock;
(ii) Each director;
(iii) Each executive officer; and
(iv) All executive officers and directors as a group.
Under securities laws, a person is considered to be the
beneficial owner of securities owned by him (or certain persons
whose ownership is attributed to him) or securities that can be
acquired by him within 60 days, including upon the exercise
of options, warrants or convertible securities. The Company
determines a beneficial owners percentage ownership by
assuming that options, warrants and convertible securities that
are held by the beneficial owner, but not those held by any
other person, and which are exercisable within 60 days,
have been exercised or converted.
Except with respect to the Voting Agreements entered into by JPE
with certain stockholders, the Company believes that all persons
named in the table have sole voting and investment power with
respect to all shares of Company common stock shown as being
owned by them. Unless otherwise indicated, the address of each
beneficial owner in the table set forth below is care of
Express-1 Expedited Solutions, Inc., 3399 South Lakeshore Drive,
Suite 225, Saint Joseph, Michigan 49085.
Included within the table are all beneficial owners of more than
5% of the outstanding common stock of the Company as of
August 1, 2011, based upon the public filings available to
the Company. Except with respect to the Voting Agreements, the
Company has no additional knowledge of any beneficial owner of
more than 5% of the Companys common stock, outside of the
records available through the SECs website.
91
Security
Ownership of Certain Beneficial Owners and Management
|
|
|
|
|
|
|
|
|
|
|
Amount and
|
|
|
|
|
|
|
Nature of
|
|
|
|
|
|
|
Beneficial
|
|
|
Percentage
|
|
Name/Address of Beneficial
Owner
|
|
Ownership
|
|
|
of Class
|
|
|
5% Stockholders:
|
|
|
|
|
|
|
|
|
Archon Capital Management,
LLC(1)
|
|
|
1,709,173
|
|
|
|
5.2
|
%
|
Federated Investors,
Inc.(2)
|
|
|
4,333,194
|
|
|
|
13.1
|
%
|
Jacobs Private Equity,
LLC(3)
|
|
|
4,363,634
|
|
|
|
13.0
|
%
|
Bradley
Jacobs(4)
|
|
|
4,363,634
|
|
|
|
13.0
|
%
|
Named Executive Officers:
|
|
|
|
|
|
|
|
|
Michael R.
Welch(5)
|
|
|
1,300,622
|
|
|
|
3.9
|
%
|
John D.
Welch(6)
|
|
|
220,767
|
|
|
|
*
|
|
Employee Director:
|
|
|
|
|
|
|
|
|
Daniel
Para(7)
|
|
|
3,063,012
|
|
|
|
9.3
|
%
|
Non-Employee Directors:
|
|
|
|
|
|
|
|
|
James J.
Martell(8)
|
|
|
324,271
|
|
|
|
*
|
|
Jay N.
Taylor(9)
|
|
|
349,133
|
|
|
|
1.1
|
%
|
Calvin R. (Pete)
Whitehead(10)
|
|
|
211,111
|
|
|
|
*
|
|
Jennifer H.
Dorris(11)
|
|
|
184,861
|
|
|
|
*
|
|
John F.
Affleck-Graves(12)
|
|
|
171,806
|
|
|
|
*
|
|
Executive Officers and Directors as a Group
|
|
|
5,825,583
|
|
|
|
16.9
|
%
|
(8 People)
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Archon Capital Management LLC is located at 1301 Fifth
Avenue, Suite 3008, Seattle, WA 98101. |
|
|
|
(2) |
|
Federated Investors, Inc. is located at Federated Investors
Tower, 5800 Corporate Dr., Pittsburgh, PA 15222. |
|
|
|
(3) |
|
Pursuant to the Voting Agreements, JPE was granted a proxy with
respect to the shares of Company common stock owned by Michael
Welch and Daniel Para. Therefore, JPE and Bradley Jacobs
(JPEs Managing Member) have shared voting power with
respect to the shares of Company common stock subject to such
Voting Agreements. Furthermore, JPE may be deemed to be the
beneficial owner of, and Mr. Jacobs may be deemed to be the
indirect beneficial owner of, the shares subject to such Voting
Agreements. Both JPE and Bradley Jacobs expressly disclaim
beneficial ownership of such shares subject to the Voting
Agreements. Such amount excludes unvested options that will
become subject to the Voting Agreements as they vest in
Mr. Daniel Para and Mr. Michael R. Welch. The address
for JPE and Bradley Jacobs is 350 Round Hill Road, Greenwich, CT
06831. |
|
|
|
(5) |
|
Includes 430,833 shares underlying options to purchase
common stock exercisable from $0.57 to $1.48 per share and
expiring at dates between July 1, 2015 and July 1,
2020. Pursuant to the Voting Agreement between JPE and
Michael R. Welch, JPE has the right to vote Michael
Welchs shares of Company common stock with respect to the
Proposals. |
|
|
|
(6) |
|
Includes 46,500 shares underlying options to purchase
common stock exercisable from $0.98 to $1.48 per share and
expiring at dates between February 7, 2017 and
March 2, 2020. |
|
|
|
(7) |
|
Includes 61,111 shares underlying options to purchase
common stock exercisable from $0.97 to $1.26 per share and
expiring at dates between January 29, 2019 and July 1,
2020. Pursuant to the Voting Agreement between JPE and Daniel
Para, JPE has the right to vote Daniel Paras shares of
Company common stock with respect to the Proposals. |
92
|
|
|
(8) |
|
Includes 286,111 shares underlying options to purchase
common stock exercisable from $0.74 to $1.35 per share and
expiring at dates between July 15, 2015 and
January 29, 2020. |
|
|
|
(9) |
|
Includes 183,333 shares underlying options to purchase
common stock exercisable from $0.67 to $1.65 per share and
expiring at dates between December 12, 2015 and
March 26, 2020 |
|
|
|
(10) |
|
Includes 186,111 shares underlying options to purchase
common stock exercisable from $0.74 to $1.35 per share and
expiring at dates between December 12, 2015 and
January 29, 2020. |
|
|
|
(11) |
|
Includes 179,861 shares underlying options to purchase
common stock exercisable from $0.74 to $1.42 per share and
expiring at dates between December 12, 2015 and
July 1, 2020 |
|
|
|
(12) |
|
Includes 161,806 shares underlying options to purchase
common stock exercisable from $1.00 to $1.34 per share and
expiring at dates between November 25, 2016 and
January 29, 2020. |
93
MULTIPLE
STOCKHOLDERS SHARING ONE ADDRESS
In accordance with
Rule 14a-3(e)(1)
under the Exchange Act, one proxy statement will be delivered to
two or more stockholders who share an address, unless we have
received contrary instructions from one or more of the
stockholders. We will deliver promptly upon written or oral
request a separate copy of the proxy statement to a stockholder
at a shared address to which a single copy of the proxy
statement was delivered. Requests for additional copies of the
proxy statement, and requests that in the future separate proxy
statements be sent to stockholders who share an address, should
be directed to Express-1 Expedited Solutions, Inc.,
3399 South Lakeshore Drive, Suite 225, Saint Joseph,
Michigan 49085, Attention: Chief Executive Officer. In addition,
stockholders who share a single address but receive multiple
copies of the proxy statement may request that in the future
they receive a single copy by contacting the Company at the
address and phone number set forth in the prior sentence.
94
SUBMISSION
OF STOCKHOLDER PROPOSALS
To be considered for inclusion in next years annual proxy
statement, any proposal of an eligible stockholder must be in
writing and received by the Chief Executive Officer of the
Company at its principal executive offices located at 3399 South
Lakeshore Drive, Suite 225, Saint Joseph, Michigan 49085.
A notice of recommendation for nomination or proposed item of
business at the Companys 2012 annual meeting must be
received by the Company not less than ninety nor more than
180 days prior to the earlier of the date of the meeting or
the corresponding date on which the immediately preceding
years annual meeting of stockholders was held. The Company
currently expects to hold its annual meeting in June 2012.
95
WHERE YOU
CAN FIND ADDITIONAL INFORMATION
We are subject to the informational requirements of the Exchange
Act. We file reports, proxy statements and other information
with the SEC. You may read and copy these reports, proxy
statements and other information at the SECs Public
Reference Section at 100 F Street, N.E.,
Washington, D.C. 20459. You may obtain information on the
operation of the Public Reference Room by calling the SEC at
1-800-SEC-0330.
The SEC also maintains an internet website, located at
www.sec.gov, which contains reports, proxy statements and other
information regarding companies and individuals that file
electronically with the SEC.
You may also obtain free copies of the documents the Company
files with the SEC by written request directed to us at
Express-1 Expedited Solutions, Inc., 3399 South Lakeshore Drive,
Suite 225, Saint Joseph, Michigan 49085, Attention: Chief
Executive Officer, or by telephonic request at
(269) 429-9761.
If you would like to request documents, please do so by
August 18, 2011, in order to receive them before the
special meeting.
The information contained in this proxy statement speaks only as
of the date indicated on the cover of this proxy statement
unless the information specifically indicates that another date
applies.
Statements contained in this proxy statement, or in any document
incorporated in this proxy statement by reference, regarding the
contents of any contract or other document, are not necessarily
complete and each such statement is qualified in its entirety by
reference to that contract or other document filed as an exhibit
with the SEC. The SEC allows us to incorporate by
reference information into this proxy statement. This
means that we can disclose important information by referring to
another document filed separately with the SEC. The information
incorporated by reference is considered to be part of this proxy
statement. This proxy statement and the information we later
file with the SEC may update and supersede the information
incorporated by reference. Similarly, the information that we
later file with the SEC may update and supersede the information
in this proxy statement. We incorporate by reference into this
proxy statement the following documents filed by us with the SEC
under the Exchange Act and any documents filed by us pursuant to
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after
the date of this proxy statement and prior to the date of the
special meeting:
|
|
|
|
|
our Annual Report on
Form 10-K
for the fiscal year ended December 31, 2010;
|
|
|
|
our Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2011; and
|
|
|
|
|
|
our Current Reports on
Form 8-K
filed on June 13, 2011, June 14, 2011, June 22,
2011 and July 22, 2011.
|
Notwithstanding the foregoing, information furnished under
Items 2.02 and 7.01 of any Current Report on
Form 8-K,
including the related exhibits, is not incorporated by reference
in this proxy statement.
96
ANNEX A
EXECUTION COPY
INVESTMENT
AGREEMENT
Among
JACOBS PRIVATE EQUITY, LLC,
THE OTHER INVESTORS PARTY HERETO
and
EXPRESS-1 EXPEDITED SOLUTIONS, INC.
Dated as of June 13, 2011
TABLE OF
CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
ARTICLE I
The Equity Investment
|
|
Section 1.01.
|
|
|
Purchase
|
|
|
A-1
|
|
|
Section 1.02.
|
|
|
Investor Representative
|
|
|
A-1
|
|
|
ARTICLE II
The Closing
|
|
Section 2.01.
|
|
|
Closing
|
|
|
A-2
|
|
|
Section 2.02.
|
|
|
Issuance of and Payment for Securities
|
|
|
A-2
|
|
|
Section 2.03.
|
|
|
Actions to be Taken at the Closing
|
|
|
A-3
|
|
|
Section 2.04.
|
|
|
Defaulting Investor
|
|
|
A-3
|
|
|
ARTICLE III
Representations and Warranties
|
|
Section 3.01.
|
|
|
Representations and Warranties of the Company
|
|
|
A-3
|
|
|
Section 3.02.
|
|
|
Representations and Warranties of the Investors
|
|
|
A-17
|
|
|
ARTICLE IV
Covenants
|
|
Section 4.01.
|
|
|
Conduct of Business
|
|
|
A-19
|
|
|
Section 4.02.
|
|
|
No Solicitation
|
|
|
A-22
|
|
|
Section 4.03.
|
|
|
Legend
|
|
|
A-24
|
|
|
ARTICLE V
Additional Agreements
|
|
Section 5.01.
|
|
|
Preparation of the Proxy Statement; Stockholders Meeting
|
|
|
A-24
|
|
|
Section 5.02.
|
|
|
Access to Information; Confidentiality
|
|
|
A-26
|
|
|
Section 5.03.
|
|
|
Reasonable Best Efforts; Consultation and Notice
|
|
|
A-26
|
|
|
Section 5.04.
|
|
|
Fees and Expenses
|
|
|
A-28
|
|
|
Section 5.05.
|
|
|
Public Announcements
|
|
|
A-29
|
|
|
Section 5.06.
|
|
|
Board Representation Rights
|
|
|
A-30
|
|
|
Section 5.07.
|
|
|
Adjustment of Stock Options
|
|
|
A-31
|
|
|
Section 5.08.
|
|
|
Engagement of Independent Registered Public Accounting Firm
|
|
|
A-31
|
|
|
Section 5.09.
|
|
|
Listing
|
|
|
A-31
|
|
|
Section 5.10.
|
|
|
Reservation of Shares
|
|
|
A-31
|
|
|
Section 5.11.
|
|
|
Indemnification, Exculpation and Insurance
|
|
|
A-31
|
|
|
ARTICLE VI
Conditions Precedent
|
|
Section 6.01.
|
|
|
Conditions to Each Partys Obligation to Effect the Equity
Investment
|
|
|
A-32
|
|
|
Section 6.02.
|
|
|
Conditions to Obligations of the Investors
|
|
|
A-32
|
|
|
Section 6.03.
|
|
|
Conditions to Obligation of the Company
|
|
|
A-33
|
|
|
Section 6.04.
|
|
|
Frustration of Closing Conditions
|
|
|
A-33
|
|
|
Section 6.05.
|
|
|
Investor Representative Cure
|
|
|
A-33
|
|
A-i
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
ARTICLE VII
Termination, Amendment and Waiver
|
|
Section 7.01.
|
|
|
Termination
|
|
|
A-34
|
|
|
Section 7.02.
|
|
|
Effect of Termination
|
|
|
A-34
|
|
|
Section 7.03.
|
|
|
Amendment
|
|
|
A-35
|
|
|
Section 7.04.
|
|
|
Extension; Waiver
|
|
|
A-35
|
|
|
ARTICLE VIII
General Provisions
|
|
Section 8.01.
|
|
|
Nonsurvival of Representations and Warranties
|
|
|
A-35
|
|
|
Section 8.02.
|
|
|
Notices
|
|
|
A-35
|
|
|
Section 8.03.
|
|
|
Definitions
|
|
|
A-36
|
|
|
Section 8.04.
|
|
|
Exhibits; Interpretation
|
|
|
A-37
|
|
|
Section 8.05.
|
|
|
Counterparts
|
|
|
A-38
|
|
|
Section 8.06.
|
|
|
Entire Agreement; No Third-Party Beneficiaries
|
|
|
A-38
|
|
|
Section 8.07.
|
|
|
Governing Law
|
|
|
A-38
|
|
|
Section 8.08.
|
|
|
Assignment
|
|
|
A-38
|
|
|
Section 8.09.
|
|
|
Consent to Jurisdiction; Service of Process; Venue
|
|
|
A-38
|
|
|
Section 8.10.
|
|
|
WAIVER OF JURY TRIAL
|
|
|
A-38
|
|
|
Section 8.11.
|
|
|
Enforcement
|
|
|
A-39
|
|
|
Section 8.12.
|
|
|
Consents and Approvals
|
|
|
A-39
|
|
|
Section 8.13.
|
|
|
Severability
|
|
|
A-39
|
|
|
|
|
|
|
|
|
|
|
|
SCHEDULE I
|
|
|
Investors
|
|
|
A-41
|
|
|
EXHIBIT A
|
|
|
Preferred Stock Certificate of Designation
|
|
|
A-42
|
|
|
EXHIBIT B
|
|
|
Warrant Certificate
|
|
|
A-56
|
|
|
EXHIBIT C
|
|
|
Summary of Principal Registration Rights Provisions
|
|
|
A-70
|
|
|
EXHIBIT D
|
|
|
The 2011 Omnibus Incentive Compensation Plan
|
|
|
A-72
|
|
A-ii
GLOSSARY
|
|
|
|
|
Term
|
|
Section
|
|
|
409A Authorities
|
|
|
3.01(o
|
)(viii)
|
Acquisition Agreement
|
|
|
4.02(b
|
)
|
Adverse Recommendation Change
|
|
|
4.02(b
|
)
|
Affiliate
|
|
|
8.03(a
|
)
|
Agreement
|
|
|
Preamble
|
|
Average Equity Value
|
|
|
8.03(b
|
)
|
Bankruptcy and Equity Exception
|
|
|
3.01(f
|
)
|
Baseline Financials
|
|
|
3.01(g
|
)(i)
|
Benefit Agreements
|
|
|
3.01(i
|
)(i)
|
Benefit Plans
|
|
|
3.01(m
|
)(i)
|
Certificate of Amendment
|
|
|
8.03(c
|
)
|
Certificate of Designation
|
|
|
3.01(c
|
)
|
Change Notice
|
|
|
4.02(b
|
)
|
Closing
|
|
|
2.01
|
|
Closing Date
|
|
|
2.01
|
|
Code
|
|
|
8.03(d
|
)
|
Commonly Controlled Entity
|
|
|
3.01(m
|
)(i)
|
Company
|
|
|
Preamble
|
|
Company Bylaws
|
|
|
3.01(a
|
)
|
Company Certificate
|
|
|
3.01(a
|
)
|
Company Common Stock
|
|
|
Preamble
|
|
Company Indemnitees
|
|
|
5.11(a
|
)
|
Company Letter
|
|
|
3.01
|
|
Company Personnel
|
|
|
3.01(i
|
)(i)
|
Company Preferred Stock
|
|
|
3.01(d
|
)(i)
|
Company SEC Documents
|
|
|
3.01(g
|
)(i)
|
Company Stock Plan
|
|
|
3.01(d
|
)(i)
|
Contract
|
|
|
3.01(f
|
)
|
DGCL
|
|
|
1.01
|
|
Environmental Claims
|
|
|
3.01(n
|
)
|
Environmental Law
|
|
|
3.01(n
|
)
|
Environmental Permits
|
|
|
3.01(n
|
)
|
Equity Equivalents
|
|
|
3.01(d
|
)(iii)
|
Equity Investment
|
|
|
1.01
|
|
ERISA
|
|
|
3.01(o
|
)(i)
|
Exchange Act
|
|
|
3.01(f
|
)
|
FCPA
|
|
|
3.01(s
|
)
|
Filed SEC Documents
|
|
|
3.01
|
|
GAAP
|
|
|
3.01(g
|
)(i)
|
Governmental Entity
|
|
|
3.01(f
|
)
|
A-iii
|
|
|
|
|
Term
|
|
Section
|
|
|
Grant Date
|
|
|
3.01(d
|
)(iii)
|
Hazardous Materials
|
|
|
3.01(n
|
)
|
HSR Act
|
|
|
3.01(f
|
)
|
indebtedness
|
|
|
3.01(d
|
)(iv)
|
Intellectual Property
|
|
|
3.01(r
|
)(iv)
|
Intervening Event
|
|
|
4.02(b
|
)
|
Investor
|
|
|
Preamble
|
|
Investor Representative
|
|
|
Preamble
|
|
Investor Representative Appointee
|
|
|
5.06(a
|
)
|
Investor Representative Expenses
|
|
|
5.04(a
|
)
|
Investors
|
|
|
Preamble
|
|
IRS
|
|
|
3.01(o
|
)(i)
|
Judgment
|
|
|
3.01(f
|
)
|
knowledge
|
|
|
8.03(e
|
)
|
Law
|
|
|
3.01(f
|
)
|
Legal Restraints
|
|
|
6.01(c
|
)
|
Liens
|
|
|
3.01(b
|
)
|
Material Adverse Effect
|
|
|
8.03(f
|
)
|
Material Contract
|
|
|
3.01(k
|
)(ii)
|
Nondisclosure Agreement
|
|
|
4.02(a
|
)
|
Nonqualified Deferred Compensation Plan
|
|
|
3.01(o
|
)(viii)
|
Omnibus ICP
|
|
|
3.01(f
|
)
|
Pension Plan
|
|
|
3.01(o
|
)(i)
|
Permits
|
|
|
3.01(l
|
)
|
Permitted Liens
|
|
|
3.01(k
|
)(i)(E)
|
person
|
|
|
8.03(g
|
)
|
Preferred Stock
|
|
|
Preamble
|
|
Proxy Statement
|
|
|
3.01(f
|
)
|
Purchase Price
|
|
|
2.02
|
|
Re-Audit Engagement
|
|
|
5.08
|
|
Release
|
|
|
3.01(n
|
)
|
Releasee
|
|
|
1.02(b
|
)
|
Releasees
|
|
|
1.02(b
|
)
|
SEC
|
|
|
3.01(f
|
)
|
Securities
|
|
|
Preamble
|
|
Securities Act
|
|
|
Preamble
|
|
SOX
|
|
|
3.01(g
|
)(ii)
|
Special Committee
|
|
|
Preamble
|
|
Specified Contracts
|
|
|
3.01(k
|
)(i)
|
Stock Options
|
|
|
3.01(d
|
)(i)
|
Stockholder Approvals
|
|
|
3.01(u
|
)
|
A-iv
|
|
|
|
|
Term
|
|
Section
|
|
|
Stockholders Meeting
|
|
|
5.01(c
|
)
|
Subsidiary
|
|
|
8.03(h
|
)
|
Superior Acquisition Proposal
|
|
|
4.02(a
|
)
|
Superior Proposal
|
|
|
4.02(a
|
)
|
Takeover Proposal
|
|
|
4.02(a
|
)
|
Tax
|
|
|
8.03(i
|
)
|
Tax Return
|
|
|
8.03(j
|
)
|
Taxing Authority
|
|
|
8.03(k
|
)
|
Termination Date
|
|
|
7.01(b
|
)(i)
|
Termination Fee
|
|
|
5.04(b
|
)
|
Voting Agreements
|
|
|
Preamble
|
|
Warrants
|
|
|
Preamble
|
|
A-v
INVESTMENT AGREEMENT dated as of June 13, 2011 (this
Agreement), by and among JACOBS PRIVATE
EQUITY, LLC (the Investor Representative),
each of the other Investors listed on Schedule I hereto
(including by joinder pursuant to Section 8.08) (including
the Investor Representative, each an
Investor, and together, the
Investors) and EXPRESS-1 EXPEDITED SOLUTIONS,
INC., a Delaware corporation (the Company).
WHEREAS, the Board of Directors of the Company, acting upon the
unanimous recommendation of the Special Committee of the Board
of Directors of the Company (the Special
Committee), deems it in the best interests of the
stockholders of the Company to enter into this Agreement and to
consummate the transactions contemplated by this Agreement, on
the terms and subject to the conditions set forth in this
Agreement, and such Board of Directors of the Company, acting
upon the unanimous recommendation of the Special Committee, has
approved this Agreement and declared the advisability of the
transactions contemplated by this Agreement;
WHEREAS, each Investor wishes to purchase, and the Company
wishes to sell to each Investor, (i) that number of shares
of the Companys convertible preferred stock having the
terms set forth in Exhibit A to this Agreement (the
Preferred Stock) set forth opposite such
Investors name in Schedule I to this Agreement, and
(ii) warrants in the form of Exhibit B to this
Agreement (the Warrants) representing the
right to purchase the number of shares of the Companys
common stock, par value $0.001 per share (the Company
Common Stock), set forth opposite such Investors
name in Schedule I to this Agreement, in each case for the
price and upon the terms and conditions set forth in this
Agreement (the Preferred Stock and the Warrants, collectively,
the Securities);
WHEREAS, the Company and the Investors are executing and
delivering this Agreement in reliance upon the exemption from
securities registration afforded by Section 4(2) of the
Securities Act of 1933, as amended, and the rules promulgated by
the SEC thereunder (collectively, the Securities
Act);
WHEREAS, concurrently with the Closing, the parties hereto will
execute and deliver a Registration Rights Agreement containing
the terms set forth in Exhibit C to this Agreement,
pursuant to which the Company will agree to provide certain
registration rights under the Securities Act with respect to the
Securities and the securities issuable upon conversion or
exercise thereof; and
WHEREAS, concurrently with the execution and delivery of this
Agreement and as a condition to the Investors willingness
to enter into this Agreement, certain stockholders of the
Company are entering into voting agreements with the Investor
Representative (the Voting Agreements)
whereby, among other things, such stockholders undertake,
subject to certain terms and conditions, to vote all of their
shares of Company Common Stock in favor of the Stockholder
Approvals at the Stockholders Meeting.
NOW, THEREFORE, in consideration of the foregoing and the
respective representations, warranties, covenants and agreements
set forth herein, the parties hereto agree as follows:
ARTICLE I
The Equity Investment
Section 1.01. Purchase. Upon
the terms and subject to the conditions set forth in this
Agreement, and in accordance with the General Corporation Law of
the State of Delaware (the DGCL), at the
Closing, the Company shall issue and sell to each Investor, and
each of the Investors, severally and not jointly (subject to
Section 2.04), shall purchase from the Company, the shares
of Preferred Stock and the Warrants in the respective amounts
set forth opposite such Investors name on Schedule I
hereto (such sale and purchase, the Equity
Investment).
Section 1.02. Investor
Representative. (a) The Investor
Representative hereby is appointed, authorized and empowered to
act, on behalf of each of the other Investors, during the period
from and including the date of this Agreement through and
including the Closing, in connection with and to facilitate this
Agreement, the Equity Investment and the other transactions
contemplated by this Agreement, and in connection with the
activities to be
A-1
performed on behalf of the Investors under this Agreement, for
the purposes and with the powers and authority hereinafter set
forth in this Section 1.02, which shall include the power
and authority:
(i) to agree to such amendments or modifications hereto as
the Investor Representative, in its sole discretion, may deem
necessary or desirable (other than any amendment or modification
increasing the purchase obligation of any other Investor with
respect to the Equity Investment or modifying in any material
respect the terms of the Securities as contemplated hereby, or
adversely affecting the terms of this Agreement as they apply to
another Investor in a manner disproportionate to the effect on
the Investors generally), and each Investor hereby agrees to any
such amendment or modification;
(ii) to execute and deliver such waivers and consents in
connection with this Agreement, the Equity Investment and the
other transactions contemplated by this Agreement as the
Investor Representative, in its sole discretion, may deem
necessary or desirable, and each Investor hereby agrees to any
such waiver or consent (subject to the parenthetical in
clause (i) above);
(iii) to make, execute, acknowledge and deliver, on behalf
of itself and the other Investors, all such other agreements,
and, in general, to do any and all things and to take any and
all actions that the Investor Representative, in its sole
discretion, may consider necessary, proper or convenient in
connection with this Agreement, the Equity Investment and the
other transactions contemplated by this Agreement (subject to
the parenthetical in clause (i) above);
(iv) to communicate to, and receive communications from,
the Company on behalf of the Investors; and
(v) to take such other actions as may be expressly provided
in this Agreement.
(b) Each Investor, on behalf of itself and its Affiliates,
releases and forever discharges the Investor Representative and
its Affiliates and each of their respective officers, directors,
agents, employees, attorneys, predecessors, successors and
assigns (individually, a Releasee and
collectively, Releasees) from any and all
claims, demands, proceedings, causes of action, orders,
obligations, debts and liabilities whatsoever, whether known or
unknown, both at law and in equity, which such Investor or its
Affiliates has or may hereafter have against any of the
Releasees, arising out of or relating to any action or failure
to act of the Investor Representative (in its capacity as such)
in connection with this Agreement, the Equity Investment and the
other transactions contemplated by this Agreement.
(c) Except as otherwise expressly set forth in
Section 2.04, the obligations of each Investor under this
Agreement are several and not joint with the obligations of any
other Investor, and no Investor shall be responsible for the
performance of the obligations of any other Investor under this
Agreement.
ARTICLE II
The Closing
Section 2.01. Closing. The
closing of the Equity Investment (the
Closing) will take place (subject to
Section 2.04) at 10:00 a.m., New York time, on a date
to be specified by the Company and the Investor Representative,
which shall be not later than the second business day after
satisfaction or (to the extent permitted by Law) waiver of the
conditions set forth in Article VI (other than those that
by their terms are to be satisfied or waived at the Closing, it
being understood that the occurrence of the Closing shall remain
subject to the satisfaction or waiver of such conditions at
Closing), at the offices of Cravath, Swaine & Moore
LLP, 825 Eighth Avenue, New York, New York 10019, unless another
time, date or place is agreed to in writing by the Company and
the Investor Representative; provided, however,
that if all the conditions set forth in Article VI shall
not have been satisfied or (to the extent permitted by Law)
waived on such second business day, then the Closing shall take
place (subject to Section 2.04) on the first business day
on which all such conditions shall have been satisfied or (to
the extent permitted by Law) waived. The date on which the
Closing occurs is referred to in this Agreement as the
Closing Date.
Section 2.02. Issuance
of and Payment for Securities. Upon the terms
and subject to the conditions set forth in this Agreement, at
the Closing, (a) the Company shall issue and sell to each
Investor, free and clear of any
A-2
and all Liens (except for transfer restrictions imposed by
applicable securities Laws), the shares of Preferred Stock and
Warrants set forth opposite the name of such Investor on
Schedule I hereto, and (b) each Investor shall pay to
the Company, in respect of the shares of Preferred Stock and
Warrants set forth opposite the name of such Investor on
Schedule I hereto, such Investors pro rata portion,
as set forth on Schedule I hereto, of the aggregate
purchase price (the Purchase Price) in
respect of the Preferred Stock and Warrants to be paid to the
Company pursuant to this Agreement.
Section 2.03. Actions
to be Taken at the Closing. To effect the
purchase and sale of Securities as set forth in
Section 2.02 and the other transactions contemplated by
this Agreement, upon the terms and subject to the conditions set
forth in this Agreement, at the Closing:
(a) The Company shall duly file the Certificate of
Amendment with the Secretary of State of the State of Delaware
in accordance with the laws of the State of Delaware.
(b) The Company shall issue and deliver to each Investor a
certificate or certificates, registered in such names as the
applicable Investor may designate in writing to the Company
(through the Investor Representative) no less than five business
days prior to the Closing, representing the shares of Preferred
Stock and the Warrants to be issued and delivered to such
Investor as set forth in Schedule I hereto, against payment
in full of such Investors pro rata portion of the Purchase
Price as set forth on Schedule I hereto.
(c) Each Investor shall cause a wire transfer in same day
funds to an account of the Company, which account shall be
designated in writing by the Company to the Investor
Representative no less than five business days prior to the
Closing, in an amount equal to such Investors pro rata
portion of the Purchase Price as set forth in Schedule I
hereto.
(d) The Board of Directors of the Company shall be
reconstituted as provided in Section 5.06, and such
reconstituted Board of Directors of the Company shall appoint
Bradley S. Jacobs as the Chairman of the Board of Directors of
the Company.
(e) Each of the Company and the Investors shall take all
such other actions required hereby to be performed and deliver
all other documents, certificates and other items required to be
delivered on its part, prior to or on the Closing Date,
including delivering the documents and satisfying the conditions
set forth in Article VI. All such documents and instruments
delivered to any party pursuant hereto shall be in form and
substance, and shall be executed in a manner, reasonably
satisfactory to such party and its counsel.
Section 2.04. Defaulting
Investor. Notwithstanding anything to the
contrary (but subject to the satisfaction or (to the extent
permitted by Law) waiver of the conditions to Closing set forth
in this Agreement), in the event that any Investor (other than
the Investor Representative) shall breach its obligation to pay
to the Company at the Closing its pro rata portion of the
Purchase Price in accordance with Section 2.03, the
Investor Representative shall purchase from the Company, and the
Company shall issue and deliver to the Investor Representative,
the shares of Preferred Stock and the Warrants otherwise
allocable to such defaulting Investor in accordance with this
Agreement. In the event that the Investor Representative shall
become obligated to purchase shares of Preferred Stock and
Warrants otherwise allocable to a defaulting Investor in
accordance with the foregoing sentence, the Investor
Representative shall have the right, in its sole discretion,
upon written notice to the Company, to delay the Closing for a
period of up to five business days. This Section 2.04 shall
be without prejudice to any rights or remedies that the Company,
the Investor Representative or any other person may have against
the defaulting Investor in respect of such breach.
ARTICLE III
Representations
and Warranties
Section 3.01. Representations
and Warranties of the Company. Except as
(A) set forth in the disclosure letter delivered by the
Company to the Investor Representative on the date hereof (the
Company Letter) (it being understood that any
information set forth on one section or subsection of the
Company Letter shall be deemed to apply to and qualify the
section or subsection of this Agreement to which it corresponds
in number and each other section or subsection of this Agreement
to the extent that it is reasonably apparent from the face of
such disclosure that such information is relevant to such other
section or subsection) or (B) disclosed in any report,
schedule, form,
A-3
statement or other document (including exhibits) filed with, or
furnished to, the SEC and publicly available prior to the date
hereof (the Filed SEC Documents), other than
any disclosures in any such Filed SEC Document contained in the
Risk Factors section thereof, the Company represents
and warrants to each Investor as follows:
(a) Organization, Standing and Corporate
Power. Each of the Company and its
Subsidiaries (i) is a corporation or other legal entity
duly organized, validly existing and in good standing under the
Laws of the jurisdiction of its organization (except, in the
case of good standing, for entities organized under the Laws of
any jurisdiction that does not recognize such concept),
(ii) has all requisite corporate, company, partnership or
other organizational power and authority to carry on its
business as currently conducted and (iii) is duly qualified
or licensed to do business and is in good standing in each
jurisdiction (except, in the case of good standing, any
jurisdiction that does not recognize such concept) in which the
nature of its business or the ownership, leasing or operation of
its properties makes such qualification or licensing necessary,
other than where the failure to be so organized, existing,
qualified or licensed or in good standing (except, in the case
of clause (i) above, with respect to the Company),
individually or in the aggregate, is not reasonably likely to
have a Material Adverse Effect. The Company has made available
to the Investors (or the same are available to the Investors on
the SECs EDGAR system) complete and correct copies of the
certificate of incorporation of the Company, as amended to the
date of this Agreement (the Company
Certificate), and the bylaws of the Company, as
amended to the date of this Agreement (the Company
Bylaws). The Company has made available to the
Investor Representative complete and correct copies of the
minutes (or, in the case of draft minutes, the most recent
drafts thereof) of all meetings of the stockholders, the Board
of Directors of the Company and each committee of the Board of
Directors of the Company and each of its Subsidiaries held since
January 1, 2009 (other than portions of any minutes (or
drafts thereof) related to the transactions contemplated by this
Agreement or any Takeover Proposal). The Company has made
available to the Investor Representative complete and correct
copies of all resolutions of the Board of Directors of the
Company, and each committee thereof, in respect of this
Agreement and the transactions contemplated hereby.
(b) Subsidiaries. Section 3.01(b)
of the Company Letter sets forth a complete and correct list of
each Subsidiary of the Company and its place and form of
organization. All the outstanding shares of capital stock of, or
other equity or voting interests in, each such Subsidiary are
owned by the Company, by one or more wholly owned Subsidiaries
of the Company or by the Company and one or more wholly owned
Subsidiaries of the Company, free and clear of all pledges,
claims, liens, charges, options, security interests or other
encumbrances of any kind or nature whatsoever (collectively,
Liens), except for transfer restrictions
imposed by applicable securities Laws, and are duly authorized,
validly issued, fully paid and nonassessable. Except for the
capital stock of, or other equity or voting interests in, its
Subsidiaries, the Company does not own, directly or indirectly,
any capital stock of, or other equity or voting interests in,
any person.
(c) Preferred Stock Certificate of
Designation. The Certificate of Designation
with respect to the Preferred Stock (the Certificate of
Designation) has been duly adopted by the Company and
will be duly filed with the Secretary of State of the State of
Delaware in accordance with the Laws of the State of Delaware on
or prior to the Closing Date. The Preferred Stock, when issued,
will have the designations, preferences and relative,
participating, optional and other special rights and
qualifications, limitations and restrictions set forth in the
Certificate of Designation.
(d) Capital
Structure. (i) The authorized capital
stock of the Company consists of 100,000,000 shares of
Company Common Stock and 10,000,000 shares of Preferred
Stock, par value $0.001 per share, of the Company (the
Company Preferred Stock). At the close of
business on June 10, 2011, (A) 33,011,561 shares
of Company Common Stock (excluding treasury shares) were issued
and outstanding, none of which were subject to vesting
restrictions
and/or
subject to forfeiture back to the Company or repurchase by the
Company, (B) 180,000 shares of Company Common Stock
were held by the Company as treasury shares and
(C) 4,626,238 shares of Company Common Stock were
reserved and available for issuance in the aggregate pursuant to
the Amended and Restated 2001 Stock Option Plan of the Company
(the Company Stock Plan), of which
2,542,750 shares of Company Common Stock were subject to
outstanding options to acquire shares of Company Common Stock
from the Company (such options, together with any other stock
options granted after June 10, 2011 under the Company Stock
Plan or otherwise, the Stock Options). All
outstanding Stock Options have been granted under the Company
Stock Plan. Other than the Company Stock Plan, there is no
A-4
plan, Contract or arrangement providing for the grant of Stock
Options. No shares of Company Preferred Stock are issued or
outstanding (excluding, for avoidance of doubt, the shares of
Preferred Stock to be issued on the Closing Date pursuant to
this Agreement). No shares of Company Common Stock are owned by
any Subsidiary of the Company. The Company has made available to
the Investor Representative a complete and correct list, as of
the close of business on June 10, 2011, of all outstanding
Stock Options, the number of shares of Company Common Stock
subject to each such Stock Option, the grant date, exercise
price per share and expiration date of each such Stock Option,
the name of the holder thereof and whether or not such Stock
Option (or any portion thereof) is intended to qualify as an
incentive stock option under Section 422 of the
Code. As of the date of this Agreement, other than the
outstanding Stock Options, there are no outstanding rights of
any person to receive Company Common Stock under the Company
Stock Plan or otherwise, on a deferred basis or otherwise.
(ii) Except as set forth in Section 3.01(d)(i), as of
the close of business on June 10, 2011, no shares of
capital stock of, or other equity or voting interests in, the
Company, or securities convertible into, or exchangeable or
exercisable for, or options, warrants, shares of deferred stock,
restricted stock awards, stock appreciation rights, phantom
stock awards or other rights to acquire any such capital stock
of, or other equity or voting interests in, the Company, or
other rights that are linked to the value of Company Common
Stock or the value of the Company or any part thereof, were
issued, reserved for issuance or outstanding. From the close of
business on June 10, 2011 to the date of this Agreement,
(A) there have been no issuances by the Company of shares
of capital stock of, or other equity or voting interests in, the
Company, other than issuances of shares of Company Common Stock
pursuant to the exercise of Stock Options outstanding as of
June 10, 2011, and only if and to the extent required by
their respective terms as in effect on such date and
(B) there have been no issuances by the Company of
securities convertible into, or exchangeable or exercisable for,
or options, warrants, shares of deferred stock, restricted stock
awards, stock appreciation rights, phantom stock awards, other
rights to acquire shares of capital stock of, or other equity or
voting interests in, the Company, or other rights that are
linked to the value of Company Common Stock or the value of the
Company or any part thereof.
(iii) All outstanding shares of capital stock of the
Company are, and all shares that may be issued pursuant to the
Company Stock Plan will be, when issued in accordance with the
terms thereof, duly authorized, validly issued, fully paid and
nonassessable and not subject to preemptive rights. Except as
set forth in this Section 3.01(d), there are no
(A) bonds, debentures, notes or other indebtedness of the
Company or any of its Subsidiaries and (B) securities or
other instruments or rights (including stock appreciation
rights, phantom stock awards, stock-based performance units or
other similar rights) issued by, or other obligations of, the
Company or any of its Subsidiaries, in each case, that are
linked to, or the value of which is in any way based upon or
derived from, the value of any class of capital stock of, or
other equity or voting interests in, the Company or any of its
Subsidiaries, the value of the Company, any of its Subsidiaries
or any part thereof, or any dividends or other distributions
declared or paid on any shares of capital stock of, or other
equity or voting interests in, the Company or any of its
Subsidiaries, or which have or which by their terms may have at
any time (whether actual or contingent) the right to vote (or
which are convertible into, or exchangeable for, securities
having the right to vote) on any matters on which stockholders
of the Company or any of its Subsidiaries may vote (the items
referred to in clauses (A) and (B) collectively,
Equity Equivalents). Except for this
Agreement and except as set forth in this Section 3.01(d),
there are no securities, options, warrants, calls, stock-based
performance units, rights or Contracts of any kind to which the
Company or any of its Subsidiaries is a party, or by which the
Company or any of its Subsidiaries is bound, obligating the
Company or any of its Subsidiaries to issue, deliver or sell, or
cause to be issued, delivered or sold, additional shares of
capital stock of, or other equity or voting interests in, or
securities convertible into, or exchangeable or exercisable for,
shares of capital stock of, or other equity or voting interests
in, the Company or any of its Subsidiaries or obligating the
Company or any of its Subsidiaries to issue, grant, extend or
enter into any such security, option, warrant, call, stock-based
performance unit, right or Contract. With respect to the Stock
Options, (1) each Stock Option intended to qualify as an
incentive stock option under Section 422 of the
Code so qualifies, (2) each grant of a Stock Option was
duly authorized no later than the date on which the grant of
such Stock Option was by its terms to be effective (the
Grant Date) by all necessary corporate action
and (3) the per share exercise price of each Stock Option
was not less than the fair market value (within the meaning of
Section 422 of the Code, in the case of each Stock Option
intended to qualify as an incentive stock option,
A-5
and within the meaning of Section 409A of the Code, in the
case of each other Stock Option) of a share of Company Common
Stock on the applicable Grant Date. Except pursuant to the
forfeiture conditions of the Stock Options outstanding as of the
date of this Agreement and except pursuant to the cashless
exercise or Tax withholding provisions of such Stock Options, in
each case as in effect on the date of this Agreement, there are
no outstanding contractual or other obligations of the Company
or any of its Subsidiaries to (I) repurchase, redeem or
otherwise acquire any shares of capital stock of, or other
equity or voting interests in, the Company or any of its
Subsidiaries or (II) vote or dispose of any shares of
capital stock of, or other equity or voting interests in, the
Company or any of its Subsidiaries. The Company is not a party
to any voting agreement with respect to any shares of capital
stock of, or other equity or voting interests in, the Company or
any of its Subsidiaries and, to the knowledge of the Company, as
of the date of this Agreement there are no irrevocable proxies
and no voting agreements (other than the Voting Agreements) with
respect to any shares of capital stock of, or other equity or
voting interests in, the Company or any of its Subsidiaries. The
Company has not knowingly granted, and there is no and has been
no Company policy or practice to grant, Stock Options prior to,
or otherwise coordinate the grant of Stock Options with, the
release or other public announcement of material information
regarding the Company or its Subsidiaries or their financial
results or prospects.
(iv) Neither the Company nor any of its Subsidiaries has
any (A) indebtedness for borrowed money,
(B) indebtedness evidenced by any bond, debenture, note,
mortgage, indenture or other debt instrument or debt security,
(C) accounts payable to trade creditors and accrued
expenses not arising in the ordinary course of business,
(D) amounts owing as deferred purchase price for the
purchase of any property, (E) capital lease obligations or
(F) guarantees with respect to any indebtedness or
obligation of a type described in clauses (A) through
(E) above of any other person (other than, in the case of
clauses (A), (B) and (D), accounts payable to trade
creditors and accrued expenses, in each case arising in the
ordinary course of business) (collectively,
indebtedness), other than indebtedness
disclosed in the unaudited financial statements (including the
notes thereto) included in the Companys
Form 10-Q
for the quarterly period ended March 31, 2011, filed with
the SEC on May 13, 2011, or incurred in the ordinary course
of business consistent with past practice after the date of such
financial statements but prior to the date of this Agreement.
(e) Valid Issuance. The shares of
Preferred Stock have been duly and validly authorized and, when
issued and paid for pursuant to this Agreement, will be validly
issued, fully paid and nonassessable, and shall be free and
clear of all Liens (other than Liens created by the Investors),
except for restrictions on transfer imposed by applicable
securities Laws. The Warrants have been duly and validly
authorized. Upon the due exercise of the Warrants or conversion
of the shares of Preferred Stock, the shares of the Company
Common Stock issuable or issued upon exercise of the Warrants or
conversion of the shares of Preferred Stock, as applicable, will
be validly issued, fully paid and nonassessable, free and clear
of all Liens, except for restrictions on transfer imposed by
applicable securities Laws and except for Liens created by the
Investors. The Company will as of the Closing Date have reserved
a sufficient number of shares of Company Common Stock for
issuance upon the exercise of the Warrants and conversion of the
shares of Preferred Stock.
(f) Authority;
Noncontravention. The Company has the
requisite corporate power and authority to execute and deliver
this Agreement, to consummate the Equity Investment and the
other transactions contemplated by this Agreement and to comply
with the provisions of this Agreement, subject, in the case of
(i) the Equity Investment, (ii) the amendment to the
Company Certificate pursuant to the Certificate of Amendment,
and (iii) the implementation of the 2011 Omnibus Incentive
Compensation Plan (substantially in the form set forth in
Exhibit D) (the Omnibus ICP), to
obtaining the Stockholder Approvals. The execution and delivery
of this Agreement by the Company, the consummation by the
Company of the Equity Investment and the other transactions
contemplated by this Agreement and the compliance by the Company
with the provisions of this Agreement have been duly authorized
by all necessary corporate action on the part of the Company,
and no other corporate proceedings on the part of the Company
are necessary to authorize this Agreement, to comply with the
terms of this Agreement or to consummate the Equity Investment
and the other transactions contemplated by this Agreement,
subject, in the case of the matters set forth in
clauses (i) through (iii) of the foregoing sentence,
to obtaining the Stockholder Approvals. This Agreement has been
duly executed and delivered by the Company and, assuming the due
execution and delivery of this Agreement by each Investor,
constitutes a valid and binding obligation of the Company,
enforceable against the Company in
A-6
accordance with its terms, except as enforceability thereof may
be limited by bankruptcy, insolvency, fraudulent conveyance,
reorganization, moratorium or other similar Laws relating to the
enforcement of creditors rights generally and by general
principles of equity (the Bankruptcy and Equity
Exception). The Board of Directors of the Company, at
a meeting duly called and held, acting upon the unanimous
recommendation of the Special Committee, duly and unanimously
adopted resolutions (1) approving this Agreement, the
Equity Investment and the other transactions contemplated by
this Agreement, (2) declaring that this Agreement, the
Equity Investment and the other transactions contemplated by
this Agreement are advisable and in the best interests of the
Company and the Companys stockholders, (3) directing
that the Equity Investment, the amendment to the Company
Certificate pursuant to the Certificate of Amendment and the
Omnibus ICP be submitted to a vote at a meeting of the
Companys stockholders to be held as set forth in
Section 5.01(c) and (4) recommending that the
Companys stockholders approve the Equity Investment, the
amendment to the Company Certificate pursuant to the Certificate
of Amendment and the Omnibus ICP, which resolutions, except to
the extent expressly permitted by Section 4.02, have not
been rescinded, modified or withdrawn in any way. The execution
and delivery of this Agreement, the consummation of the Equity
Investment and the other transactions contemplated by this
Agreement and compliance by the Company with the provisions of
this Agreement do not and will not conflict with, or result in
any violation or breach of, or default (with or without notice
or lapse of time or both) under, or give rise to a right of, or
result in, termination, cancellation or acceleration of any
obligation or to a loss of a benefit under, or result in the
creation of any Lien in or upon any of the properties or assets
of the Company or any of its Subsidiaries under, or give rise to
any increased, additional, accelerated or guaranteed rights or
entitlements under (including any right of a holder of a
security of the Company or any of its Subsidiaries to require
the Company or any of its Subsidiaries to acquire such
security), any provision of (A) the Company Certificate or
the Company Bylaws or the certificate of incorporation or bylaws
(or similar organizational documents) of any of its
Subsidiaries, (B) any loan or credit agreement, bond,
debenture, note, mortgage, indenture, guarantee, lease or other
contract, commitment, agreement, instrument, binding arrangement
or understanding, obligation, undertaking or license, whether
oral or written (each, including all amendments thereto, a
Contract), or Permit to or by which the
Company or any of its Subsidiaries is a party or bound or to or
by which any of their respective properties or assets are
subject or bound or (C) subject to the governmental filings
and other matters referred to in the following sentence, any
(1) Federal, state or local, domestic or foreign, statute,
law, code, ordinance, rule or regulation of any Governmental
Entity (each, a Law), assuming receipt of the
Stockholder Approvals, or (2) Federal, state or local,
domestic or foreign, judgment, injunction, order, writ or decree
of any Governmental Entity (each, a
Judgment), in each case, applicable to the
Company or any of its Subsidiaries or their respective
properties or assets, other than, in the case of
clauses (B) and (C), any such conflicts, violations,
breaches, defaults, terminations, cancellations, accelerations,
losses, Liens, rights or entitlements that, individually or in
the aggregate, are not reasonably likely to have a Material
Adverse Effect. No consent, approval, order or authorization of,
or registration, declaration or filing with, or notice to, any
Federal, state or local, domestic or foreign, government or any
court, administrative agency or commission or other
governmental, quasi-governmental or regulatory authority or
agency, domestic or foreign (a Governmental
Entity), is required by or with respect to the Company
or any of its Subsidiaries in connection with the execution and
delivery of this Agreement by the Company, the consummation by
the Company of the Equity Investment and the other transactions
contemplated by this Agreement or the compliance by the Company
with the provisions of this Agreement, except for (I) the
filing of a notification and report form by the Company under
the
Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended (the HSR
Act), and the termination or expiration of the
applicable waiting period thereunder, (II) the filing with
the Securities and Exchange Commission (the
SEC) of a proxy statement relating to the
Stockholder Approvals (as amended or supplemented from time to
time, the Proxy Statement) and such reports
under the Securities Exchange Act of 1934, as amended, and the
rules and regulations promulgated thereunder (collectively, the
Exchange Act), as may be required in
connection with this Agreement and the Equity Investment and the
other transactions contemplated by this Agreement,
(III) the filing of the Certificate of Amendment and
Certificate of Designation with the Secretary of State of the
State of Delaware, (IV) any filings required under the
rules and regulations of the NYSE Amex LLC and (V) such
other consents, approvals, orders, authorizations,
registrations, declarations, filings and notices the failure of
which to be obtained or made, individually or in the aggregate,
are not reasonably likely to have a Material Adverse Effect.
A-7
(g) SEC Documents. (i) The
Company has filed or furnished with the SEC all reports,
schedules, forms, statements and other documents required to be
filed or furnished by the Company with the SEC pursuant to the
Securities Act or the Exchange Act since January 1, 2009
(collectively, the Company SEC Documents) at
or prior to the time so required. No Subsidiary of the Company
is required to file or furnish any report, schedule, form,
statement or other document with, or make any other filing with,
or furnish any other material to, the SEC. As of their
respective dates, each of the SEC Documents complied as to form
in all material respects with the requirements of the Securities
Act and the Exchange Act, in each case, applicable to such SEC
Document, and none of the SEC Documents at the time it was filed
or furnished contained any untrue statement of a material fact
or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not
misleading. Except to the extent that information contained in
any Filed SEC Document has been revised or superseded by a later
filed or furnished Filed SEC Document, none of the SEC Documents
contains any untrue statement of a material fact or omits to
state a material fact required to be stated therein or necessary
in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. To the
extent complete and correct copies are not available on the
SECs website, the Company has made available to the
Investors copies of all comment letters received by the Company
from the SEC since January 1, 2009 and relating to the SEC
Documents, together with all written responses of the Company
thereto. As of the date of this Agreement, there are no
outstanding or unresolved comments received by the Company from
the SEC. As of the date of this Agreement, to the knowledge of
the Company none of the SEC Documents is the subject of any
ongoing review by the SEC. The financial statements (including
the related notes) of the Company included in the SEC Documents
complied, at the time the respective statements were filed, as
to form in all material respects with the applicable accounting
requirements and the published rules and regulations of the SEC
with respect thereto, were prepared in accordance with generally
accepted accounting principles in effect from time to time in
the United States of America (GAAP) (except,
in the case of unaudited quarterly financial statements, as
permitted by
Form 10-Q
of the SEC) applied on a consistent basis during the periods
involved (except as may be indicated in the notes thereto) and
fairly present in all material respects the consolidated
financial position of the Company and its consolidated
Subsidiaries as of the dates thereof and their consolidated
results of operations and cash flows for the periods then ended
(subject, in the case of unaudited quarterly financial
statements, to normal and recurring year-end audit adjustments).
Except as set forth in the most recent audited financial
statements (including the notes thereto) included in the Filed
SEC Documents (the Baseline Financials), the
Company and its Subsidiaries have no material liabilities or
obligations of any nature (whether accrued, absolute, contingent
or otherwise) other than such liabilities or obligations
(A) with respect to or arising from the transactions
contemplated by this Agreement, (B) incurred in the
ordinary course of business consistent with past practice after
the date of the Baseline Financials but prior to the date of
this Agreement, (C) incurred on or after the date of this
Agreement that are not reasonably likely to have, individually
or in the aggregate, a Material Adverse Effect or
(D) disclosed in the unaudited financial statements
(including the notes thereto) included in the Companys
Form 10-Q
for the period ended March 31, 2011, filed with the SEC on
May 13, 2011.
(ii) The Company is in compliance in all material respects
with the provisions of the Sarbanes-Oxley Act of 2002 and the
rules and regulations promulgated thereunder (collectively,
SOX) applicable to it. The Company has
promptly disclosed, by filing a
Form 8-K,
any change in or waiver of the Companys Code of Business
Conduct and Ethics, as required by Section 406(b) of SOX.
To the knowledge of the Company, there have been no violations
of provisions of the Companys Code of Business Conduct and
Ethics since the adoption of such Code of Business Conduct and
Ethics, including any minor violations not material to the
Companys business.
(iii) The principal executive officer of the Company and
the principal financial officer of the Company each has made all
certifications required by
Rule 13a-14
and 15d-14
under the Exchange Act and Sections 302 and 906 of SOX, as
applicable, with respect to the SEC Documents, and the
statements contained in such certifications were accurate as of
the date they were made. For purposes of this Agreement,
principal executive officer and principal
financial officer shall have the meanings given to such
terms in SOX. Neither the Company nor any of its Subsidiaries
has outstanding, or has arranged any outstanding,
extension of credit to directors or executive
officers within the meaning of Section 402 of SOX.
A-8
(iv) Neither the Company nor any of its Subsidiaries is a
party to or bound by, or has any commitment to become a party to
or bound by, any joint venture, off-balance sheet partnership or
any similar Contract (including any Contract relating to any
transaction or relationship between or among the Company and any
of its Subsidiaries, on the one hand, and any unconsolidated
Affiliate, including any structured finance, special purpose or
limited purpose entity or person, on the other hand, or any
off-balance sheet arrangements (as defined in
Item 303(a) of
Regulation S-K
of the SEC)), where the purpose or intended or known result or
effect of such joint venture, partnership or Contract is to
avoid disclosure of any material transaction involving, or
material liabilities of, the Company or any of its Subsidiaries
in the Companys or any of its Subsidiaries published
financial statements or other SEC Documents.
(v) The Company maintains internal control over
financial reporting (as defined in
Rule 13a-15(f)
of the Exchange Act) in compliance with the Exchange Act.
(vi) The Company maintains disclosure controls and
procedures (as defined in
Rule 13a-15(e)
of the Exchange Act) in compliance with the Exchange Act.
(h) Information Supplied. None of
the information included or incorporated by reference in the
Proxy Statement will, at the date it is first mailed to the
Companys stockholders, at the time of the Stockholders
Meeting or at the time of any amendment or supplement thereof,
as amended or supplemented at such date or time, contain any
untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary in
order to make the statements therein, in light of the
circumstances under which they are made, not misleading, except
that no representation is made by the Company with respect to
statements made or incorporated by reference therein based on
information supplied by or on behalf of the Investors
specifically for inclusion or incorporation by reference in the
Proxy Statement. The Proxy Statement will comply as to form in
all material respects with the requirements of the Exchange Act.
(i) Absence of Certain Changes or
Events. (i) From January 1, 2011 to
the date of this Agreement, the Company and its Subsidiaries
have conducted their respective businesses only in the ordinary
course of business consistent in all material respects with past
practice and there has not been (A) any Material Adverse
Effect or any state of facts, change, development, event,
effect, condition, occurrence, action or omission that is
reasonably likely to have a Material Adverse Effect (including
any Material Adverse Effect resulting from an occurrence prior
to January 1, 2011), (B) any declaration, setting
aside or payment of any dividend on, or other distribution
(whether in cash, stock or property) in respect of, any of the
Companys or any of its Subsidiaries capital stock or
other equity or voting interests, except for dividends by a
direct or indirect wholly owned Subsidiary of the Company to its
parent, (C) any split, combination or reclassification of
any of the Companys or any of its Subsidiaries
capital stock or other equity or voting interests or any
issuance or the authorization of any issuance of any other
securities in respect of, in lieu of or in substitution for
shares of capital stock of, or other equity or voting interests
in, the Company or any of its Subsidiaries, (D) any grant
or payment by the Company or any of its Subsidiaries to any
current or former director, officer, employee, contractor or
consultant of the Company or any of its Subsidiaries
(collectively, Company Personnel) of any
increase in any type of compensation or benefits, except in the
ordinary course of business consistent with past practice,
(E) any adoption or establishment of or entry by the
Company or any of its Subsidiaries into, any amendment of,
modification to or termination of, or agreement to amend, modify
or terminate, or any termination of (or announcement of an
intention to amend, modify or terminate), (1) any
employment, deferred compensation, change in control, severance,
termination, employee benefit, loan, indemnification, retention,
equity or equity-based compensation, consulting or similar
Contract between the Company or any of its Subsidiaries, on the
one hand, and any Company Personnel, on the other hand,
(2) any trust or insurance Contract or other agreement to
fund or otherwise secure payment of any compensation or benefit
to be provided to any Company Personnel (all such Contracts
under this clause (E), including any such Contract that is
entered into on or after the date of this Agreement,
collectively, Benefit Agreements), except in
the ordinary course of business consistent with past practice
with respect to Company Personnel who are not directors or
officers of the Company or any of its Subsidiaries, (F) the
taking of any action to accelerate, or that is reasonably likely
to result in the acceleration of, the time of vesting or payment
of any rights, compensation, benefits or funding obligations
under any Benefit Plan or Benefit Agreement or otherwise,
(G) any material change in financial or Tax accounting
methods, principles or practices by the Company or any of its
Subsidiaries, except insofar as may have been
A-9
required by GAAP or applicable Law, (H) any material Tax
election or change in any material Tax election or any
settlement or compromise of any material Tax liability or
(I) any material write-down by the Company or any of its
Subsidiaries of any of the material assets of the Company or any
of its Subsidiaries.
(ii) Since January 1, 2011, each of the Company and
its Subsidiaries has continued all pricing, sales, receivables
and payables practices in accordance with the ordinary course of
business consistent with past practice and has not engaged,
except in the ordinary course of business consistent with past
practice, in (A) any trade loading practices or any other
promotional sales or discount activity with any customers with
the effect of accelerating to prior fiscal quarters (including
the current fiscal quarter) sales to the trade or otherwise that
would otherwise be expected to occur in subsequent fiscal
quarters, (B) any practice that would have the effect of
accelerating to prior fiscal quarters (including the current
fiscal quarter) collections of receivables that would otherwise
be expected to be made in subsequent fiscal quarters,
(C) any practice that would have the effect of postponing
to subsequent fiscal quarters payments by the Company or any of
its Subsidiaries that would otherwise be expected to be made in
prior fiscal quarters (including the current fiscal quarter) or
(D) any other promotional sales or discount activity.
(j) Litigation. Section 3.01(j)
of the Company Letter sets forth, as of the date of this
Agreement, a complete and correct list of each claim, action,
suit or judicial, administrative or regulatory proceeding or
investigation pending or, to the knowledge of the Company,
threatened by or against the Company or any of its Subsidiaries
(i) for money damages (other than for immaterial amounts),
(ii) that seeks injunctive relief, (iii) that may give
rise to any legal restraint on or prohibition against or limit
the material benefits to the Investors of the Equity Investment
or the other transactions contemplated by this Agreement or
(iv) that, if resolved in accordance with plaintiffs
demands, is reasonably likely to have a Material Adverse Effect.
There is no Judgment of any Governmental Entity or arbitrator
outstanding against, or, to the knowledge of the Company,
investigation, proceeding, notice of violation, order of
forfeiture or complaint by any Governmental Entity involving,
the Company or any of its Subsidiaries that, individually or in
the aggregate, is reasonably likely to have a Material Adverse
Effect.
(k) Contracts. (i) Section 3.01(k)
of the Company Letter sets forth, as of the date of this
Agreement, a complete and correct list of:
(A) each Contract pursuant to which the Company or any of
its Subsidiaries has agreed not to compete with any person in
any area or to engage in any activity or business that is
material to the Company and its Subsidiaries, or pursuant to
which any material benefit or right is required to be given or
lost, or any material penalty or detriment is incurred, as a
result of so competing or engaging;
(B) each Contract to or by which the Company or any of its
Subsidiaries is a party or bound providing for any material
exclusivity or similar requirement, or pursuant to which any
material benefit or right is required to be given or lost, or
any material penalty or detriment is incurred, as a result of
non-compliance with any such exclusive requirements;
(C) each Contract to or by which the Company or any of its
Subsidiaries is a party or bound or with respect to which the
Company or any of its Subsidiaries has any material obligation
with (1) any Affiliate of the Company or any of its
Subsidiaries, (2) any Company Personnel, (3) any union
or other labor organization or (4) any Affiliate of any
such person (other than, in each case, (I) offer letters or
employment agreements that are terminable at will by the Company
or any of its Subsidiaries both without any penalty and without
any obligation of the Company or any of its Subsidiaries to pay
severance or other compensation or benefits (other than accrued
base salary, accrued commissions, accrued bonuses, accrued
vacation pay, accrued floating holidays and legally mandated
benefits) and (II) Benefit Plans and Benefit Agreements
other than offer letters or employment agreements);
(D) each Contract under which the Company or any of its
Subsidiaries has incurred any indebtedness having an aggregate
principal amount in excess of $200,000;
(E) each material Contract to or by which the Company or
any of its Subsidiaries is a party or bound creating or granting
a Lien (including Liens upon properties or assets acquired under
conditional sales, capital leases or other title retention or
security devices), other than (1) Liens for Taxes not yet
due and
A-10
payable, that are payable without penalty or that are being
contested in good faith and for which adequate reserves have
been established, (2) Liens for assessments and other
governmental charges or landlords, carriers,
warehousemens, mechanics, repairmens,
workers or similar Liens incurred in the ordinary course
of business, consistent with past practice, in each case for
sums not yet due and payable or due but not delinquent or being
contested in good faith by appropriate proceedings,
(3) Liens incurred in the ordinary course of business,
consistent with past practice, in connection with workers
compensation, unemployment insurance and other types of social
security or to secure the performance of tenders, statutory
obligations, surety and appeal bonds, bids, leases, government
contracts, performance and return of money bonds and similar
obligations and (4) Liens incurred in the ordinary course
of business consistent with past practice that are not
reasonably likely to adversely interfere in a material way with
the use of the properties or assets encumbered thereby
(collectively, Permitted Liens);
(F) each Contract to or by which the Company or any of its
Subsidiaries is a party or bound (other than Benefit Plans and
Benefit Agreements) containing any provisions contemplating or
relating in any way to a change in control or
similar event with respect to the Company or one or more of its
Subsidiaries, including provisions requiring consent or approval
of, or notice to, any Governmental Entity or other person in the
event of a change in control of the Company or one or more of
its Subsidiaries, or otherwise having the effect of providing
that the consummation of the Equity Investment or any of the
other transactions contemplated by this Agreement or the
execution, delivery or effectiveness of this Agreement will
materially conflict with, result in a material violation or
material breach of, or constitute a default (with or without
notice or lapse of time or both) under, such Contract, or give
rise under such Contract to any right of, or result in, a
termination, right of first refusal, material amendment,
revocation, cancellation or material acceleration of any
obligation, or a loss of a material benefit or the creation of
any material Lien upon any of the properties or assets of the
Company or any of its Affiliates, or to any increased,
guaranteed, accelerated or additional material rights or
material entitlements of any person;
(G) each Contract to or by which the Company or any of its
Subsidiaries is a party or bound for any joint venture (whether
in partnership, limited liability company or other
organizational form) or alliance or similar arrangement;
(H) each Contract to or by which the Company or any of its
Subsidiaries is a party or bound entered into in the last three
years in connection with the settlement or other resolution of
any suit, claim, action, investigation or proceeding that has
any material continuing obligations, liabilities or restrictions;
(I) except for the Contracts disclosed above, each Contract
(other than Benefit Plans and Benefit Agreements) which has
aggregate future sums due to or from the Company or any of its
Subsidiaries, taken as a whole, (i) during the period
commencing on the date of this Agreement and ending on the
12-month
anniversary of this Agreement, in excess of $200,000 or
(ii) in aggregate more than $500,000 during the life of the
Contract; and
(J) except for the Contracts disclosed above, each Contract
to or by which the Company or any of its Subsidiaries is a party
or bound not made in the ordinary course of business that is
material to the Company and its Subsidiaries, taken as a whole.
The Contracts of the Company or any of its Subsidiaries of the
type referred to in clauses (A) through (J) of this
subsection (i) are collectively referred to in this
Agreement as Specified Contracts. The Company
has made available to the Investor Representative a complete and
correct copy of each of the Specified Contracts, including all
amendments thereto.
(ii) Each Contract of the Company or any of its
Subsidiaries that is material to the Company and its
Subsidiaries (a Material Contract), as well
as each Specified Contract, is in full force and effect (except
for those Contracts that have expired in accordance with their
terms) and is a legal, valid and binding agreement of the
Company or such Subsidiary, as the case may be, and, to the
knowledge of the Company, of each other party thereto,
enforceable against the Company or such Subsidiary, as the case
may be, and, to the knowledge of the Company, against the other
party or parties thereto, in each case, in accordance with its
terms, subject to the Bankruptcy and Equity Exception. Each of
the Company and its Subsidiaries has performed or is performing
in
A-11
all material respects, all obligations required to be performed
by it under the Material Contracts and Specified Contracts and
is not (with or without notice or lapse of time or both) in
breach in any material respect or default thereunder, and has
not knowingly waived or failed to enforce any material rights or
benefits thereunder (other than in the ordinary course of
business consistent with past practice), and, to the knowledge
of the Company, no other party to any of the Material Contracts
or Specified Contracts is (with or without notice or lapse of
time or both) in breach in any material respect or default
thereunder. To the knowledge of the Company, as of the date of
this Agreement, there has occurred no event giving (with or
without notice or lapse of time or both) to others any right of
termination, material amendment or cancellation of any Material
Contract or Specified Contract.
(l) Permits; Compliance with
Laws. Except for matters that, individually
or in the aggregate, are not reasonably likely to have a
Material Adverse Effect, (i) the Company and its
Subsidiaries have in effect all certificates, permits, licenses,
franchises, approvals, concessions, qualifications,
registrations, certifications and similar authorizations from
any Governmental Entity (collectively,
Permits) that are necessary for them to own,
lease or operate their properties and assets and to carry on
their businesses as currently conducted, and (ii) each of
the Company and its Subsidiaries is in compliance with all
applicable Laws and Judgments, and no condition or state of
facts exists that is reasonably likely to give rise to a
violation of, or a liability or default under, any such
applicable Law or Judgment. The execution and delivery of this
Agreement by the Company does not, and the consummation of the
Equity Investment and the other transactions contemplated by
this Agreement and compliance with the terms hereof are not
reasonably likely to, cause the revocation or cancellation of
any material Permit.
(m) Absence of Changes in Benefit Plans; Employment
Agreements; Labor Relations. (i) Since
January 1, 2011, none of the Company or any of its
Subsidiaries has adopted, entered into, established, terminated,
amended or modified or agreed to adopt, enter into, establish,
terminate, amend or modify (or announced an intention to adopt,
enter into, establish, terminate, amend or modify) any
collective bargaining agreement or any employment, bonus,
pension, profit sharing, deferred compensation, incentive
compensation, equity or equity-based compensation, performance,
retirement, thrift, savings, cafeteria, paid time off,
perquisite, fringe benefit, vacation, unemployment, severance,
change in control, termination, retention, disability, death
benefit, hospitalization, medical or other welfare benefit or
other similar plan, program, policy, arrangement or
understanding (whether oral or written, formal or informal,
funded or unfunded and whether or not legally binding or subject
to the Laws of the United States) sponsored, maintained,
contributed to or required to be sponsored, maintained or
contributed to by the Company, any of its Subsidiaries or any
other person or entity that, together with the Company, is
treated as a single employer under Section 414(b), (c),
(m) or (o) of the Code or with respect to which the
Company is otherwise jointly or severally liable under
applicable Law (each, a Commonly Controlled
Entity), in each case, providing compensation or
benefits to any Company Personnel, including the Company Stock
Plan, but not including the Benefit Agreements (all such plans,
programs, policies, arrangements and understandings, including
any such plan, program, policy, arrangement or understanding
entered into, adopted or established on or after the date of
this Agreement, collectively, Benefit Plans),
or has made any change in any actuarial or other assumption used
to calculate funding obligations with respect to any Pension
Plan, or any change in the manner in which contributions to any
Pension Plan are made or the basis on which such contributions
are determined.
(ii) Neither the Company nor any of its Subsidiaries is a
party to any collective bargaining agreement, and there are not,
to the knowledge of the Company, any union organizing activities
concerning any employees of the Company or any of its
Subsidiaries. There are no labor strikes, slowdowns, work
stoppages or lockouts pending or, to the knowledge of the
Company, threatened in writing, against the Company or any of
its Subsidiaries. There is no unfair labor practice charge or
complaint against the Company or any of its Subsidiaries pending
or, to the knowledge of the Company, threatened, in each case
before the National Labor Relations Board or any comparable
Governmental Entity.
(n) Environmental
Matters. (i) Except for matters that,
individually or in the aggregate, are not reasonably likely to
have a Material Adverse Effect, each of the Company and its
Subsidiaries is, and has been, in compliance with all
Environmental Laws, and neither the Company nor any of its
Subsidiaries has received any (A) communication alleging
that the Company or such Subsidiary is in violation of, or may
have liability under, any Environmental Law or
(B) currently outstanding written request by any
Governmental
A-12
Entity for information pursuant to any Environmental Law; (ii)
(A) each of the Company and its Subsidiaries possesses and
is in compliance in all material respects with all Permits
required under Environmental Laws (Environmental
Permits) for the conduct of its operations,
(B) all such Environmental Permits are valid and in good
standing and (C) neither the Company nor any of its
Subsidiaries has been advised in writing by any Governmental
Entity of any actual or potential change in any material respect
in the status or terms and conditions of any such Environmental
Permit; (iii) there are no material Environmental Claims
pending or, to the knowledge of the Company, threatened against
the Company or any of its Subsidiaries; (iv) there has been
no Release of or actual or alleged exposure to any Hazardous
Material that is reasonably likely to form the basis of any
material Environmental Claim against the Company or any of its
Subsidiaries; (v) neither the Company nor any of its
Subsidiaries has retained or assumed, either contractually or by
operation of Law, any liabilities or obligations that are
reasonably likely to form the basis of any material
Environmental Claim against the Company or any of its
Subsidiaries; (vi) there are no underground or aboveground
storage tanks, generators or known or suspected
asbestos-containing materials on, at, under or about any
property owned, operated or leased by the Company or any of its
Subsidiaries; (vii) neither the Company nor any of its
Subsidiaries stores, generates or disposes of Hazardous
Materials (excluding office, cleaning or similar supplies used
in the ordinary course of the Companys or any of its
Subsidiaries operations) at, on, under, about or from
property owned or leased by the Company or any of its
Subsidiaries; and (viii) there are no past or present
events, conditions, circumstances, activities, practices,
incidents, actions or plans that are reasonably likely to form
the basis of a material Environmental Claim against the Company
or any of its Subsidiaries.
For all purposes of this Agreement,
(A) Environmental Claims means any and
all administrative, regulatory or judicial actions, suits,
Judgments, demands, directives, claims, Liens, investigations,
proceedings or written or oral notices of noncompliance or
violation by or from any person alleging liability of any kind
or nature (including liability or responsibility for the costs
of enforcement proceedings, investigations, cleanup,
governmental response, removal or remediation, natural resource
damages, property damages, personal injuries, medical
monitoring, penalties, contribution, indemnification and
injunctive relief) arising out of, based on or resulting from
(1) the presence or Release of, or exposure to, any
Hazardous Material at any location, or (2) the failure to
comply with any Environmental Law;
(B) Environmental Law means any Law,
Judgment, legally binding agreement or Permit issued,
promulgated or entered into by or with any Governmental Entity
relating to pollution, the environment (including ambient air,
surface water, groundwater, land surface or subsurface strata),
natural resources, the climate, human health and safety or the
protection of endangered or threatened species;
(C) Hazardous Materials means any
petroleum or petroleum products, radioactive materials or
wastes, asbestos in any form, polychlorinated biphenyls,
hazardous or toxic substances and any other chemical, material,
substance or waste that is prohibited, limited or regulated
under any Environmental Law; and
(D) Release means any actual or
threatened release, spill, emission, leaking, dumping,
injection, pouring, deposit, disposal, discharge, dispersal,
leaching or migration into or through the environment or within
any building, structure, facility or fixture.
(o) Employee Benefits
Matters. (i) Section 3.01(o)(i) of
the Company Letter sets forth a complete and correct list of
each material Benefit Plan that is an employee welfare
benefit plan (as defined in Section 3(1) of the
Employee Retirement Income Security Act of 1974, as amended
(ERISA)), each material Benefit Plan that is
an employee pension benefit plan (as defined in
Section 3(2) of ERISA) (each, a Pension
Plan) and all other material Benefit Plans and Benefit
Agreements that, in each case, are in effect as of the date of
this Agreement. The Company has made available to the Investor
Representative complete and correct copies of (A) each
material Benefit Plan and each material Benefit Agreement,
(B) the most recent annual report on Form 5500 (if
any) filed with the U.S. Internal Revenue Service (the
IRS) with respect to each such Benefit Plan,
(C) the most recent summary plan description (if any), and
any summary of material modifications, prepared for each such
Benefit Plan for which a summary plan description is required
under applicable Law and (D) the most recent actuarial
valuations for each such Benefit Plan (if any). To the
Companys knowledge, each Benefit Plan and Benefit
Agreement has been administered, funded and invested in all
material respects in accordance with its terms and applicable
Laws. To the Companys knowledge, the Company and its
Subsidiaries and each Benefit Plan and Benefit Agreement are in
compliance in all material respects with applicable Law,
including ERISA and the Code, and the terms of any collective
bargaining agreements or other labor union Contracts.
A-13
(ii) Each Pension Plan intended to be tax qualified under
the Code has been the subject of a favorable determination,
qualification or opinion letter from the IRS to the effect that
such Pension Plan is qualified and exempt from United States
Federal income Taxes under Sections 401(a) and 501(a),
respectively, of the Code, and no such letter has been revoked
(nor, to the knowledge of the Company, has revocation been
threatened) and no event has occurred since the date of the most
recent such letter or application therefor relating to any such
Pension Plan that is reasonably likely to adversely affect the
qualification of such Pension Plan or materially increase the
costs relating thereto or require security under
Section 307 of ERISA.
(iii) Neither the Company nor any Commonly Controlled
Entity has sponsored, maintained, contributed to or been
obligated to maintain or contribute to, or has any actual or
contingent liability under, any Benefit Plan that is a
defined benefit plan (as defined in
Section 3(35) of ERISA) or a multiemployer plan
(within the meaning of Section 4001(a)(3) of ERISA), or
that is subject to Section 302 or Title IV of ERISA or
Section 412 of the Code or that is otherwise a defined
benefit pension plan or that provides for the payment of
termination indemnities, other than any such plan that is
sponsored by a Governmental Entity, and neither the Company nor
any Commonly Controlled Entity could incur any liability with
respect to any such plan (under Title IV of ERISA or
otherwise).
(iv) Other than Stock Options held by members of the Board
of Directors as of the Closing, none of the execution and
delivery of this Agreement, the obtaining of Stockholder
Approvals or the consummation of the Equity Investment or any
other transaction contemplated by this Agreement alone will,
except as expressly contemplated by this Agreement, accelerate
the time of payment or vesting of any Stock Option. None of the
execution and delivery of this Agreement, the obtaining of
Stockholder Approvals or the consummation of the Equity
Investment or any other transaction contemplated by this
Agreement (whether alone or as a result of any termination of
employment on or following the Closing) will, except as
expressly contemplated by this Agreement, (A) entitle any
Company Personnel to severance, termination, retention, change
in control or similar compensation or benefits,
(B) accelerate the time of payment or vesting, or trigger
any payment or funding (through a grantor trust or otherwise)
of, compensation or benefits under, increase the amount payable
or trigger any other material obligation pursuant to any Benefit
Plan or Benefit Agreement or (C) result in any breach or
violation of, or a default under, any Benefit Plan or Benefit
Agreement.
(v) No Benefit Plan provides health, medical or other
welfare benefits (whether or not insured) with respect to
employees or former employees (or any of their beneficiaries) of
the Company or any of its Subsidiaries after retirement or other
termination of service (other than coverage or benefits required
to be provided under Part 6 of Subtitle B of Title I
of ERISA or any other similar applicable Law).
(vi) No Benefit Plan is maintained outside the jurisdiction
of the United States, is by its terms governed by the Laws of
any jurisdiction other than the United States or provides
compensation or benefits to Company Personnel providing services
primarily outside the United States.
(vii) As of the date of this Agreement, no employee listed
on Section 3.01(o)(vii) of the Company Letter has given
notice to the Company that such employee intends to terminate
his or her employment, and no such employee has given any
indication to the Company that such employee intends to
terminate his or her employment within the one-year period
following the date of this Agreement.
(viii) Each Benefit Plan and each Benefit Agreement that is
a nonqualified deferred compensation plan within the
meaning of Treas. Reg. Section 1.409A 1(a)(1)(a) (a
Nonqualified Deferred Compensation Plan)
(A) was operated in compliance with Section 409A of
the Code between January 1, 2005 and December 31,
2008, based upon a good faith, reasonable interpretation of
(1) Section 409A of the Code and (2) the final
Treasury Regulations and other guidance issued by the IRS
thereunder, to the extent applicable (clauses (1) and (2),
together, the 409A Authorities) and
(B) has been operated in compliance with the 409A
Authorities since January 1, 2009. Each Nonqualified
Deferred Compensation Plan has been in documentary compliance
with the 409A Authorities since January 1, 2009.
(p) Taxes. (i) Each of the
Company and its Subsidiaries has timely filed all material Tax
Returns required to have be filed and paid all material Taxes
required to have been paid (whether or not shown as due on any
Tax Return).
A-14
(ii) None of the Company or any of its Subsidiaries has
received notice from any Taxing Authority of any proposed or
asserted deficiency with respect to a material amount of Taxes
owed by the Company or any of its Subsidiaries, except for any
proposed or asserted deficiency being contested in good faith by
appropriate proceedings and for which reserves have been
established and maintained in accordance with GAAP.
(iii) There are no material liens on any of the assets of
the Company or any of its Subsidiaries with respect to Taxes,
except for liens with respect to Taxes not yet due and payable
or being contested in good faith by appropriate proceedings and
for which reserves have been established in accordance with GAAP.
(iv) Neither the Company nor any of its Subsidiaries has
constituted either a distributing corporation or a
controlled corporation (A) in a distribution of
stock qualifying for tax-free treatment under Section 355 of the
Code in the two years prior to the date of this Agreement or
(B) in a distribution that could otherwise constitute part
of a plan or series of related
transactions (within the meaning of Section 355(e) of
the Code) in conjunction with the Equity Investment or any of
the other transactions contemplated by this Agreement.
(v) Neither the Company nor any of its Subsidiaries has
ever participated in any listed transaction (as
defined in Treasury
Regulation Sections 1.6011-4(b)(2)
or 301.6111-2(b)(2)).
(vi) The Company and its Subsidiaries have no net operating
losses or net unrealized built-in losses that could become
subject to limitation under Section 382 of the Code as a
result of the Equity Investment or any of the other transactions
contemplated by this Agreement.
(vii) No amount, economic benefit or other entitlement that
could be received (whether in cash or property or the vesting of
property) as a result of the Equity Investment and the other
transactions contemplated by this Agreement (alone or in
combination with any other event, including any termination of
employment on or following the Closing) by any person who is a
disqualified individual (as such term is defined in
Treasury
Regulation Section 1.280G-1)
with respect to the Company would be characterized as an
excess parachute payment (as such term is defined in
Section 280G(b)(1) of the Code). No person is entitled to
any
gross-up,
make-whole or other additional payment from the Company or any
of its Subsidiaries in respect of any Tax (including Federal,
state, local and foreign income, excise and other Taxes
(including Taxes imposed under Section 4999 or 409A of the
Code) or interest or penalty related thereto.
(q) Properties. (i) Each of
the Company and its Subsidiaries has good and marketable title
to, or in the case of leased tangible property and leased
tangible assets, has valid and enforceable leasehold interests
in, all of its material properties and tangible assets, free and
clear of all Liens, except for Permitted Liens.
(ii) The material properties and tangible assets owned or
leased by the Company and its Subsidiaries, or which they
otherwise have the right to use, are sufficient (subject to
normal wear and tear) to operate their businesses in
substantially the same manner as they are currently conducted.
The assets of the Company and each of its Subsidiaries are each
in good working order, and have been maintained in accordance
with prudent industry practice.
(r) Intellectual
Property. (i) The Company and each of
its Subsidiaries owns, or is licensed or otherwise has the right
to use (in each case, without payments to third parties and free
and clear of any Liens), all Intellectual Property necessary for
or material to the conduct of its business as currently
conducted and such rights are not subject to termination by any
third party.
(ii) To the knowledge of the Company, none of the Company
or any of its Subsidiaries or any of its or their products or
services has infringed upon or otherwise violated, or is
infringing upon or otherwise violating, the Intellectual
Property rights of any person.
(iii) To the knowledge of the Company, no person or any
product or service of any person is infringing upon or otherwise
violating in any material respect any Intellectual Property
rights of the Company or any of its Subsidiaries.
(iv) For purposes of this Agreement, Intellectual
Property means software, trademarks, service marks,
brand names, certification marks, trade dress, assumed names,
domain names, trade names and other indications of origin, the
goodwill associated with the foregoing and registrations in any
jurisdiction of,
A-15
and applications in any jurisdiction to register, the foregoing,
including any extension, modification or renewal of any such
registration or application; patents, applications for patents
(including divisions, provisionals, continuations, continuations
in-part and renewal applications), and any renewals, extensions
or reissues thereof, in any jurisdiction; trade secrets,
know-how, formulae, processes, procedures, research records,
records of invention, test information, market surveys and
software, whether patentable or not in any jurisdiction and
rights in any jurisdiction to limit the use or disclosure
thereof by any person; writings and other works and any renewals
or extensions thereof; any similar intellectual property or
proprietary rights; and any claims or causes of action (pending,
threatened or which could be filed) arising out of any
infringement or misappropriation of any of the foregoing.
(s) Unlawful Payments. Neither the
Company nor any of its Subsidiaries, nor any of the directors,
officers, agents, employees, representatives, franchisees or
distributors of the Company or any of its Subsidiaries, has
taken any action, directly or indirectly, that:
(A) violated the FCPA or (B) would have violated the
FCPA (in any case where the Company, any of its Subsidiaries, or
any other person referenced above may not have been subject to
the FCPA). There have been no false or fictitious entries made
in the books or records of the Company or any of its
Subsidiaries relating to any payment that the FCPA prohibits,
and neither the Company nor any of its Subsidiaries has
established or maintained a secret or unrecorded fund for use in
making any such payments. As used in this Agreement, the
FCPA means the Foreign Corrupt Practices Act
of 1977, as amended from time to time.
(t) State Takeover
Statutes. Assuming the accuracy of
Section 3.02(e), the approval of the Equity Investment by
the Board of Directors of the Company referred to in
Section 3.01(f) constitutes the only action necessary to
render inapplicable to this Agreement, the Equity Investment,
the other transactions contemplated by this Agreement, including
transactions under the Voting Agreements, and compliance with
the terms of this Agreement, the restrictions on business
combinations (as defined in Section 203 of the DGCL)
set forth in Section 203 of the DGCL to the extent, if any,
such restrictions would otherwise be applicable to this
Agreement, the Voting Agreements, the Equity Investment, the
other transactions contemplated by this Agreement or compliance
with the terms of this Agreement. No other state takeover or
similar statute or regulation is applicable to this Agreement,
the Equity Investment, the other transactions contemplated by
this Agreement or compliance with the terms of this Agreement.
The Company is not party to a stockholder rights agreement,
poison pill or similar anti-takeover agreement or
plan.
(u) Voting Requirements. The
affirmative vote at the Stockholders Meeting or any adjournment
or postponement thereof of (i) the holders of a majority of
the shares of Company Common Stock voting with respect to the
Equity Issuance in favor of approving the Equity Issuance as
required by NYSE Amex Rule 713, (ii) the holders of a
majority of the outstanding shares of Company Common Stock
entitled to vote thereon in favor of approving the Certificate
of Amendment and (iii) the holders of a majority of the
shares of Company Common Stock voting with respect to the
Omnibus ICP in favor of approving the Omnibus ICP (collectively,
the Stockholder Approvals) are the only votes
of the holders of any class or series of the Companys
capital stock necessary to approve this Agreement, or to
consummate the Equity Investment and the other transactions
contemplated by this Agreement.
(v) Brokers; Schedule of Fees and
Expenses. No broker, investment banker,
financial advisor or other person, other than BB&T Capital
Markets, a division of Scott & Stringfellow, LLC, and
Ladenburg Thalmann & Co. Inc., the fees and expenses
of each of which will be paid by the Company or one or more of
its Subsidiaries, has provided any financial advisory services
to the Company or the Board of Directors of the Company or any
committee thereof in connection with the Equity Investment or
the other transactions contemplated by this Agreement or is
entitled to any brokers, finders, financial
advisors or other similar fee or commission in connection
with the Equity Investment and the other transactions
contemplated by this Agreement based upon arrangements made by
or on behalf of the Company or any of its Subsidiaries or the
Board of Directors of the Company or any committee thereof. The
Company has delivered to the Investor Representative complete
and correct copies of all agreements under which any such fees
or commissions are payable and all indemnification and other
agreements related to the engagement of the persons to whom such
fees are payable. The fees and expenses of any accountant,
broker, financial advisor, consultant, legal counsel or other
person retained by the Company or any of its Subsidiaries in
connection with this Agreement or the Equity Investment and the
other
A-16
transactions contemplated by this Agreement incurred or to be
incurred by the Company or any of its Subsidiaries in connection
with this Agreement or the Equity Investment and the other
transactions contemplated by this Agreement will not exceed the
fees and expenses set forth in Section 3.01(v) of the
Company Letter.
(w) Opinion of Financial
Advisor. The Special Committee has received
the written opinion of Ladenburg Thalmann & Co. Inc.
to the effect that, as of the date of this Agreement, and based
upon and subject to the factors and assumptions set forth
therein, the Equity Investment is fair, from a financial point
of view, to the Companys stockholders, a copy of which
opinion will be delivered to the Investor Representative solely
for informational purposes as promptly as practicable after the
date of this Agreement.
(x) Insurance Coverage. The
Company and each of its Subsidiaries maintains in full force and
effect insurance coverage that is customary for comparably
situated companies for the business being conducted and
properties owned or leased by the Company and its Subsidiaries,
and the Company reasonably believes such insurance coverage to
be adequate against all liabilities, claims and risks against
which it is customary for comparably situated companies to
insure.
(y) No Reliance. Except for the
representations and warranties of the Investor Representative
expressly set forth in Section 3.02, the Company hereby
acknowledges that the Investor Representative has not made and
is not making any express or implied representation or warranty
with respect to the Equity Investment or the Company or its
prospects, including with respect to any information provided or
made available to the Company or its representatives by the
Investor Representative or its representatives, or will have or
be subject to any liability to the Company or any other person
resulting from the delivery to or use by the Company or any of
its representatives of any projections, forecasts or other
forward-looking information, business plans or other similar
material developed by or provided or made available to the
Company.
(z) Securities Law
Compliance. Neither the Company nor any of
its Affiliates, nor any person acting on its or their behalf,
has conducted any general solicitation or general advertising
(as those terms are used in Regulation D under the
Securities Act) in connection with the offer or sale of any of
the Securities.
Neither the Company nor any of its Affiliates, nor any person
acting on its or their behalf, has, directly or indirectly, made
any offers or sales of any Company security or solicited any
offers to buy any security, under circumstances that would
adversely affect reliance by the Company on Section 4(2) of
the Securities Act for the exemption from registration for the
transactions contemplated hereby or would require registration
under the Securities Act of the offer or sale of the Securities
as contemplated hereby. Assuming the accuracy of the
representations and warranties set forth in
Sections 3.02(f), (g) and (h), the offer and sale of
the Securities to the Investors as contemplated hereby is exempt
from the registration requirements of the Securities Act.
Section 3.02. Representations
and Warranties of the Investors. Each
Investor, severally (as to itself) and not jointly, represents
and warrants to the Company and to the other Investors that:
(a) Organization. Such Investor,
other than any individual, is duly organized, validly existing
and in good standing under the Laws of the jurisdiction of its
organization and has all requisite corporate or other power and
authority to carry on its business as currently conducted.
(b) Authority;
Noncontravention. Such Investor has the
requisite corporate or other power and authority to execute and
deliver this Agreement (including, as applicable, by joinder
hereto in accordance with Section 8.08), to consummate the
Equity Investment and the other transactions contemplated by
this Agreement and to comply with the provisions of this
Agreement. The execution and delivery of this Agreement by such
Investor (including, as applicable, by joinder hereto in
accordance with Section 8.08), the consummation by such
Investor of the Equity Investment and the other transactions
contemplated by this Agreement and the compliance by such
Investor with the provisions of this Agreement have been duly
authorized by all necessary action (corporate or otherwise) on
the part of such Investor, and no other corporate or other
proceedings on the part of such Investor are necessary to
authorize this Agreement, to comply with the terms of this
Agreement or to consummate the Equity Investment and the other
transactions contemplated by this Agreement. This Agreement has
been duly executed and delivered by such Investor (including, as
applicable, by joinder hereto in accordance with
Section 8.08), and, assuming the due execution and delivery
of this Agreement by the Company, constitutes a valid and
binding obligation of such Investor, enforceable
A-17
against such Investor in accordance with its terms, subject to
the Bankruptcy and Equity Exception. The execution and delivery
of this Agreement (including, as applicable, by joinder hereto
in accordance with Section 8.08), the consummation of the
Equity Investment and the other transactions contemplated by
this Agreement and the compliance by such Investor with the
provisions of this Agreement do not and will not conflict with,
or result in any violation or breach of, or default (with or
without notice or lapse of time or both) under, or give rise to
a right of, or result in, termination, cancellation or
acceleration of any obligation or to a loss of a material
benefit under, or result in the creation of any Lien in or upon
any of the properties or assets of such Investor under, or give
rise to any increased, additional, accelerated or guaranteed
rights or entitlements under, any provision of (i) the
certificate of incorporation or bylaws or comparable
organizational documents of such Investor, other than any
individual, (ii) any Contract or Permit to or by which such
Investor is a party or bound or to or by which its properties or
assets are subject or bound or otherwise under which such
Investor has rights or benefits or (iii) subject to the
governmental filings and other matters referred to in the
following sentence, any Law (assuming receipt of the Stockholder
Approvals) or Judgment, in each case, applicable to such
Investor or its properties or assets, other than, in the case of
clauses (ii) and (iii), any such conflicts, violations,
breaches, defaults, terminations, cancellations, accelerations,
losses, Liens, rights or entitlements that, individually or in
the aggregate, are not reasonably likely to impair in any
material respect the ability of such Investor to perform its
obligations under this Agreement or prevent or materially impede
or materially delay the consummation of the Equity Investment or
the other transactions contemplated by this Agreement. No
consent, approval, order or authorization of, registration,
declaration or filing with, or notice to, any Governmental
Entity is required by or with respect to such Investor in
connection with the execution and delivery of this Agreement by
such Investor (including, as applicable, by joinder hereto in
accordance with Section 8.08), the consummation by such
Investor of the Equity Investment and the other transactions
contemplated by this Agreement or the compliance by such
Investor with the provisions of this Agreement, except for
(A) the filing of a notification and report form under the
HSR Act and the termination or expiration of the applicable
waiting period thereunder and (B) such other consents,
approvals, orders, authorizations, registrations, declarations,
filings and notices, the failure of which to be obtained or
made, individually or in the aggregate, are not reasonably
likely to impair in any material respect the ability of such
Investor to perform its obligations under this Agreement or
prevent or materially impede or materially delay the
consummation of the Equity Investment or the other transactions
contemplated by this Agreement.
(c) Information Supplied. None of
the information supplied or to be supplied by such Investor
specifically for inclusion or incorporation by reference in the
Proxy Statement will, at the date the Proxy Statement is first
mailed to the Companys stockholders, at the time of the
Stockholders Meeting or at the time of any amendment or
supplement thereto, as amended or supplemented at such date or
time, contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of
the circumstances under which they are made, not misleading.
(d) Financing. Such Investor has,
and will have available to it upon the Closing, sufficient funds
to consummate the Equity Investment as contemplated hereby with
respect to such Investor, including payment in full of its pro
rata portion of the Purchase Price.
(e) State Takeover Statutes. Such
Investor has not been an interested stockholder with
respect to the Company at any time within three years of the
date of this Agreement, as such term is used in Section 203
of DGCL.
(f) Accredited Investor. Such
Investor is an accredited investor within the
meaning of Rule 501(a) of Regulation D under the
Securities Act. Such Investor is knowledgeable, sophisticated
and experienced in business and financial matters, has
previously invested in securities similar to the Securities and
fully understands the limitations on transfer and the
restrictions on sales of such Securities. Such Investor is able
to bear the economic risk of its investment and is currently
able to afford the complete loss of such investment. The
Securities to be received by such Investor hereunder will be
acquired for such Investors own account, not as nominee or
agent, and not with a view to the resale or distribution of any
part thereof in violation of the Securities Act, and such
Investor has no present intention of selling, granting any
participation in, or otherwise distributing the same in
violation of the Securities Act, without prejudice, however, to
such Investors right at all times to sell or otherwise
dispose of all or any part of such Securities in compliance with
applicable Federal
A-18
and state securities Laws. Nothing contained herein shall be
deemed a representation or warranty by such Investor to hold the
Securities for any period of time. Such Investor is not a
broker-dealer registered with the SEC under the Exchange Act or
an entity engaged in a business that would require it to be so
registered.
(g) Advisors. Such Investor
acknowledges that prior to entering into this Agreement, it was
advised by persons deemed appropriate by such Investor
concerning this Agreement, the Equity Investment and the
transactions contemplated by this Agreement, and conducted its
own due diligence investigation and made its own investment
decision with respect to such transactions.
(h) No Reliance. Except for the
representations and warranties expressly set forth in this
Agreement, such Investor is not relying on any statements,
representations or warranties by the Company, the Investor
Representative or any other person in connection with this
Agreement or the transactions contemplated hereby. Such Investor
represents and warrants that it has had an opportunity to
receive all information related to the Company and the terms and
conditions of the Equity Investment and the Securities deemed
necessary by it for purposes of making its investment decision
with respect to the Securities. Such Investor acknowledges
receipt of
and/or free
access to the Filed SEC Documents. The decision of such Investor
to purchase Securities pursuant to this Agreement has been made
by such Investor independently of any other Investor. Such
Investor acknowledges that no other Investor (including the
Investor Representative) or its representatives has acted as
agent or representative for such Investor in connection with
making its investment decision with respect to the Securities.
(i) Private Placement
Considerations. Such Investor understands and
acknowledges that: (i) the offering of the Securities
pursuant to this Agreement will not be registered under the
Securities Act on the ground that the sale provided for in this
Agreement and the issuance of the Securities hereunder is exempt
from the registration requirements of the Securities Act;
(ii) its representations and warranties contained herein
are being relied upon by the Company as a basis for exemption of
the sale of the Securities under the Securities Act, under the
securities Laws of all applicable states and for other purposes;
(iii) no state or Federal agency has made any finding or
determination as to the fairness of the terms of the sale of the
Securities or any recommendation or endorsement thereof; and
(iv) the Securities are characterized as restricted
securities under the Securities Act inasmuch as they are
being acquired from the Company in a transaction not involving a
public offering and that under applicable securities Laws such
Securities (and the securities issuable upon conversion or
exercise thereof) may be resold without registration under the
Securities Act only in certain limited circumstances.
ARTICLE IV
Covenants
Section 4.01. Conduct
of Business. (a) Conduct of
Business by the Company. During the period
from the date of this Agreement to the Closing, except with the
prior written consent of the Investor Representative (which
shall not be unreasonably withheld) or as specifically
contemplated by this Agreement or as set forth in
Section 4.01(a) of the Company Letter, the Company shall,
and shall cause each of its Subsidiaries to, carry on their
respective businesses in the ordinary course in all material
respects and, to the extent consistent therewith, use
commercially reasonable efforts to keep available the services
of their present officers and employees and to preserve their
assets and technology and their relationships with customers,
suppliers and others having material business dealings with
them. Without in any way limiting the generality of the
foregoing, during the period from the date of this Agreement to
the Closing, except with the prior written consent of the
Investor Representative (which shall not be unreasonably
withheld) or as specifically contemplated by this Agreement or
as set forth in Section 4.01(a) of the Company Letter, the
Company shall not, and shall not permit any of its Subsidiaries
to:
(i) (A) declare, set aside or pay any dividends on, or
make any other distributions (whether in cash, stock or
property) in respect of, any of its capital stock or other
equity or voting interests, except for dividends by a direct or
indirect wholly owned Subsidiary of the Company to its parent,
(B) split, combine or reclassify any of its capital stock
or other equity or voting interests, or issue or authorize the
issuance of any other securities in respect of, in lieu of or in
substitution for, shares of its capital stock or other equity or
voting interests,
A-19
(C) purchase, redeem or otherwise acquire any shares of
capital stock, other equity or voting interests or any other
securities of the Company or any of its Subsidiaries or any
options, warrants, calls, stock-based performance rights or
rights to acquire any such shares or other securities (including
any Stock Options, except pursuant to the forfeiture conditions
of such Stock Options or the cashless exercise or tax
withholding provisions of such Stock Options, in each case only
if and to the extent required by the terms of such awards as in
effect on the date of this Agreement) or (D) take any
action that would result in any amendment, modification or
change of any term of any indebtedness of the Company or any of
its Subsidiaries;
(ii) issue, deliver, sell, pledge or otherwise encumber any
(A) shares of its capital stock, other equity or voting
interests or Equity Equivalents (other than the issuance of
shares of Company Common Stock upon the exercise of Stock
Options outstanding as of the date of this Agreement and only if
and to the extent required by the terms of the Company Stock
Plan as in effect on the date of this Agreement), or
(B) securities convertible into, or exchangeable or
exercisable for, or any options, warrants, calls or rights to
acquire, any such stock, interests or Equity Equivalents, or
adopt or implement any stockholder rights plan or similar
arrangement that would be applicable to the Equity Investment;
(iii) amend or propose to amend its certificate of
incorporation or bylaws (or similar organizational documents);
(iv) acquire or agree to acquire (A) by merging or
consolidating with, or by purchasing all or a substantial
portion of the assets of, or by purchasing all or a substantial
equity or voting interest in, or by any other manner, any
business or person or division thereof or (B) any other
assets other than immaterial assets acquired in the ordinary
course of business consistent with past practice;
(v) sell, lease, license, sell and lease back, mortgage or
otherwise encumber or subject to any Lien or otherwise dispose
of any of its material properties or assets (including any
shares of capital stock, equity or voting interests or other
rights, instruments or securities), except for (i) grants
of nonexclusive licenses in the ordinary course of business,
(ii) sales of used equipment in the ordinary course of
business consistent with past practice and
(iii) Permitted Liens incurred in the ordinary course of
business consistent with past practice;
(vi) (A) repurchase, prepay or incur any indebtedness,
including by way of a guarantee or an issuance or sale of debt
securities, or issue and sell options, warrants, calls or other
rights to acquire any debt securities of the Company or any of
its Subsidiaries, enter into any keep well or other
Contract to maintain any financial statement or similar
condition of another person or enter into any arrangement having
the economic effect of any of the foregoing or (B) make any
loans, advances or capital contributions to, or investments in,
any other person, other than the Company or any direct or
indirect wholly owned Subsidiary of the Company;
(vii) incur or commit to incur any capital expenditures, or
any obligations or liabilities in connection therewith, that
individually are in excess of $200,000 or in the aggregate are
in excess of $500,000;
(viii) (A) settle or satisfy any claims, actions or
proceedings, other than the settlement or satisfaction in the
ordinary course of business, or as required by their terms on
the date of this Agreement, of claims, actions or proceedings
for amounts not in excess of $200,000 or (B) waive any
material benefits of, or agree to modify in any adverse respect,
or fail to enforce, or consent to any matter with respect to
which its consent is required under, any confidentiality,
standstill or similar Contract to or by which the Company or any
of its Subsidiaries is a party or bound;
(ix) enter into any lease or sublease of real property
(whether as a lessor, sublessor, lessee or sublessee), or modify
or amend in any material respect, or exercise any right to
renew, any lease or sublease of real property or acquire any
interest in real property;
(x) modify or amend in any material respect, or accelerate,
terminate or cancel, any material Contract or waive any right to
enforce, relinquish, release, transfer or assign any rights or
claims thereunder, other than any immaterial modifications or
amendments made in the ordinary course of business;
A-20
(xi) except (x) as required to ensure that any Benefit
Plan or Benefit Agreement as in effect on the date of this
Agreement is not then out of compliance with applicable Law,
(y) as required pursuant to any Benefit Plan or Benefit
Agreement as in effect on the date of this Agreement or
(z) as specifically required pursuant to this Agreement,
(A) adopt, establish, enter into, terminate, amend or
modify any Benefit Plan or Benefit Agreement (which, for the
avoidance of doubt, includes the Omnibus ICP), (B) increase
in any manner the compensation or benefits of, or pay any bonus
or award to, or grant any loan to, any Company Personnel,
(C) pay or provide to any Company Personnel any
compensation or benefit, other than the payment of cash
compensation in the ordinary course of business, (D) grant
or amend any award under any Benefit Plan (including the grant
or amendment of Stock Options, restricted stock units,
restricted stock, stock appreciation rights, performance units,
stock purchase rights or other equity or equity-based
compensation) or remove or modify existing restrictions in any
Benefit Plan or Benefit Agreement or awards made thereunder,
(E) grant or pay any severance, separation, change in
control, termination, retention or similar compensation or
benefits to, or increase in any manner the severance,
separation, change in control, termination, retention or similar
compensation or benefits of, any Company Personnel,
(F) enter into any trust, annuity or insurance Contract or
similar agreement or take any other action to fund or in any
other way secure the payment of compensation or benefits under
any Benefit Plan or Benefit Agreement, (G) take any action
to accelerate, or that could reasonably be expected to result in
the acceleration of, the time of payment or vesting of any
rights, compensation, benefits or funding obligations under any
Benefit Plan or Benefit Agreement or otherwise or (H) make
any material determination under any Benefit Plan or Benefit
Agreement that is inconsistent with the ordinary course of
business or past practice;
(xii) form any Subsidiary of the Company;
(xiii) enter into any Contract containing any provisions
having the effect of providing that the consummation of the
Equity Investment or the other transactions contemplated by this
Agreement or compliance by the Company with the provisions of
this Agreement will conflict with, result in any violation or
breach of, or constitute a default (with or without notice or
lapse of time or both) under, such Contract, or give rise under
such Contract to any right of, or result in, a termination,
right of first refusal, material amendment, revocation,
cancellation or material acceleration, or a loss of a material
benefit or the creation of any material Lien upon any of the
properties or assets of the Company or any of its Subsidiaries,
or to any increased, guaranteed, accelerated or additional
rights or entitlements of any person, except to the extent such
conflicts, results, defaults, rights, losses or entitlements are
required by applicable Law;
(xiv) take any action or fail to take any action if such
action or failure to act could reasonably be expected to result
in (A) any representation and warranty of the Company set
forth in this Agreement that is qualified as to materiality
becoming untrue (as so qualified) or (B) any such
representation and warranty that is not so qualified becoming
untrue in any material respect;
(xv) except as required by applicable Law, adopt or enter
into any collective bargaining agreement or other labor union
Contract applicable to the employees of the Company or any of
its Subsidiaries;
(xvi) write-down any of its material assets, including any
Intellectual Property, or make any change in any financial or
tax accounting principle, method or practice, other than as
required by GAAP or applicable Law;
(xvii) engage in (A) any trade loading practices or
any other promotional sales or discount activity with any
customers with the effect of accelerating to prior fiscal
quarters (including the current fiscal quarter) sales to the
trade or otherwise that would otherwise be expected to occur in
subsequent fiscal quarters, (B) any practice which would
have the effect of accelerating to prior fiscal quarters
(including the current fiscal quarter) collections of
receivables that would otherwise be expected to be made in
subsequent fiscal quarters, (C) any practice which would
have the effect of postponing to subsequent fiscal quarters
payments by the Company or any of its Subsidiaries that would
otherwise be expected to be made in prior fiscal quarters
(including the current fiscal quarter) or (D) any other
promotional sales or discount activity, in each case in this
clause (D) in a manner outside the ordinary course of
business or inconsistent with past practice;
A-21
(xviii) enter into, extend or renew any Contract or
amendment thereof which, if executed prior to the date of this
Agreement, would have been required to have been disclosed
pursuant to Section 3.01(k)(i)(A) or (F); or
(xix) authorize any of, or commit, resolve or agree to take
any of, the foregoing actions.
(b) Transfer Taxes. The Company
shall pay all transfer, stamp and other similar Taxes due with
respect to the issuance or delivery of the Preferred Stock or
the Warrants or any other securities or property upon conversion
of the Preferred Stock or exercise of the Warrants.
(c) Allocation of Purchase
Price. The Company and the Investor
Representative acknowledge and agree that (i) the Company
is issuing the Preferred Stock and Warrants solely in
consideration of the Purchase Price and not in recognition of
any services provided or to be provided directly or indirectly
by any Investor as an employee or otherwise (which services, if
any, shall be separately compensated), and (ii) the
Purchase Price is equivalent to the aggregate value of the
Preferred Stock and the Warrants. The Company and the Investors
shall not take any position that is inconsistent with the
foregoing allocation unless required by applicable Law.
Section 4.02. No
Solicitation. (a) Notwithstanding any
provision in this Agreement to the contrary, the Company shall
not, nor shall it authorize or permit any of its Subsidiaries
to, nor shall it authorize or permit any director, officer or
employee of the Company or any of its Subsidiaries or any
investment banker, attorney, accountant or other advisor or
representative of the Company or any of its Subsidiaries to,
directly or indirectly, (i) solicit, initiate or knowingly
encourage, or take any other action to knowingly facilitate, any
Takeover Proposal or any inquiries or the making of any proposal
that could reasonably be expected to lead to a Takeover Proposal
or (ii) enter into, continue or otherwise participate in
any discussions or negotiations regarding, or furnish to any
person (or any representative thereof) any information with
respect to, or otherwise cooperate in any way with any person
(or any representative thereof) with respect to, any Takeover
Proposal; provided, however, that at any time
prior to obtaining the Stockholder Approvals, in response to a
bona fide written unsolicited Takeover Proposal that the Board
of Directors of the Company (acting upon the affirmative
recommendation of the Special Committee), after consultation
with its financial advisor and outside legal counsel, determines
in good faith constitutes or could reasonably be expected to
lead to a Superior Proposal, and which Takeover Proposal did not
result from a breach of this Section 4.02, the Company may,
and may permit and authorize its Subsidiaries and its
representatives and its Subsidiaries representatives to,
in each case subject to compliance with Section 4.02(c),
(A) furnish information with respect to the Company and its
Subsidiaries to the person making such Takeover Proposal (and
its representatives) pursuant to a nondisclosure agreement which
contains terms that are no less restrictive than those contained
in that certain nondisclosure letter agreement dated
December 15, 2010 between the Investor Representative and
the Company (as it may be amended from time to time, the
Nondisclosure Agreement), provided
that all such information had been provided, or is concurrently
provided, to the Investor Representative, and
(B) participate in discussions or negotiations with, and
only with, the person making such Takeover Proposal (and its
representatives) regarding such Takeover Proposal. Without
limiting the generality of the foregoing, it is understood that
any violation of the restrictions set forth in the preceding
sentence by any director, officer or employee of the Company or
any of its Subsidiaries or any investment banker, attorney,
accountant or other advisor or representative of the Company or
any of its Subsidiaries shall be deemed to be a breach of this
Section 4.02(a) by the Company.
For purposes of this Agreement, the term Takeover
Proposal means any inquiry, proposal or offer from any
person or group (other than any Investor) relating to, or that
could reasonably be expected to lead to, in one transaction or a
series of related transactions, any merger, consolidation,
business combination, recapitalization, liquidation or
dissolution involving the Company or any direct or indirect
acquisition, including by way of any merger, consolidation,
tender offer, exchange offer, stock acquisition, asset
acquisition, binding share exchange, business combination,
recapitalization, liquidation, dissolution, joint venture or
similar transaction, of (i) assets or businesses that
constitute or represent 15% or more of the total revenue, net
income, EBITDA or assets of the Company and its Subsidiaries,
taken as a whole, or (ii) 15% or more of the outstanding
shares of Company Common Stock or of any class of capital stock
of, or other equity or voting interests in, one or more of the
Subsidiaries of the Company which, in the aggregate, directly or
indirectly hold the assets or businesses referred to in
clause (i) above.
A-22
For purposes of this Agreement, the term Superior
Proposal means any binding bona fide written offer
which did not result from a breach of Section 4.02(a) made
by any person (other than any Investor) that, if consummated,
would result in such person (or, in the case of a direct merger
between such person and the Company, the stockholders of such
person) acquiring, directly or indirectly, 50% or more of the
voting power of the capital stock of the Company or 50% or more
of the assets of the Company and its Subsidiaries, taken as a
whole, and which offer, in the good faith judgment of the Board
of Directors of the Company (acting upon the affirmative
recommendations of the Special Committee) (after consultation
with its financial advisor and outside legal counsel),
(i) is more favorable to the holders of the Company Common
Stock than the Equity Investment from a financial point of view
(taking into account all of the terms and conditions of such
proposal and this Agreement (including any changes to the terms
of this Agreement proposed by the Investors in response to such
Superior Proposal or otherwise)) and (ii) is reasonably
capable of being completed, taking into account all financial,
legal, regulatory and other aspects of such proposal.
For purposes of this Agreement, the term Superior
Acquisition Proposal means a Superior Proposal that,
if consummated, would result in the applicable person (or, in
the case of a direct merger between such person and the Company,
the stockholders of such person) acquiring, directly or
indirectly, all or substantially all of the voting power of the
capital stock of the Company or all or substantially all of the
assets of the Company and its Subsidiaries, taken as a whole.
(b) Except as set forth in the next sentence, neither the
Board of Directors of the Company nor any committee thereof
shall (or shall agree or resolve to) (i) withdraw or modify
in a manner adverse to the Investors, or propose publicly to
withdraw or modify in a manner adverse to the Investors, the
approval, recommendation or declaration of advisability by such
Board of Directors or any such committee of the Equity
Investment and the other transactions contemplated by this
Agreement, (ii) approve, recommend or declare advisable, or
propose publicly to approve, recommend or declare advisable, any
Takeover Proposal (any such action, resolution or agreement to
take such action described in clause (i) or (ii) being
referred to herein as an Adverse Recommendation
Change), or (iii) cause or permit the Company to
enter into any letter of intent, memorandum of understanding,
agreement in principle, acquisition agreement, merger agreement,
option agreement, joint venture agreement, partnership agreement
or other agreement (each, an Acquisition
Agreement) constituting or related to, or which is
intended to or is reasonably likely to lead to, any Takeover
Proposal (other than a nondisclosure agreement referred to in
Section 4.02(a)). Notwithstanding the foregoing, at any
time prior to receipt of the Stockholder Approvals, the Board of
Directors of the Company may (I) in response to a Superior
Proposal or an Intervening Event, effect an Adverse
Recommendation Change or (II) in response to a Superior
Acquisition Proposal, cause the Company to enter into a
definitive agreement to consummate such Superior Acquisition
Proposal and concurrently with executing such definitive
agreement, upon payment of the Termination Fee, terminate this
Agreement pursuant to and in accordance with
Section 7.01(f); provided that, with respect to
clauses (I) and (II), the Board of Directors of the Company
determines in good faith, after consultation with its outside
legal counsel and its financial advisor that the failure to do
so would be inconsistent with its fiduciary duties to the
stockholders of the Company under applicable Law, and
provided further, that the Board of Directors of
the Company and the committees thereof shall not, and shall
cause the Company not to, take any action described in
clause (I) or (II) unless (A) the Board of
Directors of the Company shall have first provided prior written
notice to the Investor Representative (a Change
Notice) that it is prepared to take such action in
response to a Superior Proposal or an Intervening Event, which
notice shall, in the case of a Superior Proposal, attach the
most current version of any written agreement relating to the
transaction that constitutes such Superior Proposal, and, in the
case of an Intervening Event, attach information describing such
Intervening Event in reasonable detail, and (B) the
Investor Representative does not make, within three business
days after the receipt of such notice, a proposal that would, in
the good faith judgment of the Board of Directors of the Company
(acting upon the affirmative recommendation of the Special
Committee) (after consultation with its financial advisor and
outside legal counsel), (x) cause the offer previously
constituting a Superior Proposal to no longer constitute a
Superior Proposal or (y) obviate the need for an Adverse
Recommendation Change as a result of an Intervening Event (it
being understood and agreed that any amendment or modification
of such Superior Proposal shall require a new Change Notice and
a new three business day period), and provided
further, that any purported termination of this Agreement
pursuant to Section 7.01(f) shall be void and of no force
or effect unless the Company pays to the Investor Representative
the Termination Fee in accordance with Section 5.04(b)
prior to or concurrently with such termination. The Company
agrees that, during the three business
A-23
day period prior to its effecting an Adverse Recommendation
Change or taking an action described in clause (II) above,
the Company and its officers, directors and representatives
shall negotiate in good faith with the Investor Representative
and its representatives regarding any revisions to the terms of
this Agreement, the Equity Investment and the other transactions
contemplated by this Agreement proposed by the Investor
Representative.
For purposes of this Agreement, the term Intervening
Event means an event, circumstance, fact or other
information, unknown to the Board of Directors of the Company as
of the date of this Agreement, which becomes known prior to
receipt of the Stockholder Approvals and which causes the Board
of Directors of the Company to determine in good faith, after
consultation with its outside legal counsel and its financial
advisor, that its failure to effect an Adverse Recommendation
Change would be inconsistent with its fiduciary duties to the
stockholders of the Company under applicable Law;
provided, however, that in no event shall the
receipt, existence or terms of a Takeover Proposal or any matter
relating thereto or consequence thereof constitute an
Intervening Event.
(c) In addition to the obligations of the Company set forth
in paragraphs (a) and (b) of this Section 4.02,
the Company shall, as promptly as possible and in any event
within 24 hours after the receipt thereof, advise the
Investor Representative orally and in writing of (i) any
Takeover Proposal and (ii) the terms and conditions of such
Takeover Proposal (including any subsequent amendment or other
modification to such terms and conditions) and the identity of
the person making any such Takeover Proposal. Commencing upon
the provision of any notice referred to above, the Company (or
its outside counsel) shall (A) advise the Investor
Representative (or its outside counsel) on a reasonably current
basis of the progress of negotiations concerning any Takeover
Proposal, the material resolved and unresolved issues related
thereto and any other material matters identified with
reasonable specificity by the Investor Representative (or its
outside counsel) and the material details (including material
amendments or proposed amendments as to price and other material
terms) of any such Takeover Proposal and (B) promptly upon
receipt or delivery thereof, provide the Investor Representative
(or its outside counsel) with copies of all documents and
material written or electronic communications describing any
terms or conditions of any such Takeover Proposal (including the
financing thereof) exchanged between the Company, its
Subsidiaries or any of their respective officers, directors,
employees, investment bankers, attorneys, accountants or other
advisors or representatives, on the one hand, and the person
making a Takeover Proposal or any of its Affiliates, or their
respective officers, directors, employees, investment bankers,
attorneys, accountants or other advisors or representatives, on
the other hand.
(d) Nothing contained in this Section 4.02 or
elsewhere in this Agreement shall prohibit the Company from
(i) taking and disclosing to its stockholders a position
contemplated by
Rule 14d-9
and
Rule 14e-2(a)
promulgated under the Exchange Act or (ii) making any
disclosure to its stockholders if, in the good faith judgment of
the Board of Directors of the Company (after consultation with
its outside legal counsel), failure so to disclose would be
inconsistent with applicable Law; provided,
however, that in no event shall the Company or its Board
of Directors or any committee thereof take, agree or resolve to
take any action prohibited by Section 4.02(b).
Section 4.03. Legend. Each
Investor acknowledges that to the extent applicable, each
certificate evidencing the Securities shall be endorsed with a
legend substantially in the form set forth below, as well as any
additional legend imposed or required by applicable state
securities Laws:
THE SECURITIES REPRESENTED BY THIS INSTRUMENT AND THE
SECURITIES ISSUABLE UPON [CONVERSION] [EXERCISE] THEREOF HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR SECURITIES LAWS OF ANY STATE AND MAY NOT BE
TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO A
REGISTRATION STATEMENT RELATING THERETO IN EFFECT UNDER SUCH ACT
AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN
EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH
LAWS.
ARTICLE V
Additional
Agreements
Section 5.01. Preparation
of the Proxy Statement; Stockholders
Meeting. (a) As promptly as reasonably
practicable following the date of this Agreement, the Company
shall prepare and file with the SEC the preliminary
A-24
Proxy Statement. If the Company does not receive comments from
the SEC with respect to the preliminary Proxy Statement and is
not notified by the SEC that it will receive comments, absent
any Legal Restraint that has the effect of preventing such
action, the Company shall file with the SEC the definitive Proxy
Statement, and shall use its reasonable best efforts to cause
the mailing of the definitive Proxy Statement to the
stockholders of the Company, on or prior to the second business
day after the tenth calendar day immediately following the date
of filing of the preliminary Proxy Statement with the SEC. If
the Company does receive comments from the SEC with respect to
the preliminary Proxy Statement, absent any Legal Restraint that
has the effect of preventing such action, the Company shall file
with the SEC the definitive Proxy Statement, and shall use its
reasonable best efforts to cause the mailing of the definitive
Proxy Statement to the stockholders of the Company, on or prior
to the second business day immediately following clearance by
the SEC with respect to such comments. Each of the Company and
the Investors shall furnish all information concerning such
person as may be reasonably requested in connection with the
preparation, filing and distribution of the Proxy Statement. The
Company shall promptly notify the Investor Representative upon
the receipt of any comments from the SEC or its staff or any
request from the SEC or its staff for amendments or supplements
to the Proxy Statement and shall provide the Investor
Representative with copies of all correspondence between it and
its representatives, on the one hand, and the SEC, on the other
hand. Each of the Company and the Investor Representative shall
use reasonable best efforts to respond as promptly as
practicable to any comments of the SEC with respect to the Proxy
Statement. Notwithstanding the foregoing, prior to filing or
mailing the Proxy Statement (or any amendment or supplement
thereto) or responding to any comments of the SEC with respect
thereto, the Company (i) shall provide the Investor
Representative an opportunity to review and comment on such
document or response, (ii) shall consider in good faith all
comments reasonably proposed by the Investor Representative and
(iii) if the Board of Directors of the Company shall not
have made an Adverse Recommendation Change, shall not file or
mail such document, or respond to the SEC, prior to receiving
the approval of the Investor Representative, which approval
shall not be unreasonably withheld or delayed. If, at any time
prior to the Stockholders Meeting, any information relating to
the Company, the Investors or any of their respective
Affiliates, officers or directors should be discovered by the
Company or the Investors which should be set forth in an
amendment or supplement to the Proxy Statement, so that the
Proxy Statement shall not contain any untrue statement of a
material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are
made, not misleading, the party that discovers such information
shall promptly notify the other parties hereto, and an
appropriate amendment or supplement describing such information
shall be filed with the SEC and, to the extent required by
applicable Law, disseminated to the stockholders of the Company.
If the Company receives a Takeover Proposal or if an Intervening
Event occurs, the ten calendar day periods referenced in this
Section 5.01(a) and the two business day period referenced
in the third sentence of this Section 5.01(a) will be
extended until two business days after the completion of the
process set forth in Sections 4.02(b)(A) and (B).
(b) The Company agrees that the Proxy Statement will comply
as to form in all material respects with the requirements of the
Exchange Act and that none of the information included or
incorporated by reference in the Proxy Statement will, at the
date the Proxy Statement is filed with the SEC or mailed to the
stockholders of the Company or at the time of the Stockholders
Meeting, or at the time of any amendment or supplement thereof,
contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary in
order to make the statements therein, in light of the
circumstances under which they are made, not misleading, except
that no covenant is made by the Company with respect to
statements made in the Proxy Statement based on information
supplied in writing by or on behalf of the Investors
specifically for inclusion or incorporation for reference
therein. Each Investor agrees that none of such information
supplied by it will, at the date the Proxy Statement is filed
with the SEC or mailed to the stockholders of the Company or at
the time of the Stockholders Meeting, or at the time of any
amendment or supplement thereof, contain any untrue statement of
a material fact or omit to state any material fact required to
be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are
made, not misleading.
(c) As promptly as reasonably practicable after the date of
this Agreement, the Company shall, in compliance with applicable
Law, the Company Certificate, the Company Bylaws and the rules
of the NYSE Amex LLC, establish a record date (which will be as
promptly as reasonably practicable following the date of this
Agreement) for, duly call, give notice of, convene and hold a
meeting of its stockholders, which meeting the Company shall,
absent any Legal Restraint that has the effect of preventing
such action, cause to occur on the 45th calendar day (or,
A-25
if such calendar day is not a business day, on the first
business day subsequent to such calendar day) immediately
following the date of mailing of the Proxy Statement (the
Stockholders Meeting), for the purpose of
obtaining the Stockholder Approvals, regardless of whether the
Board of Directors of the Company determines at any time that
this Agreement is no longer advisable or recommends that the
stockholders of the Company reject it or any other Adverse
Recommendation Change has occurred at any time (subject to the
right of the Company to terminate this Agreement in accordance
with Section 7.01(f)); provided, however,
that (i) if the Company is unable to obtain a quorum of its
stockholders at such time, the Company may extend the date of
the Stockholders Meeting to the extent (and only to the extent)
necessary in order to obtain a quorum of its stockholders and
the Company shall use its reasonable best efforts to obtain such
a quorum as promptly as practicable, (ii) the Company may
adjourn or postpone the Stockholders Meeting to the extent (and
only to the extent) the Company reasonably determines that such
adjournment or postponement is required by applicable Law to
comply with comments made by the SEC with respect to the Proxy
Statement and (iii) if the Company receives a new Takeover
Proposal, the price or material terms of a previously received
Takeover Proposal are modified or amended or an Intervening
Event occurs, in any such case during the five calendar day
period immediately prior to the day of the Stockholders Meeting,
the Company may delay the Stockholders Meeting until the date
that is the fifth business day after the date on which the
Stockholders Meeting would otherwise have been held;
provided, however, that the Company may delay the
Stockholders Meeting pursuant to this clause (iii) no more
than twice. Subject to Section 4.02(b), (x) the Board
of Directors of the Company shall recommend to holders of
Company Common Stock that they vote in favor of the Stockholder
Approvals and shall include such recommendation in the Proxy
Statement and (y) the Company shall use its reasonable best
efforts to solicit the Stockholder Approvals. Without limiting
the generality of the foregoing, the Company agrees that its
obligations pursuant to this Section 5.01(c) shall not be
affected by the commencement, public proposal, public disclosure
or communication to the Company or any other person of any
Takeover Proposal. The Company shall provide updates to the
Investor Representative with respect to the proxy solicitation
for the Stockholders Meeting (including interim results) as
reasonably requested by the Investor Representative.
Section 5.02. Access
to Information; Confidentiality. Subject to
compliance with applicable Laws, the Company shall, and shall
cause each of its Subsidiaries to, afford to the Investor
Representative and its representatives reasonable access upon
reasonable advance notice and during normal business hours
during the period prior to the Closing or the termination of
this Agreement to all their respective properties, assets,
books, records, Contracts, Permits, documents, information,
directors, officers and employees, and during such period the
Company shall, and shall cause each of its Subsidiaries to, make
available to the Investor Representative any information
concerning its business as the Investor Representative may
reasonably request (including the work papers of Pender
Newkirk & Company LLP, subject to the customary
requirements of Pender Newkirk & Company LLP). No
investigation by the Investors or any of their respective
representatives and no other receipt of information by the
Investors or any of their respective representatives shall
operate as a waiver or otherwise affect any representation,
warranty, covenant, agreement or other provision of this
Agreement, or the obligations of the parties (or remedies with
respect thereto) or the conditions to the obligations of the
parties under the Agreement. Except as required by any
applicable Law or Judgment, the Investor Representative will
hold, and will direct its officers, employees, investment
bankers, attorneys, accountants and other advisors and
representatives to hold, any and all information received from
the Company confidential in accordance with the Nondisclosure
Agreement (it being understood that the Investor Representative
may share any such information with any Investor who has agreed
in writing with the Company to hold such information
confidential).
Section 5.03. Reasonable
Best Efforts; Consultation and
Notice. (a) Upon the terms and subject
to the conditions set forth in this Agreement, each of the
parties hereto agrees to use its reasonable best efforts to
take, or cause to be taken, all actions that are necessary,
proper or advisable to consummate and make effective the Equity
Investment and the other transactions contemplated by this
Agreement, including using its reasonable best efforts to
accomplish the following: (i) the satisfaction of the
conditions precedent set forth in Article VI, (ii) the
obtaining of all necessary actions or nonactions, waivers,
consents, approvals, orders and authorizations from, and the
giving of any necessary notices to, Governmental Entities and
other persons and the making of all necessary registrations,
declarations and filings (including filings under the HSR Act
and other registrations, declarations and filings with, or
notices to, Governmental Entities, if any), (iii) the
taking of all reasonable steps to provide any supplemental
information requested by a Governmental Entity, including
participating in meetings with officials of such entity in the
course of its review of this Agreement, the Equity Investment or
the other transactions contemplated by this
A-26
Agreement, (iv) the taking of all reasonable steps as may
be necessary to avoid any suit, claim, action, investigation or
proceeding by any Governmental Entity or third party and
(v) the obtaining of all necessary consents, approvals or
waivers from any third party; provided, that this
clause (v) shall not limit the rights of the Company or its
Board of Directors under Section 4.02(b). In connection
with and without limiting the generality of the foregoing, each
of the Company and its Board of Directors shall, if any state
takeover statute or similar statute or regulation is or becomes
applicable to this Agreement or any of the Equity Investment and
the other transactions contemplated by this Agreement, including
transactions under the Voting Agreements, take all actions
necessary to ensure that the Equity Investment and the other
transactions contemplated by this Agreement may be consummated
as promptly as practicable on the terms contemplated by this
Agreement and otherwise to minimize the effect of such statute
or regulation on this Agreement, the Voting Agreements, the
Equity Investment and the other transactions contemplated by
this Agreement. Notwithstanding the foregoing or any other
provision of this Agreement to the contrary, in no event shall
the Investors be obligated to, and the Company and its
Subsidiaries shall not without the prior written consent of the
Investor Representative, agree or proffer to divest or hold
separate, or enter into any licensing, business restriction or
similar arrangement with respect to, any assets (whether
tangible or intangible) or any portion of any business of the
Company or any of its Subsidiaries. Notwithstanding the
foregoing or any other provision of this Agreement to the
contrary, in no event shall the Investors or any of their
respective Affiliates be obligated to litigate or participate in
the litigation of any suit, claim, action or proceeding, whether
judicial or administrative, brought by any Governmental Entity
(A) challenging or seeking to restrain or prohibit the
consummation of the Equity Investment or the other transactions
contemplated by this Agreement, including transactions under the
Voting Agreements, or seeking to obtain from the Investors or
any of their respective Affiliates any damages in relation
therewith; (B) seeking to prohibit or limit in any respect,
or place any conditions on, the ownership or operation by the
Company, the Investors or any of their respective Affiliates of
all or any portion of the business or assets or any product of
the Company or its Subsidiaries or to require any such person to
dispose of, license (whether pursuant to an exclusive or
nonexclusive license) or hold separate all or any portion of the
business or assets or any product of the Company or its
Subsidiaries or the Investors or their respective Affiliates, in
each case as a result of or in connection with the Equity
Investment or any of the other transactions contemplated by this
Agreement; (C) seeking to directly or indirectly impose
limitations on the ability of the Investors or any of their
respective Affiliates to acquire or hold, or exercise full
rights of ownership of, any shares of the Preferred Stock or the
Company Common Stock, or any Warrants, including the right to
vote the Preferred Stock or Company Common Stock on all matters
properly presented to the stockholders of the Company; or
(D) seeking to (1) directly or indirectly prohibit the
Investors or any of their respective Affiliates from effectively
controlling in any respect any of the business or operations of
the Company or its Subsidiaries or (2) directly or
indirectly prevent the Company or its Subsidiaries from
operating any of their businesses in substantially the same
manner as operated by the Company and its Subsidiaries
immediately prior to the date of this Agreement. The Company and
the Investors shall provide such assistance, information and
cooperation to each other as is reasonably required to obtain
any such actions, nonactions, waivers, consents, approvals,
orders and authorizations and, in connection therewith, shall
notify the other person or persons promptly following the
receipt of any comments from any Governmental Entity and of any
request by any Governmental Entity for amendments, supplements
or additional information in respect of any registration,
declaration or filing with, or notice to, such Governmental
Entity and shall supply the other person or persons with copies
of all correspondence between such person or persons or any of
their respective representatives, on the one hand, and any
Governmental Entity, on the other hand.
(b) (i) In connection with the continuing operation of
the business of the Company and its Subsidiaries between the
date of this Agreement and the Closing, subject to applicable
Law, the Company shall consult in good faith on a reasonably
regular basis with the Investor Representative to report
material (individually or in the aggregate) operational
developments, material changes in the status of relationships
with customers and service providers, material changes in the
status of ongoing operations and other matters reasonably
requested by the Investor Representative pursuant to procedures
reasonably requested by the Investor Representative;
provided, however, that no such consultation shall
operate as a waiver or otherwise affect any representation,
warranty, covenant, agreement or other provision in this
Agreement, or the obligations of the parties (or remedies with
respect thereto) or the conditions to the obligations of the
parties under this Agreement.
A-27
(ii) Except as prohibited by applicable Law, the Company
shall promptly notify the Investor Representative in writing of:
(A) the occurrence of any matter or event that (1) is,
or that is reasonably likely to be, material (individually or in
the aggregate) to the business, assets, properties, condition
(financial or otherwise) or results of operations of the Company
and its Subsidiaries, taken as a whole, or (2) has
resulted, or is reasonably likely to result, in (I) any
representation and warranty of the Company set forth in this
Agreement that is qualified as to materiality becoming untrue,
(II) any such representation and warranty that is not so
qualified becoming untrue in any material respect or
(III) any condition to the transactions contemplated hereby
and set forth in Section 6.02 not being satisfied;
(B) the failure of the Company to perform in any material
respect any obligation to be performed by it under this
Agreement such that the condition set forth in
Section 6.02(b) could not be satisfied;
(C) any notice or other communication from any person
(other than a Governmental Entity) alleging that notice to or
consent of such person is required in connection with the Equity
Investment or the other transactions contemplated by this
Agreement;
(D) any material notice or other material communication
from any Governmental Entity in connection with the Equity
Investment or the other transactions contemplated by this
Agreement, and a copy of any such notice or communication shall
be furnished to the Investor Representative, together with the
Companys written notice; and
(E) any filing or notice made by the Company with any
Governmental Entity in connection with the Equity Investment or
the other transactions contemplated by this Agreement, and a
copy of any such filing or notice shall be furnished to the
Investor Representative together with the Companys written
notice;
provided, however, that no such notification shall
operate as a waiver or otherwise affect any representation,
warranty, covenant, agreement or other provision in this
Agreement, or the obligations of the parties (or remedies with
respect thereto) or the conditions to the obligations of the
parties under this Agreement.
(iii) Each Investor shall promptly notify the Investor
Representative and the Company in writing of (A) the
occurrence of any matter or event that has resulted, or is
reasonably likely to result, in (1) any representation and
warranty of such Investor set forth in this Agreement that is
qualified as to materiality becoming untrue, (2) any such
representation and warranty that is not so qualified becoming
untrue in any material respect or (3) any condition to the
transactions contemplated hereby and set forth in
Section 6.03(a) not being satisfied or (B) the failure
of such Investor to perform in any material respect any
obligation to be performed by such party under this Agreement
such that the condition set forth in Section 6.03(b) could
not be satisfied; provided, however, that no such
notification shall operate as a waiver or otherwise affect any
representation, warranty, covenant, agreement or other provision
in this Agreement, or the obligations of the parties (or
remedies with respect thereto) or the conditions to the
obligations of the parties under this Agreement.
(c) Without limiting the generality of the foregoing, the
Company shall give the Investor Representative the opportunity
to participate in the defense, at its own cost, of any
litigation against the Company
and/or its
directors relating to the Equity Investment or the other
transactions contemplated by this Agreement, including
transactions under the Voting Agreements, and will obtain the
prior written consent of the Investor Representative prior to
settling or satisfying any such claim, it being understood and
agreed that this Section 5.03(c) shall not give the
Investor Representative the right to direct such defense.
Section 5.04. Fees
and Expenses. (a) All fees and expenses
incurred by the Company in connection with this Agreement and
the transactions contemplated by this Agreement shall be paid by
the Company; provided that, in the event that the Closing
does not occur (other than in the event that (i) this
Agreement is terminated by the Company pursuant to
Section 7.01(f) or (ii) this Agreement is terminated
by the Investor Representative pursuant to Section 7.01(c)
or 7.01(d)(i)) and the Re-Audit Engagement is terminated in
connection therewith, the Investor Representative shall
reimburse the Company for the fees and expenses of the
accounting firm designated in accordance with Section 5.08
payable in respect of the Re-Audit Engagement as of the time of
termination of this Agreement. Whether or not the Closing
occurs, the Company shall reimburse the Investor Representative,
as
A-28
promptly as practicable (but in any event within two business
days) following the earlier of (x) the Closing and
(y) the delivery by the Investor Representative of an
invoice therefor following termination of this Agreement, in
each case by wire transfer of
same-day
funds to an account or accounts designated by the Investor
Representative, for up to $1,000,000 of
out-of-pocket
costs and expenses (including the fees and expenses of Cravath,
Swaine & Moore LLP, KPMG LLP and Brunswick Group LLP)
incurred by the Investor Representative and its Affiliates in
connection with the transactions contemplated by this Agreement
(the Investor Representative Expenses);
provided that the Company shall not be obligated to
reimburse the Investor Representative for the Investor
Representative Expenses in the event that the Closing does not
occur as a result of the termination of this Agreement
(I) pursuant to Section 7.01(a), (II) by the
Company or the Investor Representative pursuant to
Section 7.01(b)(i) or (b)(iii) (in each case other than in
circumstances under which the Termination Fee is payable in
accordance with Section 5.04(b)(i)) or
Section 7.01(b)(ii), (III) by the Investor
Representative pursuant to Section 7.01(d)(ii) or
(IV) by the Company pursuant to Section 7.01(e). The
payment of the Investor Representative Expenses pursuant to this
Section 5.04(a) shall not relieve the Company of any
obligation to pay the Termination Fee pursuant to
Section 5.04(b).
(b) In the event that (i) a Takeover Proposal has been
made to the Company or its stockholders or any person has
publicly announced an intention (whether or not conditional and
whether or not withdrawn) to make a Takeover Proposal or a
Takeover Proposal otherwise becomes publicly known and
thereafter (A) this Agreement is terminated by either the
Investor Representative or the Company pursuant to
Section 7.01(b)(i) or Section 7.01(b)(iii) or by the
Investor Representative pursuant to Section 7.01(d)(i) and
(B) prior to the date that is nine months after such
termination, the Company or any of its Subsidiaries enters into
any definitive contract to consummate any Takeover Proposal or
any Takeover Proposal is consummated (solely for purposes of
this Section 5.04(b)(i)(B), the term Takeover
Proposal shall have the meaning set forth in the
definition of Takeover Proposal contained in
Section 4.02(a) except that all references to 15% shall be
deemed references to 50%) or (ii) this Agreement is
terminated by the Investor Representative pursuant to
Section 7.01(c) or by the Company pursuant to
Section 7.01(f), then the Company shall pay the Investor
Representative a fee equal to (x) in the case of a
termination of this Agreement by the Company pursuant to
Section 7.01(f), or by the Investor Representative pursuant
to Section 7.01(c) as a result of an Adverse Recommendation
Change made in connection with a Superior Proposal, the greater
of (1) $2,249,000 and (2) the lesser of
(I) $3,373,500 and (II) 3% of the Average Equity
Value, and (y) in all other cases, $2,249,000 (the fee
determined and payable pursuant to this sentence, the
Termination Fee), by wire transfer of
same-day
funds (A) in the case of a termination by the Investor
Representative pursuant to Section 7.01(c), within two
business days after such termination, (B) in the case of a
termination by the Company pursuant to Section 7.01(f),
prior to or concurrently with, and as a condition to the
effectiveness of, such termination and (C) in the case of a
payment as a result of any event referred to in
Section 5.04(b)(i)(B), no later than the first to occur of
such events, in each case to an account designated by the
Investor Representative.
(c) The Company acknowledges that the agreements contained
in this Section 5.04 are an integral part of the
transactions contemplated by this Agreement and that, without
these agreements, the Investor Representative would not have
entered into this Agreement. Accordingly, if the Company fails
promptly to pay the amounts due pursuant to this
Section 5.04 and, in order to obtain such payment, the
Investor Representative commences a suit that results in a
judgment against the Company for the amounts set forth in this
Section 5.04, the Company shall pay to the Investor
Representative its reasonable
out-of-pocket
costs and expenses (including attorneys fees and expenses)
in connection with such suit and any appeal relating thereto,
together with interest on the amounts set forth in this
Section 5.04 at the prime rate of Citibank, N.A. in effect
on the date such payment was required to be made.
Section 5.05. Public
Announcements. The parties agree that the
initial press release to be issued with respect to the
transactions contemplated by this Agreement shall be in the form
heretofore agreed to by the parties. The Investors, on the one
hand, and the Company, on the other hand, shall, to the extent
at all reasonably practicable, consult with each other before
making, and give each other a reasonable opportunity to review
and comment upon, any press release or other public statements
with respect to this Agreement, the Equity Investment and the
other transactions contemplated by this Agreement, and shall not
issue any such press release or make any such public statement
prior to such reasonably practicable consultation, except as may
be required by applicable Law, court process or by obligations
pursuant to any listing agreement with any national securities
exchange.
A-29
Section 5.06. Board
Representation Rights. (a) On the
Closing Date, the Board of Directors of the Company shall be
reconstituted such that (i) the number of seats on the
Board of Directors of the Company shall be eight, (ii) one
of such eight directors shall be James J. Martell (or, in the
event Mr. Martell is unable or unwilling to serve as a
director, another qualified person reasonably acceptable to the
Investor Representative), (iii) seven of such eight
directors shall be individuals designated by the Investor
Representative (including Bradley S. Jacobs), (iv) each
standing committee of the Board of Directors of the Company
shall be reconstituted in a manner reasonably acceptable to the
Investor Representative and (v) Bradley S. Jacobs shall be
appointed as the Chairman of the Board of Directors of the
Company. Notwithstanding anything to the contrary, the foregoing
designations shall be made such that a majority of the Board of
Directors of the Company and the members of each standing
committee of the Board of Directors of the Company shall be
independent as required in accordance with NYSE Amex
Rule 803(A)(2) and applicable securities Law. In
furtherance of the foregoing, the Company shall deliver to the
Investor Representative prior to the Closing evidence reasonably
satisfactory to the Investor Representative of the resignation
of any directors of the Company that are not continuing
directors, effective as of the Closing. Each director designated
by the Investor Representative in accordance with this
Section 5.06 is referred to herein as an Investor
Representative Appointee.
(b) Subject to Sections 5.06(d), 5.06(e) and 5.06(f),
in connection with each meeting of stockholders at which
directors are to be elected to serve on the Board of Directors
of the Company, the Company shall take all necessary steps to
nominate each Investor Representative Appointee (or such
alternative persons who are proposed by the Investor
Representative and notified to the Company on or prior to any
date set forth in the Company Certificate, the Company Bylaws or
applicable Law) and to use its reasonable best efforts to cause
the Board of Directors of the Company to unanimously recommend
that the stockholders of the Company vote in favor of each
Investor Representative Appointee for election to the Board of
Directors of the Company. If, for any reason, a candidate
designated as an Investor Representative Appointee is determined
to be unqualified to serve on the Board of Directors of the
Company because such appointment would constitute a breach of
the fiduciary duties of the Board of Directors of the Company or
applicable Law or stock exchange requirements, the Investor
Representative shall have the right to designate an alternative
Investor Representative Appointee to be so appointed, and the
provisions of this Section 5.06(b) shall apply, mutatis
mutandis, to such alternative Investor Representative
Appointee.
(c) Each appointed or elected Investor Representative
Appointee will hold his or her office as a director of the
Company for such term as is provided in the Company Certificate
and Company Bylaws or until his or her death, resignation or
removal from the Board of Directors of the Company or until his
or her successor has been duly elected and qualified in
accordance with the provisions of this Agreement, the Company
Certificate, the Company Bylaws and applicable Law. If any
Investor Representative Appointee ceases to serve as a director
of the Company for any reason during his or her term, the
Company will use its reasonable best efforts to cause the Board
of Directors of the Company to fill the vacancy created thereby
with a replacement designated by the Investor Representative.
(d) Subject to applicable Law and applicable stock exchange
requirements, the Investor Representative shall have the right
to designate (i) no less than a majority of the members of
the Board of Directors of the Company pursuant to this
Section 5.06 for so long as the Investor Representative
owns Preferred Stock, Company Common Stock or other voting
securities, or Warrants exercisable for such securities,
representing, in the aggregate, no less than 33% of the total
voting power of the capital stock of the Company, calculated on
a fully-diluted basis, and (ii) no less than 25% of the
members of the Board of Directors of the Company pursuant to
this Section 5.06 for so long as the Investor
Representative owns Preferred Stock, Company Common Stock or
other voting securities, or Warrants exercisable for such
securities, representing, in the aggregate, less than 33% but
greater than or equal to 20% of the total voting power of the
capital stock of the Company, calculated on a fully-diluted
basis.
(e) Nothing in this Section 5.06 shall prevent the
Board of Directors of the Company from acting in accordance with
its fiduciary duties or applicable Law or stock exchange
requirements or from acting in good faith in accordance with the
Company Certificate or Company Bylaws, while giving due
consideration to the intent of this Agreement. The Board of
Directors of the Company shall have no obligation to appoint or
nominate any Investor Representative Appointee if such
appointment or nomination would violate applicable Law or stock
exchange requirements or result in a breach by the Board of
Directors of the Company of its fiduciary duties to its
A-30
stockholders; provided, however, that the
foregoing shall not affect the right of the Investor
Representative to designate an alternate Investor Representative
Appointee.
(f) The rights of the Investor Representative set forth in
this Section 5.06 shall be in addition to, and not in
limitation of, such voting rights that the Investor
Representative may otherwise have as a holder of capital stock
of the Company (including any shares of Preferred Stock held by
the Investor Representative).
Section 5.07. Adjustment
of Stock Options. As soon as practicable
following the date of this Agreement, the Board of Directors of
the Company (or, if appropriate, any committee administering the
Company Stock Plan) shall adopt such resolutions or take such
other actions (including obtaining any required consents) as may
be required to, effective as of the effective time of the
reverse stock split contemplated by the Certificate of
Amendment, appropriately adjust the number of Stock Options
outstanding immediately prior to such effective time, and the
exercise prices of such Stock Options, so as to reflect such
reverse stock split. Such adjustment shall be implemented in a
manner that (a) complies with the terms of the Company
Stock Plan and, to the extent applicable, Section 409A or
422 of the Code (including the regulations and other guidance
promulgated thereunder), (b) results in as minimal an
amount of additional accounting expense as permitted pursuant to
GAAP and (c) in the case of any Stock Options held by any
individual who is subject to the reporting requirements of
Section 16(a) of the Exchange Act with respect to the
Company, causes any acquisition or disposition of Stock Options
in connection with such adjustment (or any deemed acquisition or
disposition) to be exempt under
Rule 16b-3
promulgated under the Exchange Act.
Section 5.08. Engagement
of Independent Registered Public Accounting
Firm. As soon as practicable following the
date of this Agreement, the Company shall engage an independent
registered public accounting firm of national reputation
designated by the Investor Representative for the purpose of
re-auditing the historical consolidated financial statements of
the Company for fiscal years 2009 and 2010 (the
Re-Audit Engagement), and the Company shall,
commencing as soon as practicable following such engagement,
provide customary assistance to such accounting firm for the
purpose of completing such audits.
Section 5.09. Listing. The
Company shall, on or prior to the Closing Date, take all action
necessary to effect the listing of the shares of Company Common
Stock issuable upon conversion of the Preferred Stock and
exercise of the Warrants on the NYSE Amex, upon official notice
of issuance.
Section 5.10. Reservation
of Shares. From and after the Closing, the
Company shall at all times reserve and keep available out of its
authorized but unissued shares of Company Common Stock, solely
for the purpose of providing for the exercise of the Warrants
and the conversion of the Preferred Stock, such number of shares
of Company Common Stock as shall from time to time equal the
number of shares sufficient to permit the exercise of the
Warrants and the conversion of the shares of Preferred Stock
issued pursuant to this Agreement in accordance with their
respective terms. The Company covenants that all shares of
Company Common Stock issuable upon exercise of the Warrants or
conversion of the Preferred Stock shall, upon such issue, be
duly and validly issued and fully paid and non-assessable.
Section 5.11. Indemnification,
Exculpation and Insurance. (a) For a
period of six years after the Closing, the Company shall
indemnify and hold harmless the individuals who on or prior to
the Closing were officers, directors and employees of the
Company or its Subsidiaries or were serving at the request of
the Company as an officer, director or employee of any other
corporation, partnership or joint venture, trust, employee
benefit plan or other enterprise (collectively, the
Company Indemnitees) with respect to all acts
or omissions by them in their capacities as such or taken at the
request of the Company or any of its Subsidiaries at any time
prior to the Closing to the extent provided under the Company
Certificate or Company Bylaws or in any indemnification
agreement, in each case as in effect on the date of this
Agreement (including with respect to the advancement of
expenses).
(b) For six years after the Closing, the Company shall
procure the provision of officers and directors
liability insurance in respect of acts or omissions occurring
prior to the Closing covering each such person currently covered
by the Companys officers and directors
liability insurance policy on terms with respect to coverage and
in amounts no less than those of the policy in effect on the
date of this Agreement. In lieu of such insurance, prior to the
Closing, the Company may purchase a tail
directors and officers liability insurance policy
and fiduciary liability insurance policy for the Company and its
respective current and former directors and officers who are
currently
A-31
covered by the directors and officers and fiduciary
liability insurance coverage currently maintained by the
Company, in which event the Company shall cease to have any
obligations under the first sentence of this
Section 5.11(b); provided that in no event shall the
Company pay in the aggregate an amount per annum in excess of
250% of the premium amount the Company paid in its last full
fiscal year, which amount is set forth in Section 5.11(b)
of the Company Letter.
(c) In the event that the Company or any of its successors
or assigns (i) consolidates with or merges into any other
person and is not the continuing or surviving corporation or
entity of such consolidation or merger or (ii) transfers or
conveys all or substantially all its properties and assets to
any person, then, and in each such case, the Company shall cause
proper provision to be made so that the successors and assigns
of the Company assume the obligations set forth in this
Section 5.11.
(d) The provisions of this Section 5.11 (i) shall
survive the Closing, (ii) are intended to be for the
benefit of, and will be enforceable by, each Company Indemnitee,
his or her heirs and his or her representatives and
(iii) are in addition to, and not in substitution for, any
other rights to indemnification or contribution that any such
person may have by contract or otherwise. The Company shall pay
all reasonable expenses, including reasonable attorneys
fees, that may be incurred by any Company Indemnitee in
enforcing the indemnity and other obligations provided in this
Section 5.11, provided that such Company Indemnitee
is successful in enforcing any such enforcement claim.
ARTICLE VI
Conditions
Precedent
Section 6.01. Conditions
to Each Partys Obligation to Effect the Equity
Investment. The respective obligation of each
party to effect the Equity Investment is subject to the
satisfaction or waiver on or prior to the Closing Date of the
following conditions:
(a) Stockholder Approvals. The
Stockholder Approvals shall have been obtained.
(b) Antitrust. Any waiting period
(and any extension thereof) applicable to this Agreement, the
Equity Investment or other transactions contemplated by this
Agreement under the HSR Act shall have been terminated or shall
have expired. Any other approval or waiting period under any
other applicable competition, merger control, antitrust or
similar Law shall have been obtained or terminated or shall have
expired.
(c) No Injunctions or Legal
Restraints. No temporary restraining order,
preliminary or permanent injunction or other Judgment issued by
any court of competent jurisdiction or other legal restraint or
prohibition (collectively, Legal Restraints)
that has the effect of preventing, prohibiting or making illegal
the consummation of the Equity Investment shall be in effect.
Section 6.02. Conditions
to Obligations of the Investors. The
obligations of the Investors to effect the Equity Investment are
further subject to the satisfaction or waiver on or prior to the
Closing Date of the following conditions:
(a) Representations and
Warranties. The representations and
warranties of the Company contained herein that are qualified as
to materiality or Material Adverse Effect shall be true and
correct (as so qualified), and the representations and
warranties of the Company contained herein that are not so
qualified shall be true and correct in all material respects, in
each case as of the date of this Agreement and as of the Closing
Date with the same effect as though made as of the Closing Date,
except that the accuracy of representations and warranties that
by their terms speak as of a specified date will be determined
as of such date. The Investor Representative shall have received
a certificate signed on behalf of the Company by the chief
executive officer and chief financial officer of the Company to
such effect.
(b) Performance of Obligations of the
Company. The Company shall have performed in
all material respects all obligations required to be performed
by it under this Agreement at or prior to the Closing Date, and
the Investor Representative shall have received a certificate
signed on behalf of the Company by the chief executive officer
and the chief financial officer of the Company to such effect.
A-32
(c) No Litigation. There shall not
be pending any claim, suit, action or proceeding brought or
threatened by any Governmental Entity (i) challenging or
seeking to restrain or prohibit the consummation of the Equity
Investment or the other transactions contemplated by this
Agreement, or seeking to obtain from the Investors or any of
their Affiliates any damages in relation thereto; or
(ii) seeking to impose limitations on the ability of the
Investors to acquire or hold, or exercise full rights of
ownership of, any Warrants or any shares of Preferred Stock or
Company Common Stock, including the right to vote the Preferred
Stock or the Company Common Stock on all matters properly
presented to the stockholders of the Company.
(d) Legal Restraint. No Legal
Restraint that could reasonably be expected to result, directly
or indirectly, in any of the effects referred to in
clause (i) or (ii) of Section 6.02(c) shall be in
effect.
(e) Consents. The Investor
Representative shall have received evidence, in form and
substance reasonably satisfactory to it, that the Investors or
the Company shall have obtained all material (individually or in
the aggregate) consents, approvals, authorizations,
qualifications and orders of all Governmental Entities legally
required to effect the Equity Investment.
(f) No Material Adverse
Effect. Since the date of this Agreement,
there shall not have occurred any Material Adverse Effect or any
state of facts, change, development, event, effect, condition,
occurrence, action or omission that is reasonably likely to have
a Material Adverse Effect. The Investor Representative shall
have received a certificate signed on behalf of the Company by
the chief executive officer and the chief financial officer of
the Company to such effect.
(g) Certificate of
Designation. The Company shall have duly
adopted the Certificate of Designation, and the Certificate of
Designation shall have been duly filed with, and accepted by,
the Secretary of State of the State of Delaware in accordance
with the laws of the State of Delaware.
(h) Registration Rights
Agreement. The Investor Representative shall
have received a counterpart of the Registration Rights
Agreement, in a form reasonably acceptable to the Investor
Representative and reflecting terms consistent with those set
forth on Exhibit C, that shall have been executed and
delivered by a duly authorized officer of the Company.
(i) Trading Halt. No stop order or
suspension of trading shall have been imposed by the NYSE Amex,
the SEC or any other governmental or regulatory body with
respect to public trading in the Company Common Stock.
Section 6.03. Conditions
to Obligation of the Company. The obligation
of the Company to effect the Equity Investment is further
subject to the satisfaction or waiver on or prior to the Closing
Date of the following conditions:
(a) Representations and
Warranties. The representations and
warranties of each Investor contained herein that are qualified
as to materiality shall be true and correct (as so qualified),
and the representations and warranties of each Investor
contained herein that are not so qualified shall be true and
correct in all material respects, in each case as of the date of
this Agreement (or, with respect to any Investor made a party
hereto by joinder in accordance with Section 8.08, as of
the date of the applicable joinder) and as of the Closing Date
with the same effect as though made as of the Closing Date,
except that the accuracy of representations and warranties that
by their terms speak as of a specified date will be determined
as of such date.
(b) Performance of Obligations of
Investors. Each Investor shall have performed
in all material respects all obligations required to be
performed by it under this Agreement at or prior to the Closing
Date.
Section 6.04. Frustration
of Closing Conditions. None of the Company or
any Investor may rely on the failure of any condition set forth
in Section 6.01, 6.02 or 6.03, as the case may be, to be
satisfied if such failure was caused by such partys
failure to use reasonable best efforts to consummate the Equity
Investment and the other transactions contemplated by this
Agreement, as required by and subject to Section 5.03, or
by such partys breach of any other provision of this
Agreement.
Section 6.05. Investor
Representative Cure. In the event of any
breach by any Investor (other than the Investor Representative)
that would result in the failure of a closing condition pursuant
to Section 6.03(a) or 6.03(b),
A-33
the Investor Representative shall be entitled, in its sole
discretion (subject to Section 2.04), to purchase the
shares of Preferred Stock and Warrants otherwise allocable to
the breaching Investor on the terms set forth in this Agreement
and, in such event, the breach by such Investor that would
otherwise result in the failure of a closing condition pursuant
to Section 6.03(a) or 6.03(b) shall be deemed cured for
purposes of Section 6.03.
ARTICLE VII
Termination,
Amendment and Waiver
Section 7.01. Termination. This
Agreement may be terminated, and the Equity Investment may be
abandoned, at any time prior to the Closing, whether before or
after the Stockholder Approvals have been obtained, upon written
notice (other than in the case of Section 7.01(a) below)
from the terminating party to the non-terminating party
specifying the subsection of this Section 7.01 pursuant to
which such termination is effected:
(a) by mutual written consent of the Investor
Representative and the Company;
(b) by either the Investor Representative or the Company,
if:
(i) the Equity Investment shall not have been consummated
by the date that is six months from the date of this Agreement
(the Termination Date) for any reason;
provided, however, that the right to terminate
this Agreement under this Section 7.01(b)(i) shall not be
available to any party whose action or failure to act has been a
principal cause of or resulted in the failure of the Equity
Investment to occur on or before such date and such action or
failure to act constitutes a breach of this Agreement;
(ii) any Legal Restraint having the effect set forth in
Section 6.01(c) shall be in effect and shall have become
final and nonappealable; or
(iii) the Stockholders Meeting shall have been held and the
Stockholder Approvals shall not have been obtained thereat or at
any adjournment or postponement thereof;
(c) prior to receipt of the Stockholder Approvals, by the
Investor Representative, in the event an Adverse Recommendation
Change has occurred;
(d) by the Investor Representative, if (i) the Company
shall have breached any of its representations or warranties or
failed to perform any of its covenants or other agreements
contained in this Agreement, which breach or failure to perform
(A) would give rise to the failure of a condition set forth
in Section 6.02(a) or 6.02(b) and (B) is incapable of
being cured by the Company by the date that is 30 business days
after such breach or failure or, if capable of being cured by
the Company by such date, the Company does not commence to cure
such breach or failure within 10 business days after its receipt
of written notice thereof from the Investor Representative and
diligently pursue such cure thereafter, or (ii) any Legal
Restraint having any of the effects referred to in
clause (i) or (ii) of Section 6.02(c) shall be in
effect and shall have become final and nonappealable;
(e) by the Company, if any Investor shall have breached any
of its representations or warranties or failed to perform any of
its covenants or other agreements contained in this Agreement,
which breach or failure to perform (i) would give rise to
the failure of a condition set forth in Section 6.03(a) or
6.03(b) (after giving effect to Section 6.05) and
(ii) is incapable of being cured by such Investor or the
Investor Representative by the date that is 30 business days
after such breach or failure or, if capable of being cured by
such Investor or the Investor Representative by such date, such
Investor or the Investor Representative does not commence to
cure such breach or failure within 10 business days after its
receipt of written notice thereof from the Company and
diligently pursue such cure thereafter; or
(f) prior to receipt of the Stockholder Approvals, by the
Company in order to concurrently enter into a definitive
agreement to consummate a Superior Acquisition Proposal in
accordance with Section 4.02(b).
Section 7.02. Effect
of Termination. In the event of termination
of this Agreement by either the Company or the Investor
Representative as provided in Section 7.01, this Agreement
shall forthwith become void and have no effect, without any
liability or obligation on the part of the Investors or the
Company, other than the provisions of
A-34
Section 3.01(v), the last sentence of Section 5.02,
Section 5.04, this Section 7.02 and Article VIII
and except for any material, intentional breach by a party of
any of its representations, warranties, covenants or agreements
set forth in this Agreement (which material breach and liability
therefor shall not be affected by termination of this Agreement
or any payment of the Termination Fee or Investor Representative
Expenses pursuant to Section 5.04).
Section 7.03. Amendment. This
Agreement may be amended by the parties hereto at any time,
whether before or after the Stockholder Approvals have been
obtained; provided, however, that after the
Stockholder Approvals have been obtained, there shall be made no
amendment that by Law requires further approval by stockholders
of the Company without the further approval of such
stockholders. Except as set forth in the last sentence of
Section 8.08, this Agreement may not be amended except by
an instrument in writing signed on behalf of the Company and the
Investors (or, if permitted by Section 1.02(a), the Company
and the Investor Representative).
Section 7.04. Extension;
Waiver. At any time prior to the Closing, the
Company or the Investors (or, if permitted by
Section 1.02(a), the Investor Representative) may
(a) extend the time for the performance of any of the
obligations or other acts of the Investors or the Company,
respectively, (b) waive any inaccuracies in the
representations and warranties of any Investor or the Company,
respectively, contained herein or in any document delivered
pursuant hereto or (c) waive compliance with any of the
agreements of any Investor or the Company, respectively, or any
conditions to the obligations of the Investors or the Company,
respectively, contained herein; provided, however,
that after the Stockholder Approvals have been obtained, there
shall be made no waiver that by Law requires further approval by
stockholders of the Company without the further approval of such
stockholders. Any agreement on the part of a party to any such
extension or waiver shall be valid only if set forth in an
instrument in writing signed on behalf of such party which
specifically sets forth the terms of such extension or waiver.
The failure or delay by any party to this Agreement to assert
any of its rights under this Agreement or otherwise shall not
constitute a waiver of such rights nor shall any single or
partial exercise by any party to this Agreement of any of its
rights under this Agreement preclude any other or further
exercise of such rights or any other rights under this Agreement.
ARTICLE VIII
General
Provisions
Section 8.01. Nonsurvival
of Representations and Warranties. Except for
the representations and warranties set forth in
Sections 3.01(e), (y) and (z) and 3.02(f) through
(i), none of the representations and warranties in this
Agreement or in any instrument delivered pursuant to this
Agreement shall survive the Closing. This Section 8.01
shall not limit any covenant or agreement of the parties which
by its terms contemplates performance after the Closing.
Section 8.02. Notices. All
notices or other communications required or permitted to be
given hereunder shall be in writing and shall be delivered by
hand or sent by facsimile or sent, postage prepaid, by
registered, certified or express mail or reputable overnight
courier service and shall be deemed given when so delivered by
hand or sent by facsimile, or if mailed, three days after
mailing (one business day in the case of express mail or
overnight courier service), as follows (or at such other address
for a party as shall be specified by notice given in accordance
with this Section 8.02):
if to the Investors or to the Investor Representative, to:
Jacobs Private Equity, LLC
350 Round Hill Road
Greenwich, CT 06831
Facsimile:
203-661-6684
Attention: Bradley S. Jacobs
A-35
and with a copy to:
Cravath, Swaine & Moore LLP
Worldwide Plaza
825 Eighth Avenue
New York, NY 10019
Facsimile:
212-474-3700
Attention: Eric L. Schiele, Esq.
if to the Company, to:
c/o Special
Committee of the Board of Directors
Express-1 Expedited Solutions, Inc.
3399 South Lakeshore Drive, Suite 225
Saint Joseph, MI 49085
Facsimile:
269-695-7458
Attention: Calvin Pete Whitehead
with a copy to:
Roetzel & Andress
350 East Las Olas Blvd.
Las Olas Centre II, Suite 1150
Fort Lauderdale, FL 33301
Facsimile:
954-462-4260
|
|
|
|
Attention:
|
Clint J. Gage, Esq.
|
Joel D. Mayersohn, Esq.
Section 8.03. Definitions. For
purposes of this Agreement:
(a) Affiliate means, with respect
to any person, any other person directly or indirectly
controlling, controlled by or under common control with such
first person;
(b) Average Equity Value means
the product of (A) the weighted average (weighted in
accordance with the daily trading volume) closing price per
share of Company Common Stock on the NYSE Amex for the five
consecutive full trading days immediately after public
announcement by the Company of its entrance into this Agreement,
multiplied by (B) the number of shares of Company Common
Stock issued and outstanding at the close of business on the
final trading day of such five
trading-day
period;
(c) Certificate of Amendment
means the certificate of amendment to the Company Certificate
providing (i) for an increase in the number of authorized
shares of Company Common Stock to 150,000,000, (ii) for the
effectuation of a reverse stock split whereby every
4.0 shares of Company Common Stock shall be reverse split
into one share of Company Common Stock and (iii) that any
vacancy on the Board of Directors of the Company shall be filled
by the remaining directors or director (consistent with
Section 5 of Article III of the Company Bylaws);
(d) Code means the Internal
Revenue Code of 1986, as amended.
(e) as it relates to the Company,
knowledge means, with respect to any matter
in question, the actual knowledge, after reasonable inquiry, of
any officer or employee of the Company identified in
Section 8.03(e) of the Company Letter;
(f) Material Adverse Effect means
any state of facts, change, development, event, effect,
condition, occurrence, action or omission that, alone or
together with any other state of facts, change, development,
event, effect, condition, occurrence, action or omission,
(i) materially adversely effects the business, assets,
properties, financial condition or results of operations of the
Company and its Subsidiaries, taken as a whole, or
(ii) prevents, materially impedes or materially delays the
consummation by the Company of the Equity Investment or the
other transactions contemplated by this Agreement;
provided, however, that none of the following
shall be deemed either alone or in combination to constitute,
and none of the following shall be taken
A-36
into account in determining whether there has been or would be,
a Material Adverse Effect on the Company: (a) general
legal, market, economic or political conditions affecting the
industry in which the Company operates, provided that
such conditions do not disproportionately affect the Company and
its Subsidiaries, taken as a whole, in relation to other
companies in the industry in which the Company operates,
(b) changes affecting general worldwide economic or capital
market conditions (including changes in interest or exchange
rates), provided that such changes do not
disproportionately affect the Company and its Subsidiaries,
taken as a whole, in relation to other companies in the industry
in which the Company operates; (c) the pendency or
announcement of this Agreement or the anticipated consummation
of the Equity Investment, including any reaction of any
customer, employee, supplier, service provider, partner or other
constituency to the identity of the Investors or any of the
transactions contemplated by this Agreement; (d) any
decrease in the market price or trading volume of the Company
Common Stock (it being understood that the underlying cause or
causes of any such decrease may be deemed to constitute, in and
of itself or themselves, a Material Adverse Effect and may be
taken into consideration when determining whether there has
occurred a Material Adverse Effect); (e) the Companys
failure to meet any internal or published projections, forecasts
or other predictions or published industry analyst expectations
of financial performance (it being understood that the
underlying cause or causes of any such failure may be deemed to
constitute, in and of itself and themselves, a Material Adverse
Effect and may be taken into consideration when determining
whether there has occurred a Material Adverse Effect);
(f) any change in GAAP which occurs or becomes effective
after the date of this Agreement; (g) actions or omissions
of the Company or any of its Subsidiaries taken with the prior
written consent of the Investor Representative; and (h) any
natural disaster, any act or threat of terrorism or war anywhere
in the world, any armed hostilities or terrorist activities
anywhere in the world, any threat or escalation of armed
hostilities or terrorist activities anywhere in the world to the
extent they do not disproportionately affect the Company and its
Subsidiaries, taken as a whole, in relation to other companies
in the industry in which the Company operates.
(g) person means any natural
person, corporation, limited liability company, partnership,
joint venture, trust, business association, Governmental Entity
or other entity;
(h) a Subsidiary of any person means any
other person (i) more than 50% of whose outstanding shares
or securities representing the right to vote for the election of
directors or other managing authority of such other person are,
now or hereafter, owned or controlled, directly or indirectly,
by such first person, but such other person shall be deemed to
be a Subsidiary only so long as such ownership or control
exists, or (ii) which does not have outstanding shares or
securities with such right to vote, as may be the case in a
partnership, joint venture or unincorporated association, but
more than 50% of whose ownership interest representing the right
to make the decisions for such other person is, now or
hereafter, owned or controlled, directly or indirectly, by such
first person, but such other person shall be deemed to be a
Subsidiary only so long as such ownership or control exists;
(i) Tax means all taxes, fees,
duties, charges, levies or assessments of any kind whatsoever
imposed by any Governmental Entity, together with any interest,
penalties, additions to tax or additional amounts with respect
thereto;
(j) Tax Return means any return,
declaration, report, election, claim for refund, or information
return or statement relating to Taxes, including any schedule or
attachment thereto, and including any amendment thereof; and
(k) Taxing Authority means any
Governmental Entity exercising regulatory authority with respect
to Taxes.
Section 8.04. Exhibits;
Interpretation. The headings contained in
this Agreement or in any Exhibit hereto and in the table of
contents to this Agreement are for reference purposes only and
shall not affect the meaning or interpretation of this
Agreement. Any capitalized terms used in any Exhibit but not
otherwise defined therein shall have the meaning as defined in
this Agreement. When a reference is made in this Agreement to an
Article, Section, Subsection or Exhibit, such reference shall be
to a Section or Article of, or an Exhibit to, this Agreement
unless otherwise indicated. For all purposes hereof, the terms
include, includes and
including shall be deemed followed by the words
without limitation. The words hereof,
hereto, hereby, herein and
hereunder and
A-37
words of similar import when used in this Agreement shall refer
to this Agreement as a whole and not to any particular provision
of this Agreement. The term or is not exclusive. The
word extent in the phrase to the extent
means the degree to which a subject or other thing extends, and
such phrase does not mean simply if. The definitions
contained in this Agreement are applicable to the singular as
well as the plural forms of such terms. Any agreement or
instrument defined or referred to herein or in any agreement or
instrument that is referred to herein means such agreement or
instrument as from time to time amended, modified or
supplemented. References to a person are also to its permitted
successors and assigns.
Section 8.05. Counterparts. This
Agreement may be executed in one or more counterparts (including
by facsimile), all of which shall be considered one and the same
agreement and shall become effective when one or more such
counterparts have been signed by each of the parties and
delivered to the other parties.
Section 8.06. Entire
Agreement; No Third-Party Beneficiaries. This
Agreement, together with the Exhibits hereto and the Company
Letter, constitutes the entire agreement, and supersedes all
prior agreements and understandings, both written and oral,
among the parties with respect to the subject matter of this
Agreement, except for the Nondisclosure Agreement, and (except
with respect to the Company Indemnitees pursuant to
Section 5.11) is not intended to confer upon any person
other than the parties hereto (and their respective successors
and assigns, and including any Investor made a party hereto in
accordance with Section 8.08) any rights (legal, equitable
or otherwise) or remedies, whether as third party beneficiaries
or otherwise.
Section 8.07. Governing
Law. This Agreement shall be governed by, and
construed in accordance with, the Laws of the State of Delaware,
regardless of the Laws that might otherwise govern under
applicable principles of conflicts of Laws thereof.
Section 8.08. Assignment. Neither
this Agreement nor any of the rights, interests or obligations
hereunder shall be assigned, in whole or in part, by operation
of Law or otherwise by any of the parties without the prior
written consent of the other parties. Subject to the preceding
sentence, this Agreement shall be binding upon, inure to the
benefit of and be enforceable by, the parties hereto and their
respective successors and assigns. Notwithstanding anything to
the contrary in this Section 8.08, the Investor
Representative may assign a portion of its purchase obligation
with respect to the shares of Preferred Stock and the Warrants
otherwise allocable to it as set forth on Schedule I hereto
to one or more additional Investors made party hereto following
the date hereof pursuant to joinders in form and substance
reasonably satisfactory to the Company, and, upon execution and
delivery of any such joinder, Schedule I hereto shall be
amended to reflect such assignment; provided that
(i) in no event shall the purchase obligation of the
Investor Representative as set forth on Schedule I hereto
be reduced to less than $65,000,000 pursuant to this sentence
and (ii) the purchase obligation of any such Investor made
a party hereto in accordance with this sentence shall in all
events be subject to Section 2.04.
Section 8.09. Consent
to Jurisdiction; Service of Process;
Venue. Each of the parties hereto irrevocably
and unconditionally submits to the exclusive jurisdiction of the
Delaware Court of Chancery (and if the Delaware Court of
Chancery shall be unavailable, any Delaware State court and the
Federal court of the United States of America sitting in the
State of Delaware) for the purposes of any suit, action or other
proceeding arising out of this Agreement or the Equity
Investment or any other transaction contemplated by this
Agreement (and agrees that no such action, suit or proceeding
relating to this Agreement shall be brought by it or any of its
Subsidiaries except in such courts). Each of the parties further
agrees that, to the fullest extent permitted by applicable Law,
service of any process, summons, notice or document by
U.S. registered mail to such persons respective
address set forth above shall be effective service of process
for any action, suit or proceeding in the State of Delaware with
respect to any matters to which it has submitted to jurisdiction
as set forth above in the immediately preceding sentence. Each
of the parties hereto irrevocably and unconditionally waives
(and agrees not to plead or claim), any objection to the laying
of venue of any action, suit or proceeding arising out of this
Agreement or the Equity Investment or any of the other
transactions contemplated by this Agreement in the Delaware
Court of Chancery (and if the Delaware Court of Chancery shall
be unavailable, in any Delaware State court or the Federal court
of the United States of America sitting in the State of
Delaware) or that any such action, suit or proceeding brought in
any such court has been brought in an inconvenient forum.
Section 8.10. WAIVER
OF JURY TRIAL. EACH PARTY HERETO HEREBY
WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY
RIGHT IT MAY HAVE TO A TRIAL BY
A-38
JURY IN RESPECT OF ANY SUIT, ACTION OR OTHER PROCEEDING DIRECTLY
OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS
AGREEMENT. EACH PARTY HERETO (A) CERTIFIES THAT NO
REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS
REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH PARTY WOULD NOT,
IN THE EVENT OF ANY ACTION, SUIT OR PROCEEDING, SEEK TO ENFORCE
THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE
OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS
AGREEMENT, BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND
CERTIFICATIONS IN THIS SECTION 8.10.
Section 8.11. Enforcement. The
parties agree that irreparable damage would occur in the event
that any of the provisions of this Agreement were not performed
in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that the parties hereto shall
be entitled to an injunction or injunctions to prevent breaches
of this Agreement and to enforce specifically the terms and
provisions of this Agreement in the Delaware Court of Chancery
(and if the Delaware Court of Chancery shall be unavailable, in
any Delaware State court or the Federal court of the United
States of America sitting in the State of Delaware), this being
in addition to any other remedy to which they are entitled at
Law or in equity. Each of the parties agrees that it will not
oppose the granting of an injunction, specific performance and
other equitable relief on the basis that (x) any party has
an adequate remedy at law or (y) an award of specific
performance is not an appropriate remedy for any reason at law
or equity.
Section 8.12. Consents
and Approvals. For any matter under this
Agreement requiring the consent or approval of any party to be
valid and binding on the parties hereto, such consent or
approval must be in writing and executed and delivered to the
other parties by a person duly authorized by such party to do so.
Section 8.13. Severability. If
any provision of this Agreement or the application of any such
provision to any person or circumstance shall be held invalid,
illegal or unenforceable in any respect by a court of competent
jurisdiction, such invalidity, illegality or unenforceability
shall not affect the validity, legality or enforceability of any
other provision hereof and the invalidity of a particular
provision in a particular jurisdiction shall not invalidate such
provision in any other jurisdiction.
A-39
IN WITNESS WHEREOF, the parties hereto have caused this
Agreement to be duly executed as of the date first written above.
JACOBS PRIVATE EQUITY, LLC,
Name: Bradley S. Jacobs
EXPRESS-1 EXPEDITED SOLUTIONS, INC.,
Name: Michael R. Welch
|
|
|
|
Title:
|
Chief Executive Officer
|
A-40
SCHEDULE I
(as amended)
INVESTORS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
Number of Shares
|
|
|
|
|
|
|
Shares of
|
|
|
of Common Stock
|
|
|
|
|
|
|
Preferred
|
|
|
Subject to
|
|
|
Aggregate
|
|
Investor(1)
|
|
Stock(2)
|
|
|
Warrants(3)
|
|
|
Purchase Price
|
|
|
Jacobs Private Equity, LLC
|
|
|
67,500
|
|
|
|
38,571,428
|
|
|
$
|
67,500,000
|
|
Theodore R. Jacobs
|
|
|
1,000
|
|
|
|
571,429
|
|
|
$
|
1,000,000
|
|
Taha, LLC
|
|
|
750
|
|
|
|
428,571
|
|
|
$
|
750,000
|
|
James Martell
|
|
|
725
|
|
|
|
414,286
|
|
|
$
|
725,000
|
|
Michael G. Jesselson
12/18/80 Trust & Michael
G. Jesselson 4/8/71 Trust
|
|
|
725
|
|
|
|
414,286
|
|
|
$
|
725,000
|
|
Christopher Tsai
|
|
|
725
|
|
|
|
414,286
|
|
|
$
|
725,000
|
|
Springer Wealth Management LLC
|
|
|
650
|
|
|
|
371,429
|
|
|
$
|
650,000
|
|
Sharon Jacobs Brown & Ronald B. Brown
|
|
|
500
|
|
|
|
285,714
|
|
|
$
|
500,000
|
|
Chris Andersen
|
|
|
350
|
|
|
|
200,000
|
|
|
$
|
350,000
|
|
Adrian Kingshott
|
|
|
300
|
|
|
|
171,429
|
|
|
$
|
300,000
|
|
Jay Novik
|
|
|
250
|
|
|
|
142,857
|
|
|
$
|
250,000
|
|
Ben Gordon
|
|
|
200
|
|
|
|
114,286
|
|
|
$
|
200,000
|
|
Albert J. Jacobs Trust
|
|
|
200
|
|
|
|
114,286
|
|
|
$
|
200,000
|
|
Charlotte S. Jacobs Trust
|
|
|
200
|
|
|
|
114,286
|
|
|
$
|
200,000
|
|
Fred Bratman
|
|
|
150
|
|
|
|
85,714
|
|
|
$
|
150,000
|
|
Michael Kneeland
|
|
|
150
|
|
|
|
85,714
|
|
|
$
|
150,000
|
|
William Harrison
|
|
|
125
|
|
|
|
71,429
|
|
|
$
|
125,000
|
|
Eli Dominitz
|
|
|
100
|
|
|
|
57,143
|
|
|
$
|
100,000
|
|
Martin Flumenbaum
|
|
|
100
|
|
|
|
57,143
|
|
|
$
|
100,000
|
|
Tong Yu
|
|
|
100
|
|
|
|
57,143
|
|
|
$
|
100,000
|
|
Charles Cahn III
|
|
|
50
|
|
|
|
28,571
|
|
|
$
|
50,000
|
|
Robert Nardone
|
|
|
50
|
|
|
|
28,571
|
|
|
$
|
50,000
|
|
Michael Nervik Trust
|
|
|
50
|
|
|
|
28,571
|
|
|
$
|
50,000
|
|
Lucy Peterson
|
|
|
50
|
|
|
|
28,571
|
|
|
$
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
75,000
|
|
|
|
42,857,143
|
|
|
$
|
75,000,000
|
|
|
|
|
(1) |
|
Except for Jacobs Private Equity, LLC, each Investor made a
party to the Investment Agreement by a Joinder dated
June 13, 2011. |
|
(2) |
|
Shares of Preferred Stock shall have an initial conversion price
of $1.75 per share of Company Common Stock, without giving
effect to the 4:1 reverse stock split. Giving effect to the 4:1
reverse stock split, shares of Preferred Stock shall have an
initial conversion price of $7.00 per share of Company Common
Stock. |
|
(3) |
|
Share numbers in this column do not give effect to the 4:1
reverse stock split. The initial exercise price of the Warrants
shall be $1.75 per share of Company Common Stock, without giving
effect to the 4:1 reverse stock split. Giving effect to the 4:1
reverse stock split, the aggregate number of shares of Company
Common Stock initially subject to the Warrants shall be
10,714,286 shares, and the initial exercise price of the
Warrants shall be $7.00 per share of Company Common Stock. |
A-41
EXHIBIT A
CERTIFICATE
OF DESIGNATION OF
SERIES A CONVERTIBLE PERPETUAL PREFERRED STOCK OF
EXPRESS-1 EXPEDITED SOLUTIONS, INC.
Pursuant
to Section 151 of the
General Corporation Law of the State of Delaware
Express-1 Expedited Solutions, Inc., a Delaware corporation (the
Company), certifies that pursuant to the
authority contained in its Amended and Restated Certificate of
Incorporation (as amended, the Certificate of
Incorporation), and in accordance with the provisions
of Section 151 of the General Corporation Law of the State
of Delaware (the DGCL), the Board of
Directors of the Company (the Board of
Directors) by resolution adopted by unanimous written
consent, pursuant to Section 141(f) of the DGCL, on
[ ], 2011, duly approved and adopted the
following resolution, which resolution remains in full force and
effect on the date hereof:
RESOLVED, that pursuant to the authority vested in the Board of
Directors by the Amended and Restated Certificate of
Incorporation, as amended, the Board of Directors does hereby
designate, create, authorize and provide for the issue of a
series of the Companys preferred stock, par value $0.001
per share, with an initial liquidation preference of $1,000 per
share (the Initial Liquidation Preference),
subject to accretion and adjustment as provided in
Sections 2(c) and 15(a) of this Certificate of Designation,
which shall be designated as Series A Convertible Perpetual
Preferred Stock (the Series A Preferred
Stock), consisting of 75,000 shares, no shares of
which have heretofore been issued by the Company, having the
following powers, designations, preferences and relative,
participating, optional and other special rights, and
qualifications, limitations and restrictions thereof:
Certain defined terms used in this Certificate of Designation
have the meanings assigned thereto in Section 13.
Section 1. Ranking. The
Series A Preferred Stock shall rank, with respect to
payment of dividends and distribution of assets upon the
liquidation,
winding-up
or dissolution of the Company, (i) senior to the common
stock, par value $0.001 per share, of the Company (the
Common Stock), whether now outstanding or
hereafter issued, and to each other class or series of stock of
the Company (including any series of preferred stock established
after [ ], 2011 (the Issue
Date) by the Board of Directors) the terms of which do
not expressly provide that such class or series ranks senior to
or pari passu with the Series A Preferred
Stock as to payment of dividends and distribution of assets upon
the liquidation,
winding-up
or dissolution of the Company (collectively referred to as
Junior Stock); (ii) pari passu
with each class or series of stock of the Company (including any
series of preferred stock established after the Issue Date by
the Board of Directors) the terms of which expressly provide
that such class or series ranks pari passu with
the Series A Preferred Stock as to payment of dividends and
distribution of assets upon the liquidation,
winding-up
or dissolution of the Company (collectively referred to as
Parity Stock); and (iii) junior to each
other class or series of stock of the Company (including any
series of preferred stock established after the Issue Date by
the Board of Directors) the terms of which expressly provide
that such class or series ranks senior to the Series A
Preferred Stock as to payment of dividends and distribution of
assets upon the liquidation,
winding-up
or dissolution of the Company (collectively referred to as
Senior Stock). The Companys ability to
issue Capital Stock that ranks pari passu with or
senior to the Series A Preferred Stock shall be subject to
the provisions of Section 4.
Section 2. Dividends. (a)
General. Dividends on the Series A Preferred Stock
shall be payable quarterly, when, as and if declared by the
Board of Directors or a duly authorized committee thereof, out
of the assets of the Company legally available therefor, on the
15th calendar day (or the following Business Day if the 15th is
not a Business Day) of January, April, July and October of each
year (each such date being referred to herein as a
Dividend Payment Date) at the rate per annum
of 4% per share on the Accreted Liquidation Preference in effect
at such time (subject to the following paragraph), which
Accreted Liquidation Preference is subject to adjustment as
provided in Section 15(a). The initial dividend on the
Series A Preferred Stock for the dividend period commencing
on the Issue Date to but excluding [ ], 2011,
will be $[ ] per share (subject to the
following paragraph), and
A-42
shall be payable, when, as and if declared, on
[ ], 2011. The amount of dividends payable for
any other period that is shorter or longer than a full quarterly
dividend period will be computed on the basis of a
360-day year
consisting of twelve
30-day
months.
In the event that dividends are paid on shares of Common Stock
in any dividend period with respect to the Series A
Preferred Stock, then the dividend payable in respect of each
share of Series A Preferred Stock for such period shall be
equal to the greater of (i) the amount otherwise payable in
respect of such share of Series A Preferred Stock in
accordance with the foregoing paragraph and (ii) the
product of (A) the aggregate dividends payable per share of
Common Stock in such dividend period times (B) the number
of shares of Common Stock into which such share of Series A
Preferred Stock is then convertible.
A dividend period with respect to a Dividend Payment Date is the
period commencing on the preceding Dividend Payment Date or, if
none, the Issue Date, and ending on the day immediately prior to
the next Dividend Payment Date. Dividends payable, when, as and
if declared, on a Dividend Payment Date shall be payable to
Holders of record on the later of (i) the close of business
on the first calendar day (or the following Business Day if such
first calendar day is not a Business Day) of the calendar month
in which the applicable Dividend Payment Date falls and
(ii) the close of business on the day on which the Board of
Directors or a duly authorized committee thereof declares the
dividend payable (each, a Dividend Record
Date).
The Company shall make each dividend payment on the
Series A Preferred Stock in cash.
Holders shall not be entitled to any dividend in excess of the
then-applicable full accrued dividends calculated pursuant to
this Section 2(a) on shares of Series A Preferred
Stock. No interest or sum of money in lieu of interest shall be
payable in respect of any dividend or payment which may be in
arrears. All references in this Certificate of Designation to
dividends or to a dividend rate or accretion rate shall be
deemed to reflect any adjustment to the dividend rate or
accretion rate pursuant to this Certificate of Designation.
(b) Payment Restrictions. No
dividends or other distributions (other than a dividend or
distribution payable solely in shares of Parity Stock or Junior
Stock (in the case of Parity Stock) or Junior Stock (in the case
of Junior Stock) and other than cash paid in lieu of fractional
shares) may be declared, made or paid, or set apart for payment
upon, any Parity Stock or Junior Stock, nor may any Parity Stock
or Junior Stock be redeemed, purchased or otherwise acquired for
any consideration (or any money paid to or made available for a
sinking fund for the redemption of any Parity Stock or Junior
Stock) by or on behalf of the Company (except by conversion into
or exchange for shares of Parity Stock or Junior Stock (in the
case of Parity Stock) or Junior Stock (in the case of Junior
Stock)), unless all accrued and unpaid dividends (including any
accrued and unpaid dividends that have accreted pursuant to
Section 2(c) and are reflected in the Accreted Liquidation
Preference) shall have been or contemporaneously are declared
and paid, or are declared and a sum of cash sufficient for the
payment thereof is set apart for such payment, on the
Series A Preferred Stock and any Parity Stock for all
dividend payment periods terminating on or prior to the date of
such declaration, payment, redemption, purchase or acquisition.
Notwithstanding the foregoing, if full dividends have not been
paid on the Series A Preferred Stock and any Parity Stock,
dividends may be declared and paid on the Series A
Preferred Stock and such Parity Stock so long as the dividends
are declared and paid pro rata so that the
aggregate amounts of dividends declared per share on, and the
amounts of such dividends declared in cash per share on, the
Series A Preferred Stock and such Parity Stock will in all
cases bear to each other the same ratio that accrued and unpaid
dividends per share on the shares of Series A Preferred
Stock and such other Parity Stock bear to each other.
(c) Accretion. If the Company is
unable to, or otherwise fails to, pay dividends in full on the
Series A Preferred Stock on any Dividend Payment Date as
described above in Section 2(a), the Accreted Liquidation
Preference will be increased as of the first day of the
immediately succeeding dividend period by the Accretion Amount
in respect of the unpaid dividends. If the Company pays a
portion of the dividends payable on the Series A Preferred
Stock on a Dividend Payment Date and accretes the unpaid
portion, the Company will pay the current portion equally and
ratably to Holders of Series A Preferred Stock. The amount
of dividends payable for any dividend period following a
non-payment of dividends will be calculated on the basis of the
Accreted Liquidation Preference as of the first day of the
relevant dividend period.
A-43
The Company may pay all or a portion of the amount by which the
Accreted Liquidation Preference of a share of Series A
Preferred Stock exceeds the Initial Liquidation Preference of a
share of Series A Preferred Stock on (i) any Dividend
Payment Date or (ii) any other date fixed by the Board of
Directors or a duly authorized committee thereof. The Company
shall make any such payment in cash and any such payment shall
be made equally and ratably to Holders of Series A
Preferred Stock. The Accreted Liquidation Preference of each
share of Series A Preferred Stock will be reduced as of the
first day following the date of such payment by the amount of
such payment (the Paydown Amount) and the
amount of dividends will be calculated on the basis of the
reduced Accreted Liquidation Preference for the period of time
from the date of such reduction until the applicable Dividend
Payment Date.
The Company will use its reasonable best efforts to provide
notice to Holders of the Series A Preferred Stock not later
than ten days prior to each Dividend Payment Date if the Company
determines that it will not pay dividends on that Dividend
Payment Date. Such notice shall be given by issuing a press
release in accordance with Section 10(a) and by notifying
the Transfer Agent. If a development occurs less than ten days
prior to a Dividend Payment Date that will prevent the Company
from paying dividends on that Dividend Payment Date, and the
Company has not already provided notice, the Company will
provide prompt notice to the Holders and the Transfer Agent as
set forth above. The notice will indicate whether the Company
will accrete all or a portion of the dividends, as well as the
amount of the dividends to be accreted. Any failure by the
Company to deliver such notice will not impair the
Companys ability to accrete dividends in any respect.
Section 3. Liquidation
Preference. In the event of any voluntary or
involuntary liquidation, dissolution or
winding-up
of the Company, each Holder shall be entitled to receive out of
the assets of the Company available for distribution to
stockholders of the Company, before any distribution of assets
is made on the Common Stock or any other Junior Stock, an amount
equal to the greater of (i) the aggregate Accreted
Liquidation Preference attributable to shares of Series A
Preferred Stock held by such Holder, subject to adjustment as
provided in Section 15(a), plus an amount equal to the sum
of all accrued and unpaid dividends (whether or not declared)
for the then-current dividend period, and (ii) the product
of (x) the amount per share that would have been payable
upon such liquidation, dissolution or
winding-up
to the holders of shares of Common Stock or such other class or
series of securities into which the Series A Preferred
Stock is then convertible (assuming the conversion of each share
of Series A Preferred Stock and without deduction for the
Accreted Liquidation Preference otherwise payable pursuant to
clause (i)), multiplied by (y) the number of shares of
Common Stock or such other securities into which the shares of
Series A Preferred Stock held by such Holder are then
convertible.
None of (i) the sale of all or substantially all of the
property or business of the Company (other than in connection
with the voluntary or involuntary liquidation, dissolution or
winding-up
of the Company), (ii) the merger, conversion or
consolidation of the Company into or with any other Person or
(iii) the merger, conversion or consolidation of any other
Person into or with the Company, shall constitute a voluntary or
involuntary liquidation, dissolution or
winding-up
of the Company for the purposes of the immediately preceding
paragraph.
In the event the assets of the Company available for
distribution to Holders upon any liquidation,
winding-up
or dissolution of the Company, whether voluntary or involuntary,
shall be insufficient to pay in full all amounts to which such
Holders are entitled pursuant to this Section 3, no such
distribution shall be made on account of any shares of Parity
Stock upon such liquidation, dissolution or
winding-up
unless proportionate distributable amounts shall be paid on
account of the shares of Series A Preferred Stock, ratably,
in proportion to the full distributable amounts for which
Holders and holders of any Parity Stock are entitled upon such
liquidation,
winding-up
or dissolution, with the amount allocable to each series of such
stock determined on a pro rata basis of the
aggregate liquidation preference of the outstanding shares of
each series and accrued and unpaid dividends to which each
series is entitled.
After the payment to the Holders of the full preferential
amounts provided for above, the Holders as such shall have no
right or claim to any of the remaining assets of the Company.
Section 4. Voting
Rights. (a) The Holders of shares of
Series A Preferred Stock shall be entitled to vote along
with the holders of Common Stock on all matters on which holders
of Common Stock are entitled to vote. The Holders shall
participate in such votes as if the shares of Series A
Preferred Stock were converted into shares of Common Stock in
accordance with this Certificate of Designation as of the record
date for the determination of
A-44
holders of Common Stock entitled to vote. In addition, each
Holder shall have one vote for each share of Series A
Preferred Stock held by such Holder on all matters voted upon by
the holders of Series A Preferred Stock as a separate
class, as well as voting rights specifically required by the
DGCL from time to time.
(b) So long as any Series A Preferred Stock is
outstanding, in addition to any other vote of stockholders of
the Company required under applicable law or the Certificate of
Incorporation, the affirmative vote or consent of the Holders of
at least a majority of the outstanding shares of the
Series A Preferred Stock, voting separately as a single
class, will be required (i) for any amendment of the
Certificate of Incorporation if the amendment would alter or
change the powers, preferences, privileges or rights of the
Holders so as to affect them adversely, (ii) to issue,
authorize or increase the authorized amount of, or issue or
authorize any obligation or security convertible into or
evidencing a right to purchase, any Parity Stock or Senior
Stock, or (iii) to reclassify any authorized stock of the
Company into any Parity Stock or Senior Stock, or any obligation
or security convertible into or evidencing a right to purchase
any Parity Stock or Senior Stock, provided that, for
avoidance of doubt, no such vote shall be required for the
Company to issue, authorize or increase the authorized amount
of, or issue or authorize any obligation or security convertible
into or evidencing a right to purchase, any Junior Stock.
Section 5. Conversion
at the Option of the Holder. (a) Each
share of Series A Preferred Stock is convertible, in whole
or in part, at the option of the Holder thereof
(Optional Conversion), into the number of
shares of Common Stock (the Conversion Rate)
obtained by dividing (i) the Accreted Liquidation
Preference by (ii) the Conversion Price then in effect.
(b) Holders of shares of Series A Preferred Stock who
convert their shares on a day other than a Dividend Payment Date
will not be entitled to any accrued dividends for the dividend
period in which they convert their shares. Accordingly, shares
of Series A Preferred Stock surrendered for Optional
Conversion after the close of business on a Dividend Record Date
and before the opening of business on the immediately succeeding
Dividend Payment Date must be accompanied by payment in cash of
an amount equal to the dividend payable on such shares on such
Dividend Payment Date. Such Holders will be entitled to receive
the dividend payment on those shares on that Dividend Payment
Date. A Holder on a Dividend Record Date who (or whose
transferee) surrenders any shares for conversion on the
corresponding Dividend Payment Date shall receive the dividend
payable by the Company on the Series A Preferred Stock on
that date (and if the Company fails to pay such dividend, such
Holders shares converted on such date will be converted at
a Conversion Rate that reflects the Accreted Liquidation
Preference after giving effect to such failure), and the
converting Holder shall not be required to include payment in
the amount of such dividend upon surrender of shares of
Series A Preferred Stock for conversion. Except as provided
above, upon any Optional Conversion of shares of Series A
Preferred Stock, the Company shall make no payment or allowance
for unpaid dividends, whether or not in arrears, on such shares
of Series A Preferred Stock as to which Optional Conversion
has been effected or for dividends on the shares of Common Stock
issued upon such Optional Conversion.
(c) The conversion right of a Holder shall be exercised by
the Holder of shares of Series A Preferred Stock by the
surrender to the Company of the certificates representing shares
of Series A Preferred Stock to be converted at any time
during usual business hours at its principal place of business
or the offices of the Transfer Agent, accompanied by written
notice to the Company that the Holder elects to convert all or a
portion of the shares of Series A Preferred Stock
represented by such certificate and specifying the name or names
(with address) in which a certificate or certificates or other
appropriate evidence of ownership representing shares of Common
Stock are to be issued and (if so required by the Company or the
Transfer Agent) by a written instrument or instruments of
transfer in form reasonably satisfactory to the Company or the
Transfer Agent duly executed by the Holder or its duly
authorized legal representative and transfer tax stamps or funds
therefor, if required pursuant to Section 15(f). The date
on which a Holder satisfies the foregoing requirements for
conversion is referred to herein as the Conversion
Date. The Company will deliver shares of Common Stock
(or such other class or series of securities into which the
Series A Preferred Stock is then convertible) due upon
conversion, together with any cash in lieu of fractional shares
in accordance with Section 14 hereof, in accordance with
Section 6. Immediately prior to the close of business on
the Conversion Date, each converting Holder shall be deemed to
be the holder of record of the shares of Common Stock (or such
other class or series of securities into which the Series A
Preferred Stock is then convertible) issuable upon conversion of
such Holders Series A Preferred Stock notwithstanding
that the share register of the Company shall then be closed or
that certificates or other appropriate evidence of ownership
representing such Common Stock
A-45
(or such other class or series of securities into which the
Series A Preferred Stock is then convertible) shall not
then be actually delivered to such Holder. On the Conversion
Date, all rights with respect to the shares of Series A
Preferred Stock so converted, including the rights, if any, to
receive notices, will terminate, except the rights of Holders
thereof to (a) receive certificates or other appropriate
evidence of ownership representing the number of whole shares of
Common Stock (or such other class or series of securities into
which the Series A Preferred Stock is then convertible)
into which such shares of Series A Preferred Stock have
been converted and cash in lieu of any fractional shares, in
accordance with Section 14 hereof and (b) exercise the
rights to which they are entitled as holders of Common Stock (or
such other class or series of securities into which the
Series A Preferred Stock is then convertible).
Section 6. Settlement
upon Conversion. The Company shall satisfy
its obligation to deliver shares of Common Stock (or such other
class or series of securities into which the Series A
Preferred Stock is then convertible) upon conversion of
Series A Preferred Stock by delivering to Holders
surrendering shares for conversion a number of shares of Common
Stock (or such other class or series of securities into which
the Series A Preferred Stock is then convertible) equal to
the product of (x) the aggregate number of shares of
Series A Preferred Stock to be converted multiplied by
(y) the Conversion Rate then in effect (provided
that the Company will deliver cash in lieu of fractional shares
in accordance with Section 14), as soon as practicable
after the third Trading Day (but in no event later than the
fifth Business Day) following the Conversion Date.
Section 7. Anti-dilution
Adjustments. (a) The Conversion Price
shall be subject to the following adjustments from time to time:
(i) Stock Dividends. In case the
Company shall pay or make a dividend or other distribution on
the Common Stock in Common Stock, the Conversion Price, as in
effect at the opening of business on the day following the date
fixed for the determination of stockholders of the Company
entitled to receive such dividend or other distribution, shall
be adjusted by multiplying such Conversion Price by a fraction
of which the numerator shall be the number of shares of Common
Stock outstanding at the close of business on the date fixed for
such determination and the denominator shall be the sum of such
number of shares and the total number of shares constituting
such dividend or other distribution, such adjustment to become
effective immediately after the opening of business on the day
following the date fixed for such determination.
(ii) Stock Purchase Rights. In
case the Company shall issue to all holders of its Common Stock
options, warrants or other rights entitling them to subscribe
for or purchase shares of Common Stock for a period expiring
within 60 days from the date of issuance of such options,
warrants or other rights at a price per share of Common Stock
less than the Market Value on the date fixed for the
determination of stockholders of the Company entitled to receive
such options, warrants or other rights (other than pursuant to a
dividend reinvestment, share purchase or similar plan), the
Conversion Price in effect at the opening of business on the day
following the date fixed for such determination shall be
adjusted by multiplying such Conversion Price by a fraction, the
numerator of which shall be the number of shares of Common Stock
outstanding at the close of business on the date fixed for such
determination plus the number of shares of Common Stock which
the aggregate consideration expected to be received by the
Company upon the exercise, conversion or exchange of such
options, warrants or other rights (as determined in good faith
by the Board of Directors, whose determination shall be
conclusive and described in a Board Resolution) would purchase
at such Market Value and the denominator of which shall be the
number of shares of Common Stock outstanding at the close of
business on the date fixed for such determination plus the
number of shares of Common Stock so offered for subscription or
purchase, either directly or indirectly, such adjustment to
become effective immediately after the opening of business on
the day following the date fixed for such determination;
provided, however, that no such adjustment to the
Conversion Price shall be made if the Holders would be entitled
to receive such options, warrants or other rights upon
conversion at any time of shares of Series A Preferred
Stock into Common Stock; provided, further,
however, that if any of the foregoing options, warrants
or other rights are only exercisable upon the occurrence of a
Triggering Event, then the Conversion Price will not be adjusted
until such Triggering Event occurs.
(iii) Stock Splits, Reverse Splits and
Combinations. In case outstanding shares of
Common Stock shall be subdivided, split or reclassified into a
greater number of shares of Common Stock, the Conversion Price
in
A-46
effect at the opening of business on the day following the day
upon which such subdivision, split or reclassification becomes
effective shall be proportionately reduced, and, conversely, in
case outstanding shares of Common Stock shall be combined or
reclassified into a smaller number of shares of Common Stock,
the Conversion Price in effect at the opening of business on the
day following the day upon which such combination or
reclassification becomes effective shall be proportionately
increased, such reduction or increase, as the case may be, to
become effective immediately after the opening of business on
the day following the day upon which such subdivision, split,
reclassification or combination becomes effective.
(iv) Debt, Asset or Security
Distributions. (A) In case the Company
shall, by dividend or otherwise, distribute to all holders of
its Common Stock evidences of its indebtedness, assets or
securities (but excluding any dividend or distribution of
options, warrants or other rights referred to in paragraph
(ii) of this Section 7(a), any dividend or
distribution paid exclusively in cash, any dividend or
distribution of shares of Capital Stock of any class or series,
or similar equity interests, of or relating to a Subsidiary or
other business unit in the case of a Spin-off referred to in the
next subparagraph, or any dividend or distribution referred to
in paragraph (i) of this Section 7(a)), the Conversion
Price shall be reduced by multiplying the Conversion Price in
effect immediately prior to the close of business on the date
fixed for the determination of stockholders of the Company
entitled to receive such distribution by a fraction, the
numerator of which shall be the Market Value on the date fixed
for such determination and the denominator of which shall be
such Market Value plus the fair market value (as determined in
good faith by the Board of Directors, whose determination shall
be conclusive and described in a Board Resolution) of the
portion of the assets or evidences of indebtedness so
distributed applicable to one share of Common Stock, such
adjustment to become effective immediately prior to the opening
of business on the day following the date fixed for the
determination of stockholders of the Company entitled to receive
such distribution. In any case in which this subparagraph
(iv)(A) is applicable, subparagraph (iv)(B) of this
Section 7(a) shall not be applicable.
(B) In the case of a Spin-off, the Conversion Price in
effect immediately prior to the close of business on the date
fixed for determination of stockholders of the Company entitled
to receive such distribution shall be reduced by multiplying the
Conversion Price by a fraction, the numerator of which shall be
the Market Value and the denominator of which shall be the
Market Value plus the fair market value (as determined in good
faith by the Board of Directors, whose determination shall be
conclusive and described in a Board Resolution) of the portion
of those shares of Capital Stock or similar equity interests so
distributed applicable to one share of Common Stock. Any
adjustment to the Conversion Price under this subparagraph
(iv)(B) will occur on the date that is the earlier of
(1) the tenth Trading Day from, and including, the
effective date of the Spin-off and (2) the date of the
Initial Public Offering of the securities being distributed in
the Spin-off, if that Initial Public Offering is effected
simultaneously with the Spin-off.
(v) Tender Offers. In the case
that a tender or exchange offer made by the Company or any
Subsidiary of the Company for all or any portion of the Common
Stock shall expire and such tender or exchange offer (as amended
through the expiration thereof) shall require the payment to
stockholders of the Company (based on the acceptance (up to any
maximum specified in the terms of the tender or exchange offer)
of Purchased Shares) of aggregate consideration having a fair
market value (as determined in good faith by the Board of
Directors, whose determination shall be conclusive and described
in a Board Resolution) per share of Common Stock that exceeds
the Closing Sale Price of the Common Stock on the Trading Day
next succeeding the last date on which tenders or exchanges may
be made pursuant to such tender or exchange offer, then,
immediately prior to the opening of business on the day after
the date of the last time (the Expiration
Time) tenders or exchanges could have been made
pursuant to such tender or exchange offer (as amended through
the expiration thereof), the Conversion Price shall be reduced
by multiplying the Conversion Price immediately prior to the
close of business on the date of the Expiration Time by a
fraction (A) the numerator of which shall be equal to the
product of (x) the Market Value on the date of the
Expiration Time and (y) the number of shares of Common
Stock outstanding (including any tendered or exchanged shares)
on the date of the Expiration Time, and (B) the denominator
of which shall be equal to (x) the product of (I) the
Market Value on the date of the Expiration Time and
(II) the number of shares of Common Stock outstanding
(including any tendered or exchanged shares) on the date of the
Expiration Time less the number of all shares validly tendered
or exchanged, not withdrawn and accepted for payment on the date
of the Expiration Time (such validly tendered or exchanged
A-47
shares, up to any such maximum, being referred to as the
Purchased Shares) plus (y) the amount of
cash plus the fair market value (determined as aforesaid) of the
aggregate consideration payable to stockholders of the Company
pursuant to the tender or exchange offer (assuming the
acceptance, up to any maximum specified in the terms of the
tender or exchange offer, of Purchased Shares).
(b) De Minimis
Adjustments. Notwithstanding anything herein
to the contrary, no adjustment under this Section 7 need be
made to the Conversion Price unless such adjustment would
require an increase or decrease of at least 1.0% of the
Conversion Rate then in effect. Any lesser adjustment shall be
carried forward and shall be made at the time of and together
with the next subsequent adjustment, if any, which, together
with any adjustment or adjustments so carried forward, shall
result in an increase or decrease of at least 1.0% of such
Conversion Rate. No adjustment under this Section 7 shall
be made if such adjustment will result in a Conversion Price
that is less than the par value of the Common Stock. All
adjustments to the Conversion Rate shall be calculated to the
nearest
1/10,000th of
a share of Common Stock (or if there is not a nearest
1/10,000th of a share to the next lower
1/10,000th of
a share).
(c) Tax-Related Adjustments. The
Company may make such reductions in the Conversion Price, in
addition to those required by this Section 7, as the Board
of Directors considers advisable in order to avoid or diminish
any income tax to any holders of shares of Common Stock
resulting from any dividend or distribution of stock or issuance
of rights or warrants to purchase or subscribe for stock or from
any event treated as such for income tax purposes. In the event
the Company elects to make such a reduction in the Conversion
Price, the Company will comply with the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
regulations thereunder if and to the extent that such laws and
regulations are applicable in connection with the reduction in
the Conversion Price.
(d) Stockholder Rights Plans. Upon
conversion of the Series A Preferred Stock, to the extent
that the Holders receive Common Stock, such Holders shall
receive, in addition to the shares of Common Stock and any cash
for fractional shares in accordance with Section 14, if
any, the rights issued under any future stockholder rights plan
the Company may establish whether or not such rights are
separated from the Common Stock prior to conversion. A
distribution of rights pursuant to any stockholder rights plan
will not result in an adjustment to the Conversion Price
pursuant to Section 7(a)(ii) or 7(a)(iv), provided
that the Company has provided for the Holders to receive such
rights upon conversion.
(e) Notice of Adjustment. Whenever
the Conversion Price is adjusted in accordance with this
Section 7, the Company shall (i) compute the
Conversion Price in accordance with this Section 7 and
prepare and transmit to the Transfer Agent an Officers
Certificate setting forth the Conversion Price, the method of
calculation thereof in reasonable detail, and the facts
requiring such adjustment and upon which such adjustment is
based and (ii) as soon as practicable following the
occurrence of an event that requires an adjustment to the
Conversion Price pursuant to this Section 7 (or if the
Company is not aware of such occurrence, as soon as practicable
after becoming so aware), the Company or, at the request and
expense of the Company, the Transfer Agent shall provide a
written notice to the Holders of the occurrence of such event
and a statement setting forth in reasonable detail the method by
which the adjustment to the Conversion Price was determined and
setting forth the adjusted Conversion Price.
(f) Reversal of Adjustment. If the
Company shall take a record of the holders of its Common Stock
for the purpose of entitling them to receive a dividend or other
distribution, and shall thereafter (and before the dividend or
distribution has been paid or delivered to stockholders) legally
abandon its plan to pay or deliver such dividend or
distribution, then thereafter no adjustment in the Conversion
Price then in effect shall be required by reason of the taking
of such record.
(g) Exceptions to Adjustment. The
applicable Conversion Price shall not be adjusted:
(i) upon the issuance of any shares of Common Stock
pursuant to any present or future plan providing for the
reinvestment of dividends or interest payable on the
Companys securities and the investment of additional
optional amounts in shares of Common Stock under any such plan;
(ii) upon the issuance of any shares of Common Stock or
options or rights to purchase those shares pursuant to any
present or future employee, director or consultant benefit plan
or program of or assumed by the Company or any of its
Subsidiaries;
A-48
(iii) upon the issuance of any shares of Common Stock
pursuant to any option, warrant, right or exercisable,
exchangeable or convertible security outstanding as of the Issue
Date;
(iv) for a change in the par value of the Common
Stock; or
(v) for accrued and unpaid dividends on the Series A
Preferred Stock.
Section 8. Recapitalizations,
Reclassifications and Changes in the Companys
Stock. In the event of any reclassification
of outstanding shares of Common Stock (other than a change in
par value, or from par value to no par value, or from no par
value to par value), or any consolidation or merger of the
Company with or into another Person (other than with a
Subsidiary of the Company) or any merger of another Person with
or into the Company (other than a consolidation or merger in
which the Company is the resulting or surviving Person and that
does not result in any reclassification or change of outstanding
Common Stock), or any sale or other disposition to another
Person of all or substantially all of the assets of the Company
(computed on a consolidated basis) (any of the foregoing, a
Transaction), upon conversion of its shares
of Series A Preferred Stock, a Holder will be entitled to
receive the kind and amount of securities (of the Company or
another issuer), cash and other property receivable upon such
Transaction by a holder of the number of shares of Common Stock
into which such shares of Series A Preferred Stock were
convertible immediately prior to such Transaction, after giving
effect to any adjustment event or, in the event holders of
Common Stock have the opportunity to elect the form of
consideration to be received in any Transaction, the weighted
average of the forms and amounts of consideration received by
the holders of the Common Stock. In the event that at any time,
as a result of an adjustment made pursuant to this Certificate
of Designation, the Holders shall become entitled upon
conversion to any securities other than, or in addition to,
shares of Common Stock, thereafter the number or amount of such
other securities so receivable upon conversion shall be subject
to adjustment from time to time in a manner and on terms as
nearly equivalent as practicable to the provisions with respect
to the Common Stock set forth in this Certificate of Designation.
Section 9. Consolidation,
Merger and Sale of Assets. (a) The
Company, without the consent of the Holders (but subject, for
avoidance of doubt, to the right of the Holders to vote on any
such transaction in accordance with the first two sentences of
Section 4(a)), may consolidate with or merge into any other
Person or convey, transfer or lease all or substantially all its
assets to any Person or may permit any Person to consolidate
with or merge into, or transfer or lease all or substantially
all its properties to, the Company; provided,
however, that (i) the successor, transferee or
lessee is organized under the laws of the United States or any
political subdivision thereof; (ii) the shares of
Series A Preferred Stock will become shares of such
successor, transferee or lessee, having in respect of such
successor, transferee or lessee the same powers, preferences and
relative participating, optional or other special rights and the
qualification, limitations or restrictions thereon, the
Series A Preferred Stock had immediately prior to such
transaction; and (iii) the Company delivers to the Transfer
Agent an Officers Certificate and an Opinion of Counsel,
acceptable to the Transfer Agent, stating that such transaction
complies with this Certificate of Designation.
(b) Upon any consolidation by the Company with, or merger
by the Company into, any other Person or any conveyance,
transfer or lease of all or substantially all the assets of the
Company as described in Section 9(a), the successor
resulting from such consolidation or into which the Company is
merged or the transferee or lessee to which such conveyance,
transfer or lease is made, will succeed to, and be substituted
for, and may exercise every right and power of, the Company
under the shares of Series A Preferred Stock, and
thereafter, except in the case of a lease, the predecessor (if
still in existence) will be released from its obligations and
covenants with respect to the Series A Preferred Stock.
Section 10. Notices. (a) When
the Company is required, pursuant to this Certificate of
Designation, to give notice to Holders by issuing a press
release, rather than directly to Holders, the Company shall do
so in a public medium that is customary for such press release;
provided, however, that in such cases, publication
of a press release through the Dow Jones News Service shall be
considered sufficient to comply with such notice obligation.
(b) When the Company is required, pursuant to this
Certificate of Designation, to give notice to Holders without
specifying the method of giving such notice, the Company shall
do so by sending notice via first class mail or by overnight
courier to the Holders of record as of a reasonably current date.
A-49
Section 11. Transfer
of Securities. (a) The shares of
Series A Preferred Stock and the shares of Common Stock
issuable upon conversion of the Series A Preferred Stock
(collectively, the Securities) have not been
registered under the Securities Act or any other applicable
securities laws and may not be offered or sold except in
compliance with the registration requirements of the Securities
Act and any other applicable securities laws, or pursuant to an
exemption from registration under the Securities Act and any
other applicable securities laws, or in a transaction not
subject to such laws. The Securities will have the benefit of
certain registration rights under the Securities Act pursuant to
a Registration Rights Agreement entered into by the Company and
the Holders on the Issue Date, a copy of which may be obtained
from the Company by writing to it at Express-1 Expedited
Solutions, Inc., 3399 South Lakeshore Drive, Suite 225,
Saint Joseph, MI 49085, Attention: Secretary of the Board of
Directors.
(b) Except in connection with a registration statement
relating to the Securities, if shares of Series A Preferred
Stock in certificated form are delivered upon the transfer,
exchange or replacement of shares of Series A Preferred
Stock bearing the Restricted Stock Legend, or if a request is
made to remove such Restricted Stock Legend on shares of
Series A Preferred Stock, the shares of Series A
Preferred Stock so issued shall bear the Restricted Stock Legend
and the Restricted Stock Legend shall not be removed unless
there is delivered to the Company and the Transfer Agent such
satisfactory evidence, which may include an Opinion of Counsel
licensed to practice law in the State of New York, as may be
reasonably required by the Company, that such shares of
Series A Preferred Stock are not restricted
securities within the meaning of Rule 144 under the
Securities Act. Upon provision of such satisfactory evidence,
the Transfer Agent, at the direction of the Company, shall
countersign and deliver shares of Series A Preferred Stock
that do not bear the Restricted Stock Legend.
(c) Shares of Common Stock issued upon a conversion of the
shares of Series A Preferred Stock bearing the Restricted
Stock Legend, prior to the first anniversary of the Issue Date,
shall be in global form and bear a restricted common stock
legend that corresponds to the Restricted Stock Legend (the
Restricted Common Stock Legend).
(d) The Company will refuse to register any transfer of
Securities that is not made in accordance with the provisions of
the Restricted Stock Legend or the Restricted Common Stock
Legend, as applicable, provided that the provisions of
this Section 11(d) shall not be applicable to any Security
that does not bear any Restricted Stock Legend or any Restricted
Common Stock Legend.
Section 12. Tax
Treatment. The Company and the Holders
acknowledge and agree that it is intended that the Series A
Preferred Stock constitute stock other than preferred
stock within the meaning of Section 305 of the
Internal Revenue Code of 1986, as amended, and the Treasury
Regulations promulgated thereunder, and that neither the Company
nor the Holders shall treat the Series A Preferred Stock as
such.
Section 13. Definitions. (a) Accretion
Amount per share of Series A Preferred Stock
for any Dividend Payment Date on which accrued dividends are not
paid in full, means the product of (i) the accretion rate
of 4% per annum, calculated on a quarterly basis, as such may be
adjusted pursuant to Section 2(a), (ii) the Accreted
Liquidation Preference as of the first day of the relevant
dividend period and (iii) the fraction of the accrued
dividends for that dividend period that were not paid on the
Dividend Payment Date.
(b) Accreted Liquidation
Preference per share of Series A Preferred
Stock means, as of any date, the Initial Liquidation Preference
increased by the sum of the Accretion Amounts, if any, for all
prior Dividend Payment Dates, and decreased by the sum of the
Paydown Amounts, if any, for all prior Dividend Payment Dates or
other dates on which Paydown Amounts were paid.
(c) Board of Directors has the
meaning set forth in the first paragraph of this Certificate of
Designation.
(d) Board Resolution means a copy
of a resolution certified by the Secretary or an Assistant
Secretary of the Company to have been duly adopted by the Board
of Directors and to be in full force and effect on the date of
such certification, and delivered to the Transfer Agent.
(e) Business Day means any day
other than a Saturday or Sunday or any other day on which banks
in the City of New York are authorized or required by law or
executive order to close.
(f) Capital Stock of any Person
means any and all shares, interests, participations or other
equivalents however designated of corporate stock or other
equity participations, including partnership interests, whether
A-50
general or limited, of such Person and any rights (other than
debt securities convertible or exchangeable into an equity
interest), warrants or options to acquire an equity interest in
such Person.
(g) Certificate of Incorporation
has the meaning set forth in the first paragraph of this
Certificate of Designation.
(h) The Closing Sale Price of the Common
Stock on any date means the closing sale price per share (or if
no closing sale price is reported, the average of the closing
bid and ask prices or, if more than one in either case,
the average of the average closing bid and the average
closing ask prices) on such date as reported on
the over-the-counter
Pink Sheets market or, if the Common Stock is listed
on a national securities exchange, the principal national
securities exchange on which the Common Stock is traded. In the
absence of such a quotation, the Closing Sale Price of the
Common Stock will be an amount determined in good faith by the
Board of Directors to be the fair market value of such Common
Stock, and such determination shall be conclusive.
(i) Common Stock has the meaning
set forth in Section 1.
(j) Company has the meaning set
forth in the first paragraph of this Certificate of Designation.
(k) Conversion Date has the
meaning set forth in Section 5(c).
(l) Conversion Price shall
initially equal
$[1.75]1
per share of Common Stock, and shall be subject to adjustment as
set forth in Section 7.
(m) Conversion Rate has the
meaning set forth in Section 5(a).
(n) DGCL has the meaning set
forth in the first paragraph of this Certificate of Designation.
(o) Dividend Payment Date has the
meaning set forth in Section 2(a).
(p) Dividend Record Date has the
meaning set forth in Section 2(a).
(q) Exchange Act means the
Securities Exchange Act of 1934, as amended.
(r) Expiration Time has the
meaning set forth in Section 7(a)(v).
(s) Holder means the Person in
whose name a share of Series A Preferred Stock is
registered.
(t) including means
including, without limitation.
(u) Initial Liquidation
Preference has the meaning set forth in the first
paragraph of this Certificate of Designation.
(v) Initial Public Offering
means, in the event of a Spin-off, the first time securities of
the same class or type as the securities being distributed in
the Spin-off are bona fide offered to the public for cash.
(w) Issue Date has the meaning
set forth in Section 1.
(x) Junior Stock has the meaning
set forth in Section 1.
(y) Market Value means, with
respect to any date of determination, the average Closing Sale
Price of the Common Stock for a five consecutive Trading Day
period preceding the earlier of (i) the day preceding the
date of determination and (ii) the day before the ex
date with respect to the issuance or distribution
requiring such computation. For purposes of this definition, the
term ex date when used with respect to any issuance
or distribution, means the first date on which the Common Stock
trades, regular way, on the
over-the-counter
Pink Sheets market or, if the Common Stock is listed
on a national securities exchange, the principal national
securities exchange on which the Common Stock is traded at that
time, without the right to receive the issuance or distribution.
(z) Officer means the Chairman of
the Board, President, Chief Executive Officer, any Vice
President, the Chief Financial Officer, the Chief Accounting
Officer, the Treasurer, any Assistant Treasurer, the Controller,
any Assistant Controller, the Secretary or any Assistant
Secretary of the Company.
1 Before
giving effect to 4:1 reverse stock split.
A-51
(aa) Officers Certificate
means a certificate signed by two Officers.
(bb) Opinion of Counsel means a
written opinion from legal counsel who is acceptable to the
Company or the Transfer Agent. The counsel may be an employee of
or counsel to the Company or the Transfer Agent.
(cc) Optional Conversion has the
meaning set forth in Section 5(a).
(dd) Parity Stock has the meaning
set forth in Section 1.
(ee) Paydown Amount has the
meaning set forth in Section 2(c).
(ff) Person means any natural
person, corporation, limited liability company, partnership,
joint venture, trust, business association, governmental entity
or other entity.
(gg) Purchased Shares has the
meaning set forth in Section 7(a)(v).
(hh) Restricted Common Stock
Legend has the meaning set forth in
Section 11(c).
(ii) Restricted Stock Legend
means a legend to the following effect:
THE SECURITIES REPRESENTED BY THIS INSTRUMENT AND THE
SECURITIES ISSUABLE UPON CONVERSION THEREOF HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED, SOLD OR
OTHERWISE DISPOSED OF EXCEPT PURSUANT TO A REGISTRATION
STATEMENT RELATING THERETO IN EFFECT UNDER SUCH ACT AND
APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN
EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH
LAWS.
(jj) Securities has the meaning
set forth in Section 11(a).
(kk) Securities Act means the
Securities Act of 1933, as amended.
(ll) Senior Stock has the meaning
set forth in Section 1.
(mm) Series A Preferred
Stock has the meaning set forth in the first
paragraph of this Certificate of Designation.
(nn) Spin-off means a dividend or
other distribution of shares of Capital Stock of any class or
series, or similar equity interests, of or relating to a
Subsidiary or other business unit of the Company.
(oo) Subsidiary of any Person
means any other Person (i) more than 50% of whose
outstanding shares or securities representing the right to vote
for the election of directors or other managing authority of
such other Person are, now or hereafter, owned or controlled,
directly or indirectly, by such first Person, but such other
Person shall be deemed to be a Subsidiary only so long as such
ownership or control exists, or (ii) which does not have
outstanding shares or securities with such right to vote, as may
be the case in a partnership, joint venture or unincorporated
association, but more than 50% of whose ownership interest
representing the right to make the decisions for such other
Person is, now or hereafter, owned or controlled, directly or
indirectly, by such first Person, but such other Person shall be
deemed to be a Subsidiary only so long as such ownership or
control exists.
(pp) Trading Day means a day
during which trading in securities generally occurs on the
over-the-counter
Pink Sheets market or, if the Common Stock is listed
on a national securities exchange, the principal national
securities exchange on which the Common Stock is traded.
(qq) Transaction has the meaning
set forth in Section 8.
(rr) Transfer Agent means
Computershare Trust Company, N.A. unless and until a
successor is selected by the Company, and then such successor.
(ss) Triggering Event means a
specified event the occurrence of which entitles the holders of
rights, options or warrants to exercise such rights, options or
warrants.
Section 14. Fractional
Shares. No fractional shares of Common Stock
shall be issued to Holders. In lieu of any fraction of a share
of Common Stock that would otherwise be issuable in respect of
the aggregate number of shares of the Series A Preferred
Stock surrendered by a Holder upon a conversion, such Holder
shall have the right
A-52
to receive an amount in cash (computed to the nearest cent)
equal to the same fraction of the Closing Sale Price on the
Trading Day next preceding the date of conversion.
Section 15. Miscellaneous. (a) The
Accreted Liquidation Preference and the annual dividend rate and
accretion rate set forth herein each shall be subject to
equitable adjustment whenever there shall occur a stock split,
combination, reclassification or other similar event involving
the Series A Preferred Stock. Such adjustments shall be
determined in good faith by the Board of Directors (and such
determination shall be conclusive) and submitted by the Board of
Directors to the Transfer Agent.
(b) For the purposes of Section 7, the number of
shares of Common Stock at any time outstanding shall not include
shares held in the treasury of the Company but shall include
shares issuable in respect of scrip certificates issued in lieu
of fractions of shares of Common Stock.
(c) If the Company shall take any action affecting the
Common Stock, other than any action described in Section 7,
that in the opinion of the Board of Directors would materially
adversely affect the conversion rights of the Holders, then the
Conversion Price for the Series A Preferred Stock may be
adjusted, to the extent permitted by law, in such manner, and at
such time, as the Board of Directors may determine to be
equitable in the circumstances.
(d) The Company covenants that it will at all times reserve
and keep available, free from preemptive rights, out of the
aggregate of its authorized but unissued shares of Common Stock
for the purpose of effecting conversion of the Series A
Preferred Stock, the full number of shares of Common Stock
deliverable upon the conversion of all outstanding shares of
Series A Preferred Stock not theretofore converted. For
purposes of this Section 15(d), the number of shares of
Common Stock that shall be deliverable upon the conversion of
all outstanding shares of Series A Preferred Stock shall be
computed as if at the time of computation all such outstanding
shares were held by a single Holder.
(e) The Company covenants that any shares of Common Stock
issued upon conversion of the Series A Preferred Stock
shall be duly and validly issued and fully paid and
nonassessable, free from preemptive rights and free from all
taxes, liens, charges and security interests with respect to the
issuance thereof, except for transfer restrictions imposed by
applicable securities laws.
(f) The Company shall pay all transfer, stamp and other
similar taxes due with respect to the issuance or delivery of
shares of Common Stock or other securities or property upon
conversion of the Series A Preferred Stock;
provided, however, that the Company shall not be
required to pay any tax that may be payable with respect to any
transfer involved in the issuance or delivery of shares of
Common Stock or other securities or property in a name other
than that of the Holder of the Series A Preferred Stock to
be converted, and the Holder shall be responsible for any such
tax.
(g) The Series A Preferred Stock is not redeemable.
(h) The Series A Preferred Stock is not entitled to
any preemptive or subscription rights in respect of any
securities of the Company.
(i) Whenever possible, each provision hereof shall be
interpreted in a manner as to be effective and valid under
applicable law, but if any provision hereof is held to be
prohibited by or invalid under applicable law, such provision
shall be ineffective only to the extent of such prohibition or
invalidity, without invalidating or otherwise adversely
affecting the remaining provisions hereof. If a court of
competent jurisdiction should determine that a provision hereof
would be valid or enforceable if a period of time were extended
or shortened or a particular percentage were increased or
decreased, then such court may make such change as shall be
necessary to render the provision in question effective and
valid under applicable law.
(j) Series A Preferred Stock may be issued in
fractions of a share which shall entitle the Holder, in
proportion to such Holders fractional shares, to exercise
voting rights, receive dividends, participate in distributions
and have the benefit of all other rights of Holders of
Series A Preferred Stock.
(k) Subject to applicable escheat laws, any monies set
aside by the Company in respect of any payment with respect to
shares of the Series A Preferred Stock, or dividends
thereon, and unclaimed at the end of two years from the date
upon which such payment is due and payable shall revert to the
general funds of the Company, after which
A-53
reversion the Holders of such shares shall look only to the
general funds of the Company for the payment thereof. Any
interest accumulated on funds so deposited shall be paid to the
Company from time to time.
(l) Except as may otherwise be required by law, the shares
of Series A Preferred Stock shall not have any voting
powers, preferences and relative, participating, optional or
other special rights, other than those specifically set forth in
this Certificate of Designation or the Certificate of
Incorporation.
(m) The headings of the various subdivisions hereof are for
convenience of reference only and shall not affect the
interpretation of any of the provisions hereof.
(n) If any of the voting powers, preferences and relative,
participating, optional and other special rights of the
Series A Preferred Stock and qualifications, limitations
and restrictions thereof set forth herein is invalid, unlawful
or incapable of being enforced by reason of any rule of law or
public policy, all other voting powers, preferences and
relative, participating, optional and other special rights of
Series A Preferred Stock and qualifications, limitations
and restrictions thereof set forth herein which can be given
effect without the invalid, unlawful or unenforceable voting
powers, preferences and relative, participating, optional and
other special rights of Series A Preferred Stock and
qualifications, limitations and restrictions thereof shall,
nevertheless, remain in full force and effect, and no voting
powers, preferences and relative, participating, optional or
other special rights of Series A Preferred Stock and
qualifications, limitations and restrictions thereof herein set
forth shall be deemed dependent upon any other such voting
powers, preferences and relative, participating, optional or
other special rights of Series A Preferred Stock and
qualifications, limitations and restrictions thereof unless so
expressed herein.
(o) Shares of Series A Preferred Stock that
(i) have not been issued on or before [ ],
2011 or (ii) have been issued and reacquired in any manner,
including shares of Series A Preferred Stock purchased or
converted, shall (upon compliance with any applicable provisions
of the laws of Delaware) have the status of authorized but
unissued shares of preferred stock of the Company undesignated
as to series and may be designated or redesignated and issued or
reissued, as the case may be, as part of any series of preferred
stock of the Company; provided that any issuance of such
shares as Series A Preferred Stock must be in compliance
with the terms hereof.
(p) If any of the Series A Preferred Stock
certificates shall be mutilated, lost, stolen or destroyed, the
Company shall issue, in exchange and in substitution for and
upon cancellation of the mutilated Series A Preferred Stock
certificate, or in lieu of and substitution for the
Series A Preferred Stock certificate lost, stolen or
destroyed, a new Series A Preferred Stock certificate of
like tenor and representing an equivalent amount of shares of
Series A Preferred Stock, but only upon receipt of evidence
of such loss, theft or destruction of such Series A
Preferred Stock certificate and indemnity, if requested,
satisfactory to the Company and the Transfer Agent.
A-54
IN WITNESS WHEREOF, the Company has caused this Certificate of
Designation to be duly executed by [ ],
[ ] of the Company, and attested by
[ ], [ ] of the Company, this
[ ] day of [ ], 2011.
EXPRESS-1 EXPEDITED SOLUTIONS, INC.,
Name:
Title:
ATTEST:
Name:
Title:
A-55
EXHIBIT B
THE SECURITIES REPRESENTED BY THIS INSTRUMENT AND THE
SECURITIES ISSUABLE UPON EXERCISE THEREOF HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED, SOLD OR
OTHERWISE DISPOSED OF EXCEPT PURSUANT TO A REGISTRATION
STATEMENT RELATING THERETO IN EFFECT UNDER SUCH ACT AND
APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN
EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH LAWS.
WARRANTS
TO PURCHASE COMMON STOCK OF
EXPRESS-1 EXPEDITED SOLUTIONS, INC.
No. 1 Certificate for 42,857,143
Warrants2
This Warrant Certificate (Warrant
Certificate) certifies that [INSERT NAME OF HOLDER],
or registered assigns, is the registered holder of the number of
Warrants set forth above. Each warrant represented hereby (a
Warrant) entitles the holder thereof (the
Holder), subject to the provisions contained
herein, to purchase from Express-1 Expedited Solutions, Inc., a
Delaware corporation (the Company), one share
of the Companys common stock, par value $0.001 per share
(Company Common Stock), subject to adjustment
upon the occurrence of certain events specified herein, at the
exercise price of
[$1.75]3
per share (the Exercise Price), subject to
adjustment upon the occurrence of certain events specified
herein.
This Warrant Certificate is issued under and in accordance with
the Investment Agreement, dated as of June 13, 2011 (the
Investment Agreement), by and among Jacobs
Private Equity, LLC, the other Investors party thereto and the
Company, and is subject to the terms and provisions contained in
the Investment Agreement. Capitalized terms used but not
otherwise defined herein shall have the meanings ascribed to
such terms in the Investment Agreement.
ARTICLE I
Exercise
Price; Exercise of Warrants and Expiration of Warrants
Section 1.01. Exercise
Price. This Warrant Certificate shall entitle
the Holder hereof, subject to the provisions of this Warrant
Certificate, to purchase one share of Company Common Stock for
each Warrant represented hereby, at the Exercise Price, in each
case subject to all adjustments made on or prior to the date of
exercise thereof as herein provided.
Section 1.02. Exercise
of Warrants. (a) The Warrants shall be
exercisable in whole or in part from time to time on any
Business Day beginning on the Issuance Date and ending on the
Expiration Date in the manner provided for herein.
Section 1.03. Expiration
of Warrants. Any unexercised Warrants shall
expire and the rights of the Holder of such Warrants to purchase
Company Common Stock shall terminate at the close of business on
the Expiration Date.
Section 1.04. Method
of Exercise; Payment of Exercise
Price. (a) In order to exercise a
Warrant, the Holder hereof must (i) surrender this Warrant
Certificate to the Company, with the Exercise Subscription Form
attached hereto as Annex I duly completed and executed, and
(ii) pay in full the Exercise Price then in effect for the
shares of Company Common Stock as to which this Warrant
Certificate is submitted for exercise in the manner provided in
paragraph (b) of this Section 1.04.
2 Before
giving effect to 4:1 reverse stock split. Total warrants to be
apportioned among the Investors in accordance with
Schedule I to the Investment Agreement.
3 Before
giving effect to 4:1 reverse stock split.
A-56
(b) Simultaneously with the exercise of each Warrant,
payment in full of the Exercise Price shall be delivered to the
Company. Such payment shall be made in cash, by bank wire
transfer in immediately available funds to an account designated
by the Company.
(c) If fewer than all the Warrants represented by this
Warrant Certificate are surrendered, this Warrant Certificate
shall be surrendered and a new Warrant Certificate of the same
tenor and for the number of Warrants that were not surrendered
shall promptly be executed and delivered to the Person or
Persons as may be directed in writing by the Holder (subject to
the terms hereof), and the Company shall register the new
Warrant Certificate in the name of such Person or Persons. Any
new Warrant Certificate shall be executed on behalf of the
Company by its President, Chief Executive Officer, Chief
Financial Officer or Secretary, either manually or by facsimile
signature printed thereon. In case any Officer of the Company
whose signature shall have been placed upon any Warrant
Certificate shall cease to be such Officer of the Company before
issue and delivery thereof, such Warrant Certificate may,
nevertheless, be issued and delivered with the same force and
effect as though such person had not ceased to be such Officer
of the Company.
(d) Upon surrender of this Warrant Certificate in
accordance with the foregoing provisions, the Company shall
instruct the Transfer Agent to transfer to the Holder
appropriate evidence of ownership of any shares of Company
Common Stock or other securities or property (including cash) to
which the Holder is entitled, registered or otherwise placed in,
or payable to the order of, such name or names as may be
directed in writing by the Holder (subject to the terms hereof),
and shall deliver such evidence of ownership and any other
securities or property (including cash) to the Person or Persons
entitled to receive the same, together with an amount in cash in
lieu of any fraction of a share as provided in
Section 2.03. Upon payment of the Exercise Price therefor,
the Holder (or its designee) shall be deemed to own and have all
of the rights associated with any Company Common Stock or other
securities or property (including cash) to which it is entitled
pursuant to this Warrant Certificate upon the surrender of this
Warrant Certificate in accordance with the terms of this Warrant
Certificate.
Section 1.05. Compliance
with the Securities Act. (a) No Warrants
or shares of Company Common Stock issued upon exercise thereof
may be sold, transferred or otherwise disposed of (any such
sale, transfer or other disposition, a Sale),
except (i) pursuant to an effective registration statement
under the Securities Act or (ii) in accordance with an
available exemption from the registration requirements of the
Securities Act and applicable state securities laws. In order to
effect a Sale pursuant to clause (ii) of the foregoing
sentence, the Holder shall (x) give written notice to the
Company of its intention to effect such Sale, which notice shall
describe the manner and circumstances of the proposed
transaction in reasonable detail and shall include a
certification by the Holder to the effect that such proposed
Sale may be effected without registration under the Securities
Act or under applicable state securities laws, and
(y) provide such additional certifications of the Holder or
its transferee or Opinions of Counsel (which shall be reasonably
satisfactory to the Company) as the Company may reasonably
request solely in order to confirm the availability of the
applicable exemption. The shares of Company Common Stock
issuable upon exercise of the Warrants will have the benefit of
certain registration rights under the Securities Act pursuant to
a Registration Rights Agreement entered into by the Company on
the Issuance Date.
(b) Except for a Sale in accordance with clause (i) of
Section 1.05(a), and subject to Section 6.04, all
stock certificates issued pursuant to the exercise of the
Warrants shall bear the following legend:
THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED, SOLD OR
OTHERWISE DISPOSED OF EXCEPT PURSUANT TO A REGISTRATION
STATEMENT RELATING THERETO IN EFFECT UNDER SUCH ACT AND
APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN
EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH LAWS.
A-57
ARTICLE II
Adjustments;
Changes upon Certain Other Transactions
Section 2.01. Anti-dilution
Adjustments. (a) The number of shares
issuable upon exercise of the Warrants and the Exercise Price
shall be subject to the following adjustments from time to time:
(i) Stock Dividends. In case the
Company shall pay or make a dividend or other distribution on
the Company Common Stock in Company Common Stock, the number of
shares of Company Common Stock issuable upon exercise of each
Warrant, as in effect at the opening of business on the day
following the date fixed for the determination of stockholders
of the Company entitled to receive such dividend or
distribution, shall be adjusted so that the Holder shall
thereafter be entitled to receive the number of shares of
Company Common Stock that the Holder would have owned or have
been entitled to receive after the happening of the dividend or
other distribution, had such Warrant been exercised immediately
prior to the date fixed for such determination; and, in the
event of any such adjustment, the Exercise Price, as in effect
at the opening of business on the day following the date fixed
for the determination of stockholders of the Company entitled to
receive such dividend or other distribution, shall be adjusted
by multiplying such Exercise Price by a fraction of which the
numerator shall be the number of shares of Company Common Stock
outstanding at the close of business on the date fixed for such
determination and the denominator shall be the sum of such
number of shares and the total number of shares constituting
such dividend or other distribution. Such adjustments shall
become effective immediately after the opening of business on
the day following the date fixed for such determination.
(ii) Stock Purchase Rights. In
case the Company shall issue to all holders of Company Common
Stock options, warrants or other rights entitling them to
subscribe for or purchase shares of Company Common Stock for a
period expiring within 60 days from the date of issuance of
such options, warrants or other rights at a price per share of
Company Common Stock less than the Market Value on the date
fixed for the determination of stockholders of the Company
entitled to receive such options, warrants or other rights
(other than pursuant to a dividend reinvestment, share purchase
or similar plan), the number of shares of Company Common Stock
issuable upon the exercise of each Warrant shall be adjusted by
multiplying the number of shares of Company Common Stock
issuable upon exercise of each Warrant, as in effect at the
opening of business on the day following the date fixed for such
determination, by a fraction, the numerator of which shall be
the number of shares of Company Common Stock outstanding at the
close of business on the date fixed for such determination plus
the number of shares of Company Common Stock so offered for
subscription or purchase, either directly or indirectly, and the
denominator of which shall be the number of shares of Company
Common Stock outstanding at the close of business on the date
fixed for such determination plus the number of shares of
Company Common Stock which the aggregate consideration expected
to be received by the Company upon the exercise, conversion or
exchange of such options, warrants or other rights (as
determined in good faith by the Board, whose determination shall
be conclusive and described in a Board Resolution) would
purchase at such Market Value; and, in the event of any such
adjustment, the Exercise Price in effect at the opening of
business on the day following the date fixed for such
determination shall be adjusted by multiplying such Exercise
Price by a fraction, the numerator of which shall be the number
of shares of Company Common Stock outstanding at the close of
business on the date fixed for such determination plus the
number of shares of Company Common Stock which the aggregate
consideration expected to be received by the Company upon the
exercise, conversion or exchange of such options, warrants or
other rights (as determined in good faith by the Board, whose
determination shall be conclusive and described in a Board
Resolution) would purchase at such Market Value and the
denominator of which shall be the number of shares of Company
Common Stock outstanding at the close of business on the date
fixed for such determination plus the number of shares of
Company Common Stock so offered for subscription or purchase,
either directly or indirectly. Such adjustments shall become
effective immediately after the opening of business on the day
following the date fixed for such determination;
provided, however, that no such adjustments shall
be made if the Holder would be entitled to receive such options,
warrants or other rights upon exercise at any time of the
Warrants; provided, further, however, that
if any of the foregoing options, warrants or other rights are
only exercisable upon the occurrence of a Triggering Event, then
no such adjustments shall be made until such Triggering Event
occurs.
A-58
(iii) Stock Splits, Reverse Splits and
Combinations. In case outstanding shares of
Company Common Stock shall be subdivided, split or reclassified
into a greater number of shares of Company Common Stock, then
the number of shares of Company Common Stock issuable upon
exercise of each Warrant in effect at the opening of business on
the day following the date upon which such subdivision, split or
reclassification becomes effective shall be adjusted so that the
Holder shall thereafter be entitled to receive the number of
shares of Company Common Stock that the Holder would have owned
or would have been entitled to receive had such Warrant been
exercised immediately prior to such subdivision, split or
reclassification becoming effective; and, in the event of any
such adjustment, the Exercise Price in effect at the opening of
business on the day following the date upon which such
subdivision, split or reclassification becomes effective shall
be proportionately reduced. Conversely, in case outstanding
shares of Company Common Stock shall be combined or reclassified
into a smaller number of shares of Company Common Stock, then
the number of shares of Company Common Stock issuable upon
exercise of each Warrant in effect at the opening of business on
the day following the date upon which such combination or
reclassification becomes effective shall be adjusted so that the
Holder shall thereafter be entitled to receive the number of
shares of Company Common Stock that the Holder would have owned
or would have been entitled to receive had such Warrant been
exercised immediately prior to such combination or
reclassification becoming effective; and, in the event of any
such adjustment, the Exercise Price in effect at the opening of
business on the day following the date upon which such
combination or reclassification becomes effective shall be
proportionately increased. Such adjustments shall become
effective immediately after the opening of business on the day
following the date upon which such subdivision, split,
reclassification or combination becomes effective.
(iv) Debt, Asset or Security
Distributions. (A) In case the Company
shall, by dividend or otherwise, distribute to all holders of
Company Common Stock evidences of its indebtedness, assets or
securities (but excluding any dividend or distribution of
options, warrants or other rights referred to in paragraph
(ii) of this Section 2.01(a), any dividend or
distribution paid exclusively in cash, any dividend or
distribution of shares of Capital Stock of any class or series,
or similar equity interests, of or relating to a Subsidiary or
other business unit in the case of a Spin-off referred to in the
next subparagraph, or any dividend or distribution referred to
in paragraph (i) of this Section 2.01(a)), then the
number of shares of Company Common Stock issuable upon the
exercise of each Warrant immediately prior to the close of
business on the date fixed for the determination of stockholders
of the Company entitled to receive such distribution shall be
increased to a number determined by multiplying the number of
shares of Company Common Stock issuable upon the exercise of
such Warrant immediately prior to the date fixed for such
determination by a fraction, the numerator of which shall be the
Market Value on the date fixed for such determination plus the
fair market value (as determined in good faith by the Board,
whose determination shall be conclusive and described in a Board
Resolution) of the portion of the assets or evidences of
indebtedness so distributed applicable to one share of Company
Common Stock and the denominator of which shall be the Market
Value on the date fixed for such determination; and, in the
event of any such adjustment, the Exercise Price shall be
reduced by multiplying the Exercise Price in effect immediately
prior to the close of business on the date fixed for the
determination of stockholders of the Company entitled to receive
such distribution by a fraction, the numerator of which shall be
the Market Value on the date fixed for such determination and
the denominator of which shall be such Market Value plus the
fair market value (as determined in good faith by the Board,
whose determination shall be conclusive and described in a Board
Resolution) of the portion of the assets or evidences of
indebtedness so distributed applicable to one share of Company
Common Stock. Such adjustments shall become effective
immediately prior to the opening of business on the day
following the date fixed for the determination of stockholders
of the Company entitled to receive such distribution. In any
case in which this subparagraph (iv)(A) is applicable,
subparagraph (iv)(B) of this Section 2.01(a)(iv) shall not
be applicable.
(B) In the case of a Spin-off, the number of shares of
Company Common Stock issuable upon the exercise of each Warrant
immediately prior to the close of business on the date fixed for
determination of stockholders of the Company entitled to receive
such distribution shall be increased to a number determined by
multiplying the number of shares of Company Common Stock
issuable upon the exercise of such Warrant immediately before
the close of business on such date by a fraction, the numerator
of which shall be the Market Value plus the fair market value
(as determined in good faith by the Board, whose determination
shall be conclusive and described in a Board Resolution) of the
portion of those shares of Capital Stock or similar
A-59
equity interests so distributed applicable to one share of
Company Common Stock, and the denominator of which shall be the
Market Value; and, in the event of any such adjustment, the
Exercise Price in effect immediately prior to the close of
business on the date fixed for determination of stockholders of
the Company entitled to receive such distribution shall be
reduced by multiplying the Exercise Price by a fraction, the
numerator of which shall be the Market Value and the denominator
of which shall be the Market Value plus the fair market value
(as determined in good faith by the Board, whose determination
shall be conclusive and described in a Board Resolution) of the
portion of those shares of Capital Stock or similar equity
interests so distributed applicable to one share of Company
Common Stock. Any adjustments under this subparagraph (iv)(B)
will occur on the date that is the earlier of (1) the tenth
Trading Day from, and including, the effective date of the
Spin-off and (2) the date of the Initial Public Offering of
the securities being distributed in the Spin-off, if that
Initial Public Offering is effected simultaneously with the
Spin-off.
(v) Tender Offers. In the case
that a tender or exchange offer made by the Company or any
Subsidiary of the Company for all or any portion of the Company
Common Stock shall expire and such tender or exchange offer (as
amended through the expiration thereof) shall require the
payment to stockholders of the Company (based on the acceptance
(up to any maximum specified in the terms of the tender or
exchange offer) of Purchased Shares) of aggregate consideration
having a fair market value (as determined in good faith by the
Board, whose determination shall be conclusive and described in
a Board Resolution) per share of Company Common Stock that
exceeds the Closing Sale Price of the Company Common Stock on
the Trading Day next succeeding the last date on which tenders
or exchanges may be made pursuant to such tender or exchange
offer, then, immediately prior to the opening of business on the
day after the date of the last time (the Expiration
Time) tenders or exchanges could have been made
pursuant to such tender or exchange offer (as amended through
the expiration thereof), the number of shares of Company Common
Stock issuable upon the exercise of each Warrant immediately
prior to the close of business on the date of the Expiration
Time shall be increased to a number determined by multiplying
the number of shares of Company Common Stock issuable upon
exercise of each Warrant immediately prior to the close of
business on the date of the Expiration Time by a fraction
(A) the numerator of which shall be equal to (x) the
product of (I) the Market Value on the date of the
Expiration Time and (II) the number of shares of Company
Common Stock outstanding (including any tendered or exchanged
shares) on the date of the Expiration Time less the number of
all shares validly tendered or exchanged, not withdrawn and
accepted for payment on the date of the Expiration Time (such
validly tendered or exchanged shares, up to any such maximum,
being referred to as the Purchased Shares)
plus (y) the amount of cash plus the fair market value
(determined as aforesaid) of the aggregate consideration payable
to stockholders of the Company pursuant to the tender or
exchange offer (assuming the acceptance, up to any maximum
specified in the terms of the tender or exchange offer, of
Purchased Shares), and (B) the denominator of which shall
be equal to the product of (x) the Market Value on the date
of the Expiration Time and (y) the number of shares of
Company Common Stock outstanding (including any tendered or
exchanged shares) on the date of the Expiration Time; and, in
the event of any such adjustment, the Exercise Price shall be
reduced by multiplying the Exercise Price immediately prior to
the close of business on the date of the Expiration Time by a
fraction (A) the numerator of which shall be equal to the
product of (x) the Market Value on the date of the
Expiration Time and (y) the number of shares of Company
Common Stock outstanding (including any tendered or exchanged
shares) on the date of the Expiration Time, and (B) the
denominator of which shall be equal to (x) the product of
(I) the Market Value on the date of the Expiration Time and
(II) the number of shares of Company Common Stock
outstanding (including any tendered or exchanged shares) on the
date of the Expiration Time less the number of Purchased Shares
plus (y) the amount of cash plus the fair market value
(determined as aforesaid) of the aggregate consideration payable
to stockholders of the Company pursuant to the tender or
exchange offer (assuming the acceptance, up to any maximum
specified in the terms of the tender or exchange offer, of
Purchased Shares).
(b) De Minimis
Adjustments. Notwithstanding anything herein
to the contrary, no adjustment under this Section 2.01 need
be made to the number of shares issuable upon exercise of a
Warrant or the Exercise Price unless such adjustment would
require an increase or decrease of at least 1.0% of the number
of shares issuable upon exercise of the Warrants or the Exercise
Price immediately prior to the making of such adjustment. Any
lesser adjustment shall be carried forward and shall be made at
the time of and together with the next subsequent adjustment, if
any, which, together with any adjustment or adjustments so
carried forward, shall result in an increase
A-60
or decrease of at least 1.0% of the number of shares issuable
upon exercise of a Warrant or the Exercise Price immediately
prior to the making of such adjustment. No adjustment to the
Exercise Price under this Section 2.01 shall be made if
such adjustment will result in an Exercise Price that is less
than the par value of the Company Common Stock. All adjustments
to the number of shares issuable upon exercise of the Warrants
or the Exercise Price shall be calculated to the nearest
1/10,000th of a share of Company Common Stock (or if there
is not a nearest 1/10,000th of a share to the next lower
1/10,000th of a share) or the nearest $0.0001 (or if there
is not a nearest $0.0001 to the next lower $0.0001), as the case
may be.
(c) Tax-Related Adjustments. The
Company may make such increases in the number of shares issuable
upon exercise of the Warrants or reductions in the Exercise
Price, in addition to those required by this Section 2.01,
as the Board considers advisable in order to avoid or diminish
any income tax to any holders of shares of Company Common Stock
resulting from any dividend or distribution of stock or issuance
of rights or warrants to purchase or subscribe for stock or from
any event treated as such for income tax purposes. In the event
the Company elects to make such an increase in the number of
shares issuable upon exercise of the Warrants or such a
reduction in the Exercise Price, the Company will comply with
the requirements of
Rule 14e-1
under the Exchange Act and any other securities laws and
regulations thereunder, if and to the extent that such laws and
regulations are applicable in connection with the increase in
the number of shares issuable upon exercise of the Warrants or
the reduction in the Exercise Price.
(d) Stockholder Rights Plans. Upon
exercise of the Warrants, to the extent that the Holder receives
Company Common Stock, the Holder shall receive, in addition to
the shares of Company Common Stock and any cash for fractional
shares in accordance with Section 2.03, if any, the rights
issued under any future stockholder rights plan the Company may
establish whether or not such rights are separated from the
Company Common Stock prior to exercise. A distribution of rights
pursuant to any stockholder rights plan will not result in an
adjustment to the number of shares issuable upon exercise of the
Warrants or the Exercise Price pursuant to
Section 2.01(a)(ii) or 2.01(a)(iv), provided that
the Company has provided for the Holder to receive such rights
upon exercise.
(e) Reversal of Adjustment. If the
Company shall take a record of the holders of Company Common
Stock for the purpose of entitling them to receive a dividend or
other distribution, and shall thereafter (and before the
dividend or distribution has been paid or delivered to
stockholders) legally abandon its plan to pay or deliver such
dividend or distribution, then thereafter no adjustment in the
number of shares issuable upon exercise of the Warrants or the
Exercise Price then in effect shall be required by reason of the
taking of such record.
(f) Exceptions to Adjustment. The
applicable number of shares issuable upon exercise of the
Warrants and Exercise Price shall not be adjusted:
(i) upon the issuance of any shares of Company Common Stock
pursuant to any present or future plan providing for the
reinvestment of dividends or interest payable on the
Companys securities and the investment of additional
optional amounts in shares of Company Common Stock under any
such plan;
(ii) upon the issuance of any shares of Company Common
Stock or options or rights to purchase those shares pursuant to
any present or future employee, director or consultant benefit
plan or program of or assumed by the Company or any of its
Subsidiaries;
(iii) upon the issuance of any shares of Company Common
Stock pursuant to any option, warrant, right or exercisable,
exchangeable or convertible security outstanding as of the Issue
Date;
(iv) for a change in the par value of the Company Common
Stock; or
(v) for accrued and unpaid dividends on the Companys
Series A Convertible Perpetual Preferred Stock, par value
$0.001 per share.
Section 2.02. Recapitalizations,
Reclassifications and Changes in the Companys
Stock. In the event of any reclassification
of outstanding shares of Company Common Stock (other than a
change in par value, or from par value to no par value, or from
no par value to par value), or any consolidation or merger of
the Company with or into another Person (other than with a
Subsidiary of the Company) or any merger of another Person with
or into the Company (other than a consolidation or merger in
which the Company is the resulting or surviving Person and that
does not result in any reclassification or change of outstanding
Company Common Stock), or any sale or other
A-61
disposition to another Person of all or substantially all of the
assets of the Company (computed on a consolidated basis) (any of
the foregoing, a Transaction), upon exercise
of the Warrants, the Holder will be entitled to receive the kind
and amount of securities (of the Company or another issuer),
cash and other property receivable upon such Transaction by a
holder of the number of shares of Company Common Stock issuable
upon exercise of the Warrants immediately prior to such
Transaction, after giving effect to any adjustment event or, in
the event holders of Company Common Stock have the opportunity
to elect the form of consideration to be received in any
Transaction, the weighted average of the forms and amounts of
consideration received by the holders of Company Common Stock.
In the event that at any time, as a result of an adjustment made
pursuant to this Warrant Certificate, the Holder shall become
entitled upon exercise to any securities other than, or in
addition to, shares of Company Common Stock, thereafter the
number or amount of such other securities so receivable upon
exercise and the Exercise Price therefor shall be subject to
adjustment from time to time in a manner and on terms as nearly
equivalent as practicable to the provisions with respect to the
Company Common Stock set forth in this Warrant Certificate.
Section 2.03. Fractional
Shares. No fractional shares of Company
Common Stock shall be issued to the Holder upon exercise of any
Warrant. In lieu of any fraction of a share of Company Common
Stock that would otherwise be issuable upon exercise of the
aggregate number of Warrants exercised by the Holder, the Holder
shall have the right to receive an amount in cash (computed to
the nearest cent) equal to the same fraction of the Closing Sale
Price on the Trading Day next preceding the date of exercise.
Section 2.04. Notice
of Adjustment. Whenever the number of shares
of Company Common Stock or other stock or property issuable upon
the exercise of each Warrant or the Exercise Price is adjusted,
as herein provided, the Company shall (i) compute such
adjustment in accordance with this Article II and prepare
and transmit to the Transfer Agent an Officers Certificate
setting forth the adjustment, the method of calculation thereof
in reasonable detail and the facts requiring such adjustment and
upon which such adjustment is based and (ii) as soon as
practicable following the occurrence of an event that requires
an adjustment pursuant to this Article II (or if the
Company is not aware of such occurrence, as soon as practicable
after becoming so aware), the Company or, at the request and
expense of the Company, the Transfer Agent shall provide a
written notice to the holders of Warrants (including the Holder)
of the occurrence of such event and a statement setting forth in
reasonable detail the method by which the adjustment was
determined and setting forth the adjusted amount.
ARTICLE III
Warrant
Transfer Books
Section 3.01. Warrant
Transfer Books. (a) The Company shall
keep at its principal place of business a register in which the
Company shall provide for the registration of Warrant
Certificates and of any exchanges of Warrant Certificates as
herein provided.
(b) At the option of the Holder, Warrant Certificates may
be exchanged at such office and upon payment of the charges
hereinafter provided. Whenever any Warrant Certificates are so
surrendered for exchange, the Company shall execute and deliver
the Warrant Certificates that the Holder is entitled to receive.
(c) All Warrant Certificates issued upon any registration
of transfer or exchange of Warrant Certificates shall be the
valid obligations of the Company, evidencing the same
obligations, and entitled to the same benefits, as the Warrant
Certificates surrendered for such registration of transfer or
exchange.
(d) Every Warrant Certificate surrendered for registration
of exchange shall (if so required by the Company) be duly
endorsed, or be accompanied by a written instrument of transfer
in form reasonably satisfactory to the Company, duly executed by
the Holder or his attorney duly authorized in writing.
(e) No service charge shall be payable by the Holder for
any registration of transfer or exchange of this Warrant
Certificate, and the Company shall pay any taxes or other
governmental charges that may be imposed in connection with any
registration of exchange of Warrant Certificates.
(f) This Warrant Certificate when duly endorsed in blank
shall be deemed negotiable and when this Warrant Certificate
shall have been so endorsed, the Holder hereof may be treated by
the Company and all other Persons
A-62
dealing therewith as the absolute owner hereof for any purpose
and as the Person entitled to exercise the rights represented
hereby.
ARTICLE IV
Voting
Section 4.01. No
Voting Rights. Prior to the exercise of the
Warrants, the Holder, in its capacity as such, shall not be
entitled to any rights of a stockholder of the Company,
including the right to vote or to consent with respect to any
matter.
ARTICLE V
Covenants
Section 5.01. Reservation
of Company Common Stock for Issuance on Exercise of
Warrants. The Company covenants that it will
at all times reserve and keep available, free from preemptive
rights and solely for the purpose of issue upon exercise of the
Warrants as herein provided, out of its authorized but unissued
Company Common Stock, such number of shares of Company Common
Stock as shall then be issuable upon the exercise of all
Warrants issuable hereunder and all other Warrant Certificates.
The Company covenants that all shares of Company Common Stock
issuable upon exercise of the Warrants shall, upon such issue,
be duly and validly issued and fully paid and non-assessable,
free from preemptive rights and free from all taxes, liens,
charges and security interests with respect to the issuance
thereof.
Section 5.02. Notice
of Dividends. At any time when the Company
declares any dividend or other distribution on the Company
Common Stock, it shall give notice to the holders of all the
then outstanding Warrants (including the Holder) of any such
declaration not less than 15 days prior to the related
record date for payment of the dividend or distribution so
declared.
Section 5.03. HSR
Act Compliance. If the Holder determines that
a notification under the
Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended, and the rules
and regulations promulgated thereunder (the HSR
Act), is required in connection with the exercise of
the Warrants represented by this Warrant Certificate, the
Company shall reasonably cooperate with the Holder by
(i) promptly effecting all necessary notifications and
other filings under the HSR Act that are required to be made by
the Company and (ii) responding as promptly as reasonably
practicable to all inquiries or requests received from the
United States Federal Trade Commission (the
FTC), the Department of Justice (the
DOJ) or any other governmental authority in
connection with such notifications and other filings. For the
avoidance of doubt, nothing in this Section 5.03 shall
require that the Company or any of its Subsidiaries commit to
any divestiture, license or hold separate or similar arrangement
with respect to the business, assets or properties of the
Company or any of its Subsidiaries. Any such notifications and
responses by the Company will be in full compliance with the
requirements of the HSR Act. The Company shall, to the extent
legally permissible, keep the Holder reasonably apprised of the
status of any communications with, and any inquiries or requests
for additional information from, the FTC, the DOJ or such other
governmental authority. The Company shall pay the filing fees in
connection with the above filings, and shall otherwise each bear
its costs and expenses in connection with the preparation of
such filings and responses to inquires or requests.
Section 5.04. Certain
Other Events. If any event occurs as to which
the provisions of Article II are not strictly applicable
or, if strictly applicable, would not fairly protect the rights
of the holders of the Warrants in accordance with the essential
intent and principles of such provisions, then the Board shall
make such adjustments in the application of such provisions, in
accordance with such essential intent and principles, as shall
be reasonably necessary, in the good faith judgment of the
Board, to protect such purchase rights as aforesaid.
A-63
ARTICLE VI
Miscellaneous
Section 6.01. Tax
Matters. (a) The Company shall pay all
transfer, stamp and other similar taxes due with respect to the
issuance or delivery of shares of Company Common Stock or other
securities or property upon exercise of the Warrants;
provided, however, that the Company shall not be
required to pay any tax that may be payable with respect to any
transfer involved in the issuance or delivery of shares of
Company Common Stock or other securities or property in a name
other than that of the Holder, and the Holder shall be
responsible for any such tax.
Section 6.02. Surrender
of Warrant Certificate. This Warrant
Certificate, if surrendered for exercise or purchase, shall be
promptly canceled by the Company and shall not be reissued by
the Company. The Company shall destroy such canceled Warrant
Certificate.
Section 6.03. Mutilated,
Destroyed, Lost or Stolen Warrant
Certificate. (a) If (i) this
Warrant Certificate is mutilated and surrendered to the Company
or (ii) the Company receives evidence to its satisfaction
of the destruction, loss or theft of this Warrant Certificate,
and there is delivered to the Company such appropriate affidavit
of loss, applicable processing fee and indemnity as may be
reasonably required by the Company to save it harmless, then, in
the absence of notice to the Company that this Warrant
Certificate has been acquired by a bona fide purchaser, the
Company shall execute and deliver, in exchange for this Warrant
Certificate if mutilated or in lieu of this Warrant Certificate
if destroyed, lost or stolen, a new Warrant Certificate of like
tenor and for a like aggregate number of Warrants.
(b) Upon the issuance of any new Warrant Certificate under
this Section 6.03, the Company shall pay any taxes or other
governmental charges that may be imposed in relation thereto and
other expenses in connection therewith.
(c) Every new Warrant Certificate executed and delivered
pursuant to this Section 6.03 in lieu of any destroyed,
lost or stolen Warrant Certificate shall constitute an original
contractual obligation of the Company, whether or not the
destroyed, lost or stolen Warrant Certificate shall be at any
time enforceable by anyone.
(d) The provisions of this Section 6.03 are exclusive
and shall preclude (to the extent lawful) all other rights or
remedies with respect to the replacement of a mutilated,
destroyed, lost or stolen Warrant Certificate.
Section 6.04. Removal
of Legends. In the event (a) the shares
of Company Common Stock issued upon exercise of the Warrants are
registered under the Securities Act or (b) the Company is
presented with an Opinion of Counsel reasonably satisfactory to
the Company that transfers of the Warrants or such shares of
Company Common Stock do not require registration under the
Securities Act, the Company shall direct the Transfer Agent, and
the Transfer Agent shall, upon surrender by the Holder of this
Warrant Certificate or certificates evidencing such shares of
Company Common Stock, as applicable, to the Transfer Agent,
exchange such certificates for certificates without the legend
set forth on the first page of this Warrant Certificate or
referred to in Section 1.05(b), as applicable.
Section 6.05. Notices. Any
notice, demand or delivery to the Company authorized by this
Warrant Certificate shall be sufficiently given or made when
mailed if sent by first-class mail, postage prepaid, addressed
to the Company as follows:
Express-1 Expedited Solutions, Inc.
3399 South Lakeshore Drive, Suite 225
Saint Joseph, MI 49085
Facsimile:
269-695-7458
Attention: Secretary of the Board of Directors
Section 6.06. Applicable
Law. This Warrant Certificate and each
Warrant represented hereby and all rights arising hereunder
shall be construed in accordance with the laws of the State of
Delaware, regardless of the laws that might otherwise govern
under applicable principles of conflicts of laws thereof.
A-64
Section 6.07. Persons
Benefiting. This Warrant Certificate shall be
binding upon and inure to the benefit of the Company and its
successors, assigns, beneficiaries, executors and
administrators, and the Holder from time to time of the Warrants
represented hereby. Except as otherwise expressly provided
herein, nothing in this Warrant Certificate is intended or shall
be construed to confer upon any Person, other than the Company
and the Holder from time to time of the Warrants represented
hereby, any right, remedy or claim under or by reason of this
Warrant Certificate or any part hereof.
Section 6.08. Supplements
or Amendments. This Warrant Certificate may
not be supplemented or amended without the written approval of
both the Holder and the Company.
Section 6.09. Headings. The
descriptive headings of the several Articles and Sections of
this Warrant Certificate are inserted for convenience and shall
not control or affect the meaning or construction of any of the
provisions hereof.
Section 6.10. Copies
of Agreements. Copies of the Investment
Agreement and the Registration Rights Agreement referred to in
Section 1.05(a) are on file at the principal place of
business of the Company and may be obtained by writing to the
Company at the address set forth in Section 6.05.
ARTICLE VII
Definitions.
As used in this Warrant Certificate, the following terms shall
have the following meanings:
Board means the board of directors of
the Company.
Board Resolution means a copy of a
resolution certified by the Secretary or an Assistant Secretary
of the Company to have been duly adopted by the Board and to be
in full force and effect on the date of such certification, and
delivered to the Transfer Agent.
Business Day means any day other than
a Saturday or Sunday or any other day on which banks in the City
of New York are authorized or required by law or executive order
to close.
Capital Stock of any Person means any
and all shares, interests, participations or other equivalents
however designated of corporate stock or other equity
participations, including partnership interests, whether general
or limited, of such Person and any rights (other than debt
securities convertible or exchangeable into an equity interest),
warrants or options to acquire an equity interest in such Person.
The Closing Sale Price of the Company Common
Stock on any date means the closing sale price per share (or if
no closing sale price is reported, the average of the closing
bid and ask prices or, if more than one in either case, the
average of the average closing bid and the average closing ask
prices) on such date as reported on the
over-the-counter
Pink Sheets market or, if the Company Common Stock
is listed on a national securities exchange, the principal
national securities exchange on which the Company Common Stock
is traded. In the absence of such a quotation, the Closing Sale
Price of the Company Common Stock will be an amount determined
in good faith by the Board to be the fair market value of such
Company Common Stock, and such determination shall be conclusive.
Company has the meaning set forth in
the introduction to this Warrant Certificate, and its successors
and assigns.
Company Common Stock has the meaning
set forth in the introduction to this Warrant Certificate.
DOJ has the meaning set forth in
Section 5.03.
Exchange Act means the Securities
Exchange Act of 1934, as amended.
Exercise Price has the meaning set
forth in the introduction to this Warrant Certificate.
Expiration Date means the tenth
anniversary of the Issuance Date.
Expiration Time has the meaning set
forth in Section 2.01(a)(v).
A-65
FTC has the meaning set forth in
Section 5.03.
Holder means the initial Holder of
this Warrant Certificate and any permitted assignee or
transferee thereof.
HSR Act has the meaning set forth in
Section 5.03.
including means including,
without limitation.
Initial Public Offering means, in the
event of a Spin-off, the first time securities of the same class
or type as the securities being distributed in the Spin-off are
bona fide offered to the public for cash.
Investment Agreement has the meaning
set forth in the introduction to this Warrant Certificate.
Issuance Date means
[ ], 2011.
Market Value means, with respect to
any date of determination, the average Closing Sale Price of the
Company Common Stock for a five consecutive Trading Day period
preceding the earlier of (i) the day preceding the date of
determination and (ii) the day before the ex
date with respect to the issuance or distribution
requiring such computation. For purposes of this definition, the
term ex date, when used with respect to any issuance
or distribution, means the first date on which the Company
Common Stock trades, regular way, on the
over-the-counter
Pink Sheets market or, if the Company Common Stock
is listed on a national securities exchange, the principal
national securities exchange on which the Company Common Stock
is traded at that time, without the right to receive the
issuance or distribution.
Officer means the Chairman of the
Board, President, Chief Executive Officer, any Vice President,
the Chief Financial Officer, the Chief Accounting Officer, the
Treasurer, any Assistant Treasurer, the Controller, any
Assistant Controller, the Secretary or any Assistant Secretary
of the Company.
Officers Certificate means a
certificate signed by two Officers.
Opinion of Counsel means a written
opinion from legal counsel who is acceptable to the Company or
the Transfer Agent. The counsel may be an employee of or counsel
to the Company or the Transfer Agent.
Person means any natural person,
corporation, limited liability company, partnership, joint
venture, trust, business association, governmental entity or
other entity.
Purchased Shares has the meaning set
forth in Section 2.01(a)(v).
Sale has the meaning set forth in
Section 1.05(a).
Securities Act means the Securities
Act of 1933, as amended.
Spin-off means a dividend or other
distribution of shares of Capital Stock of any class or series,
or similar equity interests, of or relating to a Subsidiary or
other business unit of the Company.
Subsidiary of any Person means any
other Person (i) more than 50% of whose outstanding shares
or securities representing the right to vote for the election of
directors or other managing authority of such other Person are,
now or hereafter, owned or controlled, directly or indirectly,
by such first Person, but such other Person shall be deemed to
be a Subsidiary only so long as such ownership or control
exists, or (ii) which does not have outstanding shares or
securities with such right to vote, as may be the case in a
partnership, joint venture or unincorporated association, but
more than 50% of whose ownership interest representing the right
to make the decisions for such other Person is, now or
hereafter, owned or controlled, directly or indirectly, by such
first Person, but such other Person shall be deemed to be a
Subsidiary only so long as such ownership or control exists.
A-66
Trading Day means a day during which
trading in securities generally occurs on the
over-the-counter
Pink Sheets market or, if the Company Common Stock
is listed on a national securities exchange, the principal
national securities exchange on which the Company Common Stock
is traded.
Transaction has the meaning set forth
in Section 2.02.
Transfer Agent means Computershare
Trust Company, N.A. unless and until a successor is
selected by the Company, and then such successor.
Triggering Event means a specified
event the occurrence of which entitles the holders of rights,
options or warrants to exercise such rights, options or warrants.
Warrants has the meaning set forth in
the introduction to this Warrant Certificate.
A-67
EXPRESS-1 EXPEDITED SOLUTIONS, INC.,
Name:
Title:
A-68
ANNEX I
EXERCISE
SUBSCRIPTION FORM
(To be
executed only upon exercise of Warrant)
To: Express-1 Expedited Solutions, Inc. (the
Company)
The undersigned irrevocably
exercises
of the Warrants represented by the Warrant Certificate for the
purchase of one share (subject to adjustment in accordance with
the Warrant Certificate) of Company Common Stock, par value
$0.001 per share, for each such Warrant and herewith makes
payment of $ (such payment being
by bank wire transfer in immediately available funds), all at
the Exercise Price and on the terms and conditions specified in
the Warrant Certificate, surrenders this Warrant Certificate and
all right, title and interest therein to the Company and directs
that the shares of Company Common Stock deliverable upon the
exercise of such Warrants be registered in the name and
delivered at the address specified below.
(Signature of Owner)*
(Street Address)
(City) (State) (Zip
Code)
Date:
Securities to be issued to:
Please insert social security or identifying number:
Name:
Street Address:
City, State and Zip Code:
|
|
|
* |
|
The signature must correspond with the name as written upon the
face of the Warrant Certificate in every particular, without
alteration or any change whatsoever. |
A-69
EXHIBIT C
SUMMARY
OF PRINCIPAL REGISTRATION RIGHTS PROVISIONS
|
|
|
Parties:
|
|
Express-1 Expedited Solutions, Inc., Jacobs Private Equity, LLC
and the other Investors listed on Schedule I to the Investment
Agreement.4
|
Demand Registration Rights:
|
|
At any time on or after the Closing Date, Investors or
transferees thereof (including any pledgee holding any of the
following as collateral or temporarily upon foreclosure of the
underlying obligation) (each, a Holder)
holding Registrable Securities representing no less than a
majority of the Company Common Stock constituting Registrable
Securities or issuable upon conversion of Preferred Stock or
exercise of Warrants constituting Registrable Securities (the
Majority Holders) may request registration,
by giving written notice thereof to the Company, of the sale of
the Registrable Securities held by the Holders.
Registrable Securities means shares of
Preferred Stock, Warrants and shares of Company Common Stock
issued or issuable upon conversion of the Preferred Stock or
upon exercise of the Warrants, in each case other than any such
securities that are then freely transferable without
registration by the Holder thereof pursuant to Rule 144 under
the Securities Act without limitation as to volume, manner of
sale or other restrictions under Rule 144. The Company shall
then use reasonable best efforts to (i) file a registration
statement registering such Registrable Securities as promptly as
reasonably practicable and in any event within 30 days (if
on Form S-3) or 45 days (if on Form S-1) and (ii) have such
registration statement declared effective as promptly as
reasonably practicable thereafter (subject to customary
exceptions). The Majority Holders may request a total of three
demand registrations.
|
Piggyback Registration Rights:
|
|
If the Company registers its securities on a registration
statement that permits the inclusion of the Registrable
Securities, the Company shall give the Investor Representative
prompt written notice thereof (subject to certain exceptions to
be agreed). The Company shall then include on such registration
statement all Registrable Securities requested to be included
therein (subject to certain exceptions to be agreed).
|
Expenses of Registration and Selling:
|
|
All expenses incurred in connection with the registration or
sale of the Registrable Securities shall be borne by the
Company, with the exception of brokers discounts or
commissions on the sale of the Registrable Securities.
|
Suspension of Sales:
|
|
The Holders shall discontinue selling Registrable Securities
during scheduled black-out periods or upon request of the
Company for the purpose of avoiding certain adverse disclosures
(which requests shall not be made (i) more than three times
during any one-year period or (ii) for any period exceeding
45 days individually or 90 days in the aggregate for
any fiscal year). In all events the Company shall permit
resumption of such sales as promptly as reasonably practicable.
|
Indemnification:
|
|
The Company shall indemnify the Holders against losses related
to material misstatements and omissions. Each Holder shall
indemnify the Company against losses related to material
misstatements and omissions made in reliance on information
furnished by such Holder expressly for use in a registration
statement.
|
4 Capitalized
terms used but not defined herein shall have the respective
meanings set forth in the Investment Agreement.
A-70
|
|
|
Obligations of the Company:
|
|
The Company shall have certain other customary obligations,
including requirements to file necessary amendments and
supplements with the SEC, notify the Investor Representative of
certain events relating to registration statements, enter into
customary underwriting agreements and cause Company Common Stock
to be listed on a national securities exchange.
|
Holder Information:
|
|
The Holders shall furnish certain information (regarding
themselves, the Registrable Securities and the intended method
of disposition) to the Company to effect each registered
offering.
|
Rule 144 Reporting:
|
|
To permit the sale of Registrable Securities without
registration, the Company shall use its best efforts to maintain
compliance with the periodic filing requirements of the Exchange
Act.
|
A-71
EXHIBIT D
EXPRESS-1
EXPEDITED SOLUTIONS, INC.
2011
OMNIBUS INCENTIVE COMPENSATION PLAN
Section 1. Purpose. The
purpose of this Express-1 Expedited Solutions, Inc. 2011 Omnibus
Incentive Compensation Plan (the Plan) is to
promote the interests of the Company and its stockholders by
(a) attracting and retaining exceptional directors,
officers, employees and consultants (including prospective
directors, officers, employees and consultants) of the Company
(as defined below) and its Affiliates (as defined below) and
(b) enabling such individuals to participate in the
long-term growth and financial success of the Company. This Plan
is intended to replace the Prior Plan, which Prior Plan shall be
automatically terminated and replaced and superseded by this
Plan on the date on which this Plan is approved by the
Companys stockholders; provided, that this Plan
shall be null and void ab initio and of no further force or
effect if the Investment Agreement is terminated and the Closing
does not occur, in which case the Prior Plan shall remain in
place as if never terminated. Notwithstanding the foregoing, any
awards granted under the Prior Plan shall remain in effect
pursuant to their respective terms.
Section 2. Definitions. As
used herein, the following terms shall have the meanings set
forth below:
Affiliate means (a) any entity
that, directly or indirectly, is controlled by, controls or is
under common control with, the Company
and/or
(b) any entity in which the Company has a significant
equity interest, in either case, as determined by the Committee.
Award means any award that is
permitted under Section 6 and granted under the Plan or any
award that is permitted under Article 6 of the Prior Plan
and was granted under the Prior Plan.
Award Agreement means any written or
electronic agreement, contract or other instrument or document
evidencing any Award, which may (but need not) require execution
or acknowledgment by a Participant.
Applicable Exchange means the NYSE
Amex LLC or any other national stock exchange or quotation
system on which the Shares may be listed or quoted.
Board means the Board of Directors of
the Company.
Cash Incentive Award means an Award
(a) that is granted pursuant to Section 6(g),
(b) that is settled in cash and (c) the value of which
is set by the Committee and is not calculated by reference to
the Fair Market Value of Shares.
Change of Control shall (a) have
the meaning set forth in an Award Agreement; provided,
however, that except in the case of a transaction
described in subparagraph (b)(iii) below, any definition of
Change of Control set forth in an Award Agreement shall provide
that a Change of Control shall not occur until consummation or
effectiveness of a change in control of the Company, rather than
upon the announcement, commencement, stockholder approval or
other potential occurrence of any event or transaction that, if
completed, would result in a change in control of the Company,
or (b) if there is no definition set forth in an Award
Agreement, mean the occurrence of any of the following events:
(i) during any period of 12 consecutive calendar months,
individuals who were directors of the Company on the first day
of such period (the Incumbent Directors)
cease for any reason to constitute a majority of the Board;
provided, however, that any individual becoming a
director subsequent to the first day of such period whose
election, or nomination for election, by the Companys
stockholders was approved by a vote of at least majority of the
Incumbent Directors shall be considered as though such
individual were an Incumbent Director;
(ii) the consummation of (A) a merger, consolidation,
statutory share exchange or similar form of corporate
transaction involving the Company (each of the events referred
to in this clause (A) being hereinafter referred to as a
Reorganization) or (B) the sale or other
disposition of all or substantially all the assets of the
Company to an entity that is not an Affiliate (a
Sale), in each case, if such
A-72
Reorganization or Sale requires the approval of the
Companys stockholders under the law of the Companys
jurisdiction of organization (whether such approval is required
for such Reorganization or Sale or for the issuance of
securities of the Company in such Reorganization or Sale),
unless, immediately following such Reorganization or Sale,
(1) individuals and entities who were the beneficial
owners (as such term is defined in
Rule 13d-3
under the Exchange Act (or a successor rule thereto)) of the
securities eligible to vote for the election of the Board
(Company Voting Securities) outstanding
immediately prior to the consummation of such Reorganization or
Sale continue to beneficially own, directly or indirectly, more
than 50% of the combined voting power of the then outstanding
voting securities of the corporation or other entity resulting
from such Reorganization or Sale (including a corporation that,
as a result of such transaction, owns the Company or all or
substantially all the Companys assets either directly or
through one or more subsidiaries) (the Continuing
Company) (excluding, for such purposes, any
outstanding voting securities of the Continuing Company that
such beneficial owners hold immediately following the
consummation of the Reorganization or Sale as a result of their
ownership prior to such consummation of voting securities of any
corporation or other entity involved in or forming part of such
Reorganization or Sale other than the Company), (2) no
person (as such term is used in Section 13(d)
of the Exchange Act) (each, a Person)
(excluding (x) any employee benefit plan (or related trust)
sponsored or maintained by the Continuing Company or any
corporation controlled by the Continuing Company and
(y) any one or more Specified Stockholders) beneficially
owns, directly or indirectly, 50% or more of the combined voting
power of the then outstanding voting securities of the
Continuing Company and (3) at least 50% of the members of
the board of directors of the Continuing Company (or equivalent
body) were Incumbent Directors at the time of the execution of
the definitive agreement providing for such Reorganization or
Sale or, in the absence of such an agreement, at the time at
which approval of the Board was obtained for such Reorganization
or Sale;
(iii) the stockholders of the Company approve a plan of
complete liquidation or dissolution of the Company unless such
liquidation or dissolution is part of a transaction or series of
transactions described in paragraph (ii) above that does
not otherwise constitute a Change of Control; or
(iv) any Person, corporation or other entity or
group (as used in Section 14(d)(2) of the
Exchange Act) (other than (A) the Company, (B) any
trustee or other fiduciary holding securities under an employee
benefit plan of the Company or an Affiliate, (C) any
company owned, directly or indirectly, by the stockholders of
the Company in substantially the same proportions as their
ownership of the voting power of the Company Voting Securities
or (D) any one or more Specified Stockholders, including
any group in which a Specified Stockholder is a member) becomes
the beneficial owner, directly or indirectly, of securities of
the Company representing 50% or more of the combined voting
power of the Company Voting Securities; provided,
however, that for purposes of this subparagraph (iv), the
following acquisitions shall not constitute a Change of Control:
(w) any acquisition directly from the Company, (x) any
acquisition by any employee benefit plan (or related trust)
sponsored or maintained by the Company or an Affiliate,
(y) any acquisition by an underwriter temporarily holding
such Company Voting Securities pursuant to an offering of such
securities or any acquisition by a pledgee of Company Voting
Securities holding such securities as collateral or temporarily
holding such securities upon foreclosure of the underlying
obligation or (z) any acquisition pursuant to a
Reorganization or Sale that does not constitute a Change of
Control for purposes of subparagraph (ii) above.
Closing means the closing of the
Equity Investment (as defined in the Investment Agreement) as
contemplated by the Investment Agreement.
Code means the Internal Revenue Code
of 1986, as amended from time to time, or any successor statute
thereto, and the regulations promulgated thereunder.
Committee means the Compensation
Committee of the Board or a subcommittee thereof, or such other
committee of the Board as may be designated by the Board to
administer the Plan.
Company means Express-1 Expedited
Solutions, Inc., a corporation organized under the laws of
Delaware, together with any successor thereto.
A-73
Deferred Share Unit means a deferred
share unit Award that represents an unfunded and unsecured
promise to deliver Shares in accordance with the terms of the
applicable Award Agreement.
Exchange Act means the Securities
Exchange Act of 1934, as amended from time to time, or any
successor statute thereto, and the regulations promulgated
thereunder.
Exercise Price means (a) in the
case of each Option, the price specified in the applicable Award
Agreement as the
price-per-Share
at which Shares may be purchased pursuant to such Option or
(b) in the case of each SAR, the price specified in the
applicable Award Agreement as the reference
price-per-Share
used to calculate the amount payable to the applicable
Participant pursuant to such SAR.
Fair Market Value means, except as
otherwise provided in the applicable Award Agreement,
(a) with respect to any property other than Shares, the
fair market value of such property determined by such methods or
procedures as shall be established from time to time by the
Committee and (b) with respect to Shares as of any date,
(i) the closing per-share sales price of the Shares as
reported by the Applicable Exchange for such stock exchange for
such date or if there were no sales on such date, on the closest
preceding date on which there were sales of Shares or
(ii) in the event there shall be no public market for the
Shares on such date, the fair market value of the Shares as
determined in good faith by the Committee.
Incentive Stock Option means an option
to purchase Shares from the Company that (a) is granted
under Section 6(b) of the Plan or was granted under
Article 6 of the Prior Plan and (b) is intended to
qualify for special Federal income tax treatment pursuant to
Sections 421 and 422 of the Code, as now constituted or
subsequently amended, or pursuant to a successor provision of
the Code, and which is so designated in the applicable Award
Agreement.
Independent Director means a member of
the Board (a) who is neither an employee of the Company nor
an employee of any Affiliate, and (b) who, at the time of
acting, is a Non-Employee Director under
Rule 16b-3.
Investment Agreement means the
Investment Agreement, dated on or around June 13, 2011,
among Jacobs Private Equity LLC, certain other investors, and
the Company, as amended, modified or supplemented from time to
time.
Nonqualified Stock Option means an
option to purchase Shares from the Company that (a) is
granted under Section 6(b) of the Plan or was granted under
Article 6 of the Prior Plan and (b) is not an
Incentive Stock Option.
Option means an Incentive Stock Option
or a Nonqualified Stock Option or both, as the context requires.
Participant means any director,
officer, employee or consultant (including any prospective
director, officer, employee or consultant) of the
Company or its Affiliates who is eligible for an Award
under Section 5 and who is selected by the Committee to
receive an Award under the Plan or who receives a Substitute
Award pursuant to Section 4(c).
Performance Compensation Award means
any Award designated by the Committee as a Performance
Compensation Award pursuant to Section 6(e) of the Plan.
Performance Criteria means the
criterion or criteria that the Committee shall select for
purposes of establishing the Performance Goal(s) for a
Performance Period with respect to any Performance Compensation
Award, Performance Unit or, if applicable, Cash Incentive Award
under the Plan.
Performance Formula means, for a
Performance Period, the one or more objective formulas applied
against the relevant Performance Goal to determine, with regard
to the Performance Compensation Award, Performance Unit or, if
applicable, Cash Incentive Award of a particular Participant,
whether all, some portion but less than all, or none of such
Award has been earned for the Performance Period.
Performance Goal means, for a
Performance Period, the one or more goals established by the
Committee for the Performance Period based upon the Performance
Criteria.
A-74
Performance Period means the one or
more periods of time as the Committee may select over which the
attainment of one or more Performance Goals shall be measured
for the purpose of determining a Participants right to and
the payment of a Performance Compensation Award, Performance
Unit or, if applicable, Cash Incentive Award.
Performance Unit means an Award under
Section 6(f) of the Plan that has a value set by the
Committee (or that is determined by reference to a valuation
formula specified by the Committee or the Fair Market Value of
Shares), which value may be paid to the Participant by delivery
of such property as the Committee shall determine, including
without limitation, cash or Shares, or any combination thereof,
upon achievement of such Performance Goals during the relevant
Performance Period as the Committee shall establish at the time
of such Award or thereafter.
Prior Plan means the Express-1
Expedited Solutions, Inc. Amended and Restated 2001 Stock Option
Plan.
Restricted Share means a Share that is
granted under Section 6(d) of the Plan that is subject to
certain transfer restrictions, forfeiture provisions
and/or other
terms and conditions specified herein and in the applicable
Award Agreement.
RSU means a restricted stock unit
Award that is granted under Section 6(d) of the Plan and is
designated as such in the applicable Award Agreement and that
represents an unfunded and unsecured promise to deliver Shares,
cash, other securities, other Awards or other property in
accordance with the terms of the applicable Award Agreement.
Rule 16b-3
means
Rule 16b-3
as promulgated and interpreted by the SEC under the Exchange Act
or any successor rule or regulation thereto as in effect from
time to time.
SAR means a stock appreciation right
Award that is granted under Section 6(c) of the Plan and
that represents an unfunded and unsecured promise to deliver
Shares, cash, other securities, other Awards or other property
equal in value to the excess, if any, of the Fair Market Value
per Share over the Exercise Price per Share of the SAR, subject
to the terms of the applicable Award Agreement.
SEC means the Securities and Exchange
Commission or any successor thereto and shall include the staff
thereof.
Shares means shares of common stock of
the Company, $0.01 par value, or such other securities of
the Company (a) into which such shares shall be changed by
reason of a recapitalization, merger, consolidation,
split-up,
combination, exchange of shares or other similar transaction or
(b) as may be determined by the Committee pursuant to
Section 4(b).
Specified Stockholder means Bradley S.
Jacobs, Jacobs Private Equity LLC and its Affiliates, or any
other entity or organization controlled, directly or indirectly,
by Bradley S. Jacobs.
Subsidiary means any entity in which
the Company, directly or indirectly, possesses 50% or more of
the total combined voting power of all classes of its stock.
Substitute Awards shall have the
meaning specified in Section 4(c).
Treasury Regulations means all
proposed, temporary and final regulations promulgated under the
Code, as such regulations may be amended from time to time
(including corresponding provisions of succeeding regulations).
Section 3. Administration. (a) Composition
of the Committee. The Plan shall be
administered by the Committee, which shall be composed of one or
more directors, as determined by the Board; provided
that, to the extent necessary to comply with the rules of the
Applicable Exchange and
Rule 16b-3
and to satisfy any applicable requirements of
Section 162(m) of the Code and any other applicable laws or
rules, the Committee shall be composed of two or more directors,
all of whom shall be Independent Directors and all of whom shall
(i) qualify as outside directors under
Section 162(m) of the Code and (ii) meet the
independence requirements of the Applicable Exchange.
A-75
(b) Authority of the
Committee. Subject to the terms of the Plan
and applicable law, and in addition to the other express powers
and authorizations conferred on the Committee by the Plan, the
Committee shall have sole and plenary authority to administer
the Plan, including the authority to (i) designate
Participants, (ii) determine the type or types of Awards to
be granted to a Participant, (iii) determine the number of
Shares to be covered by, or with respect to which payments,
rights or other matters are to be calculated in connection with,
Awards, (iv) determine the terms and conditions of any
Awards, (v) determine the vesting schedules of Awards and,
if certain performance criteria must be attained in order for an
Award to vest or be settled or paid, establish such performance
criteria and certify whether, and to what extent, such
performance criteria have been attained, (vi) determine
whether, to what extent and under what circumstances Awards may
be settled or exercised in cash, Shares, other securities, other
Awards or other property, or canceled, forfeited or suspended
and the method or methods by which Awards may be settled,
exercised, canceled, forfeited or suspended,
(vii) determine whether, to what extent and under what
circumstances cash, Shares, other securities, other Awards,
other property and other amounts payable with respect to an
Award shall be deferred either automatically or at the election
of the holder thereof or of the Committee,
(viii) interpret, administer, reconcile any inconsistency
in, correct any default in
and/or
supply any omission in, the Plan and any instrument or agreement
relating to, or Award made under, the Plan, (ix) establish,
amend, suspend or waive such rules and regulations and appoint
such agents as it shall deem appropriate for the proper
administration of the Plan, (x) accelerate the vesting or
exercisability of, payment for or lapse of restrictions on,
Awards, (xi) amend an outstanding Award or grant a
replacement Award for an Award previously granted under the Plan
if, in its sole discretion, the Committee determines that
(A) the tax consequences of such Award to the Company or
the Participant differ from those consequences that were
expected to occur on the date the Award was granted or
(B) clarifications or interpretations of, or changes to,
tax law or regulations permit Awards to be granted that have
more favorable tax consequences than initially anticipated and
(xii) make any other determination and take any other
action that the Committee deems necessary or desirable for the
administration of the Plan.
(c) Committee Decisions. Unless
otherwise expressly provided in the Plan, all designations,
determinations, interpretations and other decisions under or
with respect to the Plan or any Award shall be within the sole
and plenary discretion of the Committee, may be made at any time
and shall be final, conclusive and binding upon all Persons,
including the Company, any Affiliate, any Participant, any
holder or beneficiary of any Award and any stockholder.
(d) Indemnification. No member of
the Board, the Committee or any employee of the Company (each
such person, a Covered Person) shall be
liable for any action taken or omitted to be taken or any
determination made in good faith with respect to the Plan or any
Award hereunder. Each Covered Person shall be indemnified and
held harmless by the Company from and against (i) any loss,
cost, liability or expense (including attorneys fees) that
may be imposed upon or incurred by such Covered Person in
connection with or resulting from any action, suit or proceeding
to which such Covered Person may be a party or in which such
Covered Person may be involved by reason of any action taken or
omitted to be taken under the Plan or any Award Agreement and
(ii) any and all amounts paid by such Covered Person, with
the Companys approval, in settlement thereof, or paid by
such Covered Person in satisfaction of any judgment in any such
action, suit or proceeding against such Covered Person;
provided that the Company shall have the right, at its
own expense, to assume and defend any such action, suit or
proceeding, and, once the Company gives notice of its intent to
assume the defense, the Company shall have sole control over
such defense with counsel of the Companys choice. The
foregoing right of indemnification shall not be available to a
Covered Person to the extent that a court of competent
jurisdiction in a final judgment or other final adjudication, in
either case not subject to further appeal, determines that the
acts or omissions of such Covered Person giving rise to the
indemnification claim resulted from such Covered Persons
bad faith, fraud or willful criminal act or omission or that
such right of indemnification is otherwise prohibited by law or
by the Companys Restated Certificate of Incorporation or
Amended and Restated Bylaws, in each case, as may be amended
from time to time. The foregoing right of indemnification shall
not be exclusive of any other rights of indemnification to which
Covered Persons may be entitled under the Companys
Restated Certificate of Incorporation or Amended and Restated
Bylaws, as a matter of law, or otherwise, or any other power
that the Company may have to indemnify such persons or hold them
harmless.
(e) Delegation of Authority to
Officers. The Committee may delegate, on such
terms and conditions as it determines in its sole and plenary
discretion, to one or more officers of the Company the authority
to make grants of
A-76
Awards to officers (other than any officer subject to
Section 16 of the Exchange Act), employees and consultants
of the Company and its Affiliates (including any prospective
officer (other than any such officer who is expected to be
subject to Section 16 of the Exchange Act), employee or
consultant) and all necessary and appropriate decisions and
determinations with respect thereto.
(f) Awards to Independent
Directors. Notwithstanding anything to the
contrary contained herein, the Board may, in its sole and
plenary discretion, at any time and from time to time, grant
Awards to Independent Directors or administer the Plan with
respect to such Awards. In any such case, the Board shall have
all the authority and responsibility granted to the Committee
herein.
Section 4. Shares Available
for Awards; Cash Payable Pursuant to
Awards. (a) Shares and Cash
Available. Subject to adjustment as provided in
Section 4(b), the maximum aggregate number of Shares that
may be delivered pursuant to Awards granted under the Plan
(which, for purposes of clarity, shall include Shares delivered
pursuant to Options granted under the Prior Plan prior to the
approval of the Plan by the Companys stockholders on
[ ], 2011) shall be equal to the sum of
(i) 2,000,000, (ii) any Shares remaining available for
future grants of Options under the Prior Plan as of the date the
Plan is approved by the Companys stockholders on
[ ], 2011, plus (iii) any Shares with
respect to Options granted under the Prior Plan that are
forfeited following the date that the Plan is approved by the
Companys stockholders on [ ], 2011 (such
sum, the Plan Share Limit), of which
2,000,000 Shares may be delivered pursuant to Incentive
Stock Options granted under the Plan (such amount, the
Plan ISO Limit); provided,
however, that any Shares with respect to Options that are
forfeited pursuant to clause (iii) shall only become
available to be delivered pursuant to Options granted under the
Plan. Upon exercise of a stock-settled SAR, the Plan Share Limit
shall be reduced by the actual number of Shares delivered upon
settlement of such stock-settled SAR. Awards that are settled in
cash will not reduce the Plan Share Limit. If, after the
effective date of the Plan, any Award is forfeited (or otherwise
expires, terminates or is canceled without the delivery of all
Shares subject thereto) or settled other than wholly by delivery
of Shares (including cash settlement), then, in any such case,
any number of Shares subject to such Award that were not issued
with respect to such Award shall not be treated as issued for
purposes of reducing the Plan Share Limit. If Shares issued upon
exercise, vesting or settlement of an Award are, or Shares owned
by a Participant are, surrendered or tendered to the Company in
payment of the Exercise Price of an Award or any taxes required
to be withheld in respect of an Award, in each case, in
accordance with the terms and conditions of the Plan and any
applicable Award Agreement, such surrendered or tendered Shares
shall again become available to be delivered pursuant to Awards
under the Plan; provided, however, that in no
event shall such Shares increase the Plan ISO Limit. With
respect to Awards that are intended to qualify as
qualified performance-based compensation under
Section 162(m) of the Code, subject to adjustment as
provided in Section 4(b), (1) in the case of Awards
that are settled in Shares, the maximum aggregate number of
Shares with respect to which Awards may be granted to any
Participant in any fiscal year of the Company under the Plan
shall be 1,000,000 (such amount, the Annual Individual
Plan Share Limit), and (2) in the case of Awards
that are settled in cash based on the Fair Market Value of a
Share, the maximum aggregate amount of cash that may be paid
pursuant to Awards granted to any Participant in any fiscal year
of the Company under the Plan shall be equal to the per-Share
Fair Market Value as of the relevant vesting, payment or
settlement date multiplied by the Annual Individual Plan Share
Limit. In the case of all Awards other than those described in
the preceding sentence, the maximum aggregate amount of cash and
other property (valued at its Fair Market Value) other than
Shares that may be paid or delivered pursuant to Awards under
the Plan to any Participant in any fiscal year of the Company
shall be equal to $3,000,000.
(b) Adjustments for Changes in Capitalization and
Similar Events. (i) In the event of any
extraordinary dividend or other extraordinary distribution
(whether in the form of cash, Shares, other securities or other
property), recapitalization, rights offering, stock split,
reverse stock split,
split-up or
spin-off, the Committee shall equitably adjust any or all of
(A) the number of Shares or other securities of the Company
(or number and kind of other securities or property) with
respect to which Awards may be granted, including (1) the
Plan Share Limit, (2) the Plan ISO Limit and (3) the
Annual Individual Plan Share Limit, and (B) the terms of
any outstanding Award, including (1) the number of Shares
or other securities of the Company (or number and kind of other
securities or property) subject to outstanding Awards or to
which outstanding Awards relate and (2) the Exercise Price,
if applicable, with respect to any Award; provided,
however, that the Committee shall determine the method
and manner in which to effect such equitable adjustment.
A-77
(ii) In the event that the Committee determines that any
reorganization, merger, consolidation, combination, repurchase
or exchange of Shares or other securities of the Company,
issuance of warrants or other rights to purchase Shares or other
securities of the Company, or other similar corporate
transaction or event affects the Shares (including any Change of
Control) such that an adjustment is determined by the Committee
in its discretion to be appropriate or desirable, then the
Committee may (A) in such manner as it may deem appropriate
or desirable, equitably adjust any or all of (1) the number
of Shares or other securities of the Company (or number and kind
of other securities or property) with respect to which Awards
may be granted, including (X) the Plan Share Limit,
(Y) the Plan ISO Limit and (Z) the Annual Individual
Plan Share Limit, and (2) the terms of any outstanding
Award, including (X) the number of Shares or other
securities of the Company (or number and kind of other
securities or property) subject to outstanding Awards or to
which outstanding Awards relate and (Y) the Exercise Price,
if applicable, with respect to any Award, (B) if deemed
appropriate or desirable by the Committee, make provision for a
cash payment to the holder of an outstanding Award in
consideration for the cancelation of such Award, including, in
the case of an outstanding Option or SAR, a cash payment to the
holder of such Option or SAR in consideration for the
cancelation of such Option or SAR in an amount equal to the
excess, if any, of the Fair Market Value (as of a date specified
by the Committee) of the Shares subject to such Option or SAR
over the aggregate Exercise Price of such Option or SAR and
(C) if deemed appropriate or desirable by the Committee,
cancel and terminate any Option or SAR having a per-Share
Exercise Price equal to, or in excess of, the Fair Market Value
of a Share subject to such Option or SAR without any payment or
consideration therefor.
(c) Substitute Awards. Awards may,
in the discretion of the Committee, be granted under the Plan in
assumption of, or in substitution for, outstanding awards
previously granted by the Company or any of its Affiliates or a
company acquired by the Company or any of its Affiliates or with
which the Company or any of its Affiliates combines
(Substitute Awards); provided,
however, that in no event may any Substitute Award be
granted in a manner that would violate the prohibitions on
repricing of Options and SARs, as set forth in clauses (i),
(ii) and (iii) of Section 7(b). The number of
Shares underlying any Substitute Awards shall be counted against
the Plan Share Limit; provided, however, that
Substitute Awards issued in connection with the assumption of,
or in substitution for, outstanding awards previously granted by
an entity that is acquired by the Company or any of its
Affiliates or with which the Company or any of its Affiliates
combines shall not be counted against the Plan Share Limit;
provided further, however, that Substitute
Awards issued in connection with the assumption of, or in
substitution for, outstanding stock options intended to qualify
for special tax treatment under Sections 421 and 422 of the
Code that were previously granted by an entity that is acquired
by the Company or any of its Affiliates or with which the
Company or any of its Affiliates combines shall be counted
against the maximum aggregate number of Shares available for
Incentive Stock Options under the Plan.
(d) Sources of Shares Deliverable Under
Awards. Any Shares delivered pursuant to an
Award may consist, in whole or in part, of authorized and
unissued Shares or of treasury Shares.
Section 5. Eligibility. Any
director, officer, employee or consultant (including any
prospective director, officer, employee or consultant) of the
Company or any of its Affiliates shall be eligible to be
designated a Participant.
Section 6. Awards. (a) Types
of Awards. Awards may be made under the Plan
in the form of (i) Options, (ii) SARs,
(iii) Restricted Shares, (iv) RSUs, (v) Deferred
Share Units, (vi) Performance Compensation Awards,
(vii) Performance Units (viii) Cash Incentive Awards
and (ix) other equity-based or equity-related Awards that
the Committee determines are consistent with the purpose of the
Plan and the interests of the Company. Awards may be granted in
tandem with other Awards. No Incentive Stock Option (other than
an Incentive Stock Option that may be assumed or issued by the
Company in connection with a transaction to which
Section 424(a) of the Code applies) may be granted to a
person who is ineligible to receive an Incentive Stock Option
under the Code.
(b) Options. (i) Grant. Subject
to the provisions of the Plan, the Committee shall have sole and
plenary authority to determine (A) the Participants to whom
Options shall be granted, (B) subject to Section 4(a),
the number of Shares subject to each Option to be granted to
each Participant, (C) whether each Option shall be an
Incentive Stock Option or a Nonqualified Stock Option and
(D) the terms and conditions of each Option, including the
vesting criteria, term, methods of exercise and methods and form
of settlement. In the case of Incentive Stock Options, the terms
and conditions of such grants shall be subject to and comply
with such rules as may be prescribed
A-78
by Section 422 of the Code and any regulations related
thereto, as may be amended from time to time. Each Option
granted under the Plan shall be a Nonqualified Stock Option
unless the applicable Award Agreement expressly states that the
Option is intended to be an Incentive Stock Option. If an Option
is intended to be an Incentive Stock Option, and if, for any
reason, such Option (or any portion thereof) shall not qualify
as an Incentive Stock Option, then, to the extent of such
nonqualification, such Option (or portion thereof) shall be
regarded as a Nonqualified Stock Option appropriately granted
under the Plan; provided that such Option (or portion
thereof) otherwise complies with the Plans requirements
relating to Nonqualified Stock Options.
(ii) Exercise Price. The Exercise
Price of each Share covered by each Option shall be not less
than 100% of the Fair Market Value of such Share (determined as
of the date the Option is granted); provided,
however, in the case of each Incentive Stock Option
granted to an employee who, at the time of the grant of such
Option, owns stock representing more than 10% of the voting
power of all classes of stock of the Company or any Affiliate,
the per-Share Exercise Price shall be no less than 110% of the
Fair Market Value per Share on the date of the grant. Each
Option is, unless otherwise specified by the Committee, intended
to qualify as qualified performance-based
compensation under Section 162(m) of the Code.
(iii) Vesting and Exercise. Each
Option shall be vested and exercisable at such times, in such
manner and subject to such terms and conditions as the Committee
may, in its sole and plenary discretion, specify in the
applicable Award Agreement or thereafter. Except as otherwise
specified by the Committee in the applicable Award Agreement,
each Option may only be exercised to the extent that it has
already vested at the time of exercise. Each Option shall be
deemed to be exercised when written or electronic notice of such
exercise has been given to the Company in accordance with the
terms of the Award by the person entitled to exercise the Award
and full payment pursuant to Section 6(b)(iv) for the
Shares with respect to which the Award is exercised has been
received by the Company. Exercise of each Option in any manner
shall result in a decrease in the number of Shares that
thereafter may be available for sale under the Option and,
except as expressly set forth in Sections 4(a) and 4(c), in
the number of Shares that may be available for purposes of the
Plan, by the number of Shares as to which the Option is
exercised. The Committee may impose such conditions with respect
to the exercise of each Option, including any conditions
relating to the application of Federal or state securities laws,
as it may deem necessary or advisable.
(iv) Payment. (A) No Shares
shall be delivered pursuant to any exercise of an Option until
payment in full of the aggregate Exercise Price therefor is
received by the Company, and the Participant has paid to the
Company (or the Company has withheld in accordance with
Section 9(d)) an amount equal to any Federal, state, local
and foreign income and employment taxes required to be withheld.
Such payments may be made in cash (or its equivalent) or, in the
Committees sole and plenary discretion, (1) by
exchanging Shares owned by the Participant (which are not the
subject of any pledge or other security interest), (2) if
there shall be a public market for the Shares at such time,
subject to such rules as may be established by the Committee,
through delivery of irrevocable instructions to a broker to sell
the Shares otherwise deliverable upon the exercise of the Option
and to deliver cash promptly to the Company, (3) by having
the Company withhold Shares from the Shares otherwise issuable
pursuant to the exercise of the Option or (4) through any
other method (or combination of methods) as approved by the
Committee; provided that the combined value of all cash
and cash equivalents and the Fair Market Value of any such
Shares so tendered to the Company, together with any Shares
withheld by the Company in accordance with this
Section 6(b)(iv) or Section 9(d), as of the date of
such tender, is at least equal to such aggregate Exercise Price
and the amount of any Federal, state, local or foreign income or
employment taxes required to be withheld, if applicable.
(B) Wherever in the Plan or any Award Agreement a
Participant is permitted to pay the Exercise Price of an Option
or taxes relating to the exercise of an Option by delivering
Shares, the Participant may, subject to procedures satisfactory
to the Committee, satisfy such delivery requirement by
presenting proof of beneficial ownership of such Shares, in
which case the Company shall treat the Option as exercised
without further payment and shall withhold such number of Shares
from the Shares acquired by the exercise of the Option.
(v) Expiration. Except as
otherwise set forth in the applicable Award Agreement, each
Option shall expire immediately, without any payment, upon the
earlier of (A) the tenth anniversary of the date the Option
is granted and (B) three months after the date the
Participant who is holding the Option ceases to be a director,
officer, employee or consultant of the Company or one of its
Affiliates. In no event may an Option be exercisable after the
tenth anniversary of the date the Option is granted.
A-79
(c) SARs. (i) Grant.
Subject to the provisions of the Plan, the Committee shall have
sole and plenary authority to determine (A) the
Participants to whom SARs shall be granted, (B) subject to
Section 4(a), the number of SARs to be granted to each
Participant, (C) the Exercise Price thereof and
(D) the conditions and limitations applicable to the
exercise thereof.
(ii) Exercise Price. The Exercise
Price of each Share covered by a SAR shall be not less than 100%
of the Fair Market Value of such Share (determined as of the
date the SAR is granted). Each SAR is, unless otherwise
specified by the Committee, intended to qualify as
qualified performance-based compensation under
Section 162(m) of the Code.
(iii) Vesting and Exercise. Each
SAR shall entitle the Participant to receive an amount upon
exercise equal to the excess, if any, of the Fair Market Value
of a Share on the date of exercise of the SAR over the Exercise
Price thereof. The Committee shall determine, in its sole and
plenary discretion, whether a SAR shall be settled in cash,
Shares, other securities, other Awards, other property or a
combination of any of the foregoing. Each SAR shall be vested
and exercisable at such times, in such manner and subject to
such terms and conditions as the Committee may, in its
discretion, specify in the applicable Award Agreement or
thereafter.
(iv) Other Terms and
Conditions. Subject to the terms of the Plan
and any applicable Award Agreement, the Committee shall
determine, at or after the grant of a SAR, the vesting criteria,
term, methods of exercise, methods and form of settlement and
any other terms and conditions of any SAR; provided,
however, that in no event may any SAR be exercisable
after the tenth anniversary of the date the SAR is granted. Any
determination by the Committee that is made pursuant to this
Section 6(c)(iv) may be changed by the Committee from time
to time and may govern the exercise of SARs granted or exercised
thereafter.
(v) Substitution SARs. The
Committee shall have the ability to substitute, without the
consent of the affected Participant or any holder or beneficiary
of SARs, SARs settled in Shares (or SARs settled in Shares or
cash in the Committees discretion) (Substitution
SARs) for outstanding Nonqualified Stock Options
(Substituted Options); provided that
(A) the substitution shall not otherwise result in a
modification of the terms of any Substituted Option,
(B) the number of Shares underlying the Substitution SARs
shall be the same as the number of Shares underlying the
Substituted Options and (C) the Exercise Price of the
Substitution SARs shall be equal to the Exercise Price of the
Substituted Options. If, in the opinion of the Companys
auditors, this provision creates adverse accounting consequences
for the Company, it shall be considered null and void.
(vi) Expiration. Except as
otherwise set forth in the applicable Award Agreement, each SAR
shall expire immediately, without any payment, upon the earlier
of (A) the tenth anniversary of the date the SAR is granted
and (B) three months after the date the Participant who is
holding the SAR ceases to be a director, officer, employee or
consultant of the Company or one of its Affiliates. In no event
may a SAR be exercisable after the tenth anniversary of the date
the SAR is granted.
(d) Restricted Shares and
RSUs. (i) Grant. Subject
to the provisions of the Plan, the Committee shall have sole and
plenary authority to determine (A) the Participants to whom
Restricted Shares and RSUs shall be granted, (B) subject to
Section 4(a), the number of Restricted Shares and RSUs to
be granted to each Participant, (C) the duration of the
period during which, and the conditions, if any, under which,
the Restricted Shares and RSUs may vest or may be forfeited to
the Company and (D) the terms and conditions of each such
Award, including the vesting criteria, term, methods of exercise
and methods and form of settlement.
(ii) Transfer
Restrictions. Restricted Shares and RSUs may
not be sold, assigned, transferred, pledged or otherwise
encumbered except as provided in the Plan or as may be provided
in the applicable Award Agreement; provided,
however, that the Committee may in its discretion,
determine that Restricted Shares and RSUs may be transferred by
the Participant for no consideration. Each Restricted Share may
be evidenced in such manner as the Committee shall determine. If
certificates representing Restricted Shares are registered in
the name of the applicable Participant, such certificates must
bear an appropriate legend referring to the terms, conditions
and restrictions applicable to such Restricted Shares, and the
Company may, at its discretion, retain physical possession of
such certificates until such time as all applicable restrictions
lapse.
(iii) Payment/Lapse of
Restrictions. Each RSU shall be granted with
respect to a specified number of Shares (or a number of Shares
determined pursuant to a specified formula) or shall have a
value equal to the Fair Market
A-80
Value of a specified number of Shares (or a number of Shares
determined pursuant to a specified formula). RSUs shall be paid
in cash, Shares, other securities, other Awards or other
property, as determined in the sole and plenary discretion of
the Committee, upon the lapse of restrictions applicable
thereto, or otherwise in accordance with the applicable Award
Agreement. If a Restricted Share or an RSU is intended to
qualify as qualified performance-based compensation
under Section 162(m) of the Code, unless the grant of such
Restricted Share or RSU is contingent on satisfaction of the
requirements for the payment of qualified
performance-based compensation under Section 162(m)
of the Code (whether pursuant to Section 6(e) of this Plan
or any other plan), all requirements set forth in
Section 6(e) must be satisfied in order for the
restrictions applicable thereto to lapse.
(e) Performance Compensation
Awards. (i) General. The
Committee shall have the authority, at the time of grant of any
Award, to designate such Award (other than an Option or SAR) as
a Performance Compensation Award in order for such Award to
qualify as qualified performance-based compensation
under Section 162(m) of the Code. Options and SARs granted
under the Plan shall not be included among Awards that are
designated as Performance Compensation Awards under this
Section 6(e).
(ii) Eligibility. The Committee
shall, in its sole discretion, designate within the first
90 days of a Performance Period (or, if shorter, within the
maximum period allowed under Section 162(m) of the Code)
which Participants shall be eligible to receive Performance
Compensation Awards in respect of such Performance Period.
However, designation of a Participant as eligible to receive an
Award hereunder for a Performance Period shall not in any manner
entitle such Participant to receive payment in respect of any
Performance Compensation Award for such Performance Period. The
determination as to whether or not such Participant becomes
entitled to payment in respect of any Performance Compensation
Award shall be decided solely in accordance with the provisions
of this Section 6(e). Moreover, designation of a
Participant as eligible to receive an Award hereunder for a
particular Performance Period shall not require designation of
such Participant as eligible to receive an Award hereunder in
any subsequent Performance Period and designation of one person
as a Participant eligible to receive an Award hereunder shall
not require designation of any other person as a Participant
eligible to receive an Award hereunder in such period or in any
other period.
(iii) Discretion of the Committee with Respect to
Performance Compensation Awards. With regard
to a particular Performance Period, the Committee shall have
discretion to select (A) the length of such Performance
Period, (B) the type(s) of Performance Compensation Awards
to be issued, (C) the Performance Criteria that shall be
used to establish the Performance Goal(s), (D) the kind(s)
and/or
level(s) of the Performance Goal(s) that is (are) to apply to
the Company or any of its Subsidiaries, Affiliates, divisions or
operational units, or any combination of the foregoing, and
(E) the Performance Formula; provided that any such
Performance Formula shall be objective and non-discretionary.
Within the first 90 days of a Performance Period (or, if
shorter, within the maximum period allowed under
Section 162(m) of the Code), the Committee shall, with
regard to the Performance Compensation Awards to be issued for
such Performance Period, exercise its discretion with respect to
each of the matters enumerated in the immediately preceding
sentence and record the same in writing.
(iv) Performance
Criteria. Notwithstanding the foregoing, the
Performance Criteria that shall be used to establish the
Performance Goal(s) with respect to Performance Compensation
Awards shall be based on the attainment of specific levels of
performance of the Company or any of its Subsidiaries,
Affiliates, divisions or operational units, or any combination
of the foregoing, and shall be limited to the following:
(A) share price, (B) net income or earnings before or
after taxes (including earnings before interest, taxes,
depreciation
and/or
amortization), (C) operating income, (D) earnings per
share (including specified types or categories thereof),
(E) cash flow (including specified types or categories
thereof), (F) cash flow return on capital,
(G) revenues (including specified types or categories
thereof), (H) return measures (including specified types or
categories thereof), (I) return on shareholders
equity, (J) return on investment or capital, (K) gross
or net profitability/profit margins, (L) objective measures
of productivity or operating efficiency, (M) costs
(including specified types or categories thereof),
(N) budgeted expenses (operating and capital),
(O) market share (in the aggregate or by segment),
(P) level or amount of acquisitions, (Q) economic
value-added, (R) enterprise value, (S) book value,
(T) working capital, (U) safety and accident rates and
(V) days sales outstanding. Such Performance Criteria may
be applied on an absolute basis, be relative to one or more peer
companies of the Company or indices or any combination thereof
or, if applicable, be computed on an accrual or cash accounting
basis. To the extent required under Section 162(m) of the
Code, the Committee shall, within the first 90 days of the
applicable Performance Period (or, if shorter, within
A-81
the maximum period allowed under Section 162(m) of the
Code), define in an objective manner the method of calculating
the Performance Criteria it selects to use for such Performance
Period.
(v) Modification of Performance
Goals. The Committee is authorized at any
time during the first 90 days of a Performance Period (or,
if shorter, within the maximum period allowed under
Section 162(m) of the Code), or any time thereafter (but
only to the extent the exercise of such authority after such
90-day
period (or such shorter period, if applicable) would not cause
the Performance Compensation Awards granted to any Participant
for the Performance Period to fail to qualify as qualified
performance-based compensation under Section 162(m)
of the Code), in its sole and plenary discretion, to adjust or
modify the calculation of a Performance Goal for such
Performance Period to the extent permitted under
Section 162(m) of the Code (A) in the event of, or in
anticipation of, any unusual or extraordinary corporate item,
transaction, event or development affecting the Company, or any
of its Affiliates, Subsidiaries, divisions or operating units
(to the extent applicable to such Performance Goal) or
(B) in recognition of, or in anticipation of, any other
unusual or nonrecurring events affecting the Company or any of
its Affiliates, Subsidiaries, divisions or operating units (to
the extent applicable to such Performance Goal), or the
financial statements of the Company or any of its Affiliates,
Subsidiaries, divisions or operating units (to the extent
applicable to such Performance Goal), or of changes in
applicable rules, rulings, regulations or other requirements of
any governmental body or securities exchange, accounting
principles, law or business conditions.
(vi) Payment of Performance Compensation
Awards. (A) Condition to Receipt
of Payment. A Participant must be employed by
the Company or one of its Subsidiaries on the last day of a
Performance Period to be eligible for payment in respect of a
Performance Compensation Award for such Performance Period.
Notwithstanding the foregoing and to the extent permitted by
Section 162(m) of the Code, in the discretion of the
Committee, Performance Compensation Awards may be paid to
Participants who have retired or whose employment has terminated
prior to the last day of the Performance Period for which a
Performance Compensation Award is made, or to the designee or
estate of a Participant who died prior to the last day of a
Performance Period.
(B) Limitation. Except as
otherwise permitted by Section 162(m) of the Code, a
Participant shall be eligible to receive payments in respect of
a Performance Compensation Award only to the extent that
(1) the Performance Goal(s) for the relevant Performance
Period are achieved and certified by the Committee in accordance
with Section 6(e)(vi)(C) and (2) the Performance
Formula as applied against such Performance Goal(s) determines
that all or some portion of such Participants Performance
Compensation Award has been earned for such Performance Period.
(C) Certification. Following the
completion of a Performance Period, the Committee shall certify
in writing whether, and to what extent, the Performance Goals
for the Performance Period have been achieved and, if so, to
calculate and certify in writing that amount of the Performance
Compensation Awards earned for the period based upon the
objective Performance Formula. The Committee shall then
determine the actual amount of each Participants
Performance Compensation Award for the Performance Period and,
in so doing, may apply negative discretion as authorized by
Section 6(e)(vi)(D).
(D) Negative Discretion. In
determining the actual amount of an individual Performance
Compensation Award for a Performance Period, the Committee may,
in its sole and plenary discretion, reduce or eliminate the
amount of the Award earned in the Performance Period, even if
applicable Performance Goals have been attained and without
regard to any employment agreement between the Company and a
Participant.
(E) Discretion. Except as
otherwise permitted by Section 162(m) of the Code, in no
event shall any discretionary authority granted to the Committee
by the Plan be used to (1) grant or provide payment in
respect of Performance Compensation Awards for a Performance
Period if the Performance Goals for such Performance Period have
not been attained, (2) increase a Performance Compensation
Award for any Participant at any time after the first
90 days of the Performance Period (or, if shorter, the
maximum period allowed under Section 162(m) of the Code) or
(3) increase the amount of a Performance Compensation Award
above the maximum amount payable under Section 4(a) of the
Plan.
(F) Form of Payment. In the case
of any Performance Compensation Award other than a Restricted
Share, RSU or other equity-based Award that is subject to
performance-based vesting conditions, such Performance
Compensation Award shall be payable, in the discretion of the
Committee, in cash or in Restricted Shares, RSUs or
A-82
fully vested Shares of equivalent value and shall be paid on
such terms as determined by the Committee in its discretion. Any
Restricted Shares and RSUs shall be subject to the terms of this
Plan (or any successor equity-compensation plan) and any
applicable Award Agreement. The number of Restricted Shares,
RSUs or Shares that is equivalent in value to a dollar amount
shall be determined in accordance with a methodology specified
by the Committee within the first 90 days of the relevant
Performance Period (or, if shorter, within the maximum period
allowed under Section 162(m) of the Code).
(f) Performance
Units. (i) Grant. Subject to the
provisions of the Plan, the Committee shall have sole and
plenary authority to determine the Participants to whom
Performance Units shall be granted.
(ii) Value of Performance
Units. Each Performance Unit shall have an
initial value that is established by the Committee at the time
of grant. The Committee shall set Performance Goals in its
discretion which, depending on the extent to which they are met
during a Performance Period, will determine in accordance with
Section 4(a) the number
and/or value
of Performance Units that will be paid out to the Participant.
(iii) Earning of Performance
Units. Subject to the provisions of the Plan,
after the applicable Performance Period has ended, the holder of
Performance Units shall be entitled to receive a payout of the
number and value of Performance Units earned by the Participant
over the Performance Period, to be determined by the Committee,
in its sole and plenary discretion, as a function of the extent
to which the corresponding Performance Goals have been achieved.
(iv) Form and Timing of Payment of Performance
Units. Subject to the provisions of the Plan,
the Committee, in its sole and plenary discretion, may pay
earned Performance Units in the form of cash or in Shares (or in
a combination thereof) that have an aggregate Fair Market Value
equal to the value of the earned Performance Units at the close
of the applicable Performance Period. Such Shares may be granted
subject to any restrictions in the applicable Award Agreement
deemed appropriate by the Committee. The determination of the
Committee with respect to the form and timing of payout of such
Awards shall be set forth in the applicable Award Agreement. If
a Performance Unit is intended to qualify as qualified
performance-based compensation under Section 162(m)
of the Code, all requirements set forth in Section 6(e)
must be satisfied in order for a Participant to be entitled to
payment.
(g) Cash Incentive Awards. (i)
Grant. Subject to the provisions of the Plan, the
Committee, in its sole and plenary discretion, shall have the
authority to determine (A) the Participants to whom Cash
Incentive Awards shall be granted, (B) subject to
Section 4(a), the number of Cash Incentive Awards to be
granted to each Participant, (C) the duration of the period
during which, and the conditions, if any, under which, the Cash
Incentive Awards may vest or may be forfeited to the Company and
(D) the other terms and conditions of the Cash Incentive
Awards. Each Cash Incentive Award shall have an initial value
that is established by the Committee at the time of grant. The
Committee shall set performance goals or other payment
conditions in its discretion, which, depending on the extent to
which they are met during a specified performance period, shall
determine the number
and/or value
of Cash Incentive Awards that shall be paid to the Participant.
(ii) Earning of Cash Incentive
Awards. Subject to the provisions of the
Plan, after the applicable vesting period has ended, the holder
of Cash Incentive Awards shall be entitled to receive a payout
of the number and value of Cash Incentive Awards earned by the
Participant over the specified performance period, to be
determined by the Committee, in its sole and plenary discretion,
as a function of the extent to which the corresponding
performance goals or other conditions to payment have been
achieved.
(iii) Payment. If a Cash Incentive
Award is intended to qualify as qualified
performance-based compensation under Section 162(m)
of the Code, all requirements set forth in Section 6(e)
must be satisfied in order for a Participant to be entitled to
payment.
(h) Other Stock-Based
Awards. Subject to the provisions of the
Plan, the Committee shall have the sole and plenary authority to
grant to Participants other equity-based or equity-related
Awards (including, but not limited to, Deferred Share Units and
fully vested Shares) (whether payable in cash, equity or
otherwise) in such amounts and
A-83
subject to such terms and conditions as the Committee shall
determine; provided that any such Awards must comply, to
the extent deemed desirable by the Committee, with
Rule 16b-3
and applicable law.
(i) Dividends and Dividend
Equivalents. In the sole and plenary
discretion of the Committee, an Award, other than an Option or
SAR or a Cash Incentive Award, may provide the Participant with
dividends or dividend equivalents, payable in cash, Shares,
other securities, other Awards or other property, on a current
or deferred basis, on such terms and conditions as may be
determined by the Committee in its sole and plenary discretion,
including, (i) payment directly to the Participant,
(ii) withholding of such amounts by the Company subject to
vesting of the Award or (iii) reinvestment in additional
Shares, Restricted Shares or other Awards.
Section 7. Amendment
and Termination. (a) Amendments to
the Plan. Subject to any applicable law or
government regulation, to any requirement that must be satisfied
if the Plan is intended to be a stockholder-approved plan for
purposes of Section 162(m) of the Code and to the rules of
the Applicable Exchange, the Plan may be amended, modified or
terminated by the Board without the approval of the stockholders
of the Company, except that stockholder approval shall be
required for any amendment that would (i) increase the Plan
Share Limit or the Plan ISO Limit, (ii) change the class of
employees or other individuals eligible to participate in the
Plan or (iii) result in the amendment, cancelation or
action described in clause (i), (ii) or (iii) of the
second sentence of Section 7(b) being permitted without
approval by the Companys stockholders; provided,
however, that any adjustment under Section 4(b)
shall not constitute an increase for purposes of
Section 7(a)(i). No amendment, modification or termination
of the Plan may, without the consent of the Participant to whom
any Award shall theretofore have been granted, materially and
adversely affect the rights of such Participant (or his or her
transferee) under such Award, unless otherwise provided by the
Committee in the applicable Award Agreement.
(b) Amendments to Awards. The
Committee may waive any conditions or rights under, amend any
terms of, or alter, suspend, discontinue, cancel or terminate
any Award theretofore granted, prospectively or retroactively;
provided, however, that, except as set forth in
the Plan, unless otherwise provided by the Committee in the
applicable Award Agreement, any such waiver, amendment,
alteration, suspension, discontinuance, cancelation or
termination that would materially and adversely impair the
rights of any Participant or any holder or beneficiary of any
Award theretofore granted shall not to that extent be effective
without the consent of the applicable Participant, holder or
beneficiary. Notwithstanding the preceding sentence, in no event
may any Option or SAR (i) be amended to decrease the
Exercise Price thereof, (ii) be cancelled at a time when
its Exercise Price exceeds the Fair Market Value of the
underlying Shares in exchange for another Option or SAR or any
Restricted Share, RSU, other equity-based Award, award under any
other equity-compensation plan or any cash payment or
(iii) be subject to any action that would be treated, for
accounting purposes, as a repricing of such Option
or SAR, unless such amendment, cancellation or action is
approved by the Companys stockholders. For the avoidance
of doubt, an adjustment to the Exercise Price of an Option or
SAR that is made in accordance with Section 4(b) or
Section 8 shall not be considered a reduction in Exercise
Price or repricing of such Option or SAR.
(c) Adjustment of Awards Upon the Occurrence of
Certain Unusual or Nonrecurring
Events. Subject to Section 6(e)(v) and
the final sentence of Section 7(b), the Committee is hereby
authorized to make adjustments in the terms and conditions of,
and the criteria included in, Awards in recognition of unusual
or nonrecurring events (including, without limitation, the
events described in Section 4(b) or the occurrence of a
Change of Control) affecting the Company, any Affiliate, or the
financial statements of the Company or any Affiliate, or of
changes in applicable rules, rulings, regulations or other
requirements of any governmental body or securities exchange,
accounting principles or law (i) whenever the Committee, in
its sole and plenary discretion, determines that such
adjustments are appropriate or desirable, including, without
limitation, providing for a substitution or assumption of
Awards, accelerating the exercisability of, lapse of
restrictions on, or termination of, Awards or providing for a
period of time for exercise prior to the occurrence of such
event, (ii) if deemed appropriate or desirable by the
Committee, in its sole and plenary discretion, by providing for
a cash payment to the holder of an Award in consideration for
the cancelation of such Award, including, in the case of an
outstanding Option or SAR, a cash payment to the holder of such
Option or SAR in consideration for the cancelation of such
Option or SAR in an amount equal to the excess, if any, of the
Fair Market Value (as of a date specified by the Committee) of
the Shares subject to such Option or SAR over the aggregate
Exercise Price of such Option or SAR and (iii) if deemed
appropriate or desirable by the Committee, in its sole and
plenary discretion, by canceling and terminating any
A-84
Option or SAR having a per-Share Exercise Price equal to, or in
excess of, the Fair Market Value of a Share subject to such
Option or SAR without any payment or consideration therefor.
Section 8. Change
of Control. Unless otherwise provided in the
applicable Award Agreement, in the event of a Change of Control
after the date on which the Closing occurs, unless provision is
made in connection with the Change of Control for
(a) assumption of Awards previously granted or
(b) substitution for such Awards of new awards covering
stock of a successor corporation or its parent
corporation (as defined in Section 424(e) of the
Code) or subsidiary corporation (as defined in
Section 424(f) of the Code) with appropriate adjustments as
to the number and kinds of shares and the Exercise Prices, if
applicable, (i) any outstanding Options or SARs then held
by Participants that are unexercisable or otherwise unvested
shall automatically be deemed exercisable or otherwise vested,
as the case may be, as of immediately prior to such Change of
Control, (ii) all Performance Units, Cash Incentive Awards
and Awards designated as Performance Compensation Awards shall
be paid out as if the date of the Change of Control were the
last day of the applicable Performance Period and
target performance levels had been attained and
(iii) all other outstanding Awards (i.e., other than
Options, SARs, Performance Units, Cash Incentive Awards and
Awards designated as Performance Compensation Awards) then held
by Participants that are unexercisable, unvested or still
subject to restrictions or forfeiture, shall automatically be
deemed exercisable and vested and all restrictions and
forfeiture provisions related thereto shall lapse as of
immediately prior to such Change of Control.
Section 9. General
Provisions. (a) Nontransferability. Except
as otherwise specified in the applicable Award Agreement, during
the Participants lifetime each Award (and any rights and
obligations thereunder) shall be exercisable only by the
Participant, or, if permissible under applicable law, by the
Participants legal guardian or representative, and no
Award (or any rights and obligations thereunder) may be
assigned, alienated, pledged, attached, sold or otherwise
transferred or encumbered by a Participant otherwise than by
will or by the laws of descent and distribution, and any such
purported assignment, alienation, pledge, attachment, sale,
transfer or encumbrance shall be void and unenforceable against
the Company or any Affiliate; provided that (i) the
designation of a beneficiary shall not constitute an assignment,
alienation, pledge, attachment, sale, transfer or encumbrance
and (ii) the Board or the Committee may permit further
transferability, on a general or specific basis, and may impose
conditions and limitations on any permitted transferability;
provided, however, that Incentive Stock Options
shall not be transferable in any way that would violate
Section 1.422-2(a)(2)
of the Treasury Regulations and in no event may any Award (or
any rights and obligations thereunder) be transferred in any way
in exchange for value. All terms and conditions of the Plan and
all Award Agreements shall be binding upon any permitted
successors and assigns.
(b) No Rights to Awards. No
Participant or other Person shall have any claim to be granted
any Award, and there is no obligation for uniformity of
treatment of Participants or holders or beneficiaries of Awards.
The terms and conditions of Awards and the Committees
determinations and interpretations with respect thereto need not
be the same with respect to each Participant and may be made
selectively among Participants, whether or not such Participants
are similarly situated.
(c) Share Certificates. All
certificates for Shares or other securities of the Company or
any Affiliate delivered under the Plan pursuant to any Award or
the exercise thereof shall be subject to such stop transfer
orders and other restrictions as the Committee may deem
advisable under the Plan, the applicable Award Agreement or the
rules, regulations and other requirements of the SEC, the
Applicable Exchange and any applicable Federal or state laws,
and the Committee may cause a legend or legends to be put on any
such certificates to make appropriate reference to such
restrictions.
(d) Withholding. (i) Authority
to Withhold. A Participant may be required to
pay to the Company or any Affiliate, and the Company or any
Affiliate shall have the right and is hereby authorized to
withhold from any Award, from any payment due or transfer made
under any Award or under the Plan or from any compensation or
other amount owing to a Participant, the amount (in cash,
Shares, other securities, other Awards or other property) of any
applicable withholding taxes in respect of an Award, its
exercise or any payment or transfer under an Award or under the
Plan and to take such other action as may be necessary in the
opinion of the Committee or the Company to satisfy all
obligations for the payment of such taxes.
A-85
(ii) Alternative Ways to Satisfy Withholding
Liability. Without limiting the generality of
clause (i) above, subject to the Committees
discretion, a Participant may satisfy, in whole or in part, the
foregoing withholding liability by delivery of Shares owned by
the Participant (which are not subject to any pledge or other
security interest) having a Fair Market Value equal to such
withholding liability or by having the Company withhold from the
number of Shares otherwise issuable pursuant to the exercise of
the Option or SAR, or the lapse of the restrictions on any other
Award (in the case of SARs and other Awards, if such SARs and
other Awards are settled in Shares), a number of Shares having a
Fair Market Value equal to such withholding liability.
(e) Section 409A. (i) It
is intended that the provisions of the Plan comply with
Section 409A of the Code, and all provisions of the Plan
shall be construed and interpreted in a manner consistent with
the requirements for avoiding taxes or penalties under
Section 409A of the Code.
(ii) No Participant or the creditors or beneficiaries of a
Participant shall have the right to subject any deferred
compensation (within the meaning of Section 409A of the
Code) payable under the Plan to any anticipation, alienation,
sale, transfer, assignment, pledge, encumbrance, attachment or
garnishment. Except as permitted under Section 409A of the
Code, any deferred compensation (within the meaning of
Section 409A of the Code) payable to any Participant or for
the benefit of any Participant under the Plan may not be reduced
by, or offset against, any amount owing by any such Participant
to the Company or any of its Affiliates.
(iii) If, at the time of a Participants separation
from service (within the meaning of Section 409A of the
Code), (A) such Participant shall be a specified employee
(within the meaning of Section 409A of the Code and using
the identification methodology selected by the Company from time
to time) and (B) the Company shall make a good faith
determination that an amount payable pursuant to an Award
constitutes deferred compensation (within the meaning of
Section 409A of the Code) the payment of which is required
to be delayed pursuant to the six-month delay rule set forth in
Section 409A of the Code in order to avoid taxes or
penalties under Section 409A of the Code, then the Company
shall not pay such amount on the otherwise scheduled payment
date but shall instead pay it on the first business day after
such six-month period. Such amount shall be paid without
interest, unless otherwise determined by the Committee, in its
sole discretion, or as otherwise provided in any applicable
employment agreement between the Company and the relevant
Participant.
(iv) Notwithstanding any provision of the Plan to the
contrary, in light of the uncertainty with respect to the proper
application of Section 409A of the Code, the Company
reserves the right to make amendments to any Award as the
Company deems necessary or desirable to avoid the imposition of
taxes or penalties under Section 409A of the Code. In any
case, a Participant shall be solely responsible and liable for
the satisfaction of all taxes and penalties that may be imposed
on such Participant or for such Participants account in
connection with an Award (including any taxes and penalties
under Section 409A of the Code), and neither the Company
nor any of its Affiliates shall have any obligation to indemnify
or otherwise hold such Participant harmless from any or all of
such taxes or penalties.
(f) Award Agreements. Each Award
hereunder shall be evidenced by an Award Agreement, which shall
be delivered to the Participant and shall specify the terms and
conditions of the Award and any rules applicable thereto,
including the effect on such Award of the death, disability or
termination of employment or service of a Participant and the
effect, if any, of such other events as may be determined by the
Committee.
(g) No Limit on Other Compensation
Arrangements. Nothing contained in the Plan
shall prevent the Company or any Affiliate from adopting or
continuing in effect other compensation arrangements, which may,
but need not, provide for the grant of options, restricted
stock, shares, other types of equity-based awards (subject to
stockholder approval if such approval is required) and cash
incentive awards, and such arrangements may be either generally
applicable or applicable only in specific cases.
(h) No Right to Employment. The
grant of an Award shall not be construed as giving a Participant
the right to be retained as a director, officer, employee or
consultant of or to the Company or any Affiliate, nor shall it
be construed as giving a Participant any rights to continued
service on the Board. Further, the Company or an Affiliate may
at any time dismiss a Participant from employment or discontinue
any directorship or consulting relationship,
A-86
free from any liability or any claim under the Plan, unless
otherwise expressly provided in the Plan or in any Award
Agreement.
(i) No Rights as a Stockholder. No
Participant or holder or beneficiary of any Award shall have any
rights as a stockholder with respect to any Shares to be
distributed under the Plan until he or she has become the holder
of such Shares. In connection with each grant of Restricted
Shares, except as provided in the applicable Award Agreement,
the Participant shall be entitled to the rights of a stockholder
(including the right to vote) in respect of such Restricted
Shares. Except as otherwise provided in Section 4(b),
Section 7(c) or the applicable Award Agreement, no
adjustments shall be made for dividends or distributions on
(whether ordinary or extraordinary, and whether in cash, Shares,
other securities or other property), or other events relating
to, Shares subject to an Award for which the record date is
prior to the date such Shares are delivered.
(j) Governing Law. The validity,
construction and effect of the Plan and any rules and
regulations relating to the Plan and any Award Agreement shall
be determined in accordance with the laws of the State of
Delaware, without giving effect to the conflict of laws
provisions thereof.
(k) Severability. If any provision
of the Plan or any Award is or becomes or is deemed to be
invalid, illegal or unenforceable in any jurisdiction or as to
any Person or Award, or would disqualify the Plan or any Award
under any law deemed applicable by the Committee, such provision
shall be construed or deemed amended to conform to the
applicable laws, or if it cannot be construed or deemed amended
without, in the determination of the Committee, materially
altering the intent of the Plan or the Award, such provision
shall be construed or deemed stricken as to such jurisdiction,
Person or Award and the remainder of the Plan and any such Award
shall remain in full force and effect.
(l) Other Laws; Restrictions on Transfer of
Shares. The Committee may refuse to issue or
transfer any Shares or other consideration under an Award if,
acting in its sole and plenary discretion, it determines that
the issuance or transfer of such Shares or such other
consideration might violate any applicable law or regulation or
entitle the Company to recover the same under Section 16(b)
of the Exchange Act, and any payment tendered to the Company by
a Participant, other holder or beneficiary in connection with
the exercise of such Award shall be promptly refunded to the
relevant Participant, holder or beneficiary. Without limiting
the generality of the foregoing, no Award granted hereunder
shall be construed as an offer to sell securities of the
Company, and no such offer shall be outstanding, unless and
until the Committee in its sole and plenary discretion has
determined that any such offer, if made, would be in compliance
with all applicable requirements of the Federal and any other
applicable securities laws.
(m) No Trust or
Fund Created. Neither the Plan nor any
Award shall create or be construed to create a trust or separate
fund of any kind or a fiduciary relationship between the Company
or any Affiliate, on one hand, and a Participant or any other
Person, on the other. To the extent that any Person acquires a
right to receive payments from the Company or any Affiliate
pursuant to an Award, such right shall be no greater than the
right of any unsecured general creditor of the Company or such
Affiliate.
(n) Recoupment of Awards. Any
Award Agreement may provide for recoupment by the Company of all
or any portion of an Award if the Companys financial
statements are required to be restated due to noncompliance with
any financial reporting requirement under the Federal securities
laws. This Section 9(n) shall not be the Companys
exclusive remedy with respect to such matters.
(o) No Fractional Shares. No
fractional Shares shall be issued or delivered pursuant to the
Plan or any Award, and the Committee shall determine whether
cash, other securities or other property shall be paid or
transferred in lieu of any fractional Shares or whether such
fractional Shares or any rights thereto shall be canceled,
terminated or otherwise eliminated.
(p) Requirement of Consent and Notification of
Election Under Section 83(b) of the Code or Similar
Provision. No election under
Section 83(b) of the Code (to include in gross income in
the year of transfer the amounts specified in Section 83(b)
of the Code) or under a similar provision of law may be made
unless expressly permitted by the terms of the applicable Award
Agreement or by action of the Committee in writing prior to the
making of such election. If an Award recipient, in connection
with the acquisition of Shares under the Plan or otherwise, is
expressly permitted under the terms of the applicable Award
Agreement or by such Committee action
A-87
to make such an election and the Participant makes the election,
the Participant shall notify the Committee of such election
within ten days of filing notice of the election with the
Internal Revenue Service (or any successor thereto) or other
governmental authority, in addition to any filing and
notification required pursuant to regulations issued under
Section 83(b) of the Code or any other applicable provision.
(q) Requirement of Notification Upon Disqualifying
Disposition Under Section 421(b) of the
Code. If any Participant shall make any
disposition of Shares delivered pursuant to the exercise of an
Incentive Stock Option under the circumstances described in
Section 421(b) of the Code (relating to certain
disqualifying dispositions) or any successor provision of the
Code, such Participant shall notify the Company of such
disposition within ten days of such disposition.
(r) Headings and
Construction. Headings are given to the
Sections and subsections of the Plan solely as a convenience to
facilitate reference. Such headings shall not be deemed in any
way material or relevant to the construction or interpretation
of the Plan or any provision thereof. Whenever the words
include, includes or
including are used in this Plan, they shall be
deemed to be followed by the words but not limited
to.
Section 10. Term
of the Plan. (a) Effective
Date. The Plan shall be effective as of the
date of its adoption by the Board and approval by the
Companys stockholders; provided, that the Plan
shall be null and void ab initio and of no further force or
effect if the Investment Agreement is terminated and the Closing
does not occur.
(b) Expiration Date. No Award
shall be granted under the Plan after the tenth anniversary of
the date the Plan is approved by the Companys stockholders
under Section 10(a). Unless otherwise expressly provided in
the Plan or in an applicable Award Agreement, any Award granted
hereunder, and the authority of the Board or the Committee to
amend, alter, adjust, suspend, discontinue or terminate any such
Award or to waive any conditions or rights under any such Award,
shall nevertheless continue thereafter.
A-88
ANNEX
B
June 12, 2011
Special Committee of the Board of Directors
Express-1 Expedited Solutions, Inc.
3399 South Lakeshore Drive, Suite 225
Saint Joseph, MI 49085
Gentlemen:
We have been advised that Express-1 Expedited Solutions, Inc.
(the Company) intends to enter into an Investment
Agreement by and among the Company, Jacobs Private Equity, LLC
(JPE) and certain other investors (together with
JPE, collectively referred to as Investors).
Capitalized terms used herein, but not defined herein, shall
have the meanings ascribed to them in the Investment Agreement.
As described in the Investment Agreement, the Investors will be
issued the following in exchange for an Investment of
$75 million: (i) convertible preferred stock, with a
liquidation preference of $75 million, convertible at $1.75
per share (Preferred Stock), or for approximately
42.9 million shares of common stock, and (ii) ten-year
warrants to purchase an additional approximately
42.9 million shares of Company common stock at an exercise
price of $1.75 per share (Warrant). The Investors
will be entitled to receive a 4% annual dividend on the
Preferred Stock. The terms described in this paragraph are
hereinafter, the Transaction.
The terms and conditions of the Transaction and the other
actions contemplated are more specifically set forth in the
Investment Agreement.
Ladenburg is a full service investment bank providing investment
banking, brokerage, equity research, institutional sales and
trading, and asset management services. In the ordinary course
of business, Ladenburg, certain of our affiliates, as well as
investment funds in which we or our affiliates may have
financial interests, may acquire, hold or sell long or short
positions, or trade or otherwise effect transactions in debt,
equity, and other securities and financial instruments
(including bank loans and other obligations) of, or investments
in, the Company or any other party that may be involved in the
Transaction
and/or their
respective affiliates.
We have been retained to render an opinion as to whether, on the
date of such opinion, the Transaction is fair, from a financial
point of view, to the Companys stockholders. The terms of
the Transaction were determined pursuant to negotiations between
the Company (including the Special Committee of the Board of
Directors), the Investors, and their respective advisors, and
not pursuant to recommendations of Ladenburg. We have not been
retained to render an opinion as to whether the Transaction is
the best price reasonably available to the Company. Further, we
do not express any opinion as to the underlying valuation or
future performance of the Company, or the price at which the
Companys securities might trade at anytime in the future.
We have not been requested to opine as to, and our opinion does
not address, the relative merits of the Transaction as compared
to any alternative business strategy that might exist for
Company, the decision whether Company should complete the
Transaction, and other alternatives to the Transaction that
might exist for the Company.
Ladenburg
Thalmann & Co. Inc.
4400
Biscayne Boulevard,
14TH
Floor
Miami, FL 33137
Phone
305·572·4200 u Fax
305·572·4220
MEMBER NYSE, NYSE
Amex,
FINRA, SIPC
B-1
Special
Committee of the Board of Directors
Express-1 Expedited Solutions Inc.
June 12, 2011
Page 2 of 3
In arriving at our opinion, we took into account an assessment
of general economic, market and financial conditions as well as
our experience in connection with similar transactions and
securities valuations generally and, among other things:
|
|
|
|
|
Reviewed a draft of the Investment Agreement dated as of
June 10, 2011.
|
|
|
|
Reviewed a draft of the Certificate of Designation of the
Preferred Stock as of June 10, 2011.
|
|
|
|
Reviewed a draft of the Warrant as of June 10, 2011.
|
|
|
|
Reviewed publicly available financial information and other data
with respect to the Company that we deemed relevant, including
its Annual Report on
Form 10-K
for the year ended December 31, 2010 and its Quarterly
Report on
Form 10-Q
for the quarter ended March 31, 2011.
|
|
|
|
Reviewed non-public information and other data with respect to
the Company, including financial projections for the five-year
period ending December 31, 2015 (the Standalone
Projections), and other internal financial information and
management reports.
|
|
|
|
Reviewed financial projections prepared by the Company and
BB&T Capital Markets (BB&T), assuming one
bolt-on acquisition per year starting in 2012 (Standalone
with Acquisitions Projections).
|
|
|
|
Reviewed financial projections assuming the Transaction takes
place (JPE Projections)
|
|
|
|
Reviewed and analyzed the Transactions pro forma impact on
the Companys outstanding securities and stockholder
ownership.
|
|
|
|
Considered the historical financial results and present
financial condition of the Company.
|
|
|
|
Reviewed certain publicly available information concerning the
trading of, and the trading market for, the Companys
common stock.
|
|
|
|
Reviewed and analyzed the Companys projected unlevered
free cash flows derived from the Standalone Projections and
prepared a discounted cash flow analysis.
|
|
|
|
Reviewed and analyzed certain financial characteristics of
publicly-traded companies that were deemed to have
characteristics comparable to the Company.
|
|
|
|
Reviewed and analyzed certain financial characteristics of
target companies in transactions where such target company was
deemed to have characteristics comparable to that of the Company.
|
|
|
|
Reviewed and compared the terms of the Transaction to the terms
of certain private investments in public entities
(PIPE) and follow-on offering transactions.
|
|
|
|
Reviewed and discussed with the Companys management, other
Company representatives, JPE, and BB&T certain financial
and operating information furnished by them, including the
Standalone Projections, Standalone with Acquisitions
Projections, and JPE Projections (collectively, the
Projections).
|
|
|
|
Performed such other analyses and examinations as were deemed
appropriate.
|
In arriving at our opinion, with your consent, we have relied
upon and assumed, without assuming any responsibility for
independent verification, the accuracy and completeness of all
of the financial and other information that was supplied or
otherwise made available to us and we have further relied upon
the assurances of Company management that they were not aware of
any facts or circumstances that would make any such information
inaccurate or misleading. With respect to the financial
information and the Projections reviewed, we assumed that such
information was reasonably prepared on a basis reflecting the
best currently available estimates
B-2
Special
Committee of the Board of Directors
Express-1 Expedited Solutions Inc.
June 12, 2011
Page 3 of 3
and judgments, and that such information provides a reasonable
basis upon which we could make our analysis and form an opinion.
We assumed that the Transaction will be consummated in a manner
that complies in all respects with applicable foreign, federal,
state and local laws, rules and regulations. We have assumed,
with your consent, that the final executed forms of the
Investment Agreement will not differ in any material respect
from the drafts we have reviewed and that the Transaction will
be consummated on the terms set forth in the Investment
Agreement, without further amendments thereto, and without
waiver by the Company of conditions to any of its obligations
thereunder or in the alternative that any such amendments or
waivers thereto will not be detrimental to the Company or its
stockholders in any material respect. We have also assumed that
the representations and warranties of the parties thereto
contained in the Investment Agreement are true and correct and
that each such party will perform all of the covenants and
agreements to be performed by it under the Investment Agreement.
Our analysis and opinion are necessarily based upon market,
economic and other conditions, as they exist on, and could be
evaluated as of, June 12, 2011. Accordingly, although
subsequent developments may affect our opinion, we do not assume
any obligation to update, review or reaffirm our opinion.
Our opinion is for the use and benefit of the Board of Directors
of the Company in connection with its consideration of the
Transaction. Our opinion may not be used by any other person or
for any other purpose without our prior written consent;
provided however, that a copy of our opinion may be included in
a proxy statement prepared by the Company in connection with the
Transaction. Our opinion is not intended to and does not
constitute an opinion or recommendation to any of the
Companys stockholders as to how such stockholder should
vote or act with respect to the Transaction, should a vote of
such stockholders be required. Our opinion should not be
construed as creating any fiduciary duty on our part to any
party to the Investment Agreement or any other person.
In connection with our services, and pursuant to that certain
Fairness Opinion Agreement between Ladenburg and the Special
Committee of the Board of Directors of the Company dated
May 24, 2011 (the Ladenburg Engagement
Agreement), we have received a retainer and are entitled
to receive the balance of our fee, which is not contingent upon
the completion of the Transaction, when we notify the Company
that we are prepared to deliver our opinion. Also, pursuant to
the Ladenburg Engagement Agreement, the Company has agreed to
indemnify us for certain liabilities that may arise out of the
rendering of this opinion. Ladenburg has not previously
provided, nor are there any pending agreements to provide, any
other services to the Company.
Based upon and subject to the foregoing, it is our opinion that,
as of the date of this letter, the Transaction is fair, from a
financial point of view, to the Companys stockholders.
Very truly yours,
Ladenburg Thalmann & Co. Inc.
B-3
ANNEX C
EXECUTION
COPY
VOTING AGREEMENT, dated as of June 13, 2011 (this
Agreement), between Jacobs Private Equity,
LLC (the Investor Representative) and Michael
R. Welch (Stockholder).
WHEREAS, as a condition to the willingness of the Investor
Representative and certain other investors to enter into the
Investment Agreement dated as of the date hereof (the
Investment Agreement), with Express-1
Expedited Solutions, Inc., a Delaware corporation (the
Company), the Investor Representative has
requested Stockholder, and Stockholder has agreed, to enter into
this Agreement with respect to all shares of the Companys
common stock, par value $0.001 per share (the Company
Common Stock), that Stockholder beneficially owns
(including any shares that Stockholder acquires after the date
hereof, including upon exercise or conversion of any options,
rights or other securities convertible into or exercisable for
Company Common Stock) (the Shares);
provided that the term Shares shall not include any
options, rights or other securities convertible into or
exercisable for Company Common Stock.
NOW, THEREFORE, the parties hereto agree as follows:
ARTICLE 1
Grant of
Irrevocable Proxy; Voting Agreement
Section 1.01. Voting
Agreement. Stockholder hereby irrevocably and
unconditionally agrees to vote or exercise its right to consent
with respect to all Shares that Stockholder is entitled to vote
at the time of any vote to approve (i) the Equity
Investment, (ii) the Certificate of Amendment,
(iii) the Omnibus ICP and (iv) any other transaction
contemplated by the Investment Agreement submitted to the
stockholders of the Company for approval (or any amendment
thereof, subject to Section 5.03), at any meeting of the
stockholders of the Company, and at any adjournment thereof, at
which the Equity Investment, the Certificate of Amendment, the
Omnibus ICP or any such other transaction is submitted for the
consideration and vote of the stockholders of the Company, or in
connection with any written consent of the stockholders of the
Company in respect thereof. Stockholder hereby agrees that it
will not vote any Shares in favor of, or consent to, and will
vote against and not consent to, the approval of any
(i) Takeover Proposal, (ii) reorganization,
recapitalization, liquidation or
winding-up
of the Company or any other extraordinary transaction involving
the Company or (iii) corporate action the consummation of
which would prevent, interfere with, impede or delay the
consummation of the transactions contemplated by the Investment
Agreement. Except as expressly set forth in this
Section 1.01, nothing in this Agreement shall limit the
right of Stockholder to vote or exercise its right to consent in
favor of or against, or abstain with respect to, any matter
presented to the Companys stockholders, including in
connection with the election of directors.
Section 1.02. Irrevocable
Proxy. Stockholder hereby revokes any and all
previous proxies granted with respect to the Shares. By entering
into this Agreement, Stockholder hereby grants a proxy
appointing the Investor Representative as Stockholders
attorney-in-fact and proxy, with full power of substitution, for
and in Stockholders name, to vote, express consent or
dissent, or otherwise to utilize such voting power solely in the
manner permitted by Section 1.01. The proxy granted by
Stockholder pursuant to this Article 1 is irrevocable and
is granted in consideration of the Investor Representative
entering into this Agreement and the Investment Agreement and
incurring certain related fees and expenses. The proxy granted
by Stockholder shall be automatically revoked upon termination
of this Agreement in accordance with its terms. Stockholder
hereby affirms that the irrevocable proxy is coupled with an
interest and, except as set forth in this Section 1.02 or
in Section 5.02, is intended to be irrevocable in
accordance with the provisions of Section 212 of the DGCL.
The parties agree that this Agreement is a voting agreement
created under Section 218(c) of the DGCL.
Section 1.03. Capacity
as a Stockholder. Notwithstanding any
provision of this Agreement to the contrary, nothing in this
Agreement shall limit or restrict Stockholder in his capacity as
a director or officer of the Company or any designee, employee,
representative or affiliate of Stockholder who is a director or
officer of the Company (in all cases, to the extent applicable)
from acting in such capacity or voting in such persons
sole discretion on any matter
C-1
(it being understood that this Agreement shall apply to
Stockholder solely in Stockholders capacity as a
stockholder of the Company).
ARTICLE 2
Representations
and Warranties of Stockholder
Stockholder represents and warrants to the Investor
Representative that:
Section 2.01. Binding
Agreement. This Agreement has been duly
executed by Stockholder and, assuming the due execution and
delivery of this Agreement by the Investor Representative,
constitutes a valid and binding agreement of Stockholder.
Section 2.02. Non-Contravention. The
execution, delivery and performance by Stockholder of this
Agreement and the consummation of the transactions contemplated
hereby do not and will not (i) violate any applicable Law
or Judgment or (ii) require any consent or other action by
any Person under, constitute a default under or give rise to any
right of termination, cancellation or acceleration or to a loss
of any benefit to which Stockholder is entitled under any
provision of any agreement or other instrument binding on
Stockholder.
Section 2.03. Ownership
of Shares. As of the date hereof, Stockholder
is the record and beneficial owner of the Shares, free and clear
of any Lien and any other limitation or restriction (including
any restriction on the right to vote or otherwise dispose of the
Shares), other than any restrictions applicable to the Shares
that may exist pursuant to securities Laws. None of the Shares
are subject to any voting trust or other agreement or
arrangement with respect to the voting of such Shares.
Section 2.04. Total
Shares. As of the date hereof, except as set
forth on the signature page hereto, Stockholder does not
beneficially own any (i) Shares entitling Stockholder to
vote at meetings of stockholders of the Company, including the
Stockholders Meeting, (ii) securities of the Company
convertible into or exchangeable for shares of the Company
entitling Stockholder to vote at meetings of stockholders of the
Company, including the Stockholders Meeting or
(iii) options or other rights to acquire from the Company
any shares of the Company or securities convertible into or
exchangeable for shares of the Company entitling Stockholder to
vote at meetings of stockholders of the Company, including the
Stockholders Meeting.
Section 2.05. Finders
Fees. No investment banker, broker, finder or
other intermediary is entitled to a fee or commission from the
Investor Representative or the Company in respect of this
Agreement based upon any arrangement or agreement made by or on
behalf of Stockholder.
ARTICLE 3
Representations
and Warranties of the Investor Representative
The Investor Representative represents and warrants to
Stockholder that:
Section 3.01. Authorization;
Binding Agreement. The execution, delivery
and performance by the Investor Representative of this Agreement
and the consummation by the Investor Representative of the
transactions contemplated hereby are within the limited
liability company powers of the Investor Representative and have
been duly authorized by all necessary limited liability company
action. This Agreement has been duly executed and delivered by
the Investor Representative and, assuming the due execution and
delivery of this Agreement by Stockholder, constitutes a valid
and binding agreement of the Investor Representative.
ARTICLE 4
Covenants
of Stockholder
Stockholder hereby covenants and agrees that:
Section 4.01. No
Proxies for or Encumbrances on Shares. Except
pursuant to the terms of this Agreement, Stockholder shall not,
without the prior written consent of the Investor
Representative, directly or indirectly,
C-2
(i) grant any proxy or power of attorney or enter into any
voting trust or other agreement or arrangement with respect to
the voting of any Shares or (ii) sell, assign, transfer,
encumber, pledge or otherwise dispose of, or enter into any
contract, option or other arrangement or understanding with
respect to the direct or indirect sale, assignment, transfer,
encumbrance, pledge or other disposition of, any Shares during
the term of this Agreement. Stockholder shall not seek or
solicit any such sale, assignment, transfer, encumbrance, pledge
or other disposition or any such contract, option or other
arrangement or understanding, and shall provide prompt notice to
the Investor Representative if Stockholder shall be approached
or solicited, directly or indirectly, by any person with respect
to any of the foregoing.
ARTICLE 5
Miscellaneous
Section 5.01. Other
Definitional and Interpretative
Provisions. The words hereof,
herein and hereunder and words of like
import used in this Agreement shall refer to this Agreement as a
whole and not to any particular provision of this Agreement. The
captions herein are included for convenience of reference only
and shall be ignored in the construction or interpretation
hereof. References to Articles and Sections are to Articles and
Sections of this Agreement unless otherwise specified. Any
singular term in this Agreement shall be deemed to include the
plural, and any plural term the singular. Whenever the words
include, includes or
including are used in this Agreement, they shall be
deemed to be followed by the words without
limitation, whether or not they are in fact followed by
those words or words of like import. References to any agreement
or contract are to that agreement or contract as amended,
modified or supplemented from time to time in accordance with
the terms hereof, including Section 5.03, and thereof.
References to any person include the successors and permitted
assigns of that person. References from or through any date
mean, unless otherwise specified, from and including or through
and including, respectively.
Section 5.02. Further
Assurances. The Investor Representative and
Stockholder will each use reasonable best efforts to execute and
deliver, or cause to be executed and delivered, all further
documents and instruments and use its reasonable best efforts to
take, or cause to be taken, all actions and to do, or cause to
be done, all things necessary, proper or advisable under
applicable Law, to effectuate the rights of the Investor
Representative and obligations of Stockholder set forth in this
Agreement.
Section 5.03. Amendments;
Termination. Any provision of this Agreement
may be amended or waived if, but only if, such amendment or
waiver is in writing and is signed, in the case of an amendment,
by each party to this Agreement or in the case of a waiver, by
the party against whom the waiver is to be effective.
Notwithstanding the foregoing, the parties acknowledge and agree
that in the event that Stockholder acquires record or beneficial
ownership of, or the power to vote or direct the voting of, any
Shares following the date hereof, such Shares shall, without
further action of the parties, be subject to the provisions of
this Agreement, and the number of Shares held by Stockholder set
forth on the signature page hereto will be deemed automatically
amended accordingly. This Agreement shall automatically
terminate upon the earliest to occur of (i) the termination
of the Investment Agreement in accordance with its terms,
(ii) the consummation of the Equity Investment and
(iii) the date of any amendment, modification, change or
waiver of the Investment Agreement executed after the date
hereof that results in a change to the terms of the Securities
that is material and adverse to the Company and that is not
consented to in writing by Stockholder in his sole discretion
prior to such amendment, modification, change or waiver of the
Investment Agreement.
Section 5.04. Successors
and Assigns. The provisions of this Agreement
shall be binding upon and inure to the benefit of the parties
hereto and their respective successors and assigns;
provided that no party may assign, delegate or otherwise
transfer any of its rights or obligations under this Agreement
without the consent of each other party hereto. Any purported
assignment in contravention of this Section 5.04 shall be
null and void.
Section 5.05. Governing
Law. This Agreement shall be governed by, and
construed in accordance with, the Laws of the State of Delaware,
regardless of the Laws that might otherwise govern under
applicable principles of conflicts of laws thereof.
C-3
Section 5.06. Jurisdiction. (a) Each
of the parties hereto irrevocably and unconditionally submits to
the exclusive jurisdiction of the Delaware Court of Chancery
(and if the Delaware Court of Chancery shall be unavailable, any
Delaware State court and the Federal court of the United States
of America sitting in the State of Delaware) for the purposes of
any suit, action or other proceeding arising out of this
Agreement or the transactions contemplated hereby (and agrees
that no such action, suit or proceeding shall be brought by it
except in such courts). Each of the parties further agrees that,
to the fullest extent permitted by applicable Law, service of
any process, summons, notice or document by U.S. registered
mail to such persons respective address set forth herein
shall be effective service of process for any action, suit or
proceeding in the State of Delaware with respect to any matters
to which it has submitted to jurisdiction as set forth above in
the immediately preceding sentence. Each of the parties hereto
irrevocably and unconditionally waives (and agrees not to plead
or claim), any objection to the laying of venue of any action,
suit or proceeding arising out of this Agreement or the
transactions contemplated hereby in the Delaware Court of
Chancery (and if the Delaware Court of Chancery shall be
unavailable, in any Delaware State court or the Federal court of
the United States of America sitting in the State of Delaware)
or that any such action, suit or proceeding brought in any such
court has been brought in an inconvenient forum.
Section 5.07. Counterparts. This
Agreement may be executed in one or more counterparts (including
by facsimile), all of which shall be considered one and the same
agreement and shall become effective when one or more such
counterparts have been signed by each of the parties and
delivered to the other party.
Section 5.08. Severability. If
any provision of this Agreement or the application of any such
provision to any person or circumstance shall be held invalid,
illegal or unenforceable in any respect by a court of competent
jurisdiction, such invalidity, illegality or unenforceability
shall not affect the validity, legality or enforceability of any
other provision hereof and the invalidity of a particular
provision in a particular jurisdiction shall not invalidate such
provision in any other jurisdiction.
Section 5.09. Specific
Performance. The parties hereto agree that
irreparable damage would occur in the event that any of the
provisions of this Agreement is not performed in accordance with
its specific terms or is otherwise breached. It is accordingly
agreed that the parties hereto shall be entitled to an
injunction or injunctions to prevent breaches of this Agreement
and to enforce specifically the terms and provisions of this
Agreement in the Delaware Court of Chancery (and if the Delaware
Court of Chancery shall be unavailable, in any Delaware State
court or the Federal court of the United States of America
sitting in the State of Delaware), this being in addition to any
other remedy to which they are entitled at law or in equity.
Each of the parties agrees that it will not oppose the granting
of an injunction, specific performance and other equitable
relief on the basis that (x) any party has an adequate
remedy at law or (y) an award of specific performance is
not an appropriate remedy for any reason at law or in equity.
Section 5.10. Capitalized
Terms. Capitalized terms used but not defined
herein shall have the respective meanings set forth in the
Investment Agreement as of the date hereof.
Section 5.11. Communications. Stockholder
hereby (i) consents to and authorizes the publication and
disclosure by the Company and the Investor Representative of
Stockholders identity and holding of Shares, and the
nature of Stockholders commitments, arrangements and
understandings under this Agreement, and any other information
that the Company or the Investor Representative reasonably
determines to be necessary in any SEC disclosure document in
connection with the Equity Investment or any other transactions
contemplated by the Investment Agreement and (ii) agrees as
promptly as practicable to notify the Investor Representative of
any required corrections with respect to any written information
supplied by it specifically for use in any such disclosure
document.
Section 5.12. Notices. All
notices, requests and other communications to any party
hereunder shall be in writing (including facsimile transmission)
and shall be given (i) if to the Investor Representative,
as provided in Section 8.02 of the Investment Agreement and
(ii) if to Stockholder, to Michael R. Welch,
c/o Express-1
Expedited Solutions, Inc., 3399 South Lakeshore Drive,
Suite 225, Saint Joseph, MI 49085, Facsimile:
269-695-7458.
C-4
IN WITNESS WHEREOF, the Investor Representative and Stockholder
have caused this Agreement to be duly executed as of the date
first above written.
JACOBS PRIVATE EQUITY, LLC,
|
|
|
|
By:
|
/s/ Bradley
S. Jacobs
|
Name: Bradley S. Jacobs
Title: Managing Member
C-5
MICHAEL R. WELCH
Shares owned by Michael R. Welch as of the date hereof:
869,789 Shares
Options, rights and other securities owned by Michael R.
Welch as of the date hereof that are exercisable for or
convertible into Shares (both vested and unvested, as the case
may be):
Options to purchase 480,000 Shares
C-6
ANNEX D
EXECUTION
COPY
VOTING AGREEMENT, dated as of June 13, 2011 (this
Agreement), between Jacobs Private Equity,
LLC (the Investor Representative) and Daniel
Para (Stockholder).
WHEREAS, as a condition to the willingness of the Investor
Representative and certain other investors to enter into the
Investment Agreement dated as of the date hereof (the
Investment Agreement), with Express-1
Expedited Solutions, Inc., a Delaware corporation (the
Company), the Investor Representative has
requested Stockholder, and Stockholder has agreed, to enter into
this Agreement with respect to all shares of the Companys
common stock, par value $0.001 per share (the Company
Common Stock), that Stockholder beneficially owns
(including any shares that Stockholder acquires after the date
hereof, including upon exercise or conversion of any options,
rights or other securities convertible into or exercisable for
Company Common Stock) (the Shares);
provided that the term Shares shall not include any
options, rights or other securities convertible into or
exercisable for Company Common Stock.
NOW, THEREFORE, the parties hereto agree as follows:
ARTICLE 1
Grant of
Irrevocable Proxy; Voting Agreement
Section 1.01. Voting
Agreement. Stockholder hereby irrevocably and
unconditionally agrees to vote or exercise its right to consent
with respect to all Shares that Stockholder is entitled to vote
at the time of any vote to approve (i) the Equity
Investment, (ii) the Certificate of Amendment,
(iii) the Omnibus ICP and (iv) any other transaction
contemplated by the Investment Agreement submitted to the
stockholders of the Company for approval (or any amendment
thereof, subject to Section 5.03), at any meeting of the
stockholders of the Company, and at any adjournment thereof, at
which the Equity Investment, the Certificate of Amendment, the
Omnibus ICP or any such other transaction is submitted for the
consideration and vote of the stockholders of the Company, or in
connection with any written consent of the stockholders of the
Company in respect thereof. Stockholder hereby agrees that it
will not vote any Shares in favor of, or consent to, and will
vote against and not consent to, the approval of any
(i) Takeover Proposal, (ii) reorganization,
recapitalization, liquidation or
winding-up
of the Company or any other extraordinary transaction involving
the Company or (iii) corporate action the consummation of
which would prevent, interfere with, impede or delay the
consummation of the transactions contemplated by the Investment
Agreement. Except as expressly set forth in this
Section 1.01, nothing in this Agreement shall limit the
right of Stockholder to vote or exercise its right to consent in
favor of or against, or abstain with respect to, any matter
presented to the Companys stockholders, including in
connection with the election of directors.
Section 1.02. Irrevocable
Proxy. Stockholder hereby revokes any and all
previous proxies granted with respect to the Shares. By entering
into this Agreement, Stockholder hereby grants a proxy
appointing the Investor Representative as Stockholders
attorney-in-fact and proxy, with full power of substitution, for
and in Stockholders name, to vote, express consent or
dissent, or otherwise to utilize such voting power solely in the
manner permitted by Section 1.01. The proxy granted by
Stockholder pursuant to this Article 1 is irrevocable and
is granted in consideration of the Investor Representative
entering into this Agreement and the Investment Agreement and
incurring certain related fees and expenses. The proxy granted
by Stockholder shall be automatically revoked upon termination
of this Agreement in accordance with its terms. Stockholder
hereby affirms that the irrevocable proxy is coupled with an
interest and, except as set forth in this Section 1.02 or
in Section 5.02, is intended to be irrevocable in
accordance with the provisions of Section 212 of the DGCL.
The parties agree that this Agreement is a voting agreement
created under Section 218(c) of the DGCL.
Section 1.03. Capacity
as a Stockholder. Notwithstanding any
provision of this Agreement to the contrary, nothing in this
Agreement shall limit or restrict Stockholder in his capacity as
a director or officer of the Company or any designee, employee,
representative or affiliate of Stockholder who is a director or
officer of the Company (in all cases, to the extent applicable)
from acting in such capacity or voting in such persons
sole discretion on any matter
D-1
(it being understood that this Agreement shall apply to
Stockholder solely in Stockholders capacity as a
stockholder of the Company).
ARTICLE 2
Representations
and Warranties of Stockholder
Stockholder represents and warrants to the Investor
Representative that:
Section 2.01. Binding
Agreement. This Agreement has been duly
executed by Stockholder and, assuming the due execution and
delivery of this Agreement by the Investor Representative,
constitutes a valid and binding agreement of Stockholder.
Section 2.02. Non-Contravention. The
execution, delivery and performance by Stockholder of this
Agreement and the consummation of the transactions contemplated
hereby do not and will not (i) violate any applicable Law
or Judgment or (ii) require any consent or other action by
any Person under, constitute a default under or give rise to any
right of termination, cancellation or acceleration or to a loss
of any benefit to which Stockholder is entitled under any
provision of any agreement or other instrument binding on
Stockholder.
Section 2.03. Ownership
of Shares. As of the date hereof, except as
set forth on the signature page hereto, Stockholder is the
record and beneficial owner of the Shares, free and clear of any
Lien and any other limitation or restriction (including any
restriction on the right to vote or otherwise dispose of the
Shares), other than any restrictions applicable to the Shares
that may exist pursuant to securities Laws. None of the Shares
are subject to any voting trust or other agreement or
arrangement with respect to the voting of such Shares.
Section 2.04. Total
Shares. As of the date hereof, except as set
forth on the signature page hereto, Stockholder does not
beneficially own any (i) Shares entitling Stockholder to
vote at meetings of stockholders of the Company, including the
Stockholders Meeting, (ii) securities of the Company
convertible into or exchangeable for shares of the Company
entitling Stockholder to vote at meetings of stockholders of the
Company, including the Stockholders Meeting or
(iii) options or other rights to acquire from the Company
any shares of the Company or securities convertible into or
exchangeable for shares of the Company entitling Stockholder to
vote at meetings of stockholders of the Company, including the
Stockholders Meeting.
Section 2.05. Finders
Fees. No investment banker, broker, finder or
other intermediary is entitled to a fee or commission from the
Investor Representative or the Company in respect of this
Agreement based upon any arrangement or agreement made by or on
behalf of Stockholder.
ARTICLE 3
Representations
and Warranties of the Investor Representative
The Investor Representative represents and warrants to
Stockholder that:
Section 3.01. Authorization;
Binding Agreement. The execution, delivery
and performance by the Investor Representative of this Agreement
and the consummation by the Investor Representative of the
transactions contemplated hereby are within the limited
liability company powers of the Investor Representative and have
been duly authorized by all necessary limited liability company
action. This Agreement has been duly executed and delivered by
the Investor Representative and, assuming the due execution and
delivery of this Agreement by Stockholder, constitutes a valid
and binding agreement of the Investor Representative.
ARTICLE 4
Covenants
of Stockholder
Stockholder hereby covenants and agrees that:
Section 4.01. No
Proxies for or Encumbrances on Shares. Except
pursuant to the terms of this Agreement or as set forth on the
signature page hereto, Stockholder shall not, without the prior
written consent of the Investor
D-2
Representative, directly or indirectly, (i) grant any proxy
or power of attorney or enter into any voting trust or other
agreement or arrangement with respect to the voting of any
Shares or (ii) sell, assign, transfer, encumber, pledge or
otherwise dispose of, or enter into any contract, option or
other arrangement or understanding with respect to the direct or
indirect sale, assignment, transfer, encumbrance, pledge or
other disposition of, any Shares during the term of this
Agreement. Stockholder shall not seek or solicit any such sale,
assignment, transfer, encumbrance, pledge or other disposition
or any such contract, option or other arrangement or
understanding, and shall provide prompt notice to the Investor
Representative if Stockholder shall be approached or solicited,
directly or indirectly, by any person with respect to any of the
foregoing.
ARTICLE 5
Miscellaneous
Section 5.01. Other
Definitional and Interpretative
Provisions. The words hereof,
herein and hereunder and words of like
import used in this Agreement shall refer to this Agreement as a
whole and not to any particular provision of this Agreement. The
captions herein are included for convenience of reference only
and shall be ignored in the construction or interpretation
hereof. References to Articles and Sections are to Articles and
Sections of this Agreement unless otherwise specified. Any
singular term in this Agreement shall be deemed to include the
plural, and any plural term the singular. Whenever the words
include, includes or
including are used in this Agreement, they shall be
deemed to be followed by the words without
limitation, whether or not they are in fact followed by
those words or words of like import. References to any agreement
or contract are to that agreement or contract as amended,
modified or supplemented from time to time in accordance with
the terms hereof, including Section 5.03, and thereof.
References to any person include the successors and permitted
assigns of that person. References from or through any date
mean, unless otherwise specified, from and including or through
and including, respectively.
Section 5.02. Further
Assurances. The Investor Representative and
Stockholder will each use reasonable best efforts to execute and
deliver, or cause to be executed and delivered, all further
documents and instruments and use its reasonable best efforts to
take, or cause to be taken, all actions and to do, or cause to
be done, all things necessary, proper or advisable under
applicable Law, to effectuate the rights of the Investor
Representative and obligations of Stockholder set forth in this
Agreement.
Section 5.03. Amendments;
Termination. Any provision of this Agreement
may be amended or waived if, but only if, such amendment or
waiver is in writing and is signed, in the case of an amendment,
by each party to this Agreement or in the case of a waiver, by
the party against whom the waiver is to be effective.
Notwithstanding the foregoing, the parties acknowledge and agree
that in the event that Stockholder acquires record or beneficial
ownership of, or the power to vote or direct the voting of, any
Shares following the date hereof, such Shares shall, without
further action of the parties, be subject to the provisions of
this Agreement, and the number of Shares held by Stockholder set
forth on the signature page hereto will be deemed automatically
amended accordingly. This Agreement shall automatically
terminate upon the earliest to occur of (i) the termination
of the Investment Agreement in accordance with its terms,
(ii) the consummation of the Equity Investment and
(iii) the date of any amendment, modification, change or
waiver of the Investment Agreement executed after the date
hereof that results in a change to the terms of the Securities
that is material and adverse to the Company and that is not
consented to in writing by Stockholder in his sole discretion
prior to such amendment, modification, change or waiver of the
Investment Agreement.
Section 5.04. Successors
and Assigns. The provisions of this Agreement
shall be binding upon and inure to the benefit of the parties
hereto and their respective successors and assigns;
provided that no party may assign, delegate or otherwise
transfer any of its rights or obligations under this Agreement
without the consent of each other party hereto. Any purported
assignment in contravention of this Section 5.04 shall be
null and void.
Section 5.05. Governing
Law. This Agreement shall be governed by, and
construed in accordance with, the Laws of the State of Delaware,
regardless of the Laws that might otherwise govern under
applicable principles of conflicts of laws thereof.
D-3
Section 5.06. Jurisdiction. (a) Each
of the parties hereto irrevocably and unconditionally submits to
the exclusive jurisdiction of the Delaware Court of Chancery
(and if the Delaware Court of Chancery shall be unavailable, any
Delaware State court and the Federal court of the United States
of America sitting in the State of Delaware) for the purposes of
any suit, action or other proceeding arising out of this
Agreement or the transactions contemplated hereby (and agrees
that no such action, suit or proceeding shall be brought by it
except in such courts). Each of the parties further agrees that,
to the fullest extent permitted by applicable Law, service of
any process, summons, notice or document by U.S. registered
mail to such persons respective address set forth herein
shall be effective service of process for any action, suit or
proceeding in the State of Delaware with respect to any matters
to which it has submitted to jurisdiction as set forth above in
the immediately preceding sentence. Each of the parties hereto
irrevocably and unconditionally waives (and agrees not to plead
or claim), any objection to the laying of venue of any action,
suit or proceeding arising out of this Agreement or the
transactions contemplated hereby in the Delaware Court of
Chancery (and if the Delaware Court of Chancery shall be
unavailable, in any Delaware State court or the Federal court of
the United States of America sitting in the State of Delaware)
or that any such action, suit or proceeding brought in any such
court has been brought in an inconvenient forum.
Section 5.07. Counterparts. This
Agreement may be executed in one or more counterparts (including
by facsimile), all of which shall be considered one and the same
agreement and shall become effective when one or more such
counterparts have been signed by each of the parties and
delivered to the other party.
Section 5.08. Severability. If
any provision of this Agreement or the application of any such
provision to any person or circumstance shall be held invalid,
illegal or unenforceable in any respect by a court of competent
jurisdiction, such invalidity, illegality or unenforceability
shall not affect the validity, legality or enforceability of any
other provision hereof and the invalidity of a particular
provision in a particular jurisdiction shall not invalidate such
provision in any other jurisdiction.
Section 5.09. Specific
Performance. The parties hereto agree that
irreparable damage would occur in the event that any of the
provisions of this Agreement is not performed in accordance with
its specific terms or is otherwise breached. It is accordingly
agreed that the parties hereto shall be entitled to an
injunction or injunctions to prevent breaches of this Agreement
and to enforce specifically the terms and provisions of this
Agreement in the Delaware Court of Chancery (and if the Delaware
Court of Chancery shall be unavailable, in any Delaware State
court or the Federal court of the United States of America
sitting in the State of Delaware), this being in addition to any
other remedy to which they are entitled at law or in equity.
Each of the parties agrees that it will not oppose the granting
of an injunction, specific performance and other equitable
relief on the basis that (x) any party has an adequate
remedy at law or (y) an award of specific performance is
not an appropriate remedy for any reason at law or in equity.
Section 5.10. Capitalized
Terms. Capitalized terms used but not defined
herein shall have the respective meanings set forth in the
Investment Agreement as of the date hereof.
Section 5.11. Communications. Stockholder
hereby (i) consents to and authorizes the publication and
disclosure by the Company and the Investor Representative of
Stockholders identity and holding of Shares, and the
nature of Stockholders commitments, arrangements and
understandings under this Agreement, and any other information
that the Company or the Investor Representative reasonably
determines to be necessary in any SEC disclosure document in
connection with the Equity Investment or any other transactions
contemplated by the Investment Agreement and (ii) agrees as
promptly as practicable to notify the Investor Representative of
any required corrections with respect to any written information
supplied by it specifically for use in any such disclosure
document.
Section 5.12. Notices. All
notices, requests and other communications to any party
hereunder shall be in writing (including facsimile transmission)
and shall be given (i) if to the Investor Representative,
as provided in Section 8.02 of the Investment Agreement and
(ii) if to Stockholder, to Daniel Para,
c/o Express-1
Expedited Solutions, Inc., 3399 South Lakeshore Drive,
Suite 225, Saint Joseph, MI 49085, Facsimile:
269-695-7458.
D-4
IN WITNESS WHEREOF, the Investor Representative and Stockholder
have caused this Agreement to be duly executed as of the date
first above written.
JACOBS PRIVATE EQUITY, LLC,
|
|
|
|
By:
|
/s/ Bradley
S. Jacobs
|
Name: Bradley S. Jacobs
D-5
DANIEL PARA
Shares owned by Daniel Para as of the date hereof:
3,001,901 Shares5
Options, rights and other securities owned by Daniel Para as
of the date hereof that are exercisable for or convertible into
Shares (both vested and unvested, as the case may be):
Options to purchase 125,000 Shares
5 The
record owner of such 3,001,901 Shares is Dan Para
Investments, LLC, a Delaware limited liability company
(DPI). Daniel Para is the manager of DPI and
has investment and voting control over the 3,001,901 Shares
held by DPI. Daniel Para, Inc., a Delaware corporation
(DP), is the holder of 51% of the voting
interests of DPI. Daniel Para is the sole owner and officer of
DP. The 3,001,901 Shares held by DPI have been pledged by
DPI to Burr Ridge Bank & Trust
(Bank) to secure DPIs obligations to
Bank under that certain Business Loan Agreement dated
August 18, 2009, between DPI and Bank, as amended.
D-6
EXPRESS-1 EXPEDITED SOLUTIONS, INC. MMMMMMMMMMMMMMM C123456789 IMPORTANT SPECIAL MEETING
INFORMATION 000004 000000000.000000 ext 000000000.000000 ext ENDORSEMENT_LINE SACKPACK
000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext MR A SAMPLE
Electronic Voting Instructions DESIGNATION (IF ANY) You can vote by Internet or telephone! ADD 1
Available 24 hours a day, 7 days a week! ADD 2 ADD 3 methods Instead of outlined mailing below your
proxy, to vote you your may proxy. choose one of the two voting ADD 4 VALIDATION DETAILS ARE
LOCATED BELOW IN THE TITLE BAR. MMMMMMMMM ADD 5 ADD 6 Proxies submitted by the Internet or
telephone must be received by 1:00 a.m., Eastern Daylight Time, on September 1, 2011. Vote by
Internet Log on to the Internet and go to www.envisionreports.com/XPO2 Follow the steps
outlined on the secured website. Vote by telephone Call toll free 1-800-652-VOTE (8683) within
the USA, US territories & Canada any time on a touch tone telephone. There is NO CHARGE to you for
the call. Using a black ink pen, mark your votes with an X as shown in X Follow the instructions
provided by the recorded message. this example. Please do not write outside the designated areas.
Special Meeting Proxy Card 1234 5678 9012 345 3IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE,
FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. 3 A
Proposals The Board of Directors recommends a vote FOR each Proposal. Proposals 1 though 5 are
conditioned on each other and Proposal 6 is conditioned on Proposals 1 through 5. If Proposals 1
through 5 are not approved by the Companys stockholders, the proposed equity investment will not
be consummated. + For Against Abstain 1. To approve the issuance to Jacobs Private Equity, LLC and
the other investors party to the Investment Agreement, dated as of June 13, 2011, for $75,000,000
in cash, of (i) 75,000 shares of Series A Convertible Perpetual Preferred Stock of the Company,
which are initially convertible into an aggregate of 42,857,143 shares of Company common stock at a
conversion price of $1.75 per share (subject to adjustment in connection with the Reverse Stock
Split (as defined below)), and (ii) warrants to purchase 42,857,143 shares of Company common stock
at an exercise price of $1.75 per share (subject to adjustment in connection with the Reverse Stock
Split). 2. To approve an amendment to the certificate of incorporation of the Company (the Company
Certificate) to increase the number of authorized shares of Company common stock to 150,000,000
shares. 3. To approve an amendment to the Company Certificate to give effect to a 4-for-1 reverse
stock split of the Company common stock (the Reverse Stock Split). 4. To approve an amendment to
the Company Certificate providing that any vacancy on our Board of Directors shall be filled by the
remaining directors or director. 5. To adopt the 2011 Omnibus Incentive Compensation Plan. 6. To
approve an amendment to the Company Certificate to change the name of the Company to XPO Logistics,
Inc. 7. To approve the adjournment of the special meeting, if necessary or appropriate, to solicit
additional proxies if there are insufficient votes at the time of the special meeting to adopt
Proposals 1 through 5. B Authorized Signatures This section must be completed for your vote to be
counted. Date and Sign Below Please date and sign as name appears hereon. When signing as
Executor, Administrator, Trustee, Guardian or Attorney, please give full title as such. If a
corporation, please sign in full corporate name by president or other authorized corporate officer.
If a partnership, please sign in partnership name by authorized person. Joint owners should each
sign. Date (mm/dd/yyyy) Please print date below. Signature 1 Please keep signature within the
box. Signature 2 Please keep signature within the box. C 1234567890 J
N T MR A SAMPLE (THIS AREA
IS SET UP TO ACCOMMODATE 140 CHARACTERS) MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A
SAMPLE AND MR A SAMPLE AND MMMMMMM1 U P X 1 1 8 7 6 9 1 MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE
AND + 01CW7G |
YOUR VOTE IS IMPORTANT Regardless of whether you plan to attend the Special Meeting of
Stockholders, you can be sure your shares are represented at the meeting by promptly returning your
proxy in the enclosed envelope. 3IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG
THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. 3 PROXY/VOTING
INSTRUCTION FORM EXPRESS-1 EXPEDITED SOLUTIONS, INC. + PROXY FOR THE SPECIAL MEETING OF
STOCKHOLDERS TO BE HELD ON SEPTEMBER 1, 2011 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF
DIRECTORS OF EXPRESS-1 EXPEDITED SOLUTIONS, INC. The undersigned holder of shares of Common Stock
of EXPRESS-1 EXPEDITED SOLUTIONS, INC., a Delaware corporation, hereby appoints Michael R. Welch
with full power of substitution, the proxy and attorney of the undersigned, to vote as specified
hereon at the Special Meeting of Stockholders of the Company to be held at the Express-1, Inc.
Training Center located at 441 Post Road, Buchanan, Michigan 49107, on September 1, 2011 at 9:00
a.m., Eastern Daylight Time, and at any adjournments or postponements thereof, with all powers
(other than the power to revoke the proxy or vote the proxy in a manner not authorized by the
executed form of proxy on the reverse side hereof) that the undersigned would have if personally
present at the Meeting, to act in the undersigneds discretion upon any other matter or matters
that may properly be brought before the Meeting and to appear and vote all the shares of Common
Stock of the Company that the undersigned may be entitled to vote. The undersigned hereby
acknowledges receipt of the accompanying Proxy Statement and hereby revokes any proxy or proxies
heretofore given by the undersigned relating to the Meeting. IMPORTANT NOTICE TO PARTICIPANTS IN
THE EMPLOYEE STOCK OWNERSHIP PLAN The undersigned, a participant in the Express-1 Expedited
Solutions, Inc. Employee Stock Ownership Plan, hereby directs Horizon Trust & Investment Management
as Trustee to vote in person or by proxy all Common Shares of Express-1 Expedited Solutions, Inc.
credited to the undersigneds account(s) under the Plan on the record date at the Special Meeting
of Stockholders of the Company to be held on Thursday, September 1, 2011 and at any adjournment
thereof, as indicated on the reverse. This proxy may be revoked at any time prior to the voting
thereof. UNLESS OTHERWISE MARKED, THIS PROXY WILL BE VOTED AS IF MARKED FOR THE PROPOSALS LISTED ON
THE REVERSE SIDE. PLEASE PROMPTLY COMPLETE, DATE, SIGN AND MAIL THIS PROXY IN THE ENCLOSED
POSTAGE-PAID ENVELOPE. (TO BE SIGNED ON THE REVERSE SIDE) C Non-Voting Items Change of Address
Please print new address below. IF VOTING BY MAIL, YOU MUST COMPLETE SECTIONS A C ON BOTH SIDES
OF THIS CARD. + |